id,summary
0,"GPT4 Correct Assistant: The study aims to investigate the role of personality traits, defense mechanisms, central sensitization, and childhood traumatic experiences in patients with chronic migraine, fibromyalgia, and vulvodynia. The study will include a total of 120 participants, with 40 participants in each group (chronic migraine, fibromyalgia, and vulvodynia). The primary outcome measures include central sensitivity index, traumatic experiences index, personality traits, defense mechanisms, mental pain, environmental sensitivity, depression, anxiety, and psychosomatic symptoms. Secondary outcome measures include quality of life, alexithymia, social support, sexual satisfaction, and genital pain. The study will use self-report questionnaires to assess the variables of interest. The results of the study may provide insights into the specific psychological factors that contribute to the onset and maintenance of these chronic pain conditions, and may help in the development of tailored interventions for each condition."
1,"GPT4 Correct Assistant: This clinical trial compares the pressure ulcer prevention effects of two mattresses with different support surfaces used in bedridden patients. The study includes participants with a low risk rating on the Braden Scale, aged 18 or older, and with a BMI not exceeding 30.00. The experimental group uses a massage mattress with a cube/block system, while the control group uses a standard viscoelastic pressure sore prevention mattress. The primary outcome measure is the number of patients without pressure ulcers after four weeks of monitoring."
2,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of exercise with augmented reality glasses on metabolic parameters, anthropometric measurement values, and quality of life in children aged 10-12 with Type 1 Diabetes Mellitus (T1DM). The study includes two groups: the experimental group, which uses augmented reality glasses for exercise, and the control group, which receives no intervention. The primary outcomes measured are changes in HbA1c levels, body mass index, and quality of life. The study hypothesizes that using augmented reality glasses for exercise will improve metabolic control, increase quality of life, and positively impact anthropometric values in children with T1DM."
3,"GPT4 Correct Assistant: The study aims to evaluate the effect of virtual reality on anxiety management before abdominal surgery. The study will be conducted on patients who will undergo abdominal surgery at the Trakya University Health Research Center General Surgery Clinic between 1st March 2023 and 1st December 2023. The participants will be divided into three groups: experimental (virtual reality glasses), placebo (non-virtual reality glasses), and control (no intervention). The primary outcome measures are preoperative anxiety levels measured by stress levels on a smart wristband and the Visual Anxiety Scale (VAS-A) before and after watching videos. The study will use a randomized parallel assignment design, with pre-test and post-test measurements, and a data collection interval of 30 minutes."
4,"GPT4 Correct Assistant: The clinical trial aims to evaluate the performance and safety of Suture-TOOL for abdominal wound closure in adult patients undergoing elective open abdominal surgery. The study is a single-arm, prospective, interventional study with no masking. The primary outcome measure is the proportion of patients with Suture length/Wound length (SL/WL) ratio ≥ 4. Secondary outcome measures include stitch count, number of sutures used, incision closure time, surgeons' comfort with the device, and surgeons' satisfaction with the final closure result."
5,"GPT4 Correct Assistant: The Immune Biomarker Study for Salivary Gland Carcinoma is a study that aims to observe changes in an established immune matrix (intratumoral and systemic) in patients with primary salivary gland carcinoma and control groups with benign salivary gland tumors and healthy individuals. The study will analyze different immune cells and tumor cell markers, immunophenotyping, cytokines, metabolic state, and microbiomic state of the patients. The study will include participants aged 18 years and older with no distant metastasis at the time of diagnosis. The primary outcome measures are the changes in the immune matrix, immunophenotyping, cytokine expression, metabolites, and microbiomic state from baseline to the end of the study period, up to 5 years."
6,"GPT4 Correct Assistant: The study aims to determine compliance with the Mediterranean diet, the use of various nutritional supplements, physical activity habits, walking-related problems, and quality of life in patients with multiple sclerosis (MS). The primary outcome measures include Mediterranean diet compliance status, quality of life of MS patients, impacts on walking, and expanded disability status scale. The study will enroll participants between the ages of 18-65 who have been diagnosed with MS and have not met the exclusion criteria. The study will use the 14-item Mediterranean Diet Adaptation Scale (PREDIMED) to determine the adaptation status of individuals to the Mediterranean diet, the Multiple Sclerosis International Quality of Life Scale to evaluate the quality of life, the 12-item Ms Gait Scale to determine the gait impact, and the Expanded Disability Status Scale (EDSS) to measure the disability status of the patients."
7,"GPT4 Correct Assistant: The SIIT-CD Study is a multicenter, prospective, randomized, controlled trial evaluating the efficacy and safety of selective intensive induction therapy based on ustekinumab clinical decision-making tools in patients with Crohn's disease. The study includes patients aged 18-75 with active disease, excluding those with extensive colectomy or significant organ diseases. The intervention is a biological treatment, while the control group receives non-intensive induction therapy. The primary outcome measure is the difference in clinical response rate at week 24 between the two groups."
8,"GPT4 Correct Assistant: The Preference of a Culturally and Linguistic Diverse (CALD) Population for Second Line OAB Therapy: a Discrete Choice Experiment is a study focused on understanding the preferences of a diverse population for second-line therapy in patients with overactive bladder (OAB). The study involves adult patients with OAB who have not previously undergone sacral neuromodulation (SNM) or botulinum toxin A (Botox) treatment. Participants will fill in a questionnaire, and the primary outcome measure is a discrete choice questionnaire, where patients choose between two fictive therapies with varying botox and SNM characteristics. The study aims to understand the preferences of a diverse population for OAB therapy options."
9,"GPT4 Correct Assistant: This study aims to evaluate the effectiveness, feasibility, acceptability, and cost of continuous glucose monitoring (CGM) devices among people living with type 1 diabetes in South Africa. The study is a three-arm pragmatic randomized controlled trial with a total of 6 study visits for all participants. The primary outcome measure is the impact of continuous and intermittent CGM use on blood glucose levels in comparison to standard care. Secondary outcome measures include variability of blood glucose concentrations, unplanned visits to outpatient clinics or hospital, and quality of life. The study also aims to assess the acceptability and feasibility of CGM use from the perspectives of participants, caregivers, and healthcare providers."
10,"GPT4 Correct Assistant: This clinical trial is designed to study the effectiveness of Stereotactic Body Radiation Therapy (SBRT) with focal dose escalation on Dominant Lesion in Localized Prostate Cancer. The trial includes male participants aged 18 years or older with primary localized prostate cancer. The intervention involves SBRT with a focal boost, aiming to deliver a dose of 36.25 Gy in 5 fractions of 7.25 Gy to the entire prostate and a simultaneous integrated focal boost (SIB) up to 50 Gy in 5 sessions to the dominant lesion. The primary outcome measures are biochemical progression-free survival and local control, while secondary outcome measures include the incidence and severity of acute and late urinary and rectal treatment-related adverse events, and patient-reported outcomes and quality of life assessment."
11,"GPT4 Correct Assistant: This clinical trial, titled ""Serious gaMe Come Interventi Emergenti di E-health Per i Giovani Con distuRbi neuroLogici o rEspiratori (SMILER) - Progetto@Cnr,"" aims to study the effectiveness of a serious game (SG) intervention for young people with asthma. Participants aged 12-17 years with controlled asthma are eligible for the study. The trial consists of two groups: one group will receive the SG intervention, while the other group will follow the standard treatment plan without the SG. The primary outcome measure is the Pediatric Quality of Life Inventory (PedsQL), and the secondary outcome measure is the Skills and Difficulties Questionnaire (SDQ-Ita). The study will measure these outcomes over a 6-month period."
12,"GPT4 Correct Assistant: The study aims to investigate the effects of acute and chronic stress on Pavlovian-to-Instrumental Transfer (PIT) in individuals with alcohol use disorder (AUD) and non-AUD individuals. The study also explores the role of cognitive control in PIT and the neural correlates of PIT effects. The study compares PIT effects among individuals with different drugs of abuse, including alcohol and nicotine. The study uses a combination of behavioral and neuroimaging methods, including functional magnetic resonance imaging (fMRI), structural MRI, Trier Social Stress Test, and various questionnaires and tasks to assess cognitive control and stress levels. The primary outcome measures include neural PIT effects and behavioral PIT effects, while secondary outcome measures include cognitive control measures, such as Stroop effect, Simon effect, and interference effect, and saliva cortisol concentration as a measure of acute stress. The study will follow up with participants for 12 months to assess alcohol consumption after testing for behavioral and neural PIT effects."
13,"GPT4 Correct Assistant: The Flow and Grow trial is a multicenter, non-blinded, randomized control trial examining the ideal time to wean Continuous Positive Airway Pressure (CPAP) in extremely low birth weight infants. The study aims to recruit 130 infants, with a primary endpoint of a binomial outcome (failed CPAP wean, yes/no). The intervention group will follow a standardized maintenance/weaning protocol, while the control group will undergo weaning based on unit-specific practices. The primary outcome measure is the number of participants with CPAP/NIS weaning failure within 72 hours after weaning."
14,"GPT4 Correct Assistant: This study aims to evaluate the efficacy and safety of Frexalimab (SAR441344) in adults with nonrelapsing secondary progressive multiple sclerosis (SPMS). It is a randomized, double-blind, phase 3 study comparing Frexalimab to a placebo. The primary outcome measure is the time to onset of composite confirmed disability progression (cCDP) confirmed over 6 months. The study will also assess various secondary outcome measures, including time to onset of individual components of the composite, confirmed over 3 months or 6 months, time to onset of confirmed disability improvement (CDI), number of new and/or enlarging T2-hyperintense lesions per scan as detected by MRI, percent change in brain volume loss as detected by MRI scans, change in cognitive function, change in multiple sclerosis impact scale 29 version 2 (MSIS-29v2) questionnaire scores, change in patient reported outcome measurement information system (PROMIS) Fatigue multiple sclerosis (MS)-8a over time, annualized relapse rate, number of participants with adverse events, SAEs, AEs leading to permanent study intervention discontinuation and AE of special interests (AESIs), number of participants with potentially clinically significant abnormalities (PCSAs) in laboratory tests, ECG, and vital signs, number of participants with antibody over time, change from baseline in serum Ig levels, change from baseline in plasma neurofilament light chain (NfL) levels, and Frexalimab plasma concentration over time."
15,"GPT4 Correct Assistant: This clinical trial compares the effectiveness of the Modified Millard and Mishra techniques in unilateral cleft lip repair. The study includes infants aged 2-6 months with unilateral isolated cleft lip and excludes those with bilateral cleft lip, recurrent repair cleft lip cases, and facial cleft cases. The primary outcome measures are vertical lip height, horizontal lip length, and philtral length at 3 months post-operative."
16,"GPT4 Correct Assistant: The study is a randomized controlled trial investigating the use of endoscopic management of controlled colo-cutaneous fistula as a complication of acute sigmoid diverticulitis. The trial aims to evaluate the advantages and safety of endoscopic management compared to surgical repair. Patients are randomized into two groups, with one group receiving endoscopic management using an over-the-scope clip system and the other group receiving surgical repair. The primary outcome measure is the incidence of recurrence of fistula within one week after the endoscopy, while the secondary outcome measure is the incidence of side effects of endoscopy within one month after the surgery."
17,"GPT4 Correct Assistant: This is a randomized, un-blinded study comparing usual care to an intervention group receiving early heart failure testing in high risk patients. The intervention group will have NT-proBNP drawn and those with an elevated NT-proBNP (>125pg/mL) will have a study visit with assessments including physical examination, electrocardiogram, and AI echocardiogram. The study aims to improve screening of heart failure and identify patients at risk for heart failure earlier to determine if early-screening and treatment can help prevent further decline in these patients. The study will measure the number of participants diagnosed with heart failure, the number of outpatient HF visits, the number of urgent HF visits, and the number of HF hospitalizations."
18,"GPT4 Correct Assistant: This clinical trial aims to evaluate the effects of Propofol dose according to lean body weight in patients with a body mass index (BMI) below 35 undergoing general anesthesia for 2-6 hours. The study will include patients aged 18-65 who are not contraindicated to propofol. Patients will receive routine anesthesia, and the total dose of Propofol given will be calculated according to total body weight (TBW), ideal body weight (IBW), and lean body weight (LBW). The relationship between the doses given and the body mass index will be evaluated."
19,"GPT4 Correct Assistant: This study is a prospective cohort design evaluating the efficacy and tolerability of oral letermovir for CMV prophylaxis in heart and lung transplant recipients. The primary outcome measures are CMV viral load and the proportion of days during which appropriately renally-dosed prophylaxis is administered. Secondary outcome measures include frequency of acute cellular rejection, proportion of subjects who develop CMV resistance, proportion of subjects who develop neutropenia, proportion of subjects who develop severe thrombocytopenia, and proportion of subjects with unplanned discontinuation of MMF or azathioprine."
20,"GPT4 Correct Assistant: The study aimed to develop and validate the PHYSIOSCORE, a tool for assessing the complexity level and physical therapy care in hospitalized patients. The PHYSIOSCORE consists of 106 items divided into three domains: respiratory, imaging, and neuromuscular. The study involved three phases: questionnaire validation construct, concordance and interrater reliability, and clinical validation of the instrument. The clinical validation was conducted on 110 consecutive clinical and surgical patients with heart and lung diseases. The study assessed respiratory and neuromuscular variables and aimed to measure the time spent on evaluating and registering electronic medical records."
21,"GPT4 Correct Assistant: The SAVAL trial is a single-arm, phase II trial evaluating selective adjuvant therapy for HPV-mediated oropharynx squamous cell carcinomas (OPSCCs) based on residual circulating tumor DNA (ctDNA) levels. The study aims to determine if patients with intermediate-risk OPSCCs can be observed post-TORS when ctDNA is cleared, rather than receiving adjuvant radiation therapy. The trial includes three risk groups: low-risk (observed), intermediate-risk (observed), and high-risk (adjuvant treatment). The primary outcome measure is progression-free survival at 2 years post-treatment. Secondary outcome measures include rate of recurrence, rate of salvage, locoregional recurrence, overall survival, freedom from distant metastases, patient-reported dysphagia scores, PEG-tube rate, and recurrence rate stratified by group and post-TORS ctDNA levels."
22,"GPT4 Correct Assistant: This is a single-institution, prospective, open-label, phase 2 trial comparing ultra-hypofractionated whole breast irradiation (WBI) to ultra-hypofractionated partial breast irradiation (PBI) in patients with breast cancer. The study aims to assess the acute and late toxicity of radiotherapy in both regimens, as well as evaluate local-regional control, disease-free survival, overall survival, distant metastasis occurrence, cosmetic outcome, and quality of life. Participants must be female, aged 50 or older, and have undergone breast-conserving surgery. The primary outcome measures are acute and late toxicity, assessed using the Common Terminology Criteria for Adverse Events (CTCAE) scale. Secondary outcome measures include local-regional control, disease-free survival, overall survival, distant metastasis occurrence, cosmetic outcome, and quality of life assessment."
23,"GPT4 Correct Assistant: This study aims to explore the use of symptom monitoring and digital life coaching (DLC) to better understand the impact of multiple myeloma on symptom burden, health self-efficacy, and financial, physiologic, and psychosocial well-being among patients with relapsed or refractory multiple myeloma. The study will enroll 100 participants, all of whom will be enrolled in a 3-month digital health coaching program and receive a Fitbit device for activity tracking. The primary outcome measure is the feasibility of the digital health coaching intervention, and secondary outcome measures include changes in the Cancer Behavior Inventory-Brief Form (CBI-B) and patient-reported outcomes (PROs). The study aims to provide a more comprehensive view of the ways in which multiple myeloma and its treatments affect individuals' lives and inform future research and interventions."
24,"GPT4 Correct Assistant: This study aims to explore the effect of a 4-week WholeFiberTM intervention on fecal calprotectin, IBD-complaints and QoL, serum inflammatory markers, gut microbiota and SCFA levels in patients with Crohn's Disease (CD) and Ulcerative Colitis (UC). The intervention consists of a daily dietary supplement of dried vegetable rich in 4 types of prebiotic fiber for the first 2 weeks and then doubled for the last 2 weeks. The primary outcome measure is the change in fecal calprotectin levels after the 4-week intervention. Secondary outcome measures include improvements in IBD-complaints, QoL, serum markers, and changes in the gut microbiota and increase in fecal SCFA-production. The study will also assess whether the response on the intervention will be different between UC and CD patients."
25,"GPT4 Correct Assistant: This is a multicenter randomized clinical trial investigating the use of porcine acellular dermal matrix (PADM) for the treatment of localized gingival recessions. The study includes participants aged 18 to 60 years, both sexes, and healthy volunteers. The primary outcome measure is the reduction of gingival recession height, and the secondary outcome measure is the evaluation of keratinized tissue thickness after periodontal plastic surgery. The study compares two interventions: Coronally advanced flap (CAF) alone and CAF associated with porcine acellular dermal matrix (CAF+PADM). The trial is designed to be randomized and quadruple-masked."
26,"GPT4 Correct Assistant: This clinical trial aims to compare the effects of physical exercise performed through virtual reality games to conventional exercise on chronic renal patients during hemodialysis sessions. The study will assess the differences in heart rate variability modulation between patients who undergo conventional exercise and those who engage in virtual environment exercises. The trial will use a Longitudinal Crossover design, with participants switching between the two types of exercise after a one-week washout period. The primary outcome measure is heart rate variability behavior during the interventions, while secondary outcome measures include blood pressure, heart rate, respiratory rate, and oxygen saturation."
27,"GPT4 Correct Assistant: The trial aims to analyze the relationship between ventilatory variability and dyspnea in patients under invasive mechanical ventilation during a weaning trial. The study will measure clinically significant dyspnea using the Dyspnea Visual Analog Scale (D-VAS) and Mechanical Ventilation Respiratory Distress Observation Scale (MV-RDOS). Secondary outcomes include the intensity of dyspnea, success or failure of the weaning trial, and EMG signal amplitude and area under the curve. The study will include 100 patients, with 50 being communicative and 50 non-communicative."
28,"GPT4 Correct Assistant: This study is a randomized controlled trial comparing the outcomes of a modified mini-incision approach versus the conventional approach for carpal tunnel release in patients with primary carpal tunnel syndrome. Patients aged 18-65 years with EMG-and NCS-proven median neuropathy at the wrist, who have failed conservative treatment and have no other hand pathology, are included. The primary outcome measure is the improvement in carpal tunnel syndrome-associated pain at 6 months postoperative, measured using the visual analogue scale for pain. Secondary outcome measures include pillar pain, recurrence of neuropathic symptoms, operative time, and scar effect."
29,"GPT4 Correct Assistant: The study aims to investigate the effectiveness of Action Observation Therapy (AOT) in improving cognitive status, upper limb function, Activities of Daily Living (ADL), gait, and balance in patients with Mild Cognitive Impairment (MCI). The study will compare the effectiveness of AOT when observed from a therapist, patients without cognitive impairment, and a control group receiving standard treatment. The intervention will last for 5 weeks, with data collected before and after the intervention. Primary outcome measures include changes in cognitive impairment, ADL, functionality, upper limb dexterity, balance, and gait."
30,"GPT4 Correct Assistant: The study, titled ""Study of the Effectiveness of Central Line Placement Using an Ultraportable Ultrasound Device,"" aims to compare the effectiveness of central venous line placement using an ultraportable ultrasound device versus conventional ultrasound technique. The study includes participants aged 18 years or older with no contraindications for the procedure. The primary outcome measure is the length of the procedure. The study has a parallel assignment design with a randomized controlled trial."
31,"GPT4 Correct Assistant: This study investigates the therapeutic efficacy of Erbium:YAG laser in postpartum patients with episiotomy scars, focusing on genital pelvic pain and scar tissue healing. The study is a randomized, sham-controlled prospective trial, with participants receiving either Er:YAG laser treatment or a sham treatment. The primary outcomes measured are the rate of change of pain and the rate of scar tissue healing, while secondary outcomes include the rate of improvement in sexual function and the incidence and severity of device-related adverse events."
32,"GPT4 Correct Assistant: This study aims to investigate the effects of Sense for Kids therapy compared to an equal dose of motor therapy on upper limb sensorimotor outcomes in children and adolescents with unilateral cerebral palsy. The study will be conducted as a randomized, controlled, and evaluator-blinded randomized controlled trial with 50 participants aged between 7 and 15 years old. Participants will receive three session of 45 minutes upper limb therapy per week for a period of 8 weeks, with the intervention group receiving Sense for Kids therapy and the control group receiving motor therapy. Outcome assessments will be conducted at three different points in time: baseline, post-intervention, and 6 months after the therapy. The primary outcome measure is the Assisting Hand Assessment, which evaluates the spontaneous use of the more impaired upper limb during bimanual activities."
33,"GPT4 Correct Assistant: This study aims to investigate the profile of the gut microbiome in adult patients diagnosed with gallstone disease and its relationship with patient outcomes, including complications and post-operative outcomes. The study will enroll 75 patients from East Kent University Hospitals NHS Foundation Trust Hospitals and collect data from electronic patient records, stool samples, and 3-day food diary cards. The primary outcome measure is the bacterial DNA profile in stool samples, which will be analyzed to identify differences between patients who experience complications and those who do not. The study aims to provide insights into the mechanisms behind the development of complications and potential interventions to reduce their occurrence."
34,"GPT4 Correct Assistant: The study aimed to investigate the association between elevated initial APRI value and the development of sepsis-associated liver dysfunction (SALD) in adult patients with sepsis. Patients were included if they were 18 years or older and had data available for their first hospitalization and first ICU admission. Exclusion criteria included various chronic liver diseases, viral hepatitis, and other conditions. The study used association analysis to assess the correlation between APRI and the occurrence of SALD, and validated the results using their own data. The study's primary outcome measure was the occurrence of SALD, and the secondary outcome measure was mortality at 30 days after ICU admission."
35,"GPT4 Correct Assistant: The study is a randomized, double-blind, active-controlled clinical trial evaluating the immunogenicity and safety of an Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine in participants aged 18 years and older. The trial compares the vaccine to a recombinant novel coronavirus protein vaccine and has four arms: two for 0-1-month immunization programs and two for 0-6-month immunization programs. The primary outcome measures are adverse events, laboratory markers of immunity, and immunogenic endpoints. The secondary outcome measures include additional laboratory markers of immunity and immunogenic endpoints."
36,"GPT4 Correct Assistant: This study aims to analyze the impact of early skin-to-skin contact on maternal-infant bonding and perception of traumatic birth in puerperant women who gave normal birth. The study was conducted at Batman Training and Research Hospital TDL service between December 2021 and May 2022. The sample consisted of 350 women, with 175 in the experimental group (early skin-to-skin contact) and 175 in the control group (standard midwifery practices). The primary outcome measures were the Maternal Attachment Scale Score and Traumatic Birth Perception Scale Score."
37,"GPT4 Correct Assistant: This is a prospective, randomized, controlled, double-blind, single-center study investigating the effect of a sacral erector spinae plane block (ESPB) on post-operative pain in patients undergoing elective lumbar discectomy. The study included 54 patients, divided into two groups: ESPB group (n=27) and control group (n=27). All patients underwent standard general anesthesia, and the ESPB group received the block at the end of the surgery. Pain scores and opioid consumption were assessed for 24 hours. The primary outcome measure was patient pain scores, while secondary outcome measures included patient total opioid consumption, incidence of side effects, and patient satisfaction."
38,"GPT4 Correct Assistant: This clinical trial aims to develop and validate a noninvasive multimodal ultrasound-based imaging biomarker for myofascial pain, a common contributor to chronic low back pain. The study will investigate the echogenicity of trigger points, dynamic spatial-temporal tissue deformation, and viscoelastic properties of the fascia and muscles using ultrasound. The biomarker will be integrated using deep learning methods and tested for its ability to predict myofascial pain and response to treatment. The trial will enroll healthy normal participants and participants with chronic low back pain with and without myofascial pain. The primary outcome measure is the diagnosis of one of four myofascial pain-related categories, while the secondary outcome measure is the presence of substantial myofascial pain."
39,"GPT4 Correct Assistant: The Pain Intervention Via Video Optimization Trial is a two-arm, blinded, randomized controlled trial aiming to estimate the effect of an adapted telehealth video intervention on pain recovery and opioid use at 3 months among opioid-naïve adult Emergency Department (ED) and urgent care patients with musculoskeletal pain. The study will encompass 200 ED/urgent care patients with acute musculoskeletal pain, randomly assigned to either the intervention (a 15-minute interactive video providing pain treatment information) or usual care (standard care provided by ED/urgent care provider and staff). The primary outcome measure is the combined pain severity and interference scores using the Brief Pain Inventory-short form (BPI-SF). Secondary outcome measures include pain severity and interference on the BPI-SF, opioid use during the past week, PROMIS measures of physical function and global health, and healthcare utilization."
40,"GPT4 Correct Assistant: This clinical trial aims to investigate the impact of Neuro-linguistic Programs (NLP) on the academic performance of primary school students in Lebanon. The study includes children aged between 5 and 11 years, with a total of 130 children and 12 teachers participating. The intervention involves four 45-minute sessions for teachers and two sessions for children, focusing on techniques such as Anchoring, Reframing, and Meta-modeling. The primary outcome measures include the identification of school triggers, schoolchildren's strengths and difficulties progression, and concentration, hyperactivity, and reasoning through the Vanderbilt Assessment Scale. The study is designed as a single-group assignment with triple masking and a primary purpose of supportive care."
41,"GPT4 Correct Assistant: This is a randomized controlled trial aimed at evaluating the effect of the ECOX teaching tool on medical students' performance in the emergency department. The study compares two groups: a control group using standard learning methods and an ECOX interventional group using the ECOX tool. The primary outcome measure is the students' average score on the end-of-course OSCEs, and secondary outcome measures include average STAI-Y scores and average behavioral assessment scores during the service ECOS."
42,"GPT4 Correct Assistant: This clinical trial aims to evaluate the effects of a web-based health care program on symptom management, social support, activity tolerance, and quality of life in patients with pulmonary hypertension. The study is designed as a parallel assignment, randomized, and single-masked trial. Participants are randomly assigned to either the experimental group, receiving the web-based health care program, or the control group, receiving usual care. The primary outcome measure is the change in pulmonary arterial hypertension symptom interference scale scores at six months. Secondary outcome measures include changes in social support, activity ability, and pulmonary hypertension quality of life at six months."
43,"GPT4 Correct Assistant: This study investigates the effects of long-term ventilation support on the quality of life of ALS patients and their families. The trial includes patients with probable ALS, their partners, and children from 8 years old. The intervention includes long-term mechanical ventilation support and no long-term mechanical ventilation support as comparators. The primary outcome measures the overall quality of life assessed by the Quality of Life Scale at various time points. Secondary outcomes include health-related quality of life assessed by the Severe Respiratory Insufficiency Questionnaire, Kidsscreen-27 for children, Zarit Burden Interview for caregiver burden, and EQ-5D-5L for health-related quality of life. The study aims to determine the impact of long-term ventilation support on the quality of life of ALS patients and their families."
44,"GPT4 Correct Assistant: The study, ""Neurologic Deficits and Recovery in Chronic Subdural Hematoma,"" aims to investigate the presence or absence of spreading depolarization in patients with chronic subdural hematoma undergoing standard of care surgical evacuation. The intervention is subdural ECoG monitoring, and the primary outcome measure is post-operative neurologic deterioration. Secondary outcome measures include extended Glasgow outcome scale, Montreal Cognitive Assessment, NIH toolbox cognitive battery, PROMIS 29 profile, TBI QOL, and Headache Disability Index at 30 days, 90 days, and 180 days post-treatment."
45,"GPT4 Correct Assistant: This is a multicenter, randomized, controlled non-inferiority trial investigating the impact of annual versus biannual infusions of Ocrelizumab in patients with active Multiple Sclerosis (MS) after 2 years of initial treatment on freedom from radiological disease activity at two years. The study includes patients aged 18 years or older with active MS, no relapse for at least 18 months, and an Expanded Disability Status Scale (EDSS) between 0 and 6 inclusive. The primary outcome measure is the percentage of patients with no new or enlarged T2 lesion >3mm on cerebrospinal MRI at 24 months compared with inclusion MRI."
46,"GPT4 Correct Assistant: The SPARCOL Study is a randomized clinical trial examining the effectiveness of Combined Endoscopic Laparoscopic Surgery (CELS) compared to standard resection for early-stage colon cancer in elderly frail patients. The primary outcome measure is the change in patient-reported postoperative recovery using the Quality of Recovery 15 (QoR-15) scale. Secondary outcome measures include changes in exercise capacity and physical condition, quality of life, frailty, duration of surgery, blood loss, intraoperative complications, conversion rate, resection margin, histopathological risk factors, and long-term oncological outcomes. The study aims to determine if CELS is a safe and effective alternative to standard resection in this patient population."
47,"GPT4 Correct Assistant: The study, titled ""Effectiveness of Nebulised Hypertonic Saline to Decrease Respiratory Exacerbations in People With Neuromuscular Disease or Neurodisability: a Phase 2 Open Label Pilot Study,"" aims to assess the effectiveness of nebulised hypertonic saline in decreasing respiratory exacerbations in individuals with neuromuscular diseases or neurodisabilities. The study is designed as a parallel assignment, open-label pilot study with a primary outcome measure of full courses of antibiotics for respiratory infections from baseline to week 52. Secondary outcome measures include lung clearance index, forced oscillation technique, lung ultrasound, electrical impedance tomography, airway inflammation, bacterial diversity, ease of airway clearance, health-related quality of life, treatment satisfaction, family impact, and health economics."
48,"GPT4 Correct Assistant: The study aims to investigate paraphilic disorders, sexual addiction, and parasomnia in a case-control study. Participants will undergo a structured medical assessment, including psychiatric evaluation, and answer questionnaires and provide blood samples. The primary outcome measure is the Karolinska Interpersonal Violence Scale. The study will also explore the progress of the disorders and the treatment received by the participants."
49,"GPT4 Correct Assistant: This clinical trial aims to develop a new metabolic imaging approach (aMRI) for evaluating neurological disease in patients with gliomas. The study will characterize how the metabolic aMRI parameter kᵢₒ*V differs in tumor versus normal brain regions and compare it to standard metabolic imaging approach ¹⁸FDG PET. It will also assess the utility of aMRI in differentiating metabolically active tumor periphery and necrotic core regions. The study will involve adult patients with glioma who require MRI and ¹⁸FDG-PET imaging. The primary outcome measure is the mean values of kᵢₒ*V of the entire tumor region, and secondary outcome measures include mean values in the tumor periphery and core regions and kᵢₒ*V in different normal appearing brain sub-regions."
50,"GPT4 Correct Assistant: The GDMT Research, Education & Assist Trial for Heart Failure Care (GREAT-HF Care) is a cluster randomized study designed to evaluate the effectiveness of interventions aimed at improving guideline-directed medical therapy (GDMT) in patients with heart failure with reduced ejection fraction (HFrEF). The study includes four arms: usual care, multi-pronged clinical decision support (CDS) with a GDMT order set, multi-pronged CDS with referral to integrated clinical pharmacist co-management, and focused education. The primary outcome measure is the proportion of patients with a new GDMT HF medication class added or an upward dose titration of existing GDMT HF medication within 30 days of the index visit. Secondary outcome measures include the proportion of patients with a new GDMT HF medication class added or an upward dose titration of existing GDMT HF medication within 60 and 90 days of the index visit, and the addition of sodium-glucose cotransporter 2 inhibitors (SGLT2i) or angiotensin-neprilysin inhibitors (ARNI) for HFrEF within 30, 60, and 90 days of the index visit."
51,GPT4 Correct Assistant: This clinical trial aims to compare the effectiveness of two treatments for upper ureteric stones: Extracorporeal Shock Wave Lithotripsy (ESWL) alone and ESWL combined with Tamsulosin therapy. The study includes patients aged 18-70 with single upper ureteric stones ranging from 6-15 mm in size. The primary outcome measure is stone clearance at 4 weeks.
52,"GPT4 Correct Assistant: This clinical trial is titled ""Interventional Therapy of Tracheal Stenosis After Percutaneous Tracheotomia."" The study aims to assess the effectiveness of interventional therapy in treating tracheal stenosis that occurs after percutaneous tracheotomy. The primary outcome measure is the rate of successful decannulations after the intervention up to 12 months. Secondary outcome measures include technical success, reintervention(s), type of intervention, clinical success, and additional treatment. The study includes participants aged 18 years and above, of both sexes, with tracheal stenosis after percutaneous tracheotomy, and excludes those with surgical tracheotomy and involvement of the larynx."
53,"GPT4 Correct Assistant: The DRIVE-Mind II study is a non-randomized, parallel assignment study comparing injecting drug users diagnosed with psychiatric disorders (depression, psychotic disorder, suicide risk) receiving community-based psychiatric intervention to a control group free of psychiatric disorders. The study aims to assess the impact of sustained psychiatric intervention on viral exposure, severity of substance use, and quality of life in injecting drug users in Haiphong, Vietnam. The study will enroll 600 participants, with 200 in the intervention group and 400 in the control group. The primary outcome measures include viral exposure score, severity of substance use score, and quality of life score, all assessed at month 12. The secondary outcome measures include percentage of compliant participant: effectiveness of HIV treatment, percentage of participant facing difficulty to access care, percentage of psychiatric disorder associated with methamphetamine use, HIV/HCV incidence, incidence of psychiatric disorders in the control groups, and cost of a specialized community-based psychiatric intervention."
54,"GPT4 Correct Assistant: The study aims to compare the effectiveness of conventional endodontic treatment with that of endodontic treatment combined with photodynamic therapy (PDT) in patients with apical lesions. It is a randomized, clinical, superiority trial with 3 parallel arms. The patient sample will be randomized into 3 treatment groups: placebo group (conventional endodontic treatment), Group 2 (PDT with diode laser at 660 nm for 10 seconds), and Group 3 (PDT with diode laser at 660 nm for 20 seconds). The primary outcome measure is the reduction in lesion size, and secondary outcome measures include disinfection of the root canals and success rate of the treatment."
55,"GPT4 Correct Assistant: The study, titled ""Psychiatric Orders in Psychoanalytic Treatment of ASD,"" aims to investigate the efficacy of a combination of psychoanalysis, sertraline, duloxetine, and cognitive behavioral therapy in treating individuals with Autism Spectrum Disorder (ASD). The study includes participants aged 18 to 70 years and excludes those with severe ASD cases with central nervous system complications. The primary outcome measures include the Hamilton Anxiety Rating Scale, Generalized Anxiety Disorder (GAD-7), Dissociative Experiences Scale - II (DES-II), The Defeat Scale (D Scale), Yale-Brown Obsessive Compulsive Scale (Y-BOCS), Severity Measure for Agoraphobia-Adult, BPD Check List, Rosenberg Self-Esteem Scale (RSE), Young Schema Questionnaire (YSQ), Personality Belief Questionnaire (PBQ), and Behavioral Satisfaction Questionnaire. Secondary outcome measures include heart rate, systolic blood pressure, and diastolic blood pressure."
56,"GPT4 Correct Assistant: This study aims to investigate the use of Trastuzumab-deruxtecan (T-DXd) in combination with liquid biopsy for the treatment of HER2-positive metastatic breast cancer. The study will assess the ability of blood-based liquid biopsy to monitor disease progression to Trastuzumab-deruxtecan (as second line treatment) in patients with histologically confirmed diagnosis of HER2-positive metastatic disease previously treated with one treatment line for metastatic disease including pertuzumab with Trastuzumab or Trastuzumab alone (associated to taxane). The primary objective is to dynamically assess circulating alterations associated with resistance to Trastuzumab-deruxtecan, including changes of the HER2 status by a novel approach named HER2-2D that simultaneously assesses HER2 amplification and (over)expression in blood. Secondary objectives include molecular stratification of patients, lead time assessment by liquid biopsy, and association between HER2-2D and outcome in terms of progression."
57,"GPT4 Correct Assistant: This study aims to implement Cognitive Processing Therapy (CPT) in earthquake-affected populations in Türkiye to address mental health issues. CPT is a cognitive behavioral treatment for PTSD consisting of 12 one-hour sessions. The study will be a pilot randomized controlled trial, comparing CPT to Enhanced-Care as Usual (E-CAU) as a control group. The primary outcome measure is post-traumatic stress disorder, with secondary outcomes including symptoms of depression, anxiety, and well-being. The study will include 30 participants, randomly assigned to either CPT or E-CAU."
58,"GPT4 Correct Assistant: The study aims to investigate the perceived quality of family planning counseling among reproductive aged women in El-Dakhla District, New Valley, using the validated and client-centered Quality of Contraceptive Counseling (QCC) Scale. The QCC Scale measures three aspects of counseling quality: information exchange, interpersonal relationship, and disrespect and abuse. Data will be collected through semi-structured interviews and questionnaires, and the study will also explore associated factors such as client, provider, and visit factors. The results will be used to improve the quality of family planning services in the area."
59,"GPT4 Correct Assistant: The PIVCO study aims to determine the optimal ablation strategy for patients with persistent atrial fibrillation (AF) using pulsed-field ablation (PFA) and multielectrode ablation catheters. The study will compare two approaches: pulmonary vein isolation (PVI) alone and PVI supplemented by additional lesions, such as left atrial posterior wall isolation and mitral and cavotricuspid isthmus lines. The primary endpoint is the recurrence of AF lasting >30 seconds as assessed using repeated 7-day ECG Holter monitoring in patients without anti-arrhythmic drugs during the entire post-blanking follow-up (three months after the index procedure). Secondary endpoints include the first recurrence of on-AADs AF/AT lasting >6 minutes during the post-blanking follow-up period, hospitalization rate, cardioversions, PFA-related complications, and assessment of the quality of life using standardized instruments."
60,"GPT4 Correct Assistant: The Catholic Health Initiatives (CHI) St. Joseph's Children Home Visiting Study is a longitudinal study aiming to investigate the effects of home visiting on child development and school readiness, as well as the reduction of child maltreatment, delinquency, and crime. The study focuses on first-born children of parents living within a 3-county area in Florida, who are at least 1 month old and under 3 months of age at the time of enrollment. The study has two groups: the Experimental group, which receives home visiting intervention, and the Business as Usual group, which does not receive the intervention. The intervention is a three-year program for families and their first-born children, using home visiting to deliver a hybrid curriculum called Partners for a Healthy Baby. The study measures child development and school readiness using the Child Behavior Checklist (CBCL) and the Ages and Stages Questionnaire (ASQ), maternal health using the Edinburgh Postnatal Depression Scale (EPDS), and child health using the Adult Adolescent Parenting Inventory (AAPI-2) and the Modified Checklist for Autism in Toddlers (M-CHAT). The study also assesses child maltreatment using the Conflict Tactics Scale Parent-Child Form (CTS-PC), reductions in child maltreatment using the Parenting Sense of Competence (PSOC), and linkages and referrals using the New Mexico Children, Youth and Families Department (CYFD) records. The study aims to measure the impact of home visiting on child development, school readiness, and the reduction of child maltreatment, delinquency, and crime."
61,"GPT4 Correct Assistant: The trial is a Phase I clinical trial assessing the safety and immunogenicity of a new malaria vaccine candidate, RH5.1 soluble protein in Matrix-MTM, using two dosing regimens in healthy adults aged 18-50 years. The primary outcome measures include the occurrence of solicited reactogenicity, unsolicited adverse events, safety laboratory measures, and serious adverse events. Secondary outcome measures include the humoral immunogenicity of RH5.1 soluble protein with Matrix-M when administered at different doses and the comparison of anti-RH5 serum IgG functional immunogenicity between the two groups."
62,"GPT4 Correct Assistant: This is a 18-month monocentric, randomized, rater-blinded study evaluating the influence of a multidisciplinary, personalized symptomatic treatment plan with integrated mobile palliative care and telemedicine on the quality of life (QoL) of individuals with Multiple System Atrophy (MSA) compared to a historical European MSA cohort. The study will recruit 46 individuals with MSA who will undergo a baseline examination and receive a personalized therapeutic plan, including telemedicine visits and mobile palliative care for wheelchair-bound individuals. The primary outcome measure is the change in the EQ-5D-5L score from baseline to 18 months. Secondary outcome measures include changes in the MSA-QoL score, motor and non-motor scales, time to clinical milestones, healthcare preferences, and healthcare costs."
63,"GPT4 Correct Assistant: This clinical trial aims to study the genetic basis of response to growth hormone treatment in children with idiopathic short stature. The study includes two participant groups: good responders (change in height SDS more than 1.0) and poor responders (change in height SDS less than 0.4). The primary outcome measure is the frequency of genetic variants that significantly differ between the two responder groups, while the secondary outcome measure is the enrichment of genetic variants per gene/pathway. No treatment is provided to the participants as part of this study."
64,"GPT4 Correct Assistant: The clinical trial ""Impact of Neurochecks on Sleep in Critically Ill Adults"" aims to assess the effect of neurocheck frequency on sleep in adults who have undergone elective coiling of unruptured cerebral aneurysm. The study is designed as a randomized controlled trial with parallel assignment and single masking. Participants are randomly assigned to either hourly or every-other-hour neurochecks. The primary outcome measure is sleep efficiency, measured within 24 hours of enrollment. Secondary outcome measures include wakefulness, REM sleep, deep sleep, arousals, and subjective sleep quality. The study includes adults aged 25-75 years who are not pregnant, not incarcerated, and can communicate in English."
65,"GPT4 Correct Assistant: The clinical trial aims to investigate the radiologic prognostic importance of extranodal extension (iENE) in head and neck cancer. The study will examine data from patients treated between 1999 and 2020 for oral cavity, oropharyngeal, carcinoma of unknown primary, laryngeal, or hypopharyngeal squamous cell carcinoma. The primary outcomes include assessing the accuracy of identifying iENE by radiologists, evaluating the prognostic significance of iENE in terms of overall survival rates and recurrence rates, and risk stratifying head and neck squamous cell carcinoma (HNSCC) patients based on radiographic ENE, HPV status, and N stage. The study will also explore the utility of existing standardized diagnostic classification systems in accurately diagnosing iENE and measure interobserver variability among radiologists in grading radiographic ENE."
66,"GPT4 Correct Assistant: The study aims to compare the efficiency and safety of bedside bone biopsy (BB) versus conventional bone biopsy in patients with diabetic foot ulcers (DFU) and suspected diabetic foot osteomyelitis (DFO). The primary outcome measure is the remission of DFO at 12 months. Secondary outcomes include clinical efficacy, microbiological results, safety, and costs. The study hypothesizes that bedside BB is non-inferior to conventional BB for DFO outcomes and can be used as a simpler alternative procedure to document DFO."
67,"GPT4 Correct Assistant: The ""African Americans (AA) Communities Speak"" trial aims to address disparities in end-of-life (EoL) care for African Americans (AAs) by developing a community-developed training program for clinicians caring for AA older adults with serious illnesses. The program, originally focused on rural Southern AA individuals, will be adapted for urban-dwelling Southern and Northern AA adults using the Community-Based Participatory Research (CBPR) platform in Birmingham, Alabama, and the Bronx, New York. The new training program, called ""Caring for Older African Americans,"" will include community-developed storytelling videos, guidelines for culturally concordant EoL care delivery, and implicit bias management training. The study will measure patient/family's perception of therapeutic alliance using the Human Connection Scale, family-reported goal-concordant care, and clinicians' knowledge, awareness, and confidence in changing practice."
68,"GPT4 Correct Assistant: This clinical trial aims to assess genomic alterations and expression profiles in HPV+ and HPV- head and neck cancers. The study will include patients with oropharyngeal squamous cell carcinoma or oral cavity histologically proven, and a biopsy or excision is required for molecular analysis. The intervention involves genetic analysis using PCR, immunohistochemistry, and immunolabelling. The primary outcome measure is the molecular profile of oropharyngeal or oral cavity HPV positive and negative tumors, analyzed through 87 Hotspot genes, full length analysis of 48 genes, copy number analysis of 43 genes, and gene fusion (inter and intra genic) of 51 genes."
69,"GPT4 Correct Assistant: The ""Validation of Visual Analog Scales to Measure SatisfactiOn and WELL-being at Work (SoWell-VAS)"" is a clinical trial aimed at validating Visual Analog Scales for measuring satisfaction and well-being at work. The study includes participants aged 18 to 80 years, with a professional activity and no protections. The primary outcome measures include burnout, anxiety, job demand, job control, social support, job demand/job control/social support, effort-reward imbalance, work addiction, and life satisfaction. Secondary outcome measures include sociodemographic factors, occupation, work hours, night and weekend work, alcohol and tobacco consumption, height, weight, sedentary behavior, physical activity, stress at work, ethical conflicts, perceived health, stress at home, fatigue, sleep quality, and mood. The study uses various questionnaires and visual analog scales to measure these outcomes at different time points."
70,"GPT4 Correct Assistant: This clinical trial aims to evaluate the effectiveness of different techniques for ridge preservation after tooth extraction. Participants will be randomly assigned to one of five groups, with or without interventions such as bone particle grafts, subepithelial connective tissue grafts, collagen membranes, or Cytoplast. The primary outcomes measured are soft tissue and hard tissue alterations, while secondary outcomes include keratinized tissue width changes and patient-reported outcomes using a Visual Analogue Scale. The study will follow participants for up to 12 months."
71,"GPT4 Correct Assistant: This clinical trial, titled ""Study of Pro-inflammatory Cytokines in Case of Essure® Contraceptive Implants,"" aims to investigate the levels of pro-inflammatory cytokines in patients with Essure® contraceptive implants and control patients with endometriosis or adenomyosis. The study includes three participant groups: Essure patients who underwent removal of the implant, control patients with no endometriosis/adenomyosis, and control patients with endometriosis/adenomyosis. The primary outcome measure is the level of cytokine IL10 in peritoneal fluid, measured over an average of four months."
72,"GPT4 Correct Assistant: This is a two-way (retrospective+prospective) cohort study investigating the impact of ursodeoxycholic acid (UDCA) treatment on COVID-19 infection and its clinical prognosis in patients with autoimmune liver disease (PBC and AIH). The study aims to compare the difference in COVID-19 infection rate, disease severity, clinical biochemical indicators, hospital stay, and prognosis between UDCA treated and non-UDCA treated patients. The primary outcome measure is the incidence of COVID-19 infection, while secondary outcomes include disease severity after infection, COVID-19 nucleic acid disappearance time, and infection outcome."
73,"GPT4 Correct Assistant: The study aims to investigate the effect of preoperative prone position training on the incidence of postoperative pulmonary complications in patients undergoing laparoscopic colorectal cancer surgery. The study is a randomized, controlled clinical trial with two groups: the prone position training group and the control group. The primary outcome measure is the incidence of postoperative pulmonary complications (PPCs) within 7 days after surgery. Secondary outcome measures include arterial partial pressure of oxygen (PaO2), extubation time, peak airway pressure, arterial partial pressure of carbon dioxide (PaCO2), and oxygenation index (OI)."
74,"GPT4 Correct Assistant: This study aims to evaluate the safety and efficacy of BLEX 404 Oral Liquid combined with Pemetrexed + Cisplatin Therapy in patients with advanced inoperable or metastatic EGFR wild-type non-small cell lung cancer. The study is a phase I/II, open-label trial with three experimental arms in Phase I (1.5 mg/kg, 3.0 mg/kg, and 6.0 mg/kg BLEX 404) and one experimental arm in Phase II (RDL of BLEX 404). The primary outcome measures are dose-limiting toxicity (DLT) determination and recommended dose level (RDL) determination within the first cycle of combination use. Secondary outcome measures include overall response rate, rate of grade 3/4 hematological toxicity, and effect on quality of life."
75,"GPT4 Correct Assistant: The AGE SELF CARE study is a pilot study designed to test the feasibility and acceptability of an 8-week virtual group visit program for community-dwelling adults aged 65 years and older who are pre-frail. The intervention focuses on chronic disease management, healthy lifestyle education, home adaptation, and anticipatory guidance. The study aims to assess recruitment rate, completion of testing, attendance, participant satisfaction, and proportion lost to follow-up. Secondary outcome measures include frailty index, loneliness, self-reported health, physical activity, self-efficacy, depression, anxiety, sleep, and short physical performance battery."
76,"GPT4 Correct Assistant: The Pan-European Study on Geriatric Rehabilitation After COVID-19 aims to investigate the course of functional and medical recovery in geriatric rehabilitation patients affected by COVID-19 in Europe. The study also seeks to understand the treatment modalities and organization of geriatric rehabilitation that post-COVID patients receive in Europe. The study is a multi-center observational cohort study, and the primary outcome measure is the change in Activities of Daily Living (ADL) functioning from two weeks before admission to geriatric rehabilitation until approximately 6 months after discharge. The secondary outcome measure is the change in Quality of Life (EQ-5D-5L) from admission to geriatric rehabilitation until approximately 6 months after discharge."
77,"GPT4 Correct Assistant: The PREPARE-iVAC trial is a multicenter, open-label, controlled, randomized study investigating the immunogenicity of COVID-19 vaccination in kidney transplant recipients. The primary objective is to determine if replacing Mycophenolate Mofetil/Mycophenolic Acid (MMF/MPA) with everolimus improves the neutralizing antibody titer against the Omicron XBB.1.5 strain of SARS-CoV-2. Secondary objectives include measuring humoral and cellular immunogenicity, safety, and adverse events. The study compares two groups: one continuing immunosuppressive therapy with MMF/MPA and another replacing MMF/MPA with everolimus. The trial will measure virus-neutralizing capacity, SARS-CoV-2 antibody concentration, SARS-CoV-2 specific T-cell response, and Varicella Zoster specific antibodies and T-cell response. Safety outcomes include serious adverse events and changes in kidney function."
78,"GPT4 Correct Assistant: This clinical trial aims to investigate the effect of resistance exercises on liver enzymes post burn in 60 patients with partial thickness burns (30% to 50% burned body surface area). The patients will be randomly assigned to either the study group, which will receive resistance exercises for 8 weeks, or the control group, which will receive physical therapy and medical treatment without resistance exercise. The primary outcome measure is the plasma liver enzyme levels (AST and ALT) at two months post intervention."
79,"GPT4 Correct Assistant: This clinical trial aims to investigate the efficacy of upper trapezius stretching on neck pain, range of motion, and disability in patients with cervical spondylosis. The study is a randomized controlled trial, with participants aged 40-65 years, assigned to either the intervention group (upper trapezius stretching) or the control group (standard care). The primary outcomes measured are changes in neck pain intensity and range of motion, while the secondary outcome is changes in neck disability index. The study duration is 3 months, with assessments at baseline, 4 weeks, and 3 months."
80,"GPT4 Correct Assistant: This clinical trial aims to investigate the effectiveness of tecartherapy on the performance of amateur athletes. The study includes athletes aged 18-30, competing in sports such as soccer, basketball, and rugby, who perform sprinting and jumping in their sports practice. The intervention group receives a single 25-minute tecartherapy procedure, while the sham group receives a sham treatment. The primary outcomes measured are change in 30-meter sprint time and changes in electromyographic activity during sprint. Secondary outcomes include countermovement jump, changes in electromyographic activity during countermovement jump, isometric leg extension, and changes in electromyographic activity during isometric leg extension."
81,"GPT4 Correct Assistant: This clinical trial aims to study the quantification of cell-free DNA in patients with endometriosis who are undergoing medical assistance to procreation, specifically In Vitro Fertilization (IVF) treatment. The study will compare patients with endometriosis to those with other infertility causes. The primary outcome measure is the cell-free DNA rate in serum in patients before they start IVF stimulation, and the secondary outcome measures include oocyte quality, fragmentation rate, number of cells at day 2 and day 3, blastulation rate at day 5 of development, and clinical pregnancy and live birth rates in both groups."
82,"GPT4 Correct Assistant: This study is a 10-year comparative prospective study comparing the treatment outcomes of fully edentulous patients with maxillary implant overdentures, supported by four implants, retained by either bars or Locator attachments. The primary outcome measure is the change in marginal peri-implant bone level 10 years after placing the overdenture. Secondary outcome measures include implant and overdenture survival, peri-implant mucosa health, and patient satisfaction. The study aims to provide evidence on the long-term effectiveness of different attachment systems for maxillary implant overdentures."
83,"GPT4 Correct Assistant: The study aims to evaluate the efficacy of a designed exercise program on pain and quality of sleeping in patients with Sickle Cell Disease Anemia. The study is a randomized clinical trial with 50 adult patients aged 18-55 years, divided into two groups: experimental and control. The experimental group receives a designed exercise program for pain relief and improved sleep quality, while the control group does not receive the exercise program. The primary outcome measure is the Pittsburgh Sleep Quality Index (PSQI), and secondary outcome measures include the World Health Organization Quality of Life (WHOQOL-BREF), Visual Analog Scale (VAS) for pain, The Fatigue Scale, and The Perceived Stress Scale (PSS). The study will assess the impact of the exercise program on patients' sleep quality, pain levels, fatigue, and stress over a 6-week period."
84,"GPT4 Correct Assistant: This is a two-armed pragmatic trial examining the effectiveness of Cognitive Stimulation Therapy (CST) for individuals with dementia, mild cognitive impairment, or mild to moderate dementia. Participants are randomly assigned to either a group receiving a referral for CST or a group receiving standard care with no CST referral. The primary outcome measure is the change in Montreal Cognitive Assessment (MoCA) score from baseline to 6-month follow-up. Secondary outcome measures include changes in MoCA score, referral acceptance rate, participant attendance, and participant attrition."
85,"GPT4 Correct Assistant: This clinical trial investigates the correlation between anxiety and reflux symptoms in patients with gastroesophageal reflux disease (GERD). The study aims to assess anxiety and depression levels of patients with physiological and pathological DeMeester scores, and examine the modulation of anxiety on the severity of reflux symptoms such as fullness, heartburn, and dysphagia. The study utilizes diagnostic tests such as high-resolution manometry, upper-GI endoscopy, and pH-impedance testing, as well as the Hospital Anxiety and Depression Scale (HADS) questionnaire to evaluate anxiety and depression in patients with GERD."
86,"GPT4 Correct Assistant: This clinical trial, titled ""Personalizing Disordered Eating Treatment Using Mobile Technology: Self-Guided, Personalized Treatment for Women,"" aims to study the effects of a self-guided personalized treatment on women with disordered eating. The study includes participants aged 18-65 who endorse disordered eating and are able to read and write in English. The intervention involves two weeks of smartphone self-monitoring to identify target problems, followed by the sending of two self-guided modules of personalized treatment directly to their smartphones. The primary outcome measures include changes in disordered eating symptoms, anxiety, depression, clinical impairment, and quality of life."
87,"GPT4 Correct Assistant: The study aims to evaluate the effectiveness of the CAD-EYE system in screening for neoplastic lesions in patients with Lynch Syndrome. The study will compare the adenoma detection rate (ADR) between the CAD-EYE group and the indigo carmin chromoendoscopy (CE) group (reference technique) through study completion, an average of 2 years. The study will also assess diagnosis performance of CAD EYE, resect and discard strategy, and time of colonoscopies."
88,"GPT4 Correct Assistant: This study aims to investigate the use of a water soluble contrast-based protocol to assist in the management of pediatric adhesive small bowel obstruction. The trial is a prospective observational study conducted at nine children's hospitals, with a total of 314 patients enrolled. The primary outcome measure is the number of patients who required an operation, while secondary outcome measures include total hospital length of stay and adverse events resulting from contrast administration. The study explores the effectiveness of using enteral contrast challenges in the management of pediatric adhesive small bowel obstruction and compares the outcomes between patients who received contrast and those who did not."
89,"GPT4 Correct Assistant: This is a Phase 1, single-center, open-label, randomized, parallel group, single-dose study comparing the pharmacokinetics of subcutaneous itepekimab administered with an autoinjector versus a prefilled syringe in healthy participants. The study aims to evaluate the primary outcome measures: Cmax, AUClast, and AUC of itepekimab. Secondary outcome measures include tmax, AUC0-28days, t1/2, CL/F, Vss/F, incidence of treatment-emergent anti-itepekimab antibodies responses, and number of participants with Adverse Events, Serious Adverse Events, and Adverse Event of Special Interest. The study is designed to treat participants aged 18-65 years, both sexes, and includes healthy volunteers."
90,"GPT4 Correct Assistant: The study, CSD201204, is an 8-week, multi-site, open-label, randomized, three-arm observational study to assess the relative impact of availability and use of different e-liquid flavors on changes in cigarette consumption among U.S. adult smokers. The study will evaluate the P12 electronic nicotine delivery system among participants who smoke at least 5 cigarettes per day and have smoked on at least 20 days in the past 30 days. The primary outcomes measured are the number and proportion of subjects who reduce their cigarettes per day (CPD) by at least 50% at Week 6 compared to baseline, and the CPD mean percent reduction at Week 6 compared to baseline."
91,"GPT4 Correct Assistant: This study, titled ""A Multicenter Randomized, Open-label Study to Compare the Efficacy of Subcutaneous Infliximab Monotherapy With Subcutaneous Infliximab and Concomitant Immunosuppression in the Treatment of Moderate to Severe Crohn's Disease,"" aims to investigate the efficacy of subcutaneous infliximab in the treatment of moderate to severe Crohn's disease with and without concomitant immunosuppression. The study will enroll 158 patients aged 18-80 years with moderate to severe Crohn's disease and randomize them into two groups: Group 1 (Infliximab monotherapy) and Group 2 (Infliximab combination therapy). The primary objective is to determine the proportion of patients in corticosteroid-free clinical remission (CDAI<150) and endoscopic response (SES-CD drop of at least 50%) at week 26. Secondary objectives include assessing the proportion of patients with endoscopic remission, clinical remission, corticosteroid-free clinical remission, and symptomatic remission at various time points, as well as evaluating biochemical remission, quality of life, and adverse events."
92,"GPT4 Correct Assistant: This clinical trial aims to study the pharmacokinetics of rivaroxaban and apixaban in adult cancer patients with venous thromboembolism or atrial fibrillation. The study will monitor the PK profile of these drugs and identify factors influencing their PK in this patient population. The primary outcome measure is the estimated area under the curve (AUC) of each drug, and the secondary outcome measure is the safety evaluation, including any thromboembolic events or major bleeding."
93,"GPT4 Correct Assistant: This study aims to evaluate bronchodilator response in patients with bronchiectasis and determine if this response is influenced by factors other than the direct effect of bronchodilators. The primary outcome measures are the change in forced expiratory volume 1 second (FEV1) from pre to post salbutamol inhalation compared to the same change after placebo. Secondary outcomes include assessing bronchodilator response in different types of bronchiectatic disease and comparing it to healthy controls, as well as examining the influence of age, sex, specific bronchiectatic disease, baseline FEV1, and other clinical factors on bronchodilator response."
94,"GPT4 Correct Assistant: This clinical trial aims to investigate the impact of gender identity, genetic sex, and hormone status on pain sensitivity. The study includes six arms, each involving cisgender men and women, and transgender men and women with or without hormone replacement therapy. The primary outcome measures are experimental heat and pressure pain thresholds, while secondary outcomes include various factors such as sleep quality, depression, social support, perceived discrimination, hormone levels, immune cell populations, and cytokine production."
95,"GPT4 Correct Assistant: This study aims to test the feasibility and acceptability of using technology-enriched stroke rehabilitation in acute and sub-acute stroke patients. The intervention includes the use of commercially available technology, such as robotics, adapted treadmills, virtual reality, and mobile digital devices, to increase rehabilitation intensity and duration. The study will assess the duration of time spent on activities within the technology-enriched rehabilitation space, movement repetitions, and rates of recruitment and attrition. Additionally, interviews with participants, family/carers, and NHS staff will be conducted to assess the acceptability of the intervention."
96,"GPT4 Correct Assistant: This study aims to evaluate the effect of immersive virtual reality (IVR) on respiratory discomfort in patients with Amyotrophic Lateral Sclerosis (ALS) at the stage of respiratory failure treated with non-invasive ventilation (NIV). The study is a randomized, open-label, monocentric, cross-over clinical trial. Patients will undergo an IVR session based on medical hypnosis (GAMIDA®) and a music therapy session, with each session lasting 15 minutes. The primary outcome measure is the evaluation of the effect of IVR on respiratory discomfort (scale A1 of the Multidimensional Dyspnea Profile (MDP) questionnaire). Secondary outcome measures include the evaluation of the effect of IVR on the sensory and emotional components of dyspnea, the effect of music therapy on respiratory discomfort, and the comparison of the evolutionary profile of dyspnea under the effect of IVR and music therapy."
97,"GPT4 Correct Assistant: This clinical trial examines the effect of selective reporting for antibiotic susceptibility testing on GPs' prescribing of broad-spectrum antibiotics in women with E. coli UTIs. The study includes two arms: an experimental group that receives a selective antibiotic susceptibility testing report with a focus on narrower-spectrum antibiotics, and a control group that receives a standard antibiotic susceptibility testing report. The primary outcome measure is the rate of broad-spectrum antibiotic dispensing, and secondary outcomes include directed broad-spectrum antibiotic dispensing, antibiotic de-escalation rate, and the impact of targeted antibiotic susceptibility testing compared to standard testing based on various factors."
98,"GPT4 Correct Assistant: This study aims to investigate the effectiveness of sodium valproate in improving clinical outcomes for patients with acute ischemic stroke. The trial is a prospective pilot study that includes patients aged 18 to 75 with acute ischemic stroke. Participants are randomly assigned to low-dose sodium valproate, high-dose sodium valproate, or placebo groups. The primary outcome measure is the proportion of patients with a favorable outcome (Modified Rankin Scale (mRS) score ≤ 2) at 90 days. Secondary outcome measures include mRS scores at 30 days, NIH Stroke Scale scores at 3 and 7 days, changes in lesion volume from baseline to day 7, and length of hospital stay."
99,"GPT4 Correct Assistant: This clinical trial aims to determine if a MyChart-enabled virtual weight loss coach offers a better solution for weight reduction in ventral hernia patients with obesity compared to standard preoperative weight loss tools. The study includes participants aged 18 to 90 with a BMI of 30 or above, who have been evaluated for elective ventral hernia repair. The primary outcome measure is the average net amount of weight change per group after 6 months. Secondary outcome measures include the number of interactions with the virtual coach, quality of life measured by the Hernia Related Quality of Life Survey (HerQLes), and satisfaction with the virtual coach."
100,"GPT4 Correct Assistant: This study aims to evaluate the safety and effectiveness of nebulized umbilical cord mesenchymal stem cell-derived exosomes combined with conventional therapy for the treatment of moderate, severe, and critically ill COVID-19 patients through a multicenter, randomized controlled, single-blind clinical trial. The intervention group will receive nebulized umbilical cord mesenchymal stem cell-derived exosomes, while the control group will receive nebulized saline solution. The primary outcomes measured are symptom remission time after atomizing medication, improvement of serum inflammatory markers, and CT review and comparison if there is a baseline CT. Secondary outcomes include length of hospital stay and recovery time (nucleic acid turning negative)."
101,"GPT4 Correct Assistant: This clinical trial aims to compare the clinical effectiveness of Calcium Silicate-based Sealer (CSS) and Epoxy Resin-based Sealer (ERS) in single-visit root canal treatment for patients with irreversible pulpitis. The study includes participants aged 18 years or older with healthy periodontal tissue and sufficient clinical teeth crown for isolation with a rubber dam. The primary outcome measures are change in pain intensity, change in pain relief, and change in treatment outcome evaluation over time. The trial is designed as a randomized, parallel assignment, single-masked study, with participants assigned to either CSS or ERS group."
102,"GPT4 Correct Assistant: This is a multi-center, open, prospective cohort study in China to evaluate the immunogenicity difference between two different domestically produced bivalent HPV vaccines (Wozehui and Cecolin) and imported HPV vaccines in adolescent females aged 13-14 years. A total of 3,000 subjects were recruited and divided into three groups: domestic bivalent HPV vaccine (Wozehui), domestic bivalent HPV vaccine (Cecolin), and imported HPV vaccine. Blood samples were collected at baseline, 12 months, and 36 months after the last dose of vaccination to perform HPV type 16 and 18 neutralizing antibody testing."
103,"GPT4 Correct Assistant: This clinical trial aims to evaluate the feasibility of integrating homeopathy as a potential treatment option for symptom control and improvement in quality of life in cancer patients in a comprehensive cancer center. The study will involve patients aged 18 or older, treated at the Division of Oncology in Rambam Health Campus, and with a performance status of ECOG 0-2. The primary outcome measures are the feasibility of a supportive approach and quality of life-level of distress. The study will use a behavioral intervention, evaluating reasons for patients to use the approach, and will measure the outcomes using questionnaires and validated quality of life questionnaires."
104,"GPT4 Correct Assistant: The study is titled ""Description of Septic Thrombophlebitis on Central Venous Catheter and Midline."" The primary objective of the study is to evaluate the duration of ultrasound signs of septic thrombophlebitis on central venous catheter and midline. The study is designed as a non-randomized parallel assignment with an open-label intervention. The inclusion criteria include adult patients hospitalized with a central venous device or midline and having catheter-related bacteremia. The primary outcome measure is the duration of ultrasound signs of septic thrombophlebitis, measured from the day of diagnosis to the day of disappearance of signs on Doppler ultrasound."
105,"GPT4 Correct Assistant: This clinical trial aims to investigate the safety and efficacy of Odronextamab in combination with Lenalidomide compared to Rituximab in combination with Lenalidomide in participants with relapsed/refractory Follicular Lymphoma and Marginal Zone Lymphoma. The study will measure dose limiting toxicities, treatment emergent adverse events, progression-free survival, and other outcomes related to the participants' quality of life."
106,"GPT4 Correct Assistant: This clinical trial is designed to investigate the effect of Proliverenol supplementation on liver function in patients with Non-Alcoholic Fatty Liver Disease (NAFLD). The study involves four treatment groups, with each group consisting of 20 subjects. Treatment regimens last for 12 weeks. The primary outcome measures are changes in serum ALT and serum AST levels from baseline to weeks 4, 8, and 12 of study treatment. Secondary outcome measures include USG examination for Controlled Attenuated Parameter (CAP) and Transient elastography (TE) measurements, as well as the AST to ALT ratio at weeks 4, 8, and 12. The study aims to determine the effectiveness of Proliverenol in improving liver function in patients with NAFLD."
107,"GPT4 Correct Assistant: The study aims to investigate the impact of ozone application in periodontitis patients. Participants aged between 18 and 65 with no contraindications for periodontal treatment and ozone application are included. The study uses a randomized, parallel assignment, double-masked design. Participants are divided into two groups: experimental (ozone therapy) and active comparator (non-surgical periodontal treatment). The primary outcome measures are probing pocket depth at baseline and at the third month after treatment. Secondary outcome measures include plaque index, gingival index, bleeding on probing, proportions of bacterial species, and inflammatory parameter levels in gingival crevicular fluid."
108,"GPT4 Correct Assistant: The clinical trial aims to study the expression of CD44, PCNA, and E-cadherin in pterygium tissue. Sixty patients with pterygium will be enrolled, with 30 patients in the control group and 30 patients in each of the pterygia groups (primary and recurrent). The expression of the mentioned proteins will be compared between the control group and the pterygia groups. The study will use immunohistochemistry and histopathological evaluation for analysis."
109,"GPT4 Correct Assistant: The TINO trial aims to investigate the underlying mechanisms and consequences of the loss of nasal T cells in vital and frail older individuals. The study focuses on young adults, healthy older adults, and frail older adults with or without recurring respiratory infections. The primary outcome measure is the frequency of nasal CD8+ T cells in young adults and frail older adults. Secondary outcome measures include phenotype, functionality, transcriptomic cluster composition, clonality, and stability of nasal and blood T cell populations. Additionally, the study explores the concentration of nasal and systemic cytokines, metabolites, respiratory tract microbiota profiles, and the presence of asymptomatic viral infections."
110,"GPT4 Correct Assistant: The clinical trial aims to investigate the Platelets to Lymphocytes Ratio and Monocytes to Lymphocytes Ratio as Predictors of Response to Treatment in Cirrhotic Patients With Spontaneous Bacterial Peritonitis. The study includes participants aged between 15 and 100 years, both sexes, and excludes patients with certain conditions. The primary outcome measures are the Platelets to Lymphocytes Ratio and Monocytes to Lymphocytes Ratio as predictors of response to treatment. The study design involves a diagnostic test: ascetic fluid study, and the study duration is from 19/4/2023 to 30/4/2024."
111,"GPT4 Correct Assistant: This is a prospective observational study investigating the added diagnostic value of point-of-care ultrasound (POCUS) in adult patients with acute dyspnea. The study will be conducted at the Emergency Department in Lund and Helsingborg, Sweden. Participants will be assessed using routine diagnostic procedures, and then a physician certified in the dyspnea POCUS protocol will perform the ultrasound. The estimated likelihoods of certain diagnoses before and after POCUS will be compared to the discharge diagnosis. Sensitivity, specificity, negative and positive predictive values of the diagnostic accuracy before and after adding POCUS will be calculated."
112,"GPT4 Correct Assistant: This clinical trial aims to investigate the effectiveness of Respiratory Training and Relaxation Techniques in improving Adjuvant Radiation Therapy in Deep Inspiration Breath Hold (DIBH) in breast cancer patients. The study includes two arms: the experimental arm (R&R) which includes relaxation techniques, breath hold training, music, and nature sounds, and the standard arm which receives conventional DIBH instruction. The primary outcome measure is the change of Dmax to the heart in DIBH under adjuvant radiotherapy of left-sided breast cancer. Secondary outcome measures include improvements in quality of life, heart Dmean, Left anterior descending (LAD) Dmean, LAD Dmax, left ventricle (LV) Dmean, clinic workflow metrics, patient satisfaction, and radiation dose in organs at risk."
113,"GPT4 Correct Assistant: This is a Phase IB study investigating the safety and tolerability of a combination of Canakinumab, Tislelizumab, Nab-Paclitaxel, and Gemcitabine in the neo-adjuvant treatment of patients with pancreatic cancer. The study aims to determine the number of dose-limiting toxicities and the number of patients who proceed to surgical resection. Secondary outcomes include overall response rate, R0 resection rate, progression-free survival, and overall survival."
114,"GPT4 Correct Assistant: This clinical trial aims to study the implementation of mental health navigation models and the Connected for Wellness app for improving connections and access to prevention resources, mental health services, and social supports for youth aged 13-22 years old. The study uses a stepped wedge design and will be conducted in 10 Los Angeles County Schools and 10 Riverside County/University of California Riverside primary care clinics. The primary outcome measure is the proportion of youth referred to mental health services who initiate care."
115,"GPT4 Correct Assistant: This clinical trial is a double-blinded, randomized, comparative-placebo study aiming to compare the effectiveness of intramyometrial tranexamic acid and oxytocin injections in reducing postpartum bleeding after cesarean delivery in primigravida women at term. The study will be conducted at Kasr Al-Ainy Hospital, Maternity Hospital, Cairo University, Cairo, Egypt, from October 2021 to October 2022. Fifty primigravida women at term pregnancy, undergoing elective cesarean delivery, will be randomly allocated into two groups: tranexamic acid group and oxytocin group. The primary outcome is to decrease intra- and postoperative blood loss to reduce the risk of postpartum hemorrhage after cesarean section."
116,"GPT4 Correct Assistant: The Innovation for Small-scale Experiments: ReceptIVFity Test is a clinical trial designed to study the effectiveness of a ReceptIVFity test (vaginal microbiome swab) in improving pregnancy rates in women undergoing IVF or IVF/ICSI procedures. The trial includes women aged 18-42 years who are naïve to IVF or IVF/ICSI and are willing to provide informed consent. The study has two experimental arms: a Shared-Decision-Making group and a Physician decision group. The primary outcome measures are the rate of successful pregnancy, the number of successful IVF or IVF/ICSI cycles, and the total number of IVF or IVF/ICSI treatment cycles per patient within a 3-year period. Secondary outcome measures include patient satisfaction scores and total treatment costs."
117,"GPT4 Correct Assistant: This clinical trial aims to investigate the lipid-lowering effect of fenugreek seed consumed as a tea in patients with hyperlipidaemia, but without diabetes, over an 8-week intervention period. The primary outcome measure is the change in serum triglycerides, while secondary outcome measures include changes in total-cholesterol, LDL-cholesterol, non-HDL-cholesterol, HDL-cholesterol, plasma apolipoprotein B, and plasma microRNAs. Participants aged 18-70 years with hyperlipidaemia (plasma triglyceride level between 1.7 - 4.5mmol/l) and not on any lipid-lowering treatment or on a stable lipid-lowering treatment will be randomized into two groups receiving either fenugreek seed tea or a control black tea."
118,"GPT4 Correct Assistant: This is a prospective, randomized, open clinical study examining the role of pioglitazone in vascular transcriptional remodeling in individuals undergoing coronary artery bypass grafting (CABG) surgery. The study includes 20 participants, aged over 40 years, who will be randomized to receive pioglitazone hydrochloride 45mg/day for 5 days before surgery. The primary outcome measure is the change in S1P content of isolated HDL between baseline and after treatment with pioglitazone hydrochloride 45 mg/day. Secondary outcome measures include differences in SPHK1 expression in the internal thoracic artery, saphenous vein, aortic artery, and atrial appendage cells."
119,"GPT4 Correct Assistant: This study is a single-dose, randomized, open-label, five-treatment, five-period, five-sequence crossover study to assess the pharmacodynamics and pharmacokinetics of three new coated glucose beads formulations and one uncoated glucose beads formulation in 20 obese, healthy subjects. The primary outcome measures are the area under the plasma concentration-time curve (AUC) and adjusted AUC of glucagon-like peptide-1 (GLP-1). Secondary outcome measures include the pharmacokinetics of caffeine and glucose, visual analogue scale (VAS) appetite and stomach rumbles, and tolerability and safety."
120,"GPT4 Correct Assistant: The study aims to evaluate the effect of using celluloid matrix tapes and oral tapes as a simple and cheap method for proper positioning of the tongue on reducing the palatoglossal airway shadow error in panoramic imaging. The study was conducted at the Oral and Maxillofacial Radiology Department, Faculty of Dentistry, Tabriz University of Medical Sciences, Iran, and involved 270 patients. The patients were randomized into three groups: the control group with no intervention, the fruit leather group, and the chewing gum strip group. The primary outcome measure was the investigation of the panoramic images, classifying them as diagnostically acceptable, unacceptable, or excellent based on the degree of the palatoglossal air space shadow error."
121,"GPT4 Correct Assistant: This clinical trial aims to compare the acute effect of Kinesio Taping and Extracorporeal Shock Wave Therapy (ESWT) on pain level, lower extremity functionality, and plantar fascia flexibility in patients with plantar fasciitis. Participants will be divided into three groups: ESWT, ESWT and Kinesio Taping, and Placebo/Sham ESWT. The study will measure pain severity using the Visual Analogue Scale (VAS) and lower extremity functionality using the Lower Extremity Functional Scale."
122,"GPT4 Correct Assistant: This clinical trial aims to establish a Couple Intervention Program for adults with Autism Spectrum Disorder (ASD). The intervention is behavioral, consisting of couple group therapy. Participants must be aged between 20 and 60 and have either an ASD diagnosis or an autism spectrum quotient score above or equal to 26. The study uses a single group assignment model and is open-label. The primary outcome measures include the Autism Diagnostic Observation Schedule (ADOS), Autism Spectrum Quotient (AQ), Empathy Quotient (EQ), Social Responsiveness Scale (SRS), and Quality of Socialization Questionnaire (QSQ)."
123,"GPT4 Correct Assistant: The study aims to evaluate the effects of an individually tailored exercise program on time spent in an upright position, health-related quality of life (HRQoL), physical activity, physical and psychological function, and work-ability in patients with postural orthostatic tachycardia syndrome (POTS), post COVID-19 condition. The study will randomize 60 adult patients with POTS, post COVID-19 condition to either an intervention group receiving standard care and an individually tailored exercise program or a control group receiving standard care alone. The primary outcome measures are change in time in upright position and HRQoL. Secondary outcome measures include changes in walking distance, oxygen saturation, dyspnea, leg fatigue, exertion, heart rate, self-reported POTS-symptoms, anxiety, depression, fatigue, physical function, blood pressure, orthostatic symptoms, insomnia, work-ability, muscle strength, and post-exertional malaise. The study will also assess compliance to intervention and changes in pharmacological treatment of POTS."
124,"GPT4 Correct Assistant: The BRANT study is a multicenter, randomized, open-label, blinded endpoint, parallel controlled trial aiming to determine if intravenous tirofiban is effective in increasing the proportion of excellent functional outcome at 90 days, when initiated within 48 hours of onset in patients with acute branch atheromatous disease (BAD)-related stroke. The study will enroll 516 eligible patients and follow them for 90 days. The primary outcome will be assessed by well-trained senior neurologists blinded to the treatment."
125,"GPT4 Correct Assistant: The Allometric-Pace Study is a clinical trial designed to evaluate the effectiveness of personalized pacing in improving the quality of life for patients with Sinus Node Dysfunction (SND). The study includes two participant groups: the PLR group and the control group. The PLR group's pacemaker lower rate is set at 75 bpm, which may be adjusted by the physician, while the control group's pacemaker lower rate is set at 60 bpm. The primary outcome measure is the life quality measurement using the SF-36 questionnaire score within three months after the surgery. Secondary outcome measures include cardiac functional changes, measured by LVEF, and the correlation of elevated blood pressure and bradycardia, measured by 24-hour ambulatory blood pressure, within three months after the surgery."
126,"GPT4 Correct Assistant: The study aims to investigate the effects of remote diagnosis and treatment on 24-hour ambulatory blood pressure rhythm in patients with obstructive sleep apnea (OSA). Patients are randomly assigned to either the telemedicine group or the outpatient group. They receive either home sleep apnea testing and APAP treatment or in-person testing and treatment. The primary outcome measure is the 24-hour mean blood pressure, and secondary outcome measures include compliance with APAP treatment, sleep apnea-related dysfunction, sleepiness symptoms, blood lipids and fasting blood glucose, and cost-effectiveness analysis. The study aims to evaluate the effectiveness of remote diagnosis and treatment in improving blood pressure rhythm and explore the underlying mechanisms."
127,"GPT4 Correct Assistant: The study, titled ""Influence of the Communication Between Nursing Staff and Patients on the Analgesic Response Following Caesarean Section,"" aims to investigate the effect of communication between nursing staff and patients on pain management after a cesarean section. The study will be conducted at Carmel Hospital and will include 80 patients undergoing elective cesarean section under spinal anesthesia. Participants will be randomly assigned to either enhanced communication or normal communication groups. The primary outcome measure is the change in pain intensity on a 0-10 pain scale one hour after analgesic administration. The study uses the Self-Consciousness Scale (SCS-R) and the Short Suggestibility Scale (SSS) to assess relevant personality traits."
128,"GPT4 Correct Assistant: The clinical trial, titled ""Assessment of Novel Biomarkers in Participants Undergoing Targeted Lung Health Checks,"" aims to identify novel molecular, immune, and clinical biomarkers to improve the sensitivity and specificity of lung cancer screening beyond conventional risk prediction models and low-dose CT scanning. The study includes participants aged 55 to 74 years, and the primary outcome measures are proteomics, metabolomics, genomics, and immune repertoire characterization performed on peripheral bloods. The study is designed to run for five years."
129,"GPT4 Correct Assistant: The study aims to evaluate the effectiveness of telepharmacy on clinical outcomes of patients with arterial hypertension. Participants are randomly assigned to either telepharmacy or in-person pharmaceutical care. The primary outcome measure is the rate of patients reaching blood pressure targets after three months. Secondary outcome measures include adherence to treatment, patient satisfaction, and level of clinical significance of interventions. The study includes elderly patients with a diagnosis of systemic arterial hypertension who are able to use a cell phone."
130,"GPT4 Correct Assistant: The ICU LIBERATION Study is an international, multicenter study investigating the current epidemiology and treatment strategy for patients with Acute Respiratory Distress Syndrome (ARDS) after the pandemic of the novel coronavirus. The study aims to clarify the actual implementation of ICU care for ARDS patients who require ventilators, and evaluate the association between the implementation of evidence-based ICU care and patient outcomes. The study will contribute to the development of ICU care guidelines, improve patient outcomes, and serve as a basis for future interventional research."
131,"GPT4 Correct Assistant: The Effect of Pomanox® on Skin Ageing (POMASKIN) study aims to evaluate the effect of consuming two doses of Pomanox®P30 on hyperpigmented skin spots in humans, and to assess the effects of the supplement on other skin ageing parameters such as wrinkles, elasticity, erythema index, hydration, pores, acne, and keratin. The study is a randomized, parallel, placebo-controlled, single-center, triple-blind clinical trial with 66 participants. Participants will be randomly assigned to one of three groups: a 367 mg Pomanox group, a 700 mg Pomanox group, or a control group. The study will measure changes in skin melanin index, skin wrinkles, skin hydration, skin elasticity, skin erythema index, skin pores, skin acne, skin keratin, and blood levels of various skin-related markers."
132,"GPT4 Correct Assistant: This clinical trial aims to investigate the role of gut microbiota in prostate cancer and prostatic hyperplasia. The study includes two cohorts: prostatic hyperplasia and prostatic cancer. Participants in the prostatic hyperplasia cohort will receive prostate hyperplasia medication (dutasteride, finasteride, or a combination of dutasteride and tamsulosin), while participants in the prostatic cancer cohort will receive androgen deprivation therapy with LHRH antagonist (degarelix). The primary outcome measures include gut microbiota signatures before and after treatment. The secondary outcome measures involve metabolic characteristics in the gut and systemic circulation before and after the use of prostate medication."
133,"GPT4 Correct Assistant: This clinical trial, titled ""Magnetic Resonance Spectroscopy Markers of Glioma Genomics,"" aims to investigate the use of MRI as a diagnostic test for glioma patients. The study includes two participant groups: Group 1 with probable grade II/III glioma scheduled for surgery and Group 2 with histologically proven grade II or III glioma without other treatment apart from surgery. The primary outcome measures are the concentrations of 2-hydroxyglutarate and cystahionine measured by MRS, which will be correlated with IDH mutational status and 1p19q codeletion derived from ex vivo analyses in tumor tissue samples. Secondary outcome measures include diffusion MRI metrics, metabolic changes during an anti-tumor treatment, and diffusion MRI and amide proton transfer signal changes during an anti-tumor treatment. The study is designed as a single group assignment with an open-label model."
134,"GPT4 Correct Assistant: This clinical trial aims to evaluate the long-term efficacy and safety of the combination therapy of hydroxyurea and thalidomide in beta-thalassemia patients. The study involves a 6-month monotherapy of hydroxyurea, followed by the introduction of thalidomide. Blood transfusions, blood count evaluations, and safety parameters are assessed during the study. The primary outcome measures include the frequency of good responders, responders, and non-responders, while the secondary outcome measures include changes in laboratory levels and liver and spleen size."
135,"GPT4 Correct Assistant: This clinical trial aims to determine the role of diagnostic imaging in the patient journey for patients with active or healed ulceration, specifically in venous leg ulcers. It seeks to assess current practices in primary care for venous leg ulcer management and availability of services for onward referral. The study will also evaluate current practices for diagnosis and management of suspected venous leg ulcers in vascular scientist departments across the UK. The trial consists of two participant groups: primary care practitioners and vascular scientists. The primary outcome measures are to determine the current practice in primary care for venous leg ulcer management and the current practice for diagnosis and management of suspected venous leg ulcers in vascular scientist departments. The study will be conducted using questionnaires and a Delphi consensus."
136,"GPT4 Correct Assistant: This clinical trial, titled ""Enhancing Prospective Thinking in Early Recovery,"" aims to study the effects of Virtual Reality on participants with substance use disorders. The study includes participants aged 18 and above who have been abstinent from drugs for at least 14 days and up to 1 year. The intervention consists of a Virtual Reality Park experience and a Virtual Reality Avatar experience for the experimental group. The primary outcomes measured are reduced drug use days, increased length and overall abstinence, increased future self-identification, future time perspective, and increased preference for delayed rewards."
137,"GPT4 Correct Assistant: The clinical trial aims to evaluate the stability of short implants versus standard length implants with internal sinus floor elevation in the posterior maxilla. The study includes participants with bone height below the maxillary sinus of 7-8mm, aged between 20-60 years, and with adequate interarch space. The primary outcome measure is the crestal bone level, assessed by periapical standardized radiographs at one year. The study is a randomized controlled trial with parallel assignment and single masking."
138,"GPT4 Correct Assistant: This clinical trial aims to investigate the use of Wharton's Jelly Mesenchymal Stromal Cell (WG-MSC) injections as graft-versus-host disease (GVHD) prophylaxis in hematopoietic allogeneic stem cell transplantation with a haploidentical donor. The study will use a dose escalation approach to determine the maximum tolerated dose (MTD) of WJ-MSC infusions. The primary outcome measure is the MTD, while secondary outcome measures include acute and chronic GVHD incidence, toxicity-related mortality, relapse incidence, overall survival, and graft-versus-host disease and relapse-free survival at 12 months post-transplant. The study is open-label and includes participants aged 18 to 70 years with hematological malignancies requiring allogeneic stem cell transplantation."
139,"GPT4 Correct Assistant: The study aims to rapidly deploy a clinical decision support tool, eCARTv5, within the electronic health record of multiple medical-surgical units. eCART combines a real-time machine learning algorithm for identifying patients at increased risk for intensive care (ICU) transfer and death with clinical pathways to standardize the care of these patients based on a real-time, quantitative assessment of patient risk. The investigators hypothesize that implementing such a tool will be associated with a decrease in ventilator utilization, length of stay, and mortality for high-risk hospitalized adults. The study will be a parallel assignment study with an intervention group of medical-surgical patients where the tool will be used by providers, and a control group wherein the tool will run silently in the background. The primary outcome measure is hospital mortality for elevated risk patients, and secondary outcome measures include total hospital length of stay (LOS) for elevated risk patients, ICU-free days following an eCART elevation, and ventilator-free days following an eCART elevation."
140,"GPT4 Correct Assistant: This clinical trial aims to assess the effectiveness of the African-American Social Support Effectiveness Treatment-Partners alleviating Perinatal Depression (ASSET-PPD) intervention in reducing maternal depression among African-American mothers. The intervention targets fathers' support of the mothers' mental health treatment and their active engagement in the family to reduce maternal stress. The study includes 50 participant dyads (100 individuals total) with African-American mothers in the second trimester who are receiving psychiatric treatment for depression. Maternal depressive symptoms are the primary outcome measure, while breastfeeding and parent-infant interactions are secondary outcome measures."
141,GPT4 Correct Assistant: This clinical trial aims to evaluate a proactive identification and digital mental health intervention approach to address unmet psychosocial needs of individuals living with cancer. The trial will compare the effectiveness of a Behavioral Activation Therapy app (Moodivate) and Treatment as Usual in managing depression and depressive symptoms among cancer survivors. Participants will be randomly assigned to either group and will be asked to complete questionnaire measures weekly for a specific period. The primary outcome measure is the proportion of eligible participants who accrue to the study during the trial's duration.
142,"GPT4 Correct Assistant: This study aims to test new algorithms for detecting insulin pump malfunctions in individuals with type 1 diabetes. The study consists of three phases: Phase 1 involves collecting data on glycemic trends and insulin administration in free-living conditions; Phase 2 simulates hyperglycemia by temporarily suspending insulin infusion; and Phase 3 retrospectively analyzes the collected data to evaluate the effectiveness of the algorithms in detecting insulin suspension, simulating a pump malfunction. The primary outcome measure is sensitivity, or the fraction of correctly detected insulin suspensions in the population, while the secondary outcome measure is false positive per day, or the number of false alarms normalized by the number of days of monitoring."
143,"GPT4 Correct Assistant: This is a study to evaluate the effect of Funk It Cycle Bites on Premenstrual Syndrome (PMS) in females aged 18-40 with a regular menstrual cycle and mild to moderate menstrual pain. Participants will consume one Cycle Bite per day for four months and complete surveys assessing changes in PMS symptoms, acne, pain levels, mood stability, energy levels, and product enjoyment."
144,"GPT4 Correct Assistant: The study aims to assess the effectiveness of the Personalized Risk Assessment and Communication Tool (PERSARC) in reducing decisional conflict and increasing informed choices in high-grade extremity Soft-tissue Sarcoma patients compared to usual care. It is a parallel cluster randomized trial conducted in six Dutch hospitals. The study measures the co-primary outcomes, decisional conflict and informed choice, and secondary outcomes such as regret, worry, involvement in decision-making, patient-reported outcomes, utilities for cost-effectiveness analysis, healthcare costs, and absenteeism/presenteeism from paid work."
145,"GPT4 Correct Assistant: This clinical trial aims to determine the prevalence of early childhood caries in Jordanian children attending kindergartens, and its associated risk factors. Additionally, it aims to assess the effectiveness of silver diamine fluoride as a caries control material and its acceptance among parents of children with early childhood caries. The study is a cross-sectional epidemiological study involving 887 children and uses a randomized controlled trial design with a sample of 159 children. The primary outcome measures include the prevalence of early childhood caries, caries prevention, and caries arrest after one year. Secondary outcome measures include risk factors for early childhood caries and parental acceptance of SDF."
146,"GPT4 Correct Assistant: This retrospective study aims to estimate the vaccine effectiveness of Pfizer's ABRYSVO against severe respiratory syncytial virus (RSV) infection in older adults, preventing severe RSV-related lower respiratory tract infection requiring hospitalization. The study uses a test negative design and a retrospective cohort design, analyzing standard of care (SOC) RSV testing and re-testing of remnant SOC respiratory specimens for those who did not have SOC testing. The study focuses on estimating vaccine effectiveness against RSV-related lower respiratory tract infection hospitalizations among high-risk groups, RSV-related acute respiratory tract infection hospitalizations, and Emergency Department (ED) visits. The retrospective cohort analysis provides vaccine effectiveness estimates against additional all-cause acute respiratory infection (ARI) and lower respiratory tract infection (LRTI) outcomes, as well as incidence rates and rate reductions for study outcomes, including outpatient outcomes. Analyses include stratifications by presence of comorbidity, RSV subgroup, severity, age, frailty, and other selected demographic factors."
147,"GPT4 Correct Assistant: The OSsIRIS study is a post-market clinical follow-up investigation to confirm the performance and safety of the bone substitute b.Bone in extremities and pelvis. The study includes patients with surgically created bone defects or bone defects/voids resulting from traumatic injury. The intervention is bone grafting using b.Bone, and the primary outcome measure is the radiographic healing/union after surgery. The study also measures patient-reported outcomes for pain and quality of life, as well as adverse events and reinterventions related to the treatment."
148,GPT4 Correct Assistant: This is a 1-year prospective cohort study examining the prognostic significance of acute change in liver and splenic stiffness in patients with acute on chronic liver failure (ACLF). The primary objective is to study the change in liver and splenic stiffness values at day 7 from baseline at day 1 between those with or without transplant-free survival at day 90. Secondary objectives include evaluating associations between liver and splenic stiffness and various clinical factors and outcomes. The study includes 200 patients aged 18-70 years with ACLF and no intervention is performed. The primary outcome measure is acute changes in liver and splenic stiffness on day 7 predicting liver transplant-free survival at 3 months. Secondary outcome measures include various associations between liver and splenic stiffness and clinical factors and outcomes.
149,"GPT4 Correct Assistant: This clinical trial aims to investigate the efficacy of botulinum neurotoxin (BoNT) injections at depths of 2mm and 4mm for the treatment of glabellar lines, a common facial wrinkle. The study will use the Merz aesthetics scale to assess the improvement of glabellar lines and evaluate any adverse effects. The investigators hypothesize that the depth of injection does not affect the efficacy of BoNT for the improvement of glabellar lines."
150,"GPT4 Correct Assistant: This clinical trial aims to investigate the effectiveness of music therapy in reducing anxiety in patients with localized breast cancer undergoing adjuvant or neoadjuvant chemotherapy. The study is a randomized, parallel assignment, open-label trial with two arms: music therapy and standard care. The primary outcome measure is the change in anxiety levels before the first and third chemotherapy sessions, assessed using the State Trait Anxiety Inventory (STAI) score. The study duration is 5 months."
151,"GPT4 Correct Assistant: This clinical trial aims to evaluate different conditioning regimens for HLA matched donor transplantation in patients with severe aplastic anemia. The study is a prospective, multicenter, randomized controlled trial. Participants are either in the experimental group receiving Busulfan and conditioning regimens of Bu/Flu/Cy/ATG or Bu/Cy/ATG, or the control group receiving Flu/Cy/ATG or Cy/ATG. The primary outcome measure is failure-free survival at 1 year post HSCT. Secondary outcome measures include incidence of mixed chimerism, regimen-related toxicity, myeloid and platelet engraftment, incidence of graft versus host disease, incidence of CMV and EBV reactivation, transplantation-related mortality, and overall survival at 1 year post HSCT."
152,"GPT4 Correct Assistant: This study aims to investigate the safety and tolerability of switching from Emicizumab to Fitusiran prophylaxis in male participants aged 18 years or older with severe hemophilia A. Participants must have a history of inhibitors or anamnestic response. The study will evaluate the number of participants with adverse events during the fitusiran treatment, peak thrombin generation, peak antithrombin levels, emicizumab concentrations in plasma, and other secondary outcomes. The primary outcome measure is the incidence, severity, and seriousness of adverse events during the fitusiran treatment period."
153,GPT4 Correct Assistant: This clinical trial aims to translate and validate the Malay version of the painDETECT Questionnaire (PDQ-M) for assessing neuropathic and nociceptive pain. The study includes participants aged 18 years and above with stable disease conditions and a pain duration of at least 4 weeks. The primary outcome measure is the total PDQ-M scores collected over 2-5 weeks. The study involves administering the PDQ-M questionnaire and collecting socio-demographic data from both neuropathic and nociceptive pain groups.
154,"GPT4 Correct Assistant: The study, titled ""Safety and Validation of Community Rehabilitation Exercise Program for Stroke Patients,"" aims to assess the safety and effectiveness of a community-based complex exercise program for stroke patients. The intervention group participates in a structured exercise program, while the control group continues their daily life without intervention. The primary outcome measure is the 6-minute walk test, and secondary outcome measures include the modified Rankin Scale, Berg Balance Scale, Functional Ambulation Category, Manual Muscle Test, Timed Up and Go test, grip strength, body composition, physical activity, Euro-Quality of Life-5 Dimension, Geriatic Depression Scale, sit to stand test, flexibility test, and coordination test."
155,"GPT4 Correct Assistant: This clinical trial aims to assess the safety, efficacy, pharmacokinetics, and pharmacodynamics of ABBV-552 in participants with mild Alzheimer's disease. The study is a randomized, double-blind, placebo-controlled, dose-finding study involving participants aged 50 to 90 years. The primary outcome measure is the change in the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog 14) score from baseline to week 12. Participants will be randomly assigned to one of four groups: ABBV-552 Dose A, ABBV-552 Dose B, ABBV-552 Dose C, or placebo. The trial will measure the change in ADAS-Cog 14 score to evaluate the effectiveness of ABBV-552 in treating mild Alzheimer's disease."
156,"GPT4 Correct Assistant: This observational study aims to evaluate cases of acute liver failure (ALF) and acute on chronic liver disease (ACLF), determine the most likely causes of disease in patients of different ages, assess complications, and evaluate mortality and morbidity rates. Participants will be contacted over the phone for a follow-up interview or visit. The study includes patients with severe acute liver disease, ALF, and ACLF. Exclusion criteria are patients with known cardiac cirrhosis and pre-existing renal disease. The study measures liver function, kidney function, and fluid overload in patients with ALF admitted to intensive care units. Secondary outcomes include mortality and morbidity rates."
157,"GPT4 Correct Assistant: This clinical trial aims to investigate the predictive effects of impulsivity and coping skills on quality of life in patients with bipolar disorder. The study will be conducted at Adıyaman Besni State Hospital between October 2023 and February 2024. The participants will be individuals diagnosed with bipolar disorder who are in the euthymic period, aged between 18 and 65, and able to understand and speak Turkish. The primary outcome measures are the effects of impulsivity and coping skills on quality of life. Data will be collected using the Personal Information Form, Brief Quality of Life in Bipolar Disorder Scale, Barratt Impulsivity Scale -11 Short Form, and Coping Attitudes Evaluation Scale. The study will utilize descriptive statistical methods, t-test, one-way Analysis of Variance, correlation, and regression analyses to evaluate the data."
158,"GPT4 Correct Assistant: The study aims to compare the clinical performance of two different single-color universal composite resin materials, OMNICHROMA and Zenchroma, in the restoration of non-carious cervical lesions with a control group using a multi-color composite resin material, Filtek Z250. The study will use modified USPHS and FDI criteria to measure clinical performance at different time points. The primary outcome measures include retention, marginal discoloration, marginal adaptation, secondary caries, and postoperative sensitivity. The secondary outcome measures include clinical performance of restorations according to the World Dental Organization criteria. The study is designed as a double-blind, prospective, randomized controlled trial."
159,"GPT4 Correct Assistant: This clinical trial aims to investigate the effect of neuromuscular reversal agents on the time for neurological assessment after endotracheal intubation in critically ill patients. Participants will be randomized into three groups: the sugammadex group, the neostigmine group, or the control group. The primary outcome measure is the time from administration of the neuromuscular blocker to the first available neurologic assessment. Secondary outcomes include time from administration of the neuromuscular blocker to the first spontaneous eye opening, changes in Patient State index values, changes in regional cerebral oxygen saturation values, time from intubation to extubation, total length of hospital and ICU stay, and in-ICU and in-hospital mortality."
160,"GPT4 Correct Assistant: This clinical trial aims to investigate the effectiveness of a behavioral weight loss intervention, in combination with either levonorgestrel-releasing IUD (LNG-IUD) or enhanced usual care, in promoting primary prevention and uterine preservation in premenopausal women with obesity and endometrial hyperplasia or grade 1 endometrial cancer. The study will measure the number of participants with atypia-free biopsy with uterine preservation at 2 years, time to resolution of hyperplasia, change in weight, and change in Cancer Worry Impact Events Scale (CWIES) at enrollment, 12 months, and end of treatment (estimated to be 2 years)."
161,"GPT4 Correct Assistant: This clinical trial investigates a new method called the ""Coconut Technique"" for performing safe cholecystectomy in patients with stage II acute cholecystitis according to the Tokyo guidelines. The study includes patients aged 50 years or younger, with both sexes eligible for participation. The primary outcome measure is the effectiveness of the new technique of subtotal cholecystectomy. The study involves using an electrocautery hook to cut three to four centimeters of the inflamed gallbladder wall and then identifying the confluence between the cystic duct and the body of the gallbladder. If successfully identified, the cystic duct is clipped, and cholecystectomy is performed as usual. The study aims to measure the effectiveness of this new technique over a two-year period."
162,"GPT4 Correct Assistant: This clinical trial aims to examine the effectiveness of the Cognitive Behavioral Therapy (CBT) protocol enriched with the contribution of virtual reality (VR) in addressing psychological problems experienced by athletes after serious injuries, such as anterior cruciate ligament (ACL) operations. The study will involve 60 athletes who meet the inclusion criteria and will be conducted in a 4X5 (group x measurement) mixed factorial design model with four groups: intervention1 (CBT+VR), intervention2 (VR), intervention3 (CBT), and control. The primary outcome measures include Re-Injury Anxiety Inventory (RIAI), Sport Injury Rehabilitation Adherence Scale (SIRAS), Athletic Injury Self-Efficacy Questionnaire (AISEQ), and Tampa Scale for Kinesiophobia."
163,"GPT4 Correct Assistant: This clinical trial aims to assess the development and implementation strategy of the Physical Therapy Frequency Clinical Decision Support Tool (PT-PENCIL) and analyze its effect on improving the proportion of patients who discharge home. The PT-PENCIL is an electronic clinical decision support tool integrated into the electronic health record (Epic) that identifies patients who may benefit from daily physical therapy for a home discharge. The study uses a pilot hybrid type 2 design and measures reach, adoption, acceptability, appropriateness, and feasibility of the PT-PENCIL. The primary outcome measure is the effectiveness of the evaluation on discharge home vs. facility."
164,"GPT4 Correct Assistant: This study is a single-arm, prospective, exploratory trial evaluating the feasibility and effect of Medical Tai Chi Exercise Healing in treating metastatic colorectal cancer (mCRC) patients. The intervention is a 7-form of Medical Tai Chi Exercise Healing for colon cancer patients, lasting 60 minutes three times a week for eight weeks. The primary outcome measure is adherence rates, and secondary outcome measures include the Brief Fatigue Inventory (BFI), the Pittsburgh Sleep Quality Index (PSQI), EORTC - Quality of Life, self-rating anxiety scale (SAS), and self-rating depression scale (SDS). The study is designed for patients aged 18 to 75 with histological or cytological documentation of adenocarcinoma of the colon or rectum, and with Eastern Cooperative Oncology Group (ECOG) Performance Status of 0-2. Exclusion criteria include previous or concurrent cancer distinct from colorectal cancer, serious or unstable medical conditions, and those unable to adhere to the treatment and follow-up schedule."
165,"GPT4 Correct Assistant: The Survivorship ECHO Project is a clinical trial designed to evaluate the effectiveness of an educational intervention platform on improving provider knowledge of cancer survivorship best practices. The trial includes participants from various healthcare professions and involves six sessions of educational intervention over 12 weeks. The primary outcome measures are change in level of understanding in key survivorship knowledge areas, met and unmet needs, acceptability of the current structure, and barriers to accessing ECHO. The study aims to assess the implementation of survivorship best practices into clinical practice and documentation after enrollment."
166,"GPT4 Correct Assistant: This study is a randomized, controlled trial comparing post facilitation stretch and Maitland mobilization in improving range of motion in post-traumatic stiff elbow. The study includes participants aged 18-35 years with a limitation of elbow joint range of motion greater than 30 degrees in extension and less than 120 degrees in flexion, 2-3 months after POP, splinting, and bone ossification on X-ray findings. The intervention groups receive either Maitland mobilization or post facilitation stretch, along with hot pack application and active and active-assisted exercises for elbow flexion and extension, wrist flexion and extension, forearm supination, and pronation. The primary outcome measures include changes in numerical pain rating scale, range of motion elbow flexion and extension, and range of motion forearm supination and pronation after 4 weeks of intervention. The secondary outcome measure is changes in disability measured through the DASH questionnaire after 4 weeks."
167,GPT4 Correct Assistant: This clinical trial aims to investigate a multidisciplinary approach for early diagnosis of heart failure in high-risk Canadians using an AI-enabled handheld echocardiogram device called Us2.ai. The study participants will be randomized into two arms: an active investigational arm and a control routine care arm. The primary outcome measure is the diagnosis of heart failure within 6 months from randomization. Secondary outcome measures include the diagnosis of heart failure with reduced ejection fraction (HFrEF) and the use of guideline-directed medical therapy within 6 months.
168,"GPT4 Correct Assistant: This clinical trial aims to explore the effects of intravenous fluid bolus, specifically Ringer's acetate, on central and cerebral hemodynamic effects and volume kinetics during experimental hypovolemia in healthy human volunteers. The study is designed as a randomized, crossover, factorial trial, with participants allocated to four arms: no intervention, Ringer's acetate, active comparator (lower body negative pressure), and experimental hypovolemia. The primary outcome measure is the half-life of change in cardiac stroke volume, while secondary outcome measures include the half-life of change in intravascular volume and middle cerebral artery blood flow velocity."
169,"GPT4 Correct Assistant: This study is a multicenter, open, naturalistic cost-effectiveness trial examining the effects of eMeistring, a therapist-guided internet-based cognitive therapy program, for patients with moderate depression, social anxiety disorder, and panic disorder. The intervention consists of eight to nine sessions of therapist-guided cognitive behavioral therapy, with a pre-treatment assessment, initial face-to-face visit, final face-to-face visit, and therapist guidance provided at least once a week via a secure email system. The study measures depression severity, social phobia, panic disorder symptoms, health-related quality of life, work and social adjustment, anxiety severity, system usability, and cost-effectiveness. The trial includes patients aged 18 and above, with the primary exclusion criteria being severe depression, suicidal impulses and thoughts, bipolar disorders, psychosis, substance abuse, unstable medication last month, and severe reading or writing disabilities."
170,"GPT4 Correct Assistant: This clinical trial aims to compare the efficacy of Thoracolumbar Interfascial Plane (TLIP) Block and Erector Spinae Plane (ESP) Block for perioperative analgesia in patients with lumbar spine fusion surgery. The study includes three groups: TLIP group, ESP group, and control group. The TLIP and ESP groups receive their respective blocks under ultrasound guidance before surgery, while the control group receives general anesthesia and lidocaine injection for incision anesthesia. The primary outcomes measured are the blockade area of TLIP and ESP block methods, perioperative effectiveness of these methods, and side effects."
171,"GPT4 Correct Assistant: This clinical trial aims to evaluate the Wearable Melanin-Adjusted Blood Oxygen Sensor (MABOS) for improved accuracy in patients of color. The study will include 12 participants with different skin tones, and the primary outcome measures are device safety and comfort, assessed using qualitative surveys. Secondary outcome measures include epidermal melanin estimation and blood oxygen level estimation, comparing the MABOS device to an FDA-approved pulse oximeter."
172,"GPT4 Correct Assistant: This study is a dose-escalation trial evaluating the safety, feasibility, and efficacy of FP-1201 (intravenous interferon-beta-1a) to prevent toxicities after CD19-directed CAR T-cell therapy in patients with recurrent B-cell malignancies. The primary outcome measure is dose-limiting toxicity rates within 14 days after the last administration of FP-1201. Secondary outcome measures include cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome rates, cumulative corticosteroid dose, and overall and complete response rates."
173,"GPT4 Correct Assistant: This is a randomized, open-label, multicenter phase III study evaluating the efficacy of Camrelizumab Plus Chemotherapy with or without Famitinib as neoadjuvant therapy in participants with Triple Negative Breast Cancer (TNBC). The primary outcome measure is the pathological complete response (pCR) rate, and secondary outcomes include event-free survival (EFS), disease-free survival (DFS), distant disease-free survival (DDFS), and objective response rate (ORR) in accordance with RECIST v1.1. Participants must be aged 18-70 years, with early or locally advanced TNBC, and must not have received prior chemotherapy, targeted therapy, or radiation therapy within the past 12 months."
174,"GPT4 Correct Assistant: This clinical trial aims to predict postpartum glucose metabolism abnormalities in Gestational Diabetes Mellitus (GDM) based on gestational metabolic profile and lipid profile. The study will include participants with GDM diagnosed at 24-28 gestational weeks, who plan to have routine prenatal examinations and give birth in the research center. The intervention includes a questionnaire survey and specimen collection. The primary outcome measures are serum lipidomics and serum metabolomics, which will be detected using a self-developed detection chip to identify markers related to postpartum glucose metabolism abnormalities in GDM."
175,"GPT4 Correct Assistant: This clinical trial, titled ""Assessment of Sleep Quality of Hospitalized Patients Treated With EEG-guided Protection Procedures: Application in Intensive Care Unit (SleepScan), aims to assess the sleep quality of critically ill patients in an intensive care unit using EEG-guided sleep protection. The study is a non-randomized, open-label trial with two arms: Usual Care (Sham Comparator) and EEG-guided sleep protection. The primary outcome measure is the proportion of continuous sleep on Day 1, while secondary outcome measures include sleep fragmentation, environmental noise and light, sleep interruptions by caregivers, workload assessed by nurses, patient agitation, performance of the algorithm, patient-reported sleep quality, anxiety level, respiratory status, presence of delirium, and unit care length of stay. Safety of the procedure will also be assessed."
176,"GPT4 Correct Assistant: This is a phase 2 clinical trial evaluating the efficacy and safety of SAR441566, a potential treatment for rheumatoid arthritis, in adult patients. The study includes four dose regimens of SAR441566 and a placebo group. The primary outcome measure is the proportion of participants achieving at least a 20% improvement in the American College of Rheumatology (ACR) score at week 12. Secondary outcome measures include changes in disease activity score-C-reactive protein (DAS-28 CRP) and the proportion of participants achieving at least a 50% improvement in the ACR score at week 12. The study duration is approximately up to 149 days."
177,"GPT4 Correct Assistant: This clinical trial is a prospective evaluation of the MaGIA IBC in-vitro diagnostics medical device for combined screening of HIV, Hepatitis B, and Hepatitis C. The study includes participants aged 18 years or older, who are either known or suspected to have HIV, HBV, or HCV infections. The intervention involves diagnostic tests using the MaGIA IBC test in capillary blood and other matrices. The primary outcome measures are performance measurement for the diagnostics of HIV, HBV, or HCV, and proportion with positive or negative test results. Secondary outcome measures include concordance of diagnostic results in different matrices and the number of participants with study-related adverse events."
178,"GPT4 Correct Assistant: This clinical trial aims to assess whether the dietary supplement Endocalyx Pro reduces sodium and water excess in patients with chronic heart failure and evaluate its effects on physical limitations, patient-reported outcomes, and working mechanisms in heart failure patients. The study is a randomized, double-blind, placebo-controlled trial involving patients with chronic heart failure, and the primary outcome measure is the change in NT-proBNP levels from baseline to week 8 in Endocalyx-treated patients compared to placebo. The trial also explores secondary outcomes such as changes in blood pressure, body weight, and hemodynamic parameters, as well as the safety and efficacy of Endocalyx in heart failure patients."
179,"GPT4 Correct Assistant: The study aims to evaluate the feasibility of using nasogastric tubes and water-soluble contrast in the management of adhesive small bowel obstruction (aSBO). The study will enroll patients aged 18 or older with aSBO and randomize them into three groups: 1) aSBO treated without NG tubes, 2) aSBO treated with NG tube and water-soluble contrast (Gastrografin), and 3) aSBO treated with NG tube and placebo (saline). The primary outcome measure is the Patient-Reported Outcomes Measurement Information System (PROMIS®)-29, which assesses quality of life."
180,"GPT4 Correct Assistant: This clinical trial is designed to evaluate the efficacy of a novel combination therapeutic strategy aiming for a functional cure for chronic hepatitis B virus infection (sustained HBsAg loss). The study will include two groups: Group 1 will receive a combination of anti-PD-1 antibody, NAs, and Peg-IFNα, while Group 2 will receive a combination of NAs and Peg-IFNα. The primary outcomes measured will include serum HBsAg and serum HBV DNA levels at baseline and at 24, 48 weeks after the treatment, and 24 weeks after the end of treatment."
181,"GPT4 Correct Assistant: This clinical trial compares wound healing in oral surgery using simple and continuous suture techniques. Participants aged 40-65 years with no uncontrolled systemic conditions and no complications about wound healing are eligible. The primary outcome measures include Laundry Healing Index and Early Wound Healing Score at days 1, 3, and 7, suturing time, knot looseness, pain at suture removal, and suture removal difficulty. The study uses a randomized parallel assignment design with a single mask."
182,"GPT4 Correct Assistant: This clinical trial, titled ""Exploring the Feasibility and Utility of In-home Body Weight Support Harness System Use in Children Treated for Spinal Muscular Atrophy: a Pilot Study,"" aims to investigate the use of an in-home body weight support harness system for children with Spinal Muscular Atrophy Type I and Type II. The study includes a diverse group of participants and utilizes a single group assignment model with an open-label design. The primary outcome measures include caregiver surveys, changes in the Neuromuscular Gross Motor Outcome (GRO) scale, Hammersmith Functional Motor Scale Expanded (HFMSE), Revised Hammersmith Scale (RHS), and Bayley Scales of Infant and Toddler Development 3rd ed. (Bayley-III), Gross motor subtest. The secondary outcome measure is the harness use log."
183,"GPT4 Correct Assistant: This clinical trial investigates the effectiveness and safety of Descemet Membrane Endothelial Keratoplasty (DMEK) in patients with a history of anterior or posterior segment surgery. The study aims to measure the occurrence rate of at least one serious DMEK post-operative complication at 12 months. The trial includes patients aged 18 years and older, and excludes those with certain contraindications such as presence of a stromal corneal cleft or inflammatory or degenerative corneal pathology other than endothelial decompensation. Outcome measures include the occurrence rates of rebulling, graft failure, graft rejection, and macular cystoid edema, as well as intraocular hypertension, graft detachment, surgeon's subjective assessment of surgical complexity, duration of surgical procedure, and evolution of visual and refractive results."
184,"GPT4 Correct Assistant: The clinical trial, ""Analysis of Mechanism on the Efficacy of Oral Antibiotic Prophylaxis in Elective Colon and Rectal Surgery With Primary Anastomosis,"" aims to investigate the correlation between septic complications and the microbiome in colorectal surgery patients. Participants are split into two groups: one receiving oral antibiotic prophylaxis with neomycin sulfate, and the other receiving mechanical bowel preparation without oral antibiotic prophylaxis. The primary outcome measure is the microbiome in the postoperative 30 days, while the secondary outcome measure is the affecting factors on the microbiome within the same time frame. The study includes participants aged 18 and above, regardless of sex, and excludes those with allergies to antibiotics, certain medical conditions, and those who have taken antibiotics within two weeks of the trial."
185,"GPT4 Correct Assistant: This clinical trial aims to assess the utility of measurements made at the point of the maximal stenosis of the median nerve in the carpal tunnel for diagnosing Carpal Tunnel Syndrome (CTS). Patients with CTS and healthy controls will undergo nerve conduction studies and ultrasound of the symptomatic median nerve with measurements of the cross-sectional area, diameter, and echogenicity at various points, including the point of the maximal stenosis. The study will measure the difference in the diameter, cross-sectional area, and echogenicity of the median nerve in the site of its maximal compression between patients with CTS and healthy controls. The study will also assess the correlation of these measurements with the Boston Carpal Tunnel Questionnaire (BCTQ) score and the electrophysiological severity grade."
186,"GPT4 Correct Assistant: This clinical trial aims to study the safety and symptom burden optimization of Tocilizumab in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation (ASCT) following high-dose Melphalan conditioning. The trial is a randomized, parallel assignment, open-label study, comparing Tocilizumab treatment to no intervention. The primary outcome measures include the MDASI questionnaire and adverse events. Participants must be between 18 and 70 years old, have multiple myeloma, and be eligible for ASCT."
187,"GPT4 Correct Assistant: This clinical trial aims to compare the effectiveness of Testicular Sperm Aspiration (TESA) and Microfluidic Sperm Separation (MSS) in couples with high sperm DNA fragmentation undergoing intracytoplasmic sperm injection (ICSI). The primary outcome measure is the clinical pregnancy rate, while the secondary outcome measure is the number of utilizable blastocysts obtained. The study includes men with high DNA fragmentation (>20%) and excludes couples with advanced maternal age (>40 years) and egg donation cycles."
188,"GPT4 Correct Assistant: This clinical trial aims to investigate the effect of stabilization and stabilization-related parameters on shooting performance at the cervical, lumbar, and scapular levels in archery athletes. The study includes 40 archery athletes aged between 10 and 18, who have been professionally engaged in archery for at least 1 year. The trial measures various factors, including cervical and lumbar stabilization, scapular dyskinesis, balance, posture, disability, upper extremity performance, hand grip strength, and muscle tightness. The primary outcome measures are cervical stabilization, lumbar stabilization grade, lumbar stabilizer muscle contraction, scapular dyskinesis type, scapular dyskinesis amount, and sportive performance. Secondary outcome measures include balance assessment, static balance assessment, posture, disability, upper extremity performance, hand grip strength, and muscle tightness."
189,"GPT4 Correct Assistant: This clinical trial aims to improve pediatrician communication with adolescents and their mothers regarding contraception through the use of an AI chatbot communication training tool. The study will be conducted in three stages: formative, development, and proof-of-concept. In the formative stage, researchers will analyze communication styles and content in real-life clinical encounters. In the development stage, the AI chatbot will be refined based on feedback from pediatrician learners. In the proof-of-concept stage, the chatbot's effectiveness will be tested by comparing pre- and post-training clinical encounters. The primary outcome measure is a questionnaire assessing communication quality, while secondary outcome measures include acceptability and feasibility questionnaires."
190,"GPT4 Correct Assistant: This study aims to investigate healthcare disparities in vitiligo by estimating the cumulative lifetime risk of the condition in the UK population, and comparing this risk across different age, sex, ethnicity, and deprivation groups. The study will also perform a subgroup analysis to identify any disparities in mental health conditions, healthcare utilisation, and work impact among people with vitiligo. The study will use observational analysis of usual care, with a focus on primary care encounters, dermatology and mental health referrals, unemployment, and time off work. The study will measure the total disease burden of vitiligo over a 17-year period (2004-2020) and assess secondary outcomes over a 2-year time frame."
191,"GPT4 Correct Assistant: The study aims to investigate the effects of self-efficacy and relationship through behavior modification by hybrid mode in caregivers with toddlers receiving early intervention. The study participants are randomly assigned to either the Hybrid group or the Self-learning group, with both groups undergoing 8 weeks of training. The primary outcome measures include Intervention Fidelity, Parenting Sense of Confidence, Parenting Stress Index: Short form, The Conflict Tactics Scales: Parent Version, habit schedule record, and satisfaction questionnaire. The study will analyze the data using Mann-Whinney U test, the Wilcoxon Signed Ranked Test, and Spearman correlation analysis."
192,"GPT4 Correct Assistant: The clinical trial titled ""A Phase I/Ib Trial of Trotabresib in Combination with Vinorelbine and Radiation Therapy for HER2+ Breast Cancer with CNS Metastases or Leptomeningeal Disease"" aims to study the safety and effectiveness of the combination of trotabresib, vinorelbine, and radiation therapy in treating HER2+ breast cancer patients with CNS metastases or leptomeningeal disease. The primary objectives of the study are to determine the maximum tolerated dose and recommended Phase 2 dose of the combination, and to assess the progression-free survival (PFS) and overall survival (OS) of the patients. Secondary objectives include assessing the objective response rate, safety, and toxicity profile of the combination."
193,"GPT4 Correct Assistant: This clinical trial aims to modify and adapt a validated program to create a culturally-relevant digital health tool for binge eating and weight management for Black women with a BMI greater than 30 kg/m^2^ who binge eat. The study will examine the feasibility and preliminary efficacy of the digital health appetite awareness + behavioral weight program in primary care. The intervention is a 6-month digital treatment of Appetite Awareness Treatment (AAT) and behavioral weight loss treatment (BWL), delivered remotely using Zoom. The study will measure feasibility, retention, attendance, and changes in weight regain and binge eating episodes."
194,"GPT4 Correct Assistant: The study aims to investigate the effects of different doses of beetroot juice supplementation on neuromuscular performance during resistance exercise. Participants will be randomly assigned to consume low, moderate, or high doses of nitrate-rich beetroot juice, or a nitrate-depleted placebo, before engaging in resistance exercise. The primary outcomes include plasma nitrate and nitrite concentrations, and various neuromuscular performance measures during countermovement jumps. The study seeks to provide insights into the potential use of beetroot juice as a performance-enhancing supplement for resistance exercise."
195,"GPT4 Correct Assistant: This clinical trial aims to investigate the effect of two different intra-abdominal pressure levels (12 mmHg and 14 mmHg) on mechanical power during laparoscopic cholecystectomy surgery on patients under general anesthesia. The study will measure mechanical power values during the operation and evaluate the incidence of ventilator-induced lung injury (VILI). The trial includes adult patients with ASA 1-2, and excludes patients with ASA 3-4, lung disease, morbid obesity, and unstable medical conditions. The primary outcome measure is the occurrence of VILI, as measured by mechanical power values during the operation."
196,"GPT4 Correct Assistant: The clinical trial titled ""Evaluation of Magnetic Resonance Imaging as Alternative to Cone Beam Computed Tomography for the Assessment of Furcation Involvement in Molars"" aims to assess the effectiveness of using MRI as an alternative to CBCT for evaluating furcation involvement in molars. Patients with furcation involvement grades II or III and needing a CBCT are eligible for the study, excluding those with MRI contraindications. The study measures horizontal furcation defects according to Hamp 1975, horizontal and vertical bone loss. The trial includes both healthy volunteers and participants of all sexes, with a minimum age of 18 and a maximum age of 120 years."
197,"GPT4 Correct Assistant: The study aims to compare the plaque removal efficacy of electric toothbrushes with manual toothbrushes in children with ADHD and healthy children. The experimental groups consist of children with ADHD, while the control groups are healthy children. The study measures gingival index values, plaque removal efficiency, and dental caries risk in the permanent and primary dentition of the children. The primary outcome measures include the determination of gingival index values and plaque index values at baseline, 1st month, and 3rd month. The secondary outcome measures include the determination of the DMFT and dft indices, a questionnaire to assess nutrition, diet, and tooth brushing habits, and sociodemographic factors."
198,"GPT4 Correct Assistant: This clinical trial aims to investigate the feasibility and stability of left bundle branch area pacing (LBBAP) for ventricular pacing in symptomatic bradycardia patients with a conventional bipolar, active fixation pacing lead. The study is a prospective, single-arm, open-label, non-randomized, multi-center study, with an approximate sample size of 150 patients. The primary outcome measure is the overall success rate of the implanted system at 12-month post-implant. Secondary outcome measures include fluoroscopic exposure time, intra-operative intracardiac electrogram, post-operative imaging data, serial paced 12-lead electrocardiogram and intracardiac EGM changes, serial echocardiography changes, and serial changes of pacing parameters."
199,"GPT4 Correct Assistant: The PRE-IOP clinical trial is a randomized study comparing the effects of different toothbrushes on gingival inflammation in pregnant women aged 18 to 40. The toothbrushes used are the Sonicare DiamondClean 9000 Philips®, HydroSonic Easy Curaden®, manual toothbrush Oral-B 123, and manual toothbrush Curaprox CS 5460. The primary outcome measure is the incidence of gingival bleeding from baseline during pregnancy, with measurements taken at baseline, 1 month, and 3 months. Secondary outcome measures include the effect on gingival bleeding, gingival inflammation, dental plaque, gingival attachment, and Periodontal Pocket. The study aims to determine the most effective toothbrush for controlling gingival inflammation in pregnant women."
200,"GPT4 Correct Assistant: This clinical trial investigates the effect of yoga-based breathing styles on memory performance in adult participants without prior experience in yoga or meditation. The trial compares nasal breathing to mouth breathing and a control group, with participants completing a memory test and undergoing two-week training periods. The primary outcome measures memory improvement and secondary outcome measures subjective stress level reduction."
201,"GPT4 Correct Assistant: This clinical trial is designed to investigate the effects of calisthenics exercises, pulsed electromagnetic therapy, or a combination of both on liver function following burn injuries. The study includes 90 participants aged between 20 and 45 years with burns covering 30-50% of their body surface area. Participants are randomly assigned to one of three groups: calisthenics exercises group, pulsed electromagnetic therapy group, or calisthenics exercises and pulsed electromagnetic therapy group. The primary outcome measures are the concentration of Alanine transaminase (ALT) and Aspartate transaminase (AST) enzymes in blood plasma, which are indicators of liver function. The study duration is three months, with measurements taken before and after the treatment."
202,"GPT4 Correct Assistant: This clinical trial, titled ""The Effects of an Oncology Tailored Nutritional Intervention on the Bioavailability and Immune-activity of PD-1 Immune Checkpoint Inhibitors in Patients With Lung Cancer,"" aims to investigate the effects of a nutritional intervention on the clearance of pembrolizumab in patients with non-small cell lung cancer (NSCLC) receiving anti-PD-1 immunotherapy. The study's primary objective is to examine the variability of clearance during a 12-week nutritional intervention period. The secondary objectives are to evaluate the feasibility of patient recruitment and compliance with the study protocol, as well as the feasibility of gathering data on exploratory parameters potentially linked to nutritional intake and clinically relevant outcomes. The study design is a feasibility study, with participants receiving the nutritional intervention prior to the start of the first infusion of anti-PD-1 ICI immunotherapy and continuing for 12 weeks of treatment. Blood samples, questionnaires, and fecal specimens will be collected at various time points during the treatment. The results will be compared to patient outcomes and a historical cohort of NSCLC patients not receiving nutritional supplements."
203,"GPT4 Correct Assistant: The study ""Integrins and Protocadherins in Glutamatergic Circuits: Identification of Common Signaling Pathways and Molecular Targets in Anxiety and Major Depressive Disorders (GAPsy)"" is a two-part study aiming to investigate the role of integrins and protocadherins in glutamatergic circuits in anxiety and major depressive disorders. The first part involves recruiting 10 patients with MDD-AD and 10 healthy controls, evaluating their depressive/manic dysintomatology through clinical scales and psychopathological tests, and performing a 7T MRI neuroimaging session to study the volumetric differences of white and gray matter in the prefrontal-limbic pathway. The second part involves using murine models to study glutamatergic signaling at the biochemical level, analyzing cortical protein lysates, and conducting electrophysiological characterization of Itgb3 and Pcdh9 murine patterns in the medial prefrontal cortex. The study aims to identify common signaling pathways and molecular targets in anxiety and major depressive disorders."
204,"GPT4 Correct Assistant: This study aims to investigate the association between cardiovascular and nervous system diseases and the intestinal microbiome using multi-omics big data and related applications. The study includes patients with cardiovascular and neurological diseases, as well as healthy controls, and collects blood and stool samples for genomic, transcriptomic, metagenomic, metabolomic, and proteomic sequencing. The data will be analyzed using machine learning methods to identify potential host genes and bacteria associated with the diseases. The findings may contribute to the understanding of the molecular mechanisms of intestinal microorganisms regulating cardiovascular and nervous system diseases, and the development of predictive models for early disease prevention and diagnosis."
205,"GPT4 Correct Assistant: The PEMBROMIC trial aims to investigate the prognostic value of a combined approach based on KEAP1/NFE2L2 mutations and pre-therapeutic FDG-PET/CT radiomic analysis in advanced non-small-cell lung cancer (NSCLC) patients with PD-L1 expression ≥ 50% treated with pembrolizumab. The study will evaluate the primary outcome measure, progression-free survival (PFS), and the secondary outcome measure, overall survival (OS). The trial will enroll adult patients with histologically or cytologically proven NSCLC, unresectable Stage III NSCLC, and Stage IV NSCLC. The study will not accept healthy volunteers."
206,"GPT4 Correct Assistant: This clinical trial, titled ""A Phase II Study of Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as Small Cell, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile Cancer,"" aims to study the clinical efficacy of sacituzumab govitecan, either alone or in combination with atezolizumab, in participants with rare genitourinary tumors. The primary outcome measure is the objective response rate (ORR), which measures the percentage of participants who experience a complete or partial response to therapy. The study will also assess secondary outcomes, such as duration of response, overall survival, progression-free survival, clinical benefit rate, and safety of the treatment."
207,GPT4 Correct Assistant: This clinical trial aims to assess the effectiveness of proprioceptive neuromuscular facilitation (PNF) and eccentric exercises with electrical stimulation on ankle dorsiflexion in professional paddle tennis players. The study includes participants aged 18 to 50 and measures the primary outcomes of vertical jump and range of ankle dorsiflexion after one month. The trial is designed as a randomized parallel assignment with an open-label design and has two arms: a PNF group and an experimental group with eccentric exercises and electrical stimulation.
208,"GPT4 Correct Assistant: The Influence of Nutrition in Depression Treatment (INDEPT) study is a 12-week multicentre randomized parallel-group open controlled trial that aims to assess the effectiveness of dietary counselling promoting adherence to the Mediterranean Diet (MedDiet) as an adjuvant treatment for Major Depressive Disorder (MDD) in patients with elevated inflammation biomarkers (CRP, IL-6). The study will include two parallel groups with an allocation ratio of 1:1, one receiving six nutrition consultations promoting adherence to MedDiet in addition to MDD treatment as usual (TAU), and the other receiving only MDD TAU. The primary outcome measure is changes in symptoms of MDD, measured using the self-administered Beck Depression Inventory-II (BDI-II) scale. The study will also assess the association between adherence to MedDiet and changes in inflammatory biomarkers, the association between changes in inflammatory biomarkers and MDD symptoms, the association between adherence to MedDiet and the effectiveness of psychiatric treatment of MDD, the association between adherence to MedDiet and changes in health-related quality of life, and the economic cost-effectiveness of dietary counselling as an adjuvant treatment in MDD."
209,"GPT4 Correct Assistant: This study aims to support refugee parenting and improve family mental health in Tijuana, Mexico. It is a community-based participatory study, with a sample size of 120 participants divided into 8 groups. The intervention includes a culturally adapted parenting curriculum for half of the participants, while the other half serves as a control group. The study measures parenting knowledge, child behavior and parental efficacy, observed parent-child interactions, parental stress, and qualitative feedback. The intervention period is four weeks, with a two-month post-intervention follow-up."
210,"GPT4 Correct Assistant: ICIHP-CAN is a longitudinal qualitative study aimed at improving healthcare experiences for patients with incurable head and neck cancer (HNC) and their families. The study involves three work packages: longitudinal interviews with patients and family carers, online focus groups with healthcare professionals, and co-design workshops with stakeholders. The study aims to generate a thematic framework based on the experiences of patients, carers, and healthcare professionals, and use this framework to identify priority areas for intervention development. The study will be conducted across three regions in the UK with diverse socio-economic backgrounds and will involve around 18-25 patients and their family carers, as well as approximately 20 healthcare professionals. The study will identify areas of congruence and incongruence between patients, carers, and healthcare professionals to inform the design of interventions aimed at improving healthcare experiences for patients with incurable HNC and their families."
211,"GPT4 Correct Assistant: This clinical trial aims to explore the application of indocyanine green (ICG) fluorescence imaging to assist in identifying nerve roots during endoscopic spinal surgery. The study includes three experimental groups receiving different doses of ICG (0.5mg/kg, 1mg/kg, and 2mg/kg) and a control group undergoing standard endoscopic spinal surgery without ICG. The primary outcomes measured are the fluorescence imaging rate of nerve roots, the fluorescence signal ratio of nerve root to back fluorescence, and the time taken to find the nerve root endoscopically. Secondary outcomes include ICG-related adverse reactions, visual analogue pain scale (VAS) scores, Oswestry disability index (ODI) scores, surgical complications, and length of surgery."
212,"GPT4 Correct Assistant: This clinical trial evaluates a home-based parenting support program for parents with intellectual and developmental disabilities (IDDs). The study involves two groups: the experimental group receives the Parenting Young Children (PYC) program, while the active comparator group receives treatment as usual (TAU). The primary outcome measures are changes in the Canadian Occupational Performance Measure (performance and satisfaction sub-scales) at baseline, 3-6 months, and 9-12 months. Secondary outcome measures include changes in the Parental Sense of Competence Scale and Strengths and Difficulties Questionnaire at the same time points."
213,"GPT4 Correct Assistant: This study aims to investigate the effectiveness of artificial urinary sphincters and male slings in treating male stress urinary incontinence. The study will follow male patients undergoing surgery for stress incontinence using these medical devices and will measure the success rate, time being continent, time being revision-free, revision-free rate, patient-reported quality of life, and post-operative general and specific adverse events. The study will collect data through patient questionnaires and follow-ups at 12 weeks, 12 months, 2 years, 3 years, 4 years, and 5 years after surgery."
214,"GPT4 Correct Assistant: This clinical trial aims to evaluate the use of 68Ga-NOTA-H006 as a diagnostic tool in pancreatic, lung, and bowel cancer. The study will inject the drug intravenously with a dose of 1.8 MBq[0.05MCi]/kg and measure the standardized uptake value (SUV) of 68Ga-NOTA-H006 on the lesions. The trial will compare the SUV with 5T4 expression in pathological specimens within 90 minutes of injection. The study will include participants between the ages of 18 and 65 with specific types of cancer."
215,"GPT4 Correct Assistant: The clinical trial aims to investigate the biological mechanisms behind resynchronization therapy in heart failure patients. It involves heart failure patients eligible for cardiac resynchronization therapy (CRT) and a control group of heart failure patients on medical therapy. Blood samples, heart tissue, and clinical data will be collected and analyzed to study proteins, exosomal miRNA, proteins, RNA, contractility, and endothelial function. The study will follow patients at 3 months, 6 months, and 12 months after CRT implantation or medical treatment initiation. The primary outcome measure is biomarkers, while the secondary outcome measure is endothelial function."
216,"GPT4 Correct Assistant: This clinical trial aims to investigate medication strategies in heart failure patients who are intolerable to Guideline-directed Medical Therapy (GDMT). The study includes patients with heart failure with reduced ejection fraction and measures all-cause mortality or worsening heart failure in 180 days. The trial compares two groups: those tolerable to GDMT and those intolerable to GDMT due to hypotension, hyperkalemia, or renal insufficiency. The primary outcome measure is all-cause mortality or worsening heart failure in 180 days, while secondary outcome measures include changes in symptoms and signs of heart failure, NT-proBNP levels, left ventricular ejection fraction, left ventricular end-diastolic diameter, left ventricular end-systolic diameter, left ventricular fractional shortening, blood pressure, and blood potassium."
217,"GPT4 Correct Assistant: This study aims to improve patient-reported outcome (PRO) adherence in cancer patients using behavioral economic strategies. It will compare usual practice (encounter-based PRO monitoring), encounter-based PRO monitoring with patient reminders and triage nurse alerts, and remote PRO monitoring with patient reminders and triage nurse alerts. The primary outcome measure is PRO adherence, measured as the proportion of expected PRO questionnaires completed per patient over a 3-month period. Secondary outcomes include acute care utilization, treatment delays/modifications, and duration of therapy."
218,"GPT4 Correct Assistant: The ProgESC Study aims to understand the prognostic awareness of patients referred to the Enhanced Supportive Care (ESC) service at University College London Hospital. The study will assess patients' prognostic understanding, psychological symptoms, quality of life, trust in medical professionals, and perceived quality of care. The primary endpoint is the level of patients' prognostic awareness, assessed by the Prognosis and Treatment Perception Questionnaire. Secondary endpoints include patients' preferences for receiving prognostic information, symptoms of depression and anxiety, quality of life, trust in their medical team, and other aspects of perceived quality of care. The study will include 100 patients aged 18 and older with advanced cancer referred to the ESC service, excluding those with cognitive impairment or already referred to community palliative care services."
219,"GPT4 Correct Assistant: This clinical trial, titled ""Effect of Direct-from-blood Bacterial Testing on Antibiotic Administration and Clinical Outcomes: A Learning Healthcare Pragmatic Randomized Trial,"" aims to study the impact of direct-from-blood bacterial testing using the T2Bacteria® Panel on antibiotic administration and clinical outcomes in patients with bloodstream infections, sepsis, MRSA bacteremia, and vancomycin use. The trial is a pragmatic, randomized controlled clinical trial with parallel group assignment and an open-label design. The primary outcome measure is time to last dose of intravenous vancomycin, while the secondary outcome measure is time to last dose of systemic anti-pseudomonal beta-lactam antibiotic. Participants must be aged 18 or older, located in the Emergency Department at Vanderbilt University Hospital within 12 hours of presentation, and have ordered blood cultures and intravenous vancomycin."
220,"GPT4 Correct Assistant: This randomized-controlled trial aims to evaluate the effect of temperature-elevating armbaths on participants with arterial hypertension. The study will include 50 participants randomized into an intervention group (performing armbaths) and a control group (waitlist). Participants will be monitored with three 24-hour ambulatory blood pressure measurements at the beginning, 8 weeks, and 6 months. The intervention group will perform armbaths for 8 weeks, while the control group will continue their treatment as usual and offered armbath instruction after the trial. The primary outcome measure is blood pressure, with secondary measures including health-related quality of life, sleep quality, heart rate, adverse events, and medication changes."
221,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of Acupuncture on Perceived Stress and Health in Military Service Members and Veterans. The study will use a randomized, parallel assignment design with an open-label model. Participants will be randomly assigned to either an experimental group receiving Manual Standardized Stress Acupuncture (MSSA) and Mindfulness-Based Stress Reduction (MBSR) or an active comparator group receiving MBSR only. The primary outcome measure is the Perceived Stress Scale (PSS), and secondary outcome measures include the Insomnia Severity Index (ISI), Short Form (SF) Health Survey, and Journal Log. The study will take place over a period of four weeks, with assessments at baseline, two weeks post-interventions, and four weeks post-interventions."
222,"GPT4 Correct Assistant: The study aims to determine the prevalence of persistent COVID-19 in Punta Arenas, Magallanes and Chilean Antarctic Region among adults aged 18 to 100 years who have had at least one positive SARS-CoV-2 RT-qPCR test. The study will run from July 2022 to July 2023. The primary outcome measure is the prevalence of persistent COVID-19 in the cohort. Secondary outcome measures include sociodemographic data, psychological profiles, sleep quality and disorders, psychosocial exposures, standard laboratory parameters, inflammatory biomarkers, immunological repertoire associated with persistent COVID-19, flow cytometry immunophenotyping, and function of the musculoskeletal system."
223,"GPT4 Correct Assistant: This is a multicenter randomized controlled trial comparing intrathecal catheter placement and resiting epidural catheter after dural puncture in obstetric patients to determine the efficacy in treating post-dural puncture headache (PDPH). The study includes female patients aged 18 years or older who have a confirmed diagnosis of PDPH during labor. The primary outcome measure is the incidence of PDPH at 24 hours from the dural puncture. Secondary outcome measures include PDPH intensity at 24 and 48 hours, quality of analgesia during labor, adverse events, chronic pain at 1 and 3 months, readmission to hospital, and patient satisfaction."
224,"GPT4 Correct Assistant: The study aims to compare the effectiveness of sectional matrix and circumferential matrix for reconstruction of proximal contact in Class 2 restorations. The trial involves patients with good general health, aged between 18 and 60 years, who have tooth decay and compound class 2 cavities. The sectional matrix and circumferential matrix will be applied in the restoration process, and the tightness of the proximal contact will be evaluated immediately after the procedure using dental floss."
225,"GPT4 Correct Assistant: This study aims to evaluate the Santa Clara County Mental Health Service Pay for Performance Quality Improvement Initiative, a program designed to improve mental health care for high-utilizers of psychiatric services. Participants are randomly assigned to either the Pay for Performance (PFP) or Usual Care (UC) group. The primary outcome measure is the total cost of 24-hour psychiatric services over 12, 24, and 36 months post-enrollment. Secondary outcome measures include the total cost of specific services such as Barbara Arons Pavilion Acute Inpatient Psychiatric Care and Emergency Psychiatric Services. The study aims to determine the effectiveness of the PFP program in reducing costs and improving mental health care for high-utilizers of psychiatric services."
226,"GPT4 Correct Assistant: This study aims to determine the clinical efficacy and cost-effectiveness of Culturally adapted Cognitive Behavioral Therapy (CaCBT) and Culturally adapted Family Intervention (CulFI) compared to Treatment as Usual (TAU) in reducing overall symptoms of psychosis in individuals with First Episode Psychosis (FEP) in Pakistan. The study includes 390 participants from ten psychiatric units and randomizes them into three groups: CaCBT + TAU, CulFI + TAU, or TAU alone. The primary outcome measure is the Positive and Negative Syndrome Scale (PANSS). Secondary outcome measures include the Calgary Depression Scale for Schizophrenia, EuroQol-5 Dimensions, World Health Organization Disability Assessment Scale, Schedule for Assessment of Insight, Experience of Caregiving Inventory, Carer Well-Being and Support, Illness Perception Questionnaire, Generalized Anxiety Disorder, Patient Health Questionnaire (PHQ-9), Cognitive Behavior Therapy Rating Scale, Cognitive Therapy for Psychosis Adherence Scale, The Psychosocial Treatment Compliance Scale (PTCS), Treatment Adherence Rating Scale, and Session Attendance Log."
227,"GPT4 Correct Assistant: This is a Phase 1/2 multi-center study evaluating the safety and efficacy of IMPT-314, a CD19/20 bispecific chimeric antigen receptor (CAR) T cell therapy in participants with relapsed or refractory aggressive B-cell non-Hodgkin lymphoma. The study includes two dose levels in each of the Phase I and Phase II parts, with two cohorts in each phase. The primary outcomes measured are incidence of dose-limiting toxicities (DLTs), investigator-assessed complete response rate, and proportion of enrolled participants who receive the target dose. Secondary outcomes include overall response rate, duration of response, duration of complete response, median progression-free survival, and median overall survival."
228,"GPT4 Correct Assistant: This clinical trial aims to study the effect of Metabolic Syndrome (MetS) on cognitive performance and physical activity in middle-aged individuals. Participants will be divided into two groups: MetS Group (diagnosed with MetS) and Control Group (healthy individuals). The study will assess various parameters such as waist circumference, blood pressure, triglyceride, HDL-C, fasting plasma levels, MetS severity score, Monreal Cognitive Assessment, Stroop Test TBAG Form, Mini Mental State Examination, Visual Reaction Test, International Physical Activity Questionnaire Short-Form, and pedometer. The primary outcome measures will be evaluated at baseline, while secondary outcome measures will also be assessed."
229,"GPT4 Correct Assistant: This clinical trial aims to test the effectiveness of two brief digital interventions in increasing COVID-19 vaccination among individuals with anxiety or depression symptoms. The study participants will be randomly assigned to one of three intervention arms: attitudinal inoculation, cognitive-behavioral therapy-informed, or conventional public health messaging. The primary outcome measure is self-reported receipt of a COVID vaccine dose at 4 weeks post-intervention, and secondary measures include vaccine hesitancy and self-reported receipt of a COVID vaccine dose at 6 months post-intervention."
230,"GPT4 Correct Assistant: This clinical trial examines the effects of binaural beat music on sleep quality, heart rate variability, and depression in older people with poor sleep quality in a long-term care institution. The study uses a randomized controlled design with two groups: a binaural beat music group and a control group. The participants in the binaural beat music group listen to the music thrice a week for two weeks, while the control group listens to familiar music without the binaural beat. The primary outcome measures include the Pittsburgh Sleep Quality Index (PSQI) and heart rate variability (HRV), while the secondary outcome measure is the Geriatric Depression Scale (GDS)."
231,"GPT4 Correct Assistant: This study aims to evaluate the implementation of a personalized follow-up pathway for head and neck cancer patients, exploring its acceptability, safety, and sustainability. The pathway involves a transition from routine oncology follow-up two years after radical treatment. The study will collect data through patient surveys, semi-structured interviews, and clinical data, with outcomes measured at the end of the study (12 months)."
232,GPT4 Correct Assistant: This is a randomized clinical trial comparing the effects of intrathecal bupivacaine-dexmedetomidine and intrathecal bupivacaine-neostigmine in elective caesarean sections. The study includes ASA physical status I and II patients aged 18-40 years with a height of 150-170 cm and weight of 70-110 kg. The primary outcome measure is the time from the end of intrathecal injection to the achievement of a bilateral sensory block at T10.
233,"GPT4 Correct Assistant: This is a randomized clinical study evaluating the performance of an air-polishing device with erythritol in preventing white spot lesions (WSLs) and gingivitis among patients undergoing multi-bracketed fixed orthodontic treatment. The study involves 60 patients and compares the use of an air-polishing device with a standard ultrasonic scaler. The primary outcomes measured are the appearance of WSLs and inflammatory lesions during orthodontic treatment. Secondary outcomes include patient acceptance, tooth sensitivity, total bacterial counts, inflammatory markers in gingival crevicular fluid, and total treatment time."
234,GPT4 Correct Assistant: The Atrial Fibrillation Driver Study is a pilot project that aims to analyze the tissue obtained from cardiothoracic surgery patients to understand the role of fibrosis in promoting and sustaining atrial fibrillation (AF). The study will include up to 10 patients undergoing cardiothoracic surgery at University Hospital Southampton NHS Foundation Trust. The primary outcome measures are histological analysis and molecular analysis.
235,"GPT4 Correct Assistant: This clinical trial aims to compare the effects of integrated and isolated resisted exercise on strength, power, and endurance in gym beginners. Participants are randomly assigned to either integrated resisted training (Group 1) or isolated resisted training (Group 2). The study measures endurance using a sit-up test, power using a vertical jump test, and strength using a 1RM maximum test. The results of the study can help coaches and trainers identify the most effective training methods for improving strength, power, and endurance in gym beginners."
236,"GPT4 Correct Assistant: This clinical trial aims to compare the effects of Play Based Therapy and Functional Communication Training in children with speech and language delay. The study includes children aged 2 to 6 years with a comorbidity of behavioral disorder, Autism, and ADHD, but excludes those with other syndromes. The primary outcome measure is the Speech Questionnaire, which assesses functional language ability. The study is designed as a randomized, parallel assignment, single-masked trial with two arms: Group A receiving Play Based Therapy and Group B receiving Functional Communication Training. Both interventions last for three months, with assessments conducted at baseline and after three months. The study seeks to determine which therapy is more effective for children with speech and language delay."
237,"GPT4 Correct Assistant: The study aims to assess the barriers and facilitators of integrating Horyzons, an evidence-based digital intervention, in outpatient mental health clinics in North Carolina for individuals with schizophrenia spectrum and other unspecified psychotic disorders. The primary aim is to evaluate and identify unique barriers and facilitators in implementing Horyzons at each first episode psychosis (FEP) clinic as part of standard care and distinct implementation strategies. The secondary and tertiary aims are to evaluate client engagement with Horyzons and attrition as part of clinical care and assess the change in clients' psychological measures across in addition to their use of state-funded services (e.g., emergency department and social services) across the 12-month intervention."
238,"GPT4 Correct Assistant: This clinical trial aims to investigate inflammatory and anti-inflammatory gene expressions in liver transplant patients before and after the operation. The study includes healthy volunteers and liver transplant patients aged between 18 and 65 years. The primary outcome measures are biochemical parameters such as ALT, AST, PLT, AFP, Bilirubin Direct, Bilirubin Total, and CRP levels. The secondary outcome measures are gene expression parameters, including Interleukin-2, Interleukin-6, Interferon-gamma, Tumor Necrosis Factor-alpha, Interleukin-4, Interleukin-10, Triggering Receptors Expressed on Myeloid Cells-1, Human Leukocyte Antigen-G5, Forkhead box p3, and Cluster of Differentiation (CD)14."
239,"GPT4 Correct Assistant: This clinical trial aims to test the safety, tolerability, and pharmacokinetics of intravitreal single rising doses and multiple doses of BI 771716 in patients with geographic atrophy secondary to age-related macular degeneration. The study involves four experimental groups receiving different doses of BI 771716. The primary outcome measures are the occurrence of ocular dose-limiting events and drug-related adverse events. Secondary outcome measures include the occurrence of any ocular adverse events, maximum serum concentration of BI 771716, area under the concentration-time curve, and time from dosing to maximum serum concentration."
240,"GPT4 Correct Assistant: This clinical trial aims to compare the effects of furosemide-induced diuresis with matched dehydration using the RenalGuard device to standard diuretic therapy in patients with acute heart failure and overt fluid overload. The study will enroll participants aged 18 and above with NYHA functional class III or IV, estimated weight gain due to peripheral fluid overload greater than 4 kg, and admission BNP values greater than 400 pg/ml if in sinus rhythm and greater than 600 pg/ml if in atrial fibrillation. The primary outcome measure is daily serum creatinine measurement, while the secondary outcome measure is daily weight decrease during study treatment."
241,"GPT4 Correct Assistant: This is a pilot study designed to determine the feasibility, acceptability, and effectiveness of a self-guided mindfulness-based intervention in pediatric patients with idiopathic chest pain. The study participants will be randomly assigned to either the standard of care control group or the mindfulness-based intervention group. The primary outcome measures include participant recruitment rate, participant retention rate, mindfulness-based intervention program adherence, and acceptability. Secondary outcome measures include pain coping strategies, perceived stress, patient quality of life, chest pain episode frequency, and chest pain episode intensity."
242,"GPT4 Correct Assistant: The trial is a four-arm, double-blind, non-inferiority study investigating the safety and immunogenicity of concomitant administration of the Novavax (NVX) vaccine and a 20-valent pneumococcal conjugate vaccine (PCV20) in adults aged 60 years or older. The study includes participants who have received three Covid-19 vaccines, including the third mRNA vaccine (BNT162b2 or mRNA-1273) at least 16 weeks prior. The primary outcome measure is antibody levels measured at day 28. The study has four participant groups: NVX plus placebo, PCV20 plus placebo, NVX plus PCV20, and placebo plus placebo."
243,"GPT4 Correct Assistant: This clinical trial aims to investigate the combination of Durvalumab, an anti-PD-L1 immune checkpoint inhibitor, and Rintatolimod, a TLR-3 agonist, in patients with metastatic pancreatic ductal adenocarcinoma (PDAC) who have completed standard chemotherapy (FOLFIRINOX). The primary objective of the phase Ib study is to determine the safety of this combination therapy, while the primary objective of the phase II study is to determine the clinical benefit rate. The study will also explore the immunogenic effect of the combination therapy on the circulating and infiltrating immune profile, and its impact on quality of life."
244,"GPT4 Correct Assistant: The study aims to analyze the potential effects of supplementation with the flavonoid diosmin on delayed-onset muscle soreness (DOMS) in female athletes from the women's five-a-side soccer team in Brazil. It is a randomized, double-blinded, and placebo-controlled trial with a total of approximately 40 female athletes. The intervention group will receive diosmin supplementation, while the control group will receive a placebo. The study will assess muscle soreness, muscle tissue damage, oxidative stress, and recovery of muscle function through various tests."
245,"GPT4 Correct Assistant: The study aims to investigate the predictive factors for treatment success of Intrathecal Baclofen (ITB) therapy in children with cerebral palsy (CP). It is a prospective observational study using the Netherlands CP register to collect data over a period of 4.5 years. The primary research question is to determine the short-term (3 months), medium-term (1 year), and long-term (2 years) effects of ITB on personal treatment goals in children with CP. Secondary objectives include determining the association between the effect on personal treatment goals and spasticity/dystonia and identifying factors associated with ITB treatment success. The study will include a total of 67 to 90 children, with data collected at baseline, 3 months, 1 year, and 2 years. The primary outcome measure is goal attainment scaling (GAS), and secondary outcome measures include patient characteristics, treatment history, range of motion, spasticity, dystonia, scoliosis, selectivity, functional strength, gait analysis, and questionnaires on activities and participation. A linear mixed-model analysis will be used to determine the development over time for the primary and secondary outcome measures, and statistical significance will be set at p-value < 0.05."
246,"GPT4 Correct Assistant: This clinical trial aims to investigate the impact of vitamin D supplementation on the development of gestational diabetes mellitus (GDM) in high-risk pregnant women with low vitamin D levels. Pregnant women between 21-40 years of age with low vitamin D levels (<30 ng/mL) will be randomly assigned to receive either vitamin D3 supplementation (200,000 IU/week) for 4-6 weeks or placebo. The primary outcome measure is the incidence of GDM based on the International Association of Diabetes and Pregnancy Study Groups Criteria after a 75g oral glucose tolerance test (OGTT). The study seeks to contribute to the understanding of the relationship between vitamin D and GDM risk and inform clinical practice and public health recommendations for vitamin D supplementation during pregnancy."
247,"GPT4 Correct Assistant: The PERFORMANCE III trial is a prospective, multicenter, single-arm, open-label study to evaluate the safety and effectiveness of the Neuroguard IEP® Direct System for the treatment of carotid artery stenosis in patients at elevated risk for adverse events following carotid endarterectomy (CEA). The Neuroguard IEP Direct System is a 3-in-1 carotid stent delivery system consisting of an angioplasty balloon, an integrated embolic protection device, and a nitinol self-expanding stent. The study's primary outcome measure is the 30-day rate of Major Adverse Events (MAE), which includes stroke, myocardial infarction, and death."
248,"GPT4 Correct Assistant: This is a pilot study aiming to test the feasibility and safety of a Nordic Walking activity program for community-dwelling older adults at risk of falling or experiencing fear of falling. The study also aims to determine the distribution and effect sizes of outcomes to inform future sample size calculations and explore participants' perspectives of the intervention. The study will be conducted in two stages, with Stage One involving a two-arm, parallel, single-blind, randomized controlled pilot trial with 40 older adults randomly assigned to either a Nordic Walking intervention group or a control group. Outcome measures will assess feasibility and safety data, recruitment and adherence rates, and effectiveness outcomes using various tests and scales. Stage Two will involve qualitative interviews with all participants in the intervention group to gather feedback on the acceptability, perceived value, barriers, and facilitators of participating."
249,"GPT4 Correct Assistant: This study aims to evaluate the feasibility, usability, and acceptability of a web-based intervention program for sexual minority adolescents (SMAs) experiencing anxiety or depression. The program includes various components addressing intersectionality, confidentiality, educational tools, and finding affirming caregivers. The study will enroll 200 participants, who will be randomly assigned to one of 16 groups. The primary outcome measures include feasibility (proportion of IP components completed, proportion of IP use days, and average length of IP use time), usability (System Usability Scale), and acceptability of the intervention (open-ended questions about the helpfulness of the intervention, timing and amount of content, privacy and confidentiality, and potential negative consequences). Secondary outcome measures include help-seeking intentions, perceived need for treatment, social support, anxiety and depression symptoms, mental health stigma, antidepressant outcome expectations, barriers to seeking help, depression and anxiety knowledge, expectation of rejection due to SGM status, confidentiality concerns, receipt of any mental health treatment, physical and mental health component scores, social isolation, internalized homophobia, and internalized transphobia."
250,"GPT4 Correct Assistant: The study aims to investigate the application of a mixture of propofol and remifentanil in fiber colonoscopy for controlled sedation and analgesia. The trial includes two groups: the controlled analgesia/sedation (PCAS) group and the intravenous combined anesthesia group. The primary outcome measure is auditory evoked potential (AEP), while the secondary outcome measures include the time from surgery to OAA/S score of 5 and Aldrete score of 9. The study aims to determine the effectiveness and safety of propofol mixed with remifentanil in fiber colonoscopy for controlled sedation and analgesia."
251,"GPT4 Correct Assistant: This is a prospective, observational, confirmatory clinical study aimed at predicting the chronicization of radiation-induced acute intestinal injury based on the expression level of immune factors. The study includes patients diagnosed with locally advanced rectal cancer who undergo NCRT and TME and develop RAII during NCRT or within 1 month. The primary outcome is the AUC of chronicization of RAII predicted by the prediction model, while the secondary outcomes are the accuracy, precision, specificity, and sensitivity of the prediction model in predicting chronicization of RAII. The study plans to enroll 200 patients and follow up on the occurrence and progression of radiation-induced intestinal injury within 1 year after TME."
252,"GPT4 Correct Assistant: The Omicron BA.4/5-Delta COVID-19 Vaccine Phase I Clinical Trial is a randomized, double-blind, placebo-controlled study that aims to evaluate the safety and tolerability of the Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells) in individuals aged 18 years and above. The primary outcome measure is the incidence of adverse events within 12 months after vaccination. The secondary outcome measure is the geometric mean titer (GMT) of SARS-CoV-2 neutralizing antibody 14 days after vaccination."
253,"GPT4 Correct Assistant: The study titled ""Evaluation of the Safety and Performance of ENDOMATIC SEPIOLA Left Atrial Appendage (LAA) Closure Device in Patients With Atrial Fibrillation"" is designed to assess the safety and performance of the SEPIOLA System, an implantable device, in patients with atrial fibrillation. The study includes participants aged 18 years and older with a calculated CHA2DS2-VASc score of 2 or greater, non-valvular atrial fibrillation, and suitable LAA anatomical measurements. The primary outcome measure is the incidence of device and investigational procedure-related serious adverse events (SAE) within 7 days, 45 days, and 6 months post-procedure. The secondary outcome measure is the confirmation of functional LAA closure at 45 days."
254,"GPT4 Correct Assistant: This clinical trial aims to investigate the efficacy of Motivational Interviewing (MI) for patients with acute psychosis. The study includes participants with psychosis or schizophrenia, aged between 18 and 65 years, who are fluent in German and able to understand instructions. Participants will be randomly assigned to either the MI group or the control group. The MI group will receive four sessions of motivational interviewing, while the control group will receive four sessions of supportive conversations. The primary outcome measures are changes in therapeutic alliance and treatment adherence. Secondary outcome measures include changes in symptom severity, motivation for psychotherapy, and self-efficacy."
255,"GPT4 Correct Assistant: This clinical trial aims to investigate the application of chromosomal instability (CIN) in the early diagnosis of biliary tract carcinoma. The study will analyze bile samples from gallbladder cancer and cholangiocarcinoma patients, as well as control groups without any tumor, to compare the specificity and sensitivity of the BileCAD test for diagnosing biliary tract carcinoma. The BileCAD test involves extracting DNA from bile, analyzing it by low-coverage whole-genome sequencing, and processing the data using bio-information techniques. The primary outcomes measured are the sensitivity and specificity of the BileCAD test, while secondary outcomes include the consistency of BileCAD microbial analysis results with clinical microbial culture results and the sensitivity of BileCAD to different types and sites of malignant tumors."
256,"GPT4 Correct Assistant: This clinical trial aims to evaluate the success of lumbar plexus block applied in lower extremity orthopedic surgeries using Near Infrared Spectroscopy (NIRS) to measure tissue oxygenation. The study includes participants aged 18-90 with specific conditions, and uses a single-group assignment model with no masking. The primary outcome measure is regional oxymetry (rSO2) measured in the quadriceps femoris muscle, while secondary outcome measures include sensory block level, blood pressure values, and fingertip SO2 measured by pulse oximetry."
257,"GPT4 Correct Assistant: The study aims to evaluate the use of a digital platform for supporting the clinical effectiveness and integration of task-shared delivery of the evidence-based COPSI (Community care for People with Schizophrenia in India) program in primary care. The study will involve participants with schizophrenia and at least one risk factor for early mortality. The intervention groups include COPSI alone and COPSI plus the mindLAMP mobile application. The study will measure outcomes using the Indian Disability Evaluation and Assessment Scale (IDEAS), Positive and Negative Syndrome Scale (PANSS), Generalized Anxiety Disorder Assessment-7 (GAD-7), Patient Health Questionnaire-9 (PHQ-9), and Clinical Global Impression-Schizophrenia (CGI-SCH) Scale."
258,"GPT4 Correct Assistant: This clinical trial aims to investigate the characteristics of cytokine response in patients with temporomandibular disorders (TMD) treated with occlusal splint therapy. The study involves patients diagnosed with myalgia, arthralgia, headache attributed to TMP, and painful disk displacement (with and without reduction) according to the diagnostic criteria for temporomandibular disorders. Participants will be treated with a stabilizing occlusal splint made of hard acrylate resin. The primary outcome measures are the change in cytokine levels in circulating blood and gingival crevicular fluid after treatment. Secondary outcome measures include changes in pain-free opening, maximum unassisted and assisted opening, pain intensity and pain-related disability, oral health-related quality of life, perceived stress levels, jaw function limitation, depressed mood, anxious feelings and behavior, and physical symptoms."
259,"GPT4 Correct Assistant: This clinical trial aims to evaluate the effectiveness of digital training for addiction professionals in maximizing treatment admission and retention rates for opioid use disorder in affected families. The study will test three levels of digital training: a digital tutorial, digital tutorial plus training materials, and digital tutorial plus training materials plus feedback and coaching. The primary outcome measure is CRAFT procedure fidelity, while secondary outcome measures include CRAFT knowledge, program implementation potential, and new treatment entry. The study will enroll participants who are over 19 years old, working in a counselor-related profession, and have not been trained in CRAFT."
260,"GPT4 Correct Assistant: The study aims to describe the pattern of regional myocardial distribution of 3,3-diphosphono-1,2-propanedicarboxylic acid (DPD) Single-Photon Emission Computed Tomography (SPECT) uptake among patients with hereditary (ATTRm) and wild-type (ATTRwt) cardiac transthyretin (ATTR) amyloidosis. The study will investigate clinical, biochemical, and echocardiographic aspects, including left ventricle longitudinal strain profile. Additionally, it will evaluate the presence and extent of DPD cardiac uptake among asymptomatic ATTRm variants carriers. This is a prospective multi-center observational study including patients with Grade 1-3 cardiac DPD retention in scintigraphy and first-degree relatives of patients with ATTRm. The collected data will be analyzed statistically to verify research hypotheses."
261,"GPT4 Correct Assistant: The study aims to investigate the early diagnosis, prognosis, and prevention of post-COVID syndrome in children during the pandemic of the new coronavirus infection COVID-19. The study will focus on children aged 6 to 18 years, and the intervention will involve laboratory tests, questionnaires, and physical examination. The primary outcome measure is the number of participants with post-COVID syndrome."
262,"GPT4 Correct Assistant: This clinical trial aims to evaluate the effectiveness of treadmill perturbation training in preventing falls after total knee replacement. The study will recruit 378 participants who are scheduled for primary unilateral total knee arthroplasty and can commit to 4 additional study visits. Participants will be randomized into two groups: the training group, which will undergo treadmill-based perturbation training, and the education group, which will only receive educational materials. The primary outcome measures are post-training trunk angle, post-training trunk angular velocity, and fall rate during the first year after surgery."
263,"GPT4 Correct Assistant: This clinical trial aims to study the effectiveness of a combination of cadonilimab and nab-paclitaxel in patients with persistent, recurrent, or metastatic cervical cancer who have previously been treated with immune checkpoint inhibitors. The primary objective is to determine the objective response rate of the combination therapy. Secondary objectives include evaluating the duration of response, disease control rate, time to response, progression-free survival, overall survival, and safety and tolerability of the treatment. The study includes a single arm intervention with cadonilimab 10mg/kg every 3 weeks and nab-paclitaxel ≤260mg/m2 every 3 weeks."
264,"GPT4 Correct Assistant: The study is a single-center, prospective, randomized, unblinded, controlled study to assess the visual performance of Hanita Lenses Intensity SL IOL in comparison to Alcon Panoptix IOL in patients with bilateral age-related cataracts. The primary outcome measure is binocular distance-corrected visual acuity for far, intermediate, and near distances. A total of approximately 58 patients will be included at one clinical center, and the study duration is 3-7 months."
265,"GPT4 Correct Assistant: This study investigates the haemodynamic effects of low-dose spinal anaesthesia for hip fracture surgery. It is a retrospective, observational, single-centre, cohort database analysis. The study includes adults over 18 years with unilateral hip fractures who received surgery under low-dose spinal anaesthesia. The primary outcome measure is the cohort mean (SD) mean non-invasive blood pressure (MAP) taken at 2-minute intervals peri-operatively. Secondary outcome measures include the cohort prevalence of hypotension, mean depth x duration area under curve product for cohort hypotension, quantification of cohort systolic and mean arterial blood pressure changes, effective cohort duration of spinal anaesthesia, and correlations between individual hypotension and outcomes (death at 30 days, length of stay in hospital)."
266,"GPT4 Correct Assistant: The COVID-19 Transmission and Morbidity in Malawi study aims to investigate the potential protective role of malaria and intestinal parasitic diseases on symptomatic COVID-19 infection. The study will enroll up to 200 symptomatic individuals (index cases), 700 of their household contacts, and up to 600 vaccinees. The study will assess specific innate immune phenotypes that differentiate uninfected Malawians from Western controls, and whether these responses are protecting Malawians from infection and/or progression of the disease. Participants will be followed for up to 1.5 years to assess the acquisition and longevity of antibody responses and memory B cells. The study will also measure the risk of asymptomatic infection among contacts who acquire infection, the duration of neutralizing antibody responses against two viruses, and the change in frequencies of classical monocytes and markers of activation/inflammation with and without stimulation by toll-like receptor (TLR) and retinoic acid-inducible gene I (RIG-I) like receptors (RLR) ligands."
267,"GPT4 Correct Assistant: This clinical trial aims to determine the effect of hot-cold application to the bladder on postoperative urinary retention in orthopedic surgery patients. The study is a single-blind randomized controlled trial, with two arms: experimental (hot-cold application) and control (routine clinical care). The primary outcome measure is the prevention of postoperative urinary retention during the first 6 hours of the postoperative period."
268,"GPT4 Correct Assistant: This clinical trial aims to evaluate the sensitivity and specificity of a deep-learning integrated model using relevant clinical factors and radiomic features from high-concentration Iopromide-enhanced pancreatic CT images obtained within 14 days after the first onset of symptoms for quantitative prediction of the first recurrence of acute pancreatitis within a 12-month follow-up period. The study plans to enroll 694 participants, with the primary outcome being the sensitivity and specificity of the model in predicting the first recurrence of acute pancreatitis at 12 months. Secondary outcomes include the total number of subjects who developed the first recurrence of acute pancreatitis within 3, 6, and 12 months, as well as the sensitivity and specificity of the model in predicting overall recurrence of acute pancreatitis at 3 and 6 months follow-up periods."
269,"GPT4 Correct Assistant: The study, titled ""CPAP Effect on the Polycythemia in Patients With Obstructive Sleep Apnea,"" aims to investigate the effect of continuous positive airway pressure (CPAP) treatment on polycythemia in patients with obstructive sleep apnea. The study includes participants aged 18-80 with a diagnosis of polycythemia and moderate or severe sleep apnea. The primary outcome measure is the change from baseline in hematocrit levels after 12 months. Secondary outcome measures include changes in hemoglobin levels, health-related quality of life, relationship between hypoxic burden and hemoglobin and hematocrit, sleepiness assessed by Epworth scale, and the relationship between night time below SaO2 90% (T90) and oxygen desaturation index (ODI) and hematocrit."
270,"GPT4 Correct Assistant: This clinical trial aims to assess the vaginal axis in patients undergoing apical prolapse surgery, whether they have undergone hysterectomy or not. The study uses Magnetic Resonance Imaging (MRI) to compare the preoperative and postoperative vaginal axis in patients receiving lateral mesh suspension, pectopexy, and sacrospinous ligament fixation procedures. The primary outcome measures are the vaginal axis and vaginal distances at four months post-operation. Secondary outcome measures include prolapse symptoms, urinary symptoms, postoperative de novo dyspareunia, sexual functions, quality of life measures, and patient global impression of improvement."
271,"GPT4 Correct Assistant: This clinical trial aims to evaluate the effectiveness of simulation training in electronic fetal monitor management for midwifery students. The study includes 68 participants, divided into an experimental group (simulation training) and a control group (theory training). The primary outcome measures include information evaluation forms, student satisfaction and self-confidence scales, and a self-efficacy scale in monitoring and management of electronic fetal monitoring. Secondary outcome measures involve a simulation design scale. The trial is designed as a parallel assignment with a randomized intervention model and an open-label masking."
272,"GPT4 Correct Assistant: This study, conducted at Dessie Comprehensive Specialized Hospital from August 2023 to January 2024, aims to investigate the outcome and predictors of mortality among patients on prolonged mechanical ventilation. It is a retrospective cohort study using data from patient charts. The primary outcome measure is the clinical outcome of critically ill patients undergoing prolonged mechanical ventilation. The study will use bivariate and multivariate analyses to determine the effect of independent variables on the outcome variable."
273,"GPT4 Correct Assistant: This clinical trial aims to compare the efficacy and safety of two bleeding reduction approaches in patients undergoing percutaneous coronary intervention (PCI): DAPT de-escalation (switching from prasugrel or ticagrelor to clopidogrel while maintaining aspirin) and potent P2Y12 inhibitor monotherapy (maintaining prasugrel or ticagrelor and dropping aspirin). The primary outcome measure is thrombus formation, as determined by Total Thrombus formation Analysis System (T-TAS), measured at 30 days."
274,"GPT4 Correct Assistant: This clinical trial investigates the age-dependent effects of egg intake on HDL (high-density lipoprotein) and immune profiles. The study includes participants aged 18-30 and 60-70 years old, with a BMI under 30 kg/m2. Participants are randomly assigned to consume whole eggs, egg whites, or egg yolks for four weeks each, with a four-week egg-free period in between. The primary outcome measure is the change in serum concentration of large HDL particles between diet periods."
275,"GPT4 Correct Assistant: This clinical trial aims to investigate the effectiveness of a Patient-Driven Augmented Reality-Based Rehabilitation System, MyoTrain AR, in improving upper limb amputee outcomes. The study includes participants with trans-radial unilateral limb loss, aged 18 or older, who are fluent in English and have a healed residual limb. Participants will undergo functional task training using the MyoTrain AR system or receive motor imagery exercises as an active comparator. The primary outcome measures are GaMA Cup Transfer Task Mean Completion Time and Mean Relative Grasp Duration, assessed on Day 35. Secondary outcome measures include Assessment of Capacity for Myoelectric Controls (ACMC), GaMA Cup Transfer Task Completion Rate, and Wrist Activation."
276,"GPT4 Correct Assistant: This is a prospective double-blinded randomized controlled trial studying the use of a gastric electric pacemaker as a treatment for postoperative ileus following extensive surgery. The study includes patients over 18 years of age with colorectal or appendiceal cancer or peritoneal metastases or pseudomyxoma peritonei. Patients are randomly assigned to either a treatment group (receiving a gastric electric pacemaker) or a control group (mounting of a temporary gastric pacemaker without activation). The primary outcome measure is the time from surgery to the first stool, while secondary outcome measures include whole gut and regional transit times, length of hospital stay, medical and surgical complications, need for surgical or radiological interventions, re-hospitalization within 30 days, time till initiation of postoperative systemic adjuvant chemotherapy, and 90-day mortality."
277,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of aromatherapy and music therapy on pain, anxiety, and vital parameters in patients with cancer. The study is designed as a randomized controlled trial with four groups: music group, aromatherapy group, music and aromatherapy group, and control group. The music group listens to specially composed music, the aromatherapy group uses 5% lavender oil with a diffuser, and the music and aromatherapy group receives both interventions. The primary outcome measures include Visual Analog Scale (VAS) for pain, Facial Anxiety Scale (FAS), Distress Thermometer, and Edmonton Symptom Diagnostic Scale (ESAS)."
278,"GPT4 Correct Assistant: The Somatosensation Device Trial is a non-randomized crossover study designed to test the effectiveness of the Somatosensation Device in enhancing feedback in lower extremities for individuals with below-knee amputation or neuropathy. The study includes participants aged 18-65 years and measures functional gait assessment, 10-meter walk test, Mini-BESTest, Activities Specific Balance Confidence Scale, and Vestibular Disorders Activities of Daily Living Scale. The intervention involves wearing the device during the tests, while the active comparator is the baseline without the device."
279,"GPT4 Correct Assistant: This is a decentralized clinical trial investigating the use of the OtoBand device in treating vertigo symptoms in real-world settings. The study aims to enroll 108 participants with vertigo conditions such as Benign Paroxysmal Positional Vertigo, Ménière's disease, and vestibular migraine. Participants will be randomized into one of four arms: two using the OtoBand experimental device and two using a sham device, with the device's effectiveness measured through changes in vertigo severity and quality of life scores. The study will run for approximately 49 days, with virtual meetings at specific intervals, and participants will be compensated via Venmo or PayPal."
280,"GPT4 Correct Assistant: The study, titled ""The Effect of the Multistrain Probiotic OMNi-BiOTiC® Active for Upper Respiratory Tract Infections in Older People: A Randomised Controlled Trial,"" aims to investigate the prevention of Acute Upper Respiratory Tract Infection (URTI) in older individuals (65 years or older) through the use of a dietary supplement, OMNi-BiOTiC® Active. The study is a randomized, parallel assignment, quadruple-masked trial, with participants receiving either the probiotic supplement or a placebo for 12 weeks. The primary outcome measure is the incidence of URTI, while secondary outcome measures include the duration of URTI, changes in concentration of leukocytes, neutrophils, lymphocytes, monocytes, eosinophils, basophils in serum, and changes in concentration of Immunoglobulin A (IgA) in serum."
281,"GPT4 Correct Assistant: This study aims to compare the effectiveness of Gong's and Kaltenborn's mobilization techniques in treating Adhesive Capsulitis (frozen shoulder). It is a randomized controlled trial with a single-blind design, where participants are allocated to either Group A (receiving Gong's mobilization) or Group B (receiving Kaltenborn's mobilization). Both groups also receive routine physical therapy, including electrical muscle stimulation and heat therapy. The study's primary outcomes are pain assessment using the Numeric Pain Rating Scale, function evaluation through the Shoulder Pain & Disability Index, and range of motion measurement using goniometry. The study is projected to last nine months, with data collection at baseline, 1.5 weeks, and 3 weeks."
282,"GPT4 Correct Assistant: This is a phase 3 study evaluating the efficacy and safety of disitamab vedotin in combination with pembrolizumab compared to standard chemotherapy in patients with previously untreated locally advanced or metastatic urothelial carcinoma that expresses HER2. The primary outcomes are progression-free survival and overall survival. Secondary outcomes include objective response rate, duration of response, control rate, and quality of life measures."
283,"GPT4 Correct Assistant: This clinical trial aims to study the effect of lactoferrin versus placebo in improving clinical outcomes in ICU patients. The study is a double-blinded, randomized controlled trial (RCT) with a sample size of 650 patients, divided into two groups: Group A receiving lactoferrin and Group B receiving placebo. The primary outcome measure is 28-day mortality rate, while secondary outcome measures include incidence of hypersensitivity reactions, need for invasive mechanical ventilation, and duration of ICU stay. The study aims to determine if lactoferrin can improve clinical outcomes in ICU patients when compared to placebo."
284,"GPT4 Correct Assistant: This is a 10-week randomized double-blinded crossover trial evaluating the efficacy of BiOkuris® chitin-glucan based formulation (BK003) versus placebo in patients with Crohn's disease in remission and having Irritable Bowel Syndrome-like symptoms. The study includes participants aged 18 to 75 years, both male and female, who have long-standing steroid-free clinical remission of Crohn's disease. The primary outcome measure is the subject's global assessment of relief responder rate, scored on a 5-point Likert scale. Secondary outcome measures include individual symptoms, stool consistency and dyschesia, stool number, IBS-related quality of life, anxiety and depression, serum CRp & fecal calprotectin, and adverse events. The study aims to determine if BK003 is effective in alleviating IBS-like symptoms in patients with Crohn's disease in remission."
285,"GPT4 Correct Assistant: This clinical trial aims to develop a novel biomarker, virus-host chimera DNA (vh-DNA), for response and prognosis prediction in HBV-related hepatocellular carcinoma (HCC) patients undergoing radiotherapy. The investigators hypothesize that HBV vh-DNA can accurately diagnose residual tumors and predict early recurrence/metastasis, allowing early intervention of salvage therapies. The study will analyze Capture-NGS and vh-DNA specific PCR data from HBV-related HCC patients. The primary outcomes will be the retrospective analysis of Capture-NGS and vh-DNA specific PCR, serial changes of serum vh-DNA copies, and survival between pre- and post-radiotherapy. The study will also prospectively test the concordance of vh-DNA copies between serum and plasma samples and analyze the serial changes of plasma vh-DNA copies associated with treatment response and overall survival."
286,"GPT4 Correct Assistant: The study aims to test the effectiveness of an online individual intervention program, the Meaning-Centered Coping Program (MCCP), in improving the psychological health and overall well-being of women diagnosed with breast cancer. The intervention program is designed based on the Meaning-Making Model, principles of meaning therapy, and existing meaning-centered psychotherapy approaches. The study includes 44 women with breast cancer who are randomly assigned to either the intervention group or the waitlist control group. The primary outcome measures include the Meaning in Life Questionnaire, Posttraumatic Growth Inventory-X, Stress Appraisal Measure, Global Meaning Violations Scale, Impact of Event Scale-Revised, Acceptance and Action Scale-II, and Hospital Anxiety and Depression Scale. The study aims to determine if the MCCP group would show better improvements in meaning in life and PTG scores, situational meaning (stress appraisal and violations in general meaning), automatic meaning making efforts, and psychological flexibility and distress compared to the control group."
287,"GPT4 Correct Assistant: This clinical trial aims to investigate the nutritional intake, nutritional status, and physical activity level in people who have undergone a major dysvascular lower limb amputation. The study includes participants aged 18 years or older who have had an amputation within the last seven weeks. The primary outcome measures include nutritional intake, diet quality, nutritional status, muscle mass, muscle strength, body mass index, and physical activity level. Secondary outcome measures include mortality, wound healing, quality of life, potential level of functioning, and physical functioning."
288,"GPT4 Correct Assistant: This study aims to assess the feasibility of a remote clinical trial in patients with diabetes mellitus and proteinuria. The study will evaluate the individual response to treatment with empagliflozin, an SGLT2 inhibitor, and its additive effects when combined with finerenone, a mineralocorticoid receptor antagonist. Participants will be followed for six months, with primary outcomes measuring the feasibility of remote data collection, including urine, blood pressure, and body weight measurements. Secondary outcomes will assess the individual response to treatment, including changes in albuminuria, blood pressure, body weight, eGFR, and fasting plasma glucose."
289,"GPT4 Correct Assistant: This study aims to test the effectiveness of high-intensity interval training on physical fitness, skills, and tactical performance among college male ice hockey players in China. The experiment involves 20 students in the experimental group and 20 students in the control group, with both groups undergoing 12 weeks of training. The experimental group engages in high-intensity interval training, while the control group participates in traditional technical skill training. The study measures various performance outcomes, including maximum oxygen uptake, endurance, power, agility, skill performance, passing and shooting performance, and tactical performance. The results of this study will provide a theoretical basis for improving ice hockey training methods and enhancing athletes' competitive performance, particularly in physical fitness and technique."
290,"GPT4 Correct Assistant: This clinical trial aims to explore the effects of chlorhexidine mouthwash on the oral microbiome, salivary pellicle, and vascular function in individuals with dental erosion and healthy controls. The study is a double-blind, randomized, crossover trial with two groups: healthy controls (n=12) and individuals with dental erosion (n=12). Participants will undergo 15 visits over a 15-week period, with each visit consisting of various measurements and sample collections. The primary outcomes measured include salivary protein identification via SDS-PAGE electrophoresis and proteomics analysis, microbiome diversity using DNA extraction and 16s ribosomal RNA analysis, blood pressure measurement, endothelial function test, and flow-mediated dilation of the brachial artery. The secondary outcomes include nitrate and nitrite in saliva and plasma, oxidative stress markers and redox-related molecules in saliva and blood samples."
291,"GPT4 Correct Assistant: The study aims to explore if a Pain and Coordination Plan (PAC-plan) for patients after accidental injury can reduce opioid use and improve quality of life. The study is a prospective randomized controlled trial with two arms: an experimental group receiving the PAC-plan and a control group with treatment as usual. The primary outcome is oral morphine equivalent (OMEQ) consumption 6 weeks after discharge, and secondary outcomes include OMEQ at 52 weeks, pain intensity, health-related quality of life, and other patient-reported outcome measures at 6 and 52 weeks. The study will recruit patients from the Division of orthopaedic surgery at Oslo University Hospital, Norway."
292,"GPT4 Correct Assistant: This is a cluster randomized controlled cohort study comparing guided versus standard antiplatelet therapy in intracranial aneurysm intervention with stents. The study includes patients with unruptured intracranial aneurysms who received intracranial stenting and standard dual antiplatelet therapy for at least 5 days before stent implantation. The primary outcome measure is ischemic events, including ischemic stroke, transient ischemic stroke (TIA), and stent thrombosis, measured 30 days after stent implantation."
293,"GPT4 Correct Assistant: This clinical trial aims to investigate the relationship between bone mineral density, gross motor function, and quality of life in children with cerebral palsy. The study involves two groups of participants: Group 1 (ambulant) and Group 2 (non-ambulant). The primary outcome measures include bone mineral density assessed using Dual-energy X-ray absorptiometry (DXA) scans, gross motor function measured using the Gross Motor Function Measurement Scale (GMFM), and quality of life assessed using the Quality of Life Questionnaire for Children (CP QOL-Child)."
294,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of Sulpiride on working memory gating in healthy volunteers aged 18-45 years. The study is a within-subjects, double-blind, randomized, placebo-controlled trial with two intervention days, each separated by at least 14 days. The primary outcomes are reaction time and accuracy during working memory gating tasks. Secondary outcomes include eye-blink rate, cognitive tasks, and questionnaires assessing mood, anxiety, and burnout."
295,"GPT4 Correct Assistant: The HYGEF study aims to determine the prevalence of obesity and hypertension in a cohort of Italian adolescents, investigate the link between specific gene polymorphisms and hypertension, and explore the relationship between urine Na+/K+ excretion and urinary markers of inflammation and oxidative stress in participants with selected genotypes. The study will enroll adolescents from high schools across Italy and collect data on their eating habits, lifestyle, family history, blood pressure, weight, height, urine, and saliva samples. The primary outcome measure is the establishment of a link between specific gene polymorphisms and hypertension, obesity, and sodium and potassium intake."
296,"GPT4 Correct Assistant: The EPigenetic Consequences in Children of Intravenous vs Volatile Anaesthesia for Surgery (EPIVA) is a randomized, clinical, feasibility trial investigating the effects of intravenous and inhalational anaesthesia on epigenetic changes in children undergoing hypospadias surgery. The trial aims to determine the feasibility of conducting a larger-scale study on anaesthesia and surgery in relation to changes in DNA markers (epigenetics) and whether the type of anaesthetic given impacts any observed changes. The study includes participants aged 6 months to 3 years, and the primary outcome measures include recruitment rate, retention rate, and protocol compliance. Secondary outcomes measure epigenetic changes in whole blood and comparisons between the two trial arms (TIVA vs inhalational anaesthesia)."
297,"GPT4 Correct Assistant: The study aims to investigate whether additional markers such as fT3 and the derived fT3/fT4 ratio can improve laboratory diagnostics in patients with hypothyroidism receiving levothyroxine (L-T4) in whom TSH cannot be used as a reflection of thyroid hormone status (e.g., central hypothyroidism). The study includes four patient groups with different forms of hypothyroidism and a control group of healthy euthyroid individuals. The primary outcomes are TSH, fT4, and fT3 concentrations, and the fT3/fT4 ratio. Secondary outcomes include total T4 (TT4), total T3 (TT3), reversed T3 (rT3), sex-hormone binding globulin (SHBG), acylcarnitines, and several amino acids. The study hypothesizes that patients with normal TSH levels but high fT4 concentrations will have fT3 levels or fT3/fT4 ratios within the reference interval, indicating a better assessment of thyroid hormone status in these patients."
298,"GPT4 Correct Assistant: The study aims to implement Palliative NonOperative Management (PNOM) in all Dutch hospitals for selected frail elderly patients with a limited life expectancy who sustain a hip fracture. The primary objective is to ensure these patients receive care that meets their needs in the final phase of life. The study design is a multicenter prospective cohort study, with a mix of methods in its four phases. The target population includes frail elderly individuals aged 70 or older who either live in a nursing home or receive similar care at home or another institution, and have at least one of the following characteristics: malnourished, mobility issues, or severe comorbidities. The study does not have any exclusion criteria. The study measures the effectiveness of nonoperative treatment for these patients."
299,"GPT4 Correct Assistant: This clinical trial aims to generate proof-of-concept for using a physiological CTV for radiotherapy treatment planning in patients with brain tumours. The study will involve 10 patients diagnosed with IDH-wildtype glioblastoma, and will use advanced MRI techniques to assess oxygenation status and cell proliferation. The primary outcome measure is the volume and location analysis of physiological and standard CTVs, while the secondary outcome measure is the pattern-of-failure analysis of the physiological and standard CTVs. The study aims to demonstrate that the physiological CTV is more precise in capturing microscale tumour invasion and has the same pattern-of-failure as the standard CTV, while being smaller in volume."
300,"GPT4 Correct Assistant: This clinical trial aims to evaluate the acceptance and effectiveness of SARS-CoV-2 vaccination in Systemic Sclerosis (SSc) patients who have undergone Autologous Hematopoietic Stem Cell Transplantation (AHSCT) and compare them with SSc patients who have not undergone AHSCT. The study will measure the cumulative incidence of asymptomatic or symptomatic COVID-19 infection after AHSCT as compared to non-AHSCT SSc patients, the proportion of SSc patients who refused vaccination, the cumulative incidence of symptomatic COVID-19 infection in both groups, the time of onset of first COVID-19 infection, the severity of symptomatic COVID-19, and the proportion of SSc patients with at least grade 3 adverse events after COVID-19 vaccination. The study will also assess the humoral response in SSc patients treated by AHSCT and in controls after mRNA vaccine against SARS-CoV-2."
301,"GPT4 Correct Assistant: The study aims to evaluate the effectiveness of the Chez NICU Home (CNH+) intervention, a bundled eHealth intervention designed to improve parental self-efficacy and family-centered care in the Neonatal Intensive Care Unit (NICU). The intervention consists of evidence-based educational modules, virtual and text message support, and a mobile application for parents to access the resources. The primary outcome measures are parental self-efficacy, measured using the Perceived Maternal Parenting Self-Efficacy Scale (PM-PSE) at baseline, 21 days, 6 months, and 12 months after the infant's discharge from the NICU. Secondary outcome measures include parental stress, NICU-specific stressors, parental depression, infant weight growth, infant head growth, infant length of stay, and infant mortality. The study will enroll 400 parents of infants admitted to the NICU and will be conducted in a stepped-wedge design across three NICUs in Canada."
302,"GPT4 Correct Assistant: This clinical trial investigates the effects of physical activity on physical fitness parameters, functional fitness age, and quality of life in women at risk of osteoporosis. Participants are at medium-high risk, 54 years old and over, and post-menopausal. The study consists of an experimental group participating in the Otago Exercise Program and a control group with no intervention. The primary outcome measures are lower extremity strength, upper extremity strength, aerobic endurance, upper extremity flexibility, agility, and quality of life. The study aims to determine the impact of the Otago Exercise Program on these parameters and overall quality of life."
303,"GPT4 Correct Assistant: This study aims to investigate the feasibility and effectiveness of a digital-based diet quality intervention for adolescents with overweight or obesity. The two-arm pilot randomized controlled trial involves adolescents aged 14-17 years with a history of having overweight or obesity and poor diet quality. Participants are randomized to receive either usual care or a nutrition intervention with personal goals, meal timing, nutrition skills, and home food environment intervention components delivered through text messaging. The primary outcome measure is the change in Healthy Eating Index (HEI) 2020 score, and secondary outcome measures include change in urinary Na:K ratio."
304,"GPT4 Correct Assistant: This clinical trial aims to predict cerebral hyperperfusion syndrome after carotid artery stenting using multi-parameter characteristics based on cerebral autoregulation. The study will enroll 400 patients with carotid artery stenosis and analyze the incidence of postoperative complications such as cerebral hyperperfusion and cerebral hyperperfusion syndrome within one month. The primary outcome measure is cerebral hyperperfusion, defined as a more than 100% increase in MCA mean velocity within 48 hours after carotid artery stent. The secondary outcome measures include the incidence of major stroke and cerebral hyperperfusion syndrome within one month post-operation."
305,"GPT4 Correct Assistant: This clinical trial aims to test the effects of a group-based, videoconference-delivered expressive writing (EW) program on emotional, social, and physical well-being among informal caregivers of persons diagnosed with cancer. The study will examine if participation in the EW intervention improves distress and identifies potential moderators of benefit. The intervention involves four group-based expressive writing sessions led by a trained facilitator, delivered via videoconference. Primary outcome measures include psychological distress, quality of life, and caregiver-specific quality of life. Secondary outcome measures include depression and perceived stress."
306,"GPT4 Correct Assistant: This clinical trial investigates the use of intravenous tranexamic acid (IV TXA) in patients undergoing gender-affirming mastectomy. It is a prospective, randomized, controlled single-surgeon trial conducted at the University of California San Francisco. The study aims to determine the effects of IV TXA on postoperative bleeding, hematoma, seroma, drain output, and time to drain removal. Patients aged 18 or older, who meet the WPATH guidelines for gender-affirming mastectomy, are eligible to participate. They will be randomized into two groups: one receiving IV TXA and the other receiving standard care. The primary outcomes will be the presence of hematoma, seroma, and drain output, and time to drain removal, while the secondary outcomes consist of thromboembolic events and wound complications."
307,"GPT4 Correct Assistant: The study aims to investigate the effects of smell training (ST) and trigeminal nerve stimulation (TNS) in treating COVID-related persistent smell loss. Participants will be randomly assigned to one of three groups: active ST, placebo ST, or a combination of TNS and active ST. The primary outcomes measured are changes in psychophysical olfactory function, perceived intensity and hedonic perception of odorants, and olfactory-related quality of life. Secondary outcomes include changes in long COVID symptoms, sustained attention, cognitive function, mood state, sleep quality, excessive daytime sleepiness, and symptoms of depression and anxiety."
308,"GPT4 Correct Assistant: This study is a randomized controlled trial evaluating the clinical effect of Tiaoshen acupuncture on primary insomnia. The participants are divided into two groups: the acupuncture group and the placebo acupuncture group. The primary outcome measure is the Pittsburgh Sleep Quality Index (PSQI) score. Secondary outcome measures include the Fatigue Scale-14, Epworth Sleepiness Scale, Self-Rating Anxiety Scale, Self-Rating Depression Scale, polysomnography, and heart rate variability. The study aims to determine the effectiveness of Tiaoshen acupuncture in treating primary insomnia and its impact on fatigue, anxiety, and depression levels."
309,"GPT4 Correct Assistant: This clinical trial is designed to evaluate the efficacy of shorter chemo-immunotherapy with or without anthracyclines for early-stage triple negative breast cancer. The trial includes two treatment arms: Arm I (usual chemo-immunotherapy) and Arm II (shorter chemo-immunotherapy). The primary outcome measure is breast cancer event-free survival (BC-EFS), comparing the two arms using Cox regression with adjustment for nodal status and stromal tumor infiltrating lymphocytes (sTIL) enrichment. Secondary outcome measures include pathologic complete response (pCR), residual cancer burden (RCB), distant relapse-free survival (DRFS), overall survival (OS), relapse-free survival (RFS), and adverse events. The trial also includes patient-reported outcomes, such as fatigue and physical function."
310,"GPT4 Correct Assistant: The Parent-Child Assistance Program (PCAP) is a three-year, intensive case management intervention for pregnant and postpartum individuals who have used substances during their current or most recent pregnancy. The program provides mothers with a case manager who helps them set goals, offers practical assistance, serves as a role model, and provides emotional support and encouragement. The case managers connect mothers to community resources and recovery supports tailored to their needs and goals. The standard PCAP program is designed to be a three-year intervention, but this study seeks to evaluate a one-year version of PCAP, which may be a better fit for many clients, especially those who are child welfare-involved. The specific objectives of this project are to: 1) establish causal evidence of effectiveness of PCAP-1 in preventing the need for foster care and promoting reunification, 2) establish causal evidence of the effectiveness of PCAP-1 in achieving other key goals, 3) estimate cost savings associated with PCAP-1 from the perspective of the agency administering a state's child welfare system, and 4) lay the groundwork to be rated by relevant federal registries according to the strength of the program's evidence of effectiveness for purposes of sustainability, spread, and replication."
311,"GPT4 Correct Assistant: This clinical trial is a comparative study of the Tomey OA-2000, Tomey CASIA2, and LenStar LS900 devices in measuring optical properties in normal, cataract, and special eye (aphakic or pseudophakic) subjects. The primary outcome measures are agreement between the test devices and the predicate device, precision of the test devices, and safety of the test devices. The study aims to evaluate the performance of these devices in different subject populations and determine their suitability for clinical use."
312,"GPT4 Correct Assistant: This is a Phase 3, interventional, multicenter, open-label, randomized study comparing the efficacy of zanubrutinib plus rituximab versus rituximab monotherapy in previously untreated patients with splenic marginal zone lymphoma (SMZL). The study aims to evaluate whether the combination of zanubrutinib and rituximab will result in improved Progression Free Survival (PFS) compared to rituximab alone. Approximately 120 participants will be randomized in a 1:1 ratio to receive zanubrutinib and rituximab (Treatment Arm A) or rituximab (Treatment Arm B). The primary outcome measure is the PFS rate at 3 years."
313,"GPT4 Correct Assistant: The study aims to compare the efficacy of perioperative US-guided serratus anterior plane block (SAPB) versus thoracic epidural in adult patients undergoing thoracotomy for malignancy resection. The primary outcome measure is postoperative total morphine requirement within 24 hours. Secondary outcomes include intraoperative fentanyl requirement, time to the first analgesia requested by the patient, postoperative pain, length of hospital stay, and patient satisfaction score. A total of 74 patients will be randomized into two groups, with 37 patients in each group. Inclusion criteria include physical status ASA II and III, body mass index (BMI) > 20 kg/m2 and < 40 kg/m2, and patients undergoing thoracotomy for cancer surgery. Exclusion criteria include patient refusal, known sensitivity or contraindication to local anesthetics, history of psychological disorders, localized infection at the site of block, coagulopathies, and patients needing prolonged mechanical ventilation postoperatively."
314,"GPT4 Correct Assistant: This clinical trial aims to assess the effectiveness of a PICU Journal intervention in enhancing parent/caregiver engagement in the Pediatric Intensive Care Unit (PICU). The study includes 75 parents/caregivers of children aged 1 month to 21 years admitted to the PICU at Monroe Carell Jr. Children's Hospital at Vanderbilt. The intervention is a hard-copy, customizable educational/therapeutic/expressive journal for parents/caregivers to document their child's PICU experiences and outcomes. The study measures parent/caregiver reported stress levels, care engagement levels, depression and anxiety symptoms, impact of events, and use and satisfaction with the PICU journal. Data will be collected at three time points: time one (T1) between 24 and 72 hours of the child's admission, time two (T2) peri-discharge, and time three (T3) three months post-discharge."
315,"GPT4 Correct Assistant: This clinical trial aims to improve the health and well-being of Hispanic/Latino autistic children by improving the utilization of the evidence-based autism intervention Ayres Sensory Integration and to improve stakeholder engagement in the research process for effective outcomes. The study compares two methods of stakeholder engagement, Design Thinking (DT) and Focus Groups (FG), to determine which is better at getting input on the facilitators and barriers to access therapy for autistic children. The trial includes participants who are autistic individuals, parents/caregivers, OT practitioners, teachers, and cultural experts. The primary outcome measure is the Stakeholder-Centric Engagement Evaluation, and the secondary outcome measures are the Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM), and the Feasibility of Intervention Measure (FIM)."
316,"GPT4 Correct Assistant: This clinical trial aims to evaluate harm reduction products as a second line intervention for adult smokers who do not quit with nicotine replacement therapy (NRT). The study includes participants aged 22-65 who smoke at least 10 cigarettes per day and have used NRT for four weeks without success. Participants are randomized into one of six groups, with different interventions such as Nicoderm, Nicorette 4Mg Chewing Gum, Nicorette Lozenge Product, on! Nicotine Pouch, BIDI e-cigarette, or remaining on NRT. The primary outcome measure is the change in smoke exposure for NRT non-responders, while the secondary outcome measures are smoking abstinence rates for NRT non-responders."
317,"GPT4 Correct Assistant: This study aims to investigate the effect of the flipped learning model on nursing students' asepsis knowledge and learning skills. The experimental group will receive flipped training on the principles of asepsis two weeks before the infection control course, while the control group will receive normal education. The study will be conducted with first-year students of Bilecik Şeyh Edebali University Nursing Department, and the primary outcome measure will be the effect of the flipped learning model on the course success of nursing students."
318,"GPT4 Correct Assistant: The clinical trial aims to evaluate the ability of Epitel's™ Remote EEG Monitoring System (REMI™) to record electroencephalography (EEG) of seizure events in an ambulatory setting for extended periods (14-28 days). Patients with a history of seizures who meet the study inclusion and exclusion criteria will be prescribed a REMI system. The primary outcome measure is the number of ictal events identified in the first 14 days, while the secondary outcome measure is the number of events identified in the entire 28 days."
319,"GPT4 Correct Assistant: This study aims to compare the effects of a multi-component training (MCT) programme versus a continuous cardiovascular training (CVT) programme on blood pressure levels in adult hypertensive subjects. The study is a controlled, randomised, longitudinal, and prospective clinical trial, with three intervention groups: MCT, CVT, and a control group. The intervention programmes last for 12 weeks, with two sessions per week, each lasting 60 minutes. The primary outcome measure is the change in blood pressure from baseline to week 12. Secondary outcome measures include changes in mean blood pressure, pulse pressure, dual product, baseline heart rate, weight, skeletal muscle mass, body fat mass, body mass index, body fat percentage, visceral fat, phase angle, waist circumference, total cholesterol, HDL, LDL, triglycerides, glucose, manual handgrip strength, upper body strength, and lower body strength."
320,"GPT4 Correct Assistant: The study titled ""Observance of Preoperative Fasting Time a Before-and-after Sensitization Campaign to Fasting Guidelines Study"" aims to assess the observance of preoperative fasting time before and after a sensitization campaign on preoperative fasting rules. The study includes adult participants undergoing a surgical procedure, excluding intubated patients, redo surgeries, and those with certain medical conditions. The primary outcome measure is the duration of liquid and solid fasting time before surgery. The study will also measure secondary outcomes such as preoperative anxiety, discomfort, thirst, hunger, nausea, vomiting, postoperative nausea and vomiting, patient satisfaction, post-operative quality of recovery, length of stay, and post-operative surgical complications."
321,"GPT4 Correct Assistant: The study aims to test the effects of the Mentored Planning to be Active + Family (MPBA+F) intervention on physical activity outcomes and health outcomes among rural Appalachian 7th and 8th grade children suffering from overweight and obesity. It is a community-based randomized controlled trial targeting 7th grade students in rural Appalachia, with half receiving MPBA+F and the other half receiving a comparison program of self-guided modules. The study measures changes in daily physical activity and body composition as primary outcomes, and aims to reduce high rates of overweight, obesity, and type 2 diabetes in Appalachia youth through effective, sustainable interventions."
322,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of virtual reality animation and ice massage on labor pain, duration of labor, and satisfaction in primiparous and singleton pregnancies. Participants are randomly assigned to either the experimental group (receiving ice massage or virtual reality animation for 20 minutes) or the control group (standard care). The primary outcome measures include labor pain, labor duration, and birth satisfaction. The study is designed as an open-label, parallel assignment study with no masking."
323,"GPT4 Correct Assistant: This clinical trial aims to study the epidemiology of cytomegalovirus (CMV) disease in pediatric and adult liver transplant recipients in China. The study includes participants aged 18 years and younger in the children group and older than 18 years in the adults group. The primary outcome measure is clinically significant CMV reactivation or CMV disease within 12 months of transplantation. The study follows participants for up to 22 months after liver transplantation, with secondary outcome measures including loss to follow-up and participant withdrawal."
324,"GPT4 Correct Assistant: This clinical trial aims to develop a biomarker-based process to identify patients who should be administered Prism Adaptation Therapy (PAT) for right brain stroke rehabilitation. The study will involve 180 participants, 120 with spatial neglect and 60 without, to define and validate brain imaging biomarkers that predict the presence of Aiming Spatial Neglect (Aim 1). The investigators will then examine the correlation between the biomarkers and improvements in daily life function after PAT (Aim 2) and determine if adding behavioral predictors to biomarker predictors accounts for additional variance in the trajectory of functional recovery (Aim 3). The goal is to establish a validated biomarker that routinely identifies Veterans with spatial neglect after stroke who are the best candidates for PAT, allowing for a more personalized approach to stroke rehabilitation."
325,"GPT4 Correct Assistant: The study aims to analyze blood samples from glioma-affected patients to detect and quantify circulating tumor DNA (ctDNA). The primary goal is to use liquid biopsy as a diagnostic tool for gliomas and validate the results with corresponding tissue biopsies. The study will include patients aged 18 or older with de novo primary brain lesions compatible with glioma according to contrast-enhanced magnetic resonance images. The intervention is a diagnostic test using liquid biopsy, and the primary outcome measure is the detection of circulating free DNA in blood samples."
326,"GPT4 Correct Assistant: This study aims to evaluate the safety, tolerability, and efficacy of combining zimberelimab, quemliclustat, and chemotherapy in patients with borderline resectable or locally advanced pancreatic cancer. The primary objectives are to determine the resection rate for patients with borderline resectable pancreatic cancer and progression-free survival for patients with locally advanced pancreatic cancer. Secondary objectives include estimating the efficacy of the treatment by measuring changes in CA 19-9 levels and objective response rate, and evaluating pathologic complete response rate and overall survival. The study will also explore the effects of the treatment on tumor-stromal cells and the tumor microenvironment."
327,"GPT4 Correct Assistant: This clinical trial aims to study the effect of probiotics, specifically MIYAIRI 588, on depression syndrome and risk factors of cardiovascular disease in hemodialysis patients. The study will randomize participants into two groups: one group will receive the intervention (MIYAIRI 588) and the other group will serve as the control. The primary outcome measure is the change in depression score using the Beck Depression Inventory Chinese version 2.0. The study will run for 3 months, and participants will take 1g of MIYAIRI 588 with each meal, three times a day."
328,"GPT4 Correct Assistant: The study aims to test the feasibility and acceptability of integrated cognitive-motivational enhancement therapy for alcohol use disorder (AUD) in young adults aged 18-24 years. The study is designed in two phases: K99 Phase (formative) and R00 Phase (efficacy). In the K99 Phase, 20 participants will receive 8 sessions of integrated cognitive-motivational enhancement therapy via videoconferences. In the R00 Phase, a 2-arm randomized control trial will be conducted, with 42 participants in each arm receiving either integrated cognitive-motivational enhancement therapy or cognitive-motivational therapy alone. The primary outcome measure is alcohol abstinence, assessed over 6 months. Secondary outcome measures include changes in AUD severity, alcohol-related negative consequences, alcohol and drug use, reasons for drinking, and affect."
329,"GPT4 Correct Assistant: This clinical trial compares the efficacy of a triplet therapy (encorafenib, binimetinib, pembrolizumab) versus a doublet/control therapy (nivolumab and ipilimumab) in patients with advanced melanoma. The study aims to enroll approximately 150 participants with metastatic or unresectable locally advanced BRAF V600E/K-mutant melanoma who have progressed during or after prior treatment. The primary outcome measure is the objective response rate, while secondary outcome measures include progression-free survival, overall survival, duration of response, disease control rate, time to response, and incidence of adverse events."
330,"GPT4 Correct Assistant: The study aims to investigate the effect of high fidelity and virtual reality-based simulation applications on simulation-based learning, reflective thinking, and therapeutic communication skills in undergraduate nursing students. The research is set to be conducted at Hacettepe University Faculty of Nursing, with a sample of 68 students, divided into two groups: one receiving high fidelity simulation and the other receiving high fidelity and virtual reality-based simulation. The study will use pre- and post-test assessments to measure the outcomes, with data analysis employing statistical tests to determine significant differences between the groups."
331,"GPT4 Correct Assistant: This clinical trial aims to compare the effectiveness of two air traps, Emboless and Fresenius 4008/5008 (F5008), in reducing microemboli of air during hemodialysis. The study uses a crossover design, with each patient undergoing two series of treatments using each air trap. The primary outcome measure is the reduction of air microemboli contamination, assessed using an ultrasound device. The study aims to include up to 30 patients, with a total of 120 dialyses."
332,"GPT4 Correct Assistant: The study aims to determine the impact of repetitive transcranial magnetic stimulation (theta burst stimulation) on movement among individuals with and without a concussion history. The purpose is to improve injury risk biomechanics to reduce the risk of future musculoskeletal injuries. The study uses a single-blinded cross-over design with two intervention groups: left dorsolateral prefrontal cortex (experimental) and vertex (control). Participants complete various tests, including reaction time, knee and hip flexion/abduction angles, and trunk flexion/lateral bending angles, before and after theta burst stimulation. Secondary measures include the NASA Task Load Index and Tampa Scale of Kinesiophobia 11."
333,"GPT4 Correct Assistant: The study, titled ""Extended Pancreatic Neck Transection Versus Conventional Pancreatic Neck Transection During Laparoscopic Pancreaticoduodenectomy (LPDEXCEPT): a Multicenter Randomized Controlled Trial,"" aims to compare the efficacy of extended pancreatic neck transection during laparoscopic pancreaticoduodenectomy with conventional transection. The study includes patients with benign or resectable malignant tumors of the lower common bile duct, Vater ampulla, head or uncinate process of the pancreas, aged between 18 and 80 years. The primary outcome measure is the incidence of clinically relevant pancreatic fistula at 3 months postoperatively. Secondary outcome measures include location of the pancreatic duct in the pancreatic transverse section, surgical performance of pancreaticojejunostomy, postoperative morbidity, and postoperative mortality."
334,"GPT4 Correct Assistant: This clinical trial aims to study the effects of traditional concurrent training and concurrent training consisting of strength training combined with dance classes on functional performance, cognitive function, and quality of life in older adults. Participants aged between 65 and 75 years who do not have a history of competitive sports or certain health conditions are eligible. The study will measure changes in dynamic balance, cognitive function, quality of life, static balance, seat to stand capacity, stairs climb capacity, leg strength, leg power, hand grip strength, and cardiorespiratory capacity. The study is designed as a randomized controlled trial with three arms: traditional concurrent training, concurrent training with dance classes, and a control group with no intervention."
335,"GPT4 Correct Assistant: This clinical trial aims to assess the effectiveness of a Virtual Reality (VR)-based sensory stimulation intervention in preventing delirium in Intensive Care Units (ICUs). The study includes participants aged 18 to 90 years who are admitted to the ICU for the first time. Patients with dementia, delirium, acute psychiatric illness, end-stage cancer, severe hearing impairment, or admitted with radioactive material are excluded. The study is designed as a randomized controlled trial with two arms: experimental (VR-based sensory stimulation) and control (usual care). The primary outcome measures are delirium incidence, duration, and severity. Secondary outcome measures include sleep quality, post-traumatic stress disorder, ICU memory, patients' clinical outcomes, quality of life, independence, and cognitive function."
336,"GPT4 Correct Assistant: This clinical trial, conducted at Sohag University Hospital, aims to study the outcome of surgical fixation of multiple fractured ribs. The primary purpose of the study is treatment, and it is designed as a randomized, parallel assignment, open-label study. The intervention is surgical rib fixation (open reduction and internal rib fixation), and the control group receives conservative treatment. The primary outcomes measured are the need and duration of mechanical ventilation and the severity of thoracic pain using a pain scale from 0 to 10. The study includes both male and female participants with multiple fractured ribs, excluding healthy volunteers. The study duration is one year."
337,"GPT4 Correct Assistant: This clinical trial aims to compare acute psychobiological responses to the Mannheim Multicomponent Stress Test (MMST) and the Trier Social Stress Test (TSST). Participants are healthy, recreationally active men and women aged 18-35 years who have provided informed consent. The primary outcome measure is the change in saliva cortisol levels, while secondary outcome measures include state anxiety inventory (STAI-S) response to acute psychological stress, heart rate, and salivary alpha amylase (sAA). The study uses a randomized, parallel assignment design with stratified block randomization based on sex and trait anxiety."
338,"GPT4 Correct Assistant: The DELI_NAFLD study is a randomized, placebo-controlled trial assessing the short-term efficacy and safety of postbiotic and metabiotic supplementation in adults with non-alcoholic fatty liver disease (NAFLD). The intervention consists of a twice-daily oral dose of a postbiotic containing dry fermented cell lysate and DNA fragments of the probiotic strain L. rhamnosus DV-NRRLB-68023, or a placebo, for three months. The primary outcomes are changes in hepatic fat content measured by MRI-PDFF and ultrasonography at three months. Secondary outcomes include changes in hepatic fat content, hepatic steatosis index, transaminases, biochemical hepatic steatosis indices, chronic systemic inflammatory markers, liver stiffness, TyG index, hs-CRP, total cholesterol, triglycerides, LDL-C, VLDL-C, HDL-C, waist circumferences, BMI, body fat percentage, and visceral fat content at three and six months."
339,"GPT4 Correct Assistant: This clinical trial aims to examine the effectiveness of Virtual Reality (VR) as an adjuvant therapy for Sickle Cell Vaso-Occlusive Crisis (VOC) in pediatric emergency departments. The study will compare the use of VR plus standard medical therapy to historical standard medical care alone in patients aged 6 to 21 years with sickle cell VOC who present to the emergency department. The primary outcomes measured are pain scores, patient disposition, length of stay in the emergency department, and time to emergency department disposition. The study will be conducted in two separate arms: a control arm with a retrospective chart review and a trial arm with a prospective convenience sampling of up to 100 patients who will receive VR in addition to standard medical therapy."
340,"GPT4 Correct Assistant: The study aims to investigate the efficacy of a web-based empowerment program on secondary cardiovascular prevention in patients post-acute myocardial infarction (AMI). The experimental intervention includes personalized, agreed, multidisciplinary, and blended actions focusing on patient empowerment. The primary outcome measures include changes in measurable risk factors such as BMI, systolic and diastolic blood pressure, LDL-cholesterol levels, glycemia levels, glycosylated hemoglobin in diabetic patients, and expired carbon monoxide in smokers. Secondary outcomes include lifestyle changes and cardioprotective treatment adherence. The study will enroll patients aged 18 to 75 years, with a maximum of 12 months follow-up."
341,"GPT4 Correct Assistant: The study aims to investigate the accuracy of pocket-sized ultrasound (PsUS) in diagnosing pediatric elbow fractures. The project consists of two parts: a feasibility study and an active study. The feasibility study will involve training study providers to perform elbow PsUS exams, while the active study will recruit children aged 1-16 years old with acute elbow pain. Participants will undergo bilateral standardized elbow exams using PsUS. The primary aim of the feasibility portion is to determine the acceptability of the PsUS study training for obtaining adequate elbow images. The primary aim of the active study is to compare the initial test performance characteristics of PsUS performed by bedside physicians to standard radiography in the diagnosis of pediatric elbow fractures."
342,"GPT4 Correct Assistant: This clinical trial aims to compare the effects of two different orthoses, a toe separator orthosis and a dynamic orthosis, on individuals with hallux valgus, a deformity of the big toe. The study will involve 60 participants, aged 18-65, with mild to moderate hallux valgus deformity. Participants will be randomly assigned to use either the toe separator orthosis or the dynamic orthosis for one month. Hallux valgus angle and plantar pressure will be measured at three time points: before using the orthosis, when first wearing the orthosis, and one month after using the orthosis. The Manchester-Oxford Foot Questionnaire will be used to assess the effects of the deformity on participants' daily activities and quality of life. Additionally, participants will evaluate their satisfaction with the orthosis using a numerical scale."
343,"GPT4 Correct Assistant: This clinical trial, titled ""Prospective Evaluation of Speech Function Through Patient- and Parent-response Outcome Measurements in Velopharyngeal Insufficiency,"" aims to evaluate the speech function of children with isolated or combined cleft palate due to velopharyngeal insufficiency. The study will use patient- and parent-response outcome measurements, specifically the CLEFT-Q and Intelligibility in Context Scale, to assess speech function before and after surgical treatment with pharyngeal flap. The primary outcomes will be the changes in speech function preoperatively and 1 year postoperatively."
344,"GPT4 Correct Assistant: This study aims to evaluate the efficacy of probiotics for the treatment of alcohol use disorder among adult males, in comparison to placebo and acceptance and commitment therapy (ACT) in a randomized controlled trial. The study will include three arms: probiotics, placebo, and ACT. The primary outcome measures are the differences in severity of alcohol dependence, anxiety, and alcohol craving between the groups at four time points (baseline, 8 weeks, 12 weeks, and 24 weeks after intervention). Secondary outcome measures include changes in depression, anxiety, serum pro-inflammatory cytokines, EEG monitoring, and gut microbiota profiles. The study will be conducted at the Second Affiliated Hospital of Xi'an Jiaotong University and the Psychiatric Outpatient Clinic of Advanced Medical and Dental Education Advanced Medical and Dental Education of Universiti Sains Malaysia."
345,"GPT4 Correct Assistant: This is a randomized controlled trial comparing the use of barbed absorbable suture versus standard absorbable suture for vaginal cuff closure after total laparoscopic hysterectomy. The study aims to measure the primary outcomes of vaginal cuff dehiscence at 30 and 90 days after surgery, and secondary outcomes including vaginal cuff complications, hospital stay, operative time, intraoperative blood loss, 30-day post-surgical morbidity, quality of life index, and sexual function. The study includes female patients aged 18 years and older undergoing elective total laparoscopic hysterectomy for benign pathology."
346,"GPT4 Correct Assistant: This clinical trial aims to test a new neurobiological model of gambling addiction by studying two opposite brain phenotypes in gambling addiction: striatal hyper-reactivity to reward combined with amygdala hypo-reactivity to emotional stimuli, and striatal hypo-reactivity to reward combined with amygdala hyper-reactivity to emotional stimuli. The study will include individuals with gambling problems and healthy controls. The primary outcome measures are striatal BOLD response to reward outcomes and amygdala BOLD response to emotional stimuli. The secondary outcome measure is the correlation between emotional states and gambling behavior in everyday life, measured using Ecological Momentary Assessment on gamblers' smartphones."
347,"GPT4 Correct Assistant: This clinical trial, titled ""Comparison of 2D 4K vs. 3D HD Laparoscopic Imaging Systems in Bariatric Surgery: a Randomized Controlled Prospective Trial,"" aims to compare the use of 2D 4K and 3D HD laparoscopic imaging systems in bariatric surgery. The study includes patients with a BMI greater than 35 and aged 18 or older, who are eligible for gastric bypass surgery according to SMOB guidelines. The primary outcome measure is operation time, while secondary outcome measures include intraoperative and postoperative complications and the workload of the operating surgeon. The study is designed as a randomized controlled trial with parallel assignment and single masking."
348,"GPT4 Correct Assistant: This clinical trial aims to evaluate the efficacy and safety of Huaier granule in patients with stage I primary ovarian fallopian tube cancer after peritoneal cancer. The study includes patients aged 18 years and older with histopathologically confirmed stage I primary ovarian cancer, fallopian tube cancer, or peritoneal cancer. The primary outcome measure is the 1-year progression-free survival rate. Secondary outcome measures include progression-free survival, overall survival rate, quality of life score (FACT-O), pain score, and rates of adverse events and serious adverse events. The study uses a single-arm, open-label design, and the intervention is Huaier granule, administered orally three times a day for 28 days, with cycles continuing until disease progression or 24 months have elapsed."
349,"GPT4 Correct Assistant: This study aims to investigate the prevalence of Small Intestinal Bacterial Overgrowth (SIBO) in critically ill patients requiring mechanical ventilation in the ICU. It is a non-invasive observational study using a modified hydrogen breath test for SIBO diagnosis. The primary outcome measure is the prevalence of SIBO in ICU patients, while secondary outcomes include the effects of SIBO on ventilator-associated pneumonia, ICU length of stay, and all-cause in-hospital mortality rate in critically ill patients."
350,"GPT4 Correct Assistant: This study aims to investigate exercise-induced hypoalgesia (EIH) in patients after total knee arthroplasty (TKA) and whether it changes with exercise intensity. It is a randomized, single-blinded study with 38 patients assigned to either low intensity exercises (LIE) or high intensity exercises (HIE) groups. The exercise programs lasted for five days during the hospitalization period, and pain severity was assessed using a Visual Analog Scale (VAS). The primary outcome measures are the change in pain severity and change in pressure pain threshold (PPTs) from admission to discharge."
351,"GPT4 Correct Assistant: The Nigerian Breast Cancer Risk-Reduction Study is a randomized, double-masked trial designed to assess the effects of risk assessment and counselling on adherence to risk reduction recommendations among female relatives of breast cancer patients in Southwestern Nigeria. The study includes women aged 20 to 75 years who are first-degree relatives of breast cancer patients and have no personal history of breast cancer or previous exposure to breast cancer risk assessment and counselling. Participants are assigned to either standard care or standard care plus risk assessment and counselling. The primary outcome measures are adherence to breast screening and lifestyle risk reduction recommendations, assessed using questionnaires. Secondary outcome measures include perception of familial breast cancer risk, knowledge of familial breast cancer risk, and knowledge, attitude, and perception towards genetic testing and breast cancer aetiology."
352,"GPT4 Correct Assistant: This study aims to investigate the interaction of CYP2B6 genotype and efavirenz on the pharmacokinetics and pharmacodynamics of methadone and tizanidine in healthy volunteers. The study involves three groups of participants: normal metabolizers, intermediate metabolizers, and poor metabolizers. The study will evaluate the effects of efavirenz pretreatment on the disposition and pharmacodynamics of methadone and tizanidine."
353,"GPT4 Correct Assistant: This clinical trial aims to evaluate serum magnesium levels in Type 2 Diabetes Mellitus patients. The study includes female participants aged 30 years or older with Type 2 DM, excluding those with renal failure, Type I DM, acute pancreatitis, hyperthyroidism, hyperparathyroidism, malignancies, on loop/thiazide diuretics, Mg supplements, or Mg-containing antacids. The study measures serum magnesium levels as a primary outcome measure over a one-year period."
354,"GPT4 Correct Assistant: This clinical trial aims to investigate the effect of Ophiochepalus striatus extract on serum IGF-1 and IL-6 levels in elderly patients with sarcopenia. The study is a randomized, double-masked, parallel assignment trial, with participants receiving either the Ophiochepalus striatus extract or a placebo for 14 days. The primary outcome measures are IGF-1 and IL-6 serum levels, while secondary outcomes include SARC-F Score, muscle mass, muscle strength, and physical performance. Participants must be aged 60 years or older and diagnosed with sarcopenia using AWGS criteria."
355,"GPT4 Correct Assistant: This study aims to evaluate the 2Morrow Chronic Pain Self-Management Program, a digital therapeutic mobile app, for improving pain self-management and function in patients with chronic pain. It is a 2-arm randomized control feasibility study to assess the feasibility of using the mobile app and an optional activity tracker, the feasibility of conducting a 2-arm trial, and to estimate the effect size for planning a larger efficacy trial. Participants in the intervention arm will use the mobile app and have the option to use a tracker that integrates with the app. The primary outcome measure is the PROMIS Pain Interference Scale - Short Form 6b, and secondary outcome measures are the Patient Health Questionnaire 9 (PHQ-9) and Generalized Anxiety Disorder 7 (GAD-7)."
356,"GPT4 Correct Assistant: The Stentless Florence Robotic Intracorporeal Neobladder (FloRIN) clinical trial is a study designed to evaluate the effectiveness of two different procedures for robot-assisted radical cystectomy in patients with bladder cancer. The experimental group receives the stentless FloRIN procedure, while the active comparator group receives the stented FloRIN procedure. The primary outcome measure is the rate of mid-term complications at six months, and the secondary outcome measure is the rate of perioperative complications within seven days. The study aims to compare the two procedures in terms of safety and efficacy."
357,"GPT4 Correct Assistant: This study aims to compare the effects of different storage conditions (dry and wet) on the microbial colony counts, surface roughness, colour stability, and compressive strength of removable retainers, as well as the Oral Health-Related Quality of Life (OHRQoL) of participants. The study will use a randomized crossover clinical trial design and involve 24 participants who will store their removable retainers in either dry or wet conditions for 6 months. The study will provide evidence-based guidelines for storing removable retainers and potentially save costs of retainer replacements."
358,"GPT4 Correct Assistant: The study aims to test a new model of continuity of nutrition care for sustainability and impact on malnutrition outcomes in older adults. The model involves enhanced communication and referrals between acute care hospital settings and community meal provision organizations, with the goal of improving food security, quality of life, and reducing determinants of malnutrition in patients aged 60 and older, particularly from vulnerable populations. The study will use a stepped wedge cluster-randomized trial design at eight sites throughout the US, and the results will inform future scalability of the model."
359,"GPT4 Correct Assistant: This clinical trial, titled ""Hemodynamic Effects of Modulating Circulating Ketone Bodies With 1,3-butanediol,"" aims to study the hemodynamic effects of 1,3-butanediol, a dietary supplement, in patients with chronic heart failure (NYHA class II-III) and left ventricular ejection fraction (LVEF) <40%. The study will be a randomized, crossover assignment with single masking, comparing the effects of 1,3-butanediol and placebo on cardiac output, stroke volume, heart rate, LVEF, and changes in circulating 3-OHB and free fatty acids (FFA) over a 6-hour period. The study is open to adults aged 18 years and older, excluding those with diabetes, significant cardiac valve disease, severe angina pectoris, severe comorbidity, and inability to give informed consent."
360,"GPT4 Correct Assistant: This clinical trial aims to investigate the effectiveness of subpectoral bupivacaine for pain management in adolescent reduction mammaplasty. The study is a randomized, parallel assignment, single-masked trial with two arms: one receiving subpectoral bupivacaine and the other receiving subpectoral saline. The primary outcome measure is post-operative pain score, while secondary outcome measures include narcotic use, length of stay in the post-anesthesia care unit, return to full activity, and demographics. The study includes female participants aged 13-21 undergoing bilateral reduction mammaplasty at Connecticut Children's from 1/1/2022-12/31/2025."
361,"GPT4 Correct Assistant: This clinical trial aims to evaluate the radiobiological effects of skin toxicities in breast cancer patients undergoing Pencil Beam Scanning Proton Therapy with the Spot Delete technique. The study will compare the extent of skin reactions in patients receiving this treatment to historical data from patients who did not receive the Spot Delete technique. Digital photographs and self-report questionnaires will be used to assess radiation dermatitis, and the study will investigate the relationship between the linear energy transfer (LET) of the proton beam and skin reactions. The primary outcome measure is the reduction in radiation dermatitis, with assessments conducted weekly over 10 weeks."
362,"GPT4 Correct Assistant: This is a multicenter, non-inferiority, randomized controlled trial investigating the effectiveness of generic versus reference cetrorelix acetate for ovarian stimulation using a GnRH antagonist protocol in women undergoing IVF. The study includes infertile women aged 20-42 years who are planning to undergo IVF/ICSI treatment. The primary outcome measure is the cumulative live birth rate. The study has two arms: one group receives generic cetrorelix acetate and the other group receives reference cetrorelix acetate. The study will run for an average of 18 months."
363,"GPT4 Correct Assistant: This clinical trial aims to evaluate the safety and tolerability of the combination of the anti-cancer drug peposertib and low-dose pegylated liposomal doxorubicin in patients with advanced sarcoma. The primary objectives are to determine the recommended phase 2 dose and the maximal tolerated dose of the combination. Secondary objectives include assessing the pharmacokinetics of the drugs in combination, estimating the objective response rate and progression-free survival in patients with leiomyosarcoma treated with the combination, and testing hypotheses related to the susceptibility of soft tissue sarcomas to the drug combination."
364,"GPT4 Correct Assistant: The study aims to examine the feasibility and potential benefits of a free online Zoom t'ai chi and qigong gentle movement and meditation program for individuals with chronic back pain. The primary objective is to determine if the program improves pain levels, sleep, and quality of life. The study consists of a prospective, randomized controlled trial with two groups: a t'ai chi and qigong exercise (treatment) group and a waitlist control group. The treatment group will participate in a 12-week, twice per week t'ai chi and qigong program, while the control group will wait to start the program until January 2023. The study will use self-administered survey instruments to assess primary outcomes of low back pain, sleep, and quality of life. A total of 300 participants will be recruited, with 150 in each group. Statistical comparisons will be based on four surveys: baseline, intermediate, post-intervention, and follow-up. Additionally, the study will explore if improvements in pain levels are different among smokers and those with unhealthy BMI compared to others."
365,"GPT4 Correct Assistant: The EMBOL-AF study is a multicenter, international, observational study designed as a retrospective registry that investigates the characteristics of systemic arterial embolic events after treatment of atrial fibrillation by catheter ablation. The primary objectives are to study the acute clinical profile, symptoms, signs, and results of image techniques of stroke/TIA associated with AFAbl, the acute therapeutic management of these events, and the sequelae and clinical consequences at 3 months of follow-up. The secondary objectives are to study whether the risk of stroke/TIA is more frequently associated with certain ablation techniques, whether the severity of stroke/TIA is associated with any specific ablation techniques, and whether other measures associated with AFAbl procedures have any impact on the incidence and severity of stroke/TIA."
366,"GPT4 Correct Assistant: This clinical trial aims to evaluate the patient-reported outcome measures (PROMs) during the acceleration of en-masse retraction of upper anterior teeth using a low-intensity direct electrical current. The study includes adult patients with class II division 1 malocclusion and compares two groups: one using electrical stimulation and another using traditional retraction. The primary outcome measures are the changes in the perception of pain and discomfort, while secondary outcome measures include changes in the perception of burning, swelling, chewing ability, speech ability, analgesic consumption, patient satisfaction, ease of the procedure, the possibility of repeating the procedure, and recommendation of the procedure to a friend. The trial uses questionnaires to assess these outcomes at various time points during the treatment."
367,"GPT4 Correct Assistant: This is a single-site, non-randomized prospective observational study examining the association between baseline plasma Amyloid-beta 42/40 (Aβ42/40) ratio and cognitive decline in men with prostate cancer upon starting Androgen Deprivation Therapy (ADT). The study aims to evaluate whether ADT is associated with a decline in plasma Aβ42/40 ratio and whether intensified ADT (iADT) receipt is associated with greater cognitive decline compared to ADT. The study includes participants with prostate cancer starting ADT (ADT Cohort) and participants in remission with no ADT (Prostate cancer Control (PC) Cohort). The primary outcome measures include the proportion of participants with cognitive decline, mean cognitive decline, and proportion of participants with cognitive impairment after ADT. Secondary outcome measures include change in mean plasma Aβ42/40 ratio, mean cognition score, and mean study partner-reported cognition score."
368,"GPT4 Correct Assistant: The High-dose Cephalexin for Cellulitis (HI-DOCC) trial is a multicentre, parallel-arm, double-blind, randomized controlled study comparing high-dose (1000 mg QID) cephalexin to standard-dose (500 mg QID) cephalexin for treating non-purulent cellulitis in adult patients. The primary outcome is oral antibiotic treatment failure within 7 days. Secondary outcomes include clinical cure, clinical response, unplanned healthcare visits, unplanned hospitalization, adverse events, antibiotic intolerance, antibiotic allergy, medication adherence, and health-related quality of life. The trial aims to determine if high-dose cephalexin is superior to standard-dose cephalexin in terms of treatment failure, adverse events, and health service utilization."
369,"GPT4 Correct Assistant: This study aims to determine the Turkish validity and reliability of the Health Literacy Scale for Acute Complications of Type 1 Diabetes for Children (8-12 years) and to provide a diabetes health literacy box game to 8-12-year-old children diagnosed with Type 1 diabetes. The study is conducted in two stages to evaluate the effect of educational games on acute complications of diabetes and health literacy in children. The experimental group participates in three interviews, while the control group only fills out data collection forms in three interviews. The study measures the validity and reliability of the Health Literacy Scale for Acute Complications of Type 1 Diabetes for Children (8-12 years) in Turkish and evaluates the diabetes health literacy of children with Type 1 diabetes aged 8-12 years."
370,"GPT4 Correct Assistant: This is a randomized controlled clinical trial comparing biofilm accumulation on the surface of zirconia versus titanium implants. The study will be conducted in the Master of Oral Surgery and Implantology of the Faculty of Dentistry of the Complutense University of Madrid. The primary outcome measure is the total amount of biofilm and specific bacterial species on implants placed prior to crown placement, at 6 months and 1 year after final crown placement. The study will include 30 participants, with 15 in each group, and will use a pilot study design to ensure robustness of the results."
371,"GPT4 Correct Assistant: The study ""Scentsational Smiles: The Impact of Aromatherapy on Alleviating Dental Anxiety in Children"" aims to investigate the effect of aromatherapy on dental anxiety in children aged 6-9 years old. The participants will be randomly assigned to one of three groups: no intervention (control group), rosemary group, or lemongrass group. The rosemary group will inhale two drops of rosemary oil for 3 minutes before dental anesthesia and extraction, while the lemongrass group will inhale two drops of lemongrass oil for the same duration. The primary outcome measures include pulse rate, oxygen saturation, blood pressure, and pain level, which will be measured before and after the procedure."
372,"GPT4 Correct Assistant: This clinical trial aims to investigate the effect of puzzles on concept learning in nursing students. The study will be conducted with first-year students of Bilecik Şeyh Edebali University Nursing Department. Participants will be divided into an experimental group and a control group. The experimental group will use puzzles for two weeks, while the control group will receive regular education. The primary outcome measure is student scores, which will be assessed after five weeks. The study aims to determine if the use of puzzles can improve nursing students' knowledge levels and understanding of vital signs concepts."
373,"GPT4 Correct Assistant: The study aims to determine the effect of the Transtheoretical Model (TTM) and motivational interview-based online intervention program on smartphone addiction and sleep quality levels in nursing students. The study is designed as a quasi-experimental study with pre-test and post-test, with intervention and control groups randomly selected. The intervention group will participate in a motivational interviewing program based on the TTM, while the control group will not receive any intervention. The primary outcome measures are the Smartphone Addiction Scale Short Form (SAS-SF) and the Pittsburgh Sleep Quality Index (PSQI)."
374,"GPT4 Correct Assistant: The study aims to compare the efficacy of Potassium-titanyl Phosphate (KTP) Laser alone and KTP Laser combined with Ivermectin 1% cream in treating facial rosacea. The study includes participants with Fitzpatrick skin type I-IV and permanent erythema, excluding those with a history of adverse events related to KTP laser therapy, pregnant or breastfeeding women, and those with intolerance or allergic reaction to ivermectin 1% cream. The study measures the efficacy of the treatments in reducing erythema as assessed by various indices, as well as clinical improvement of skin lesions, patient satisfaction, and the severity of telangiectasia. The study has a 16-week duration, with assessments at 4, 8, 12, and 16 weeks."
375,"GPT4 Correct Assistant: The study aims to investigate cerebral glucose metabolism in patients with neurodegenerative diseases and head trauma through a retrospective review of a large cohort of FDG PET data. Participants must be 18 years or older, and the study measures hypo or hyper regional metabolism in patients with neurodegenerative diseases using FDG PET. The primary outcome measures the characterization of different pathologies based on regional metabolism and functional activity of brain circuits. The study is designed to distribute FDG tracers in patients with neurodegenerative diseases to identify regions of altered brain function specific to each clinical condition. The study duration is 4 years."
376,"GPT4 Correct Assistant: The COVID-19 Antibody Responses in Cystic Fibrosis: CAR-CF study is a 3-year, prospective, longitudinal cohort study investigating SARS-CoV-2 seroprevalence and its clinical impact on people with Cystic Fibrosis (pwCF). The study will enroll pediatric and adult pwCF from participating CF centers and follow them for 24 months. Blood samples will be collected at baseline and months 6, 12, 18, and 24, with additional samples taken opportunistically. Serum from blood samples will be analyzed for SARS-CoV-2 antibodies. Clinical data will be collected from patient health records and input into case report forms. The study aims to observe changes in antibody prevalence over the course of the COVID-19 pandemic and to determine long-term clinical outcomes for pwCF who are SARS-CoV-2 seropositive."
377,"GPT4 Correct Assistant: The clinical trial titled ""The Use and Reproducibility of Duplex Ultrasound to Provide Indices of Left Common Iliac Vein Diameter"" aims to investigate the use of duplex ultrasound as a diagnostic tool for May-Thurner Syndrome in patients with unexplained left leg swelling. The study includes participants aged 18 and above, both symptomatic and asymptomatic, and measures the diameter of the left common iliac vein and the inter- and intra-operator variation of the diameter measurement using duplex ultrasound. The study is designed as a non-randomized, single group assignment, open-label trial with a duration of 6 months."
378,"GPT4 Correct Assistant: The study, titled ""The Health-Related Quality of Life of the Patients With Symptomatic Convergence Insufficiency,"" aims to investigate the impact of visual training on the health-related quality of life of patients with symptomatic convergence insufficiency. The study includes participants aged 8 to 15 years with myopia and convergence insufficiency, and they are divided into two groups: a training group that receives visual training and a non-training group that does not. The primary outcome measures are the changes in EuroQol five dimensions questionnaire (EQ-5D-5L) score and shortForm 6D (SF-6D) questionnaire score between baseline and 3 months."
379,"GPT4 Correct Assistant: This clinical trial, titled ""Sentinel Lymph Node Mapping and Detection With Indocyanine Green and Spy-Phi Handheld Camera Technology in Early-Stage Vulvar Cancer (PILOT),"" aims to investigate the effectiveness of using Indocyanine green (ICG) dye and a special camera technology for sentinel lymph node mapping in early-stage vulvar cancer patients undergoing surgery. The study will compare the detection rate of sentinel lymph nodes using ICG dye with the standard method using blue dye and radioactive tracer. The primary outcome measures include the detection rate of sentinel lymph nodes using ICG dye and blue dye, and the secondary outcome measures include sensitivity, specificity, and negative predictive value of ICG dye compared to the standard blue dye."
380,"GPT4 Correct Assistant: This study is a crossover, experimental, randomized, and double-blind trial that aims to compare the effects of different NMES protocols on evoked torque, muscle fatigue, sensory discomfort, and peripheral oxygen extraction in the triceps surae muscle of apparently healthy participants. The study participants will undergo five sessions with seven days between them, during which they will be exposed to various NMES protocols and their effects will be assessed. The primary outcome measures include submaximal voluntary isometric contraction, maximum voluntary isometric contraction, maximum evoked torque, and torque evoked during the fatigue protocol. Secondary outcome measures include muscle fatigue assessment before and during the muscle fatigue protocol, sensory discomfort during maximum evoked torques and fatigue protocol, electromyographic signals, and peripheral oxygen extraction."
381,"GPT4 Correct Assistant: The study titled ""Metabolic Effects of Four-week Lactate-ketone Ester Supplementation"" is a clinical trial investigating the effects of a combined lactate and ketone body ester supplement, known as LaKe Ester, on insulin sensitivity, lipolysis, appetite, and other related metabolic effects in participants with obesity. The study uses a randomized, double-masked, crossover design, with participants receiving either the LaKe Ester or a placebo treatment for four weeks, followed by a four-week washout period before crossing over to the other treatment. The primary outcome measure is insulin sensitivity, while secondary outcome measures include changes in body weight, composition, gastric emptying rate, cardiac output, echocardiographic parameters, blood concentrations of various metabolites, and mood and anxiety levels. The study aims to determine the effects of LaKe Ester supplementation on metabolic parameters in participants with obesity, and to assess its tolerability and impact on appetite control."
382,"GPT4 Correct Assistant: This 6-week study aims to explore the impact of FitnessGenes' platform on NHS staff wellbeing. Participants will undergo a DNA test and complete questionnaires to assess their mental and physical wellbeing. The primary outcome measure is the change in wellbeing as evaluated by the 5-item World Health Organisation Well-being Index (WHO-5). The study will also assess participant experiences with the platform, perceptions of genetic testing, and the sustainability of the personalized recommendations."
383,"GPT4 Correct Assistant: This clinical trial aims to identify volatile organic compounds (VOCs) in breath samples that can predict the presence of Invasive Pulmonary Aspergillosis (IPA) in patients with acute myeloid leukemia. Patients with a new diagnosis of acute myeloid leukemia and chest CT performed within 30 days from sampling are eligible for the study. Exclusion criteria include any condition impairing the patient's ability to provide informed consent. The study is designed as a single-arm, open-label, prospective longitudinal study. The primary outcome measure is the diagnosis of Invasive Pulmonary Aspergillosis, defined according to the updated EORTC criteria."
384,"GPT4 Correct Assistant: The study, titled ""Psoas Tenotomy Under Ultrasound,"" is a clinical trial aimed at treating hip injuries through psoas tenotomy under ultrasound guidance. The trial includes patients aged 18 years or older with ilio-psoas conflict after total hip replacement. The primary outcome measure is the success rate of the new ultrasound-guided ilio-psoas tendon tenotomy technique, evaluated by the disappearance of ilio-psoas conflict after surgery. Secondary outcome measures include patient pain, hip scores, technical difficulty of the surgical procedure, operative time, installation time, blood loss, hospital stay, scarring after surgery, quality of life, patient satisfaction, subjective value of the hip, forgotten hip sensation, Forgotten Hip score, early and late surgical complications, and the rate of patients requiring rehabilitation."
385,"GPT4 Correct Assistant: This clinical trial aims to compare the effectiveness of different local anesthetic volumes for thoracic paravertebral block (TPVB) in post-thoracotomy analgesia. The study includes participants aged 18 to 80 with elective thoracotomy surgery and excludes those with a history of chronic opioid or analgesic use. The trial consists of three arms: TPVB with 20 ml, 25 ml, and 30 ml of 0.25% bupivacaine, with each group receiving the respective volume under real-time ultrasound guidance. The primary outcome measures are pain scores assessed at various time points after surgery, and the secondary outcome measure is morphine consumption for 24 hours post-surgery."
386,"GPT4 Correct Assistant: This clinical trial aims to investigate the effect of muscle vibration on fatigue in patients with Multiple Sclerosis (MS). The study is an interventional type, involving 40 patients with MS, with 20 in the experimental group receiving vibration treatment in addition to traditional rehabilitation, and 20 in the control group receiving only traditional rehabilitation. The primary outcomes measured are mobility (motricity index) and postural control (Tinetti's scale, Berg's scale). Secondary outcomes include changes in fatigue (Fatigue Severity Scale, Modified Fatigue Impact Scale, Fatigue Scale for Motor and Cognitive Functions, Borg Scale, Medical Research Council Scale) and quality of life (Multiple Sclerosis Quality of Life-54 scale, Coping Orientation to Problems Experienced questionnaire)."
387,"GPT4 Correct Assistant: This is a Phase I study evaluating the safety and efficacy of the combination of osimertinib, cetuximab, and tucatinib in patients with EGFR-mutant Stage IV or recurrent non-small cell lung cancer who have acquired resistance to EGFR-tyrosine kinase inhibitors. The primary objective is to estimate the maximum tolerated dose (MTD) of the combination, while secondary objectives include evaluating toxicities and assessing the anti-tumor activity of the treatment."
388,"GPT4 Correct Assistant: This clinical trial aims to study the diagnostic efficacy of transbronchial cryobiopsy versus traditional transbronchial lung biopsy for diagnosing lung transplantation rejection. The trial includes patients aged 18-65 years who have undergone unilateral or bilateral lung transplantation and have unexplained pulmonary function decline, acute/chronic clinical lung injury, or new pulmonary infiltrates. The study will compare the diagnostic yield of transbronchial cryobiopsy with that of traditional transbronchial lung biopsy, with the reference standard being the result of Multi-Disciplinary Treatment (MDT). The trial will also measure the incidence of complications, sample size, number of alveoli, number of blood vessels, and percentage of the area of lung parenchyma without artifacts in the biopsy sample."
389,"GPT4 Correct Assistant: This clinical trial investigates selective fetal growth restriction (sFGR) in monochorionic twins, aiming to improve outcome prediction at the time of sFGR diagnosis. The study includes participants with a diagnosis of sFGR before 28 weeks of gestational age, and utilizes ultrasound as a diagnostic test. The primary outcome measure is a composite outcome consisting of fetal single or double demise, including selective fetal reduction and/or an iatrogenic elective birth < 32 weeks of gestational age because of fetal distress. Secondary outcome measures include ultrasound parameters, prenatal and postnatal attachment, post-traumatic stress, and PARCA-R evaluation."
390,"GPT4 Correct Assistant: The TransHealthGUIDE clinical trial aims to evaluate the effectiveness of an interactive educational digital platform for transgender and gender-diverse (TGD) youth and caregivers in reducing suicidal ideation and improving mental health outcomes. The study includes participants aged 15-25 years, and they will be randomized into either immediate access or deferred access groups. The primary outcome measure is suicidal ideation, while secondary measures include depression, anxiety, perceived family acceptance, family communication, and self-harm. The study will last 18 months, with assessments performed every 3 months."
391,"GPT4 Correct Assistant: This clinical trial aims to phenotype patients with alcohol and cannabis use disorders using the Addictions Neuroclinical Assessment. The study includes two participant groups: AUD (Alcohol Use Disorder) and CUD (Cannabis Use Disorder). The intervention is a 12-week CBT (Cognitive Behavioral Therapy) program, with AUD participants also receiving evidence-based pharmacotherapy guided by a pharmacotherapy algorithm. The primary outcome measures include changes in binge drinking days, average drinks per day, and alcohol craving for the AUD group, and changes in cannabis use frequency, amount of cannabis used per week, and cannabis craving for the CUD group. Secondary outcome measures include retention in treatment, change in depressive symptoms, change in anxiety symptoms, and change in quality of life."
392,"GPT4 Correct Assistant: This study aims to investigate the impact of positive, neutral, and negative expectation speech on pain intensity in patients with chronic low-back pain undergoing spinal manipulative therapy. The study is a randomized controlled trial with a blinded assessor, and the primary outcome measure is pain intensity. Secondary outcomes include the global perceived effect of improvement, patient expectations regarding spinal manipulative therapy, and perceived empathy in the therapeutic encounter. The study will analyze the immediate effects of the intervention and the patients' perceptions of the videos."
393,GPT4 Correct Assistant: This clinical trial aims to evaluate the effects of transcranial focused ultrasound (tFUS) on fronto-striatal resting state functional connectivity in healthy individuals. Participants will be randomly assigned to either active tFUS or sham tFUS intervention. The primary outcome measure is resting state functional connectivity between the nucleus accumbens and connected brain regions. The study will investigate whether tFUS increases or decreases the resting-state connectivity between these regions.
394,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of semaglutide on intracranial blood flow and brain-barrier permeability in patients with type-2 diabetes. The study is a randomized, double-blind, and placebo-controlled trial, with participants receiving either semaglutide or a placebo for one year. The primary outcome measures are intracranial blood flow, measured as total length and number of distal vessels, and blood-brain barrier permeability, measured by dynamic contrast-enhanced MRI. Secondary outcome measures include inflammatory markers such as hsCRP, interleukin-6, and tumor necrosis factor-a."
395,"GPT4 Correct Assistant: This study is a retrospective cross-sectional study that aims to potentially guide patients younger than 50 years old to undergo colonoscopy earlier. The study focuses on patients with colorectal neoplasms and compares the prevalence or occurrence of upper gastrointestinal diseases in two groups: those with normal colonoscopy examination and those with colorectal polyps diagnosed by colonoscopy. The study measures the prevalence of upper gastrointestinal diseases, including Helicobacter pylori, atrophic gastritis/intestinal metaplasia, reflux esophagitis, Barrett's esophagus, peptic ulcer, gastric polyps, low-grade intraepithelial neoplasia (LGIN), and high-grade intraepithelial neoplasia (HGIN) in the 1-year time frame."
396,"GPT4 Correct Assistant: The study aims to compare the screw tent pole technique and the autogenous bone block technique for augmentation of atrophic anterior maxilla in patients. It is a randomized clinical trial with a parallel group design. The primary outcome measure is bone gain, and the secondary outcome measure is bone quality evaluation. The study will follow patients for six months after the surgical procedure to assess the effectiveness of both techniques in bone augmentation."
397,"GPT4 Correct Assistant: This clinical trial aims to evaluate the Interferon Gamma Release Assay (IGRA) as a diagnostic test for monitoring anti-tuberculosis treatment in patients with pulmonary tuberculosis (PTB). The study includes participants with clinical symptoms of PTB and positive tests for mycobacterium tuberculosis. The primary outcome measure is the degree of correlation between changes in IFN-γ response in the first antigen tube (TB1) and the newly added antigen tube (TB2) and the reference standard of treatment response (culture conversion) in smear-positive and smear-negative/culture-positive pulmonary TB cases. The study measures these correlations at four time points: diagnosis, 30+4 days after treatment initiation, 2 months after treatment initiation, and at the end of the anti-TB therapy."
398,"GPT4 Correct Assistant: The clinical trial aims to evaluate the accuracy of brain responses to mechanical and radiofrequency stimuli in humans. The study will assess the effect of stimulation intensity on signal parameters like EP latency and amplitude. The relationship between these parameters and psychophysical results will be explored to investigate their relationship. The trial will be conducted in two experimental settings, with participants aged 18-60 years, and will use radiofrequency and pinprick stimuli to evaluate brain responses."
399,"GPT4 Correct Assistant: The study aims to characterize the biomechanical coupling of the brain to the skull in human volunteers with and without a history of traumatic brain injury (TBI) using magnetic resonance elastography (MRE). The objectives are to apply MRE to characterize the skull-brain interface in 25 mild TBI patients with a history of acute TME (TME+), 25 TME-patients (mild TBI patients without TME) and 25 healthy controls. The study endpoints are the completion of the MRE visit for each volunteer. The MRE data will be used to characterize the S-BI using the amplitudes and temporal delays of translation and rotation across the S-BI."
400,"GPT4 Correct Assistant: The study aims to determine the impact of home blood pressure monitoring in addition to pharmacist care compared to usual care on blood pressure control in women with elevated blood pressure. The study is a randomized controlled trial conducted in community pharmacies in Ontario, Canada. Eligible participants are female patients aged 18 or older with elevated blood pressure. The intervention group receives a home blood pressure monitor and enhanced community pharmacist care, while the control group receives usual pharmacist care. The primary outcome measure is the difference in change in systolic blood pressure between the two groups at 24 weeks. Secondary outcome measures include proportion of patients at their blood pressure target, percentage of home blood pressure readings recorded, adherence to medications, changes to antihypertensive medication regimen, lifestyle changes, and consultant satisfaction."
401,GPT4 Correct Assistant: This is a multicenter randomized controlled trial investigating the effects of moderate alcohol consumption on heart function in patients with recent myocardial infarction. The study includes participants aged 18 years and older who have been hospitalized for acute ST-elevation MI (STEMI) or non-ST elevation MI (NSTEMI) within 365 days prior to screening. The intervention involves randomizing participants to either moderate alcohol consumption (1 standard unit a day) or abstinence (no alcohol beverages) for 12 months. The primary outcome measure is the change in left ventricular ejection fraction between baseline and 12-month visits.
402,"GPT4 Correct Assistant: This clinical trial aims to evaluate the efficacy and safety of Lactulose for bowel preparation in patients with Inflammatory Bowel Disease (IBD). The study includes patients aged between 16-75 years who require a colonoscopy. The intervention groups are Lactulose oral solution and 3L-polyethylene glycol for bowel preparation. The primary outcome measures are effective preparation rate, incidence of adverse events, and taste score evaluated by patients. Secondary outcome measures include the effects of bowel preparation drugs on liver function and serum electrolyte."
403,"GPT4 Correct Assistant: This study aims to investigate the effects of aromatherapy on sleep quality and quality of life in older adults at risk of metabolic syndrome in the community. It is a longitudinal study with a prospective randomized control design, involving 64 elderly participants from two community bases. The experimental group receives lavender essential oil compound aromatherapy, while the control group receives a placebo, sweet almond oil. The primary outcome measures are the quality of sleep and quality of life of the participants, assessed using the Chinese version of the Pittsburgh Sleep Quality Index, and the World Health Organization Quality of Life Questionnaire -Taiwan Version and -old. The study is expected to show that the experimental group has better sleep and quality of life compared to the control group."
404,"GPT4 Correct Assistant: This clinical trial is a prospective, randomized controlled study designed to compare the efficacy of soft tissue augmentation with connective tissue graft (CTG) versus collagen matrix (Fibro-Gide) in patients with soft tissue thickness deficiency in the distal part of the lower jaw. The study includes 32 patients randomly assigned to either the CTG or collagen matrix group. The primary outcome measures include the amount of soft tissue thickness gain at 90 and 180 days post-surgery. Secondary outcome measures include assessment of pain syndrome, collateral edema, analgesic consumption, quality of life, attached mucosa measurement, and soft tissue aesthetics."
405,"GPT4 Correct Assistant: This clinical trial aims to evaluate the effectiveness of intraoral guided injection of botulinum toxin in the masseter muscle for myofascial pain. The study includes two participant groups: one receiving transcutaneous injection and the other receiving intraoral injection. The primary outcome measure is the pain score measured on a 10-point visual analogue scale (VAS) at 6 weeks post-injection. The secondary outcome measure is the OHIP-14 scale, which assesses patients' self-reported discomfort, disability, and functional limitation due to oral conditions at 6 weeks. The study is designed as a randomized, parallel assignment, single-masked trial."
406,"GPT4 Correct Assistant: The OptimizeD study aims to determine whether patients with moderate to severe depression respond differently to brief psychological treatment (Healthy Activity Program) or antidepressant medication (fluoxetine). The study will use machine learning to develop a precision treatment rule and assess the cost-effectiveness of optimization. The primary outcome measure is depression severity as measured by the Patient Health Questionnaire-9 (PHQ-9) at 3 months post-recruitment. Secondary outcomes include cost-effectiveness, depression remission, generalized anxiety, disability, minimal clinically important difference, and well-being."
407,"GPT4 Correct Assistant: This clinical trial, titled ""Pulmonary Immune Cell-microbiome Interactions in Acute Respiratory Distress Syndrome: The ILLUMINA-1 Study,"" aims to investigate the interactions between immune cells and the microbiome in patients with acute respiratory distress syndrome (ARDS). The study will include 40 patients with either none-to-mild or moderate-to-severe ARDS, and will collect endotracheal aspirate, bronchoalveolar lavage fluid, oral and nasal swabs, and blood samples. The composition of immune cell populations, immune cell function and differentiation, and the composition of the microbiome will be assessed using single-cell RNA sequencing and targeted amplicon sequencing. The primary outcome measures are the lung microbiome and lymphocyte populations, while secondary outcome measures include cell differential counts, trans-compartmental fluxes, auto-antibodies against type I interferons, white blood cell counts, cytokines, number and characterizations of respiratory pathogens, and number and characterizations of microorganisms."
408,"GPT4 Correct Assistant: This study aims to compare the effects of 3D printed insoles versus prefabricated insoles in subjects with flexible flat feet. Participants will be divided into two groups, one receiving 3D printed insoles and the other receiving prefabricated insoles. Subjective feedback will be collected at week zero and at the end of the fourth week. The study will use a randomized controlled design and the primary outcome measures will be pain levels assessed using the Visual Analog Scale and user satisfaction measured using the Quebec User Evaluation of Satisfaction with Assistive Technology questionnaire."
409,"GPT4 Correct Assistant: This cross-sectional study aims to investigate the pulmonary ventilation function between patients with primary and recurrent incisional hernia. The study population consists of patients diagnosed with abdominal incisional hernia, excluding those with other types of abdominal external hernia. Patients with complete pulmonary function test data are included, and the primary outcome is recurrence after repair. The study examines the pulmonary ventilation function as the main observation index, using a fixed threshold method to grade pulmonary ventilation dysfunction."
410,"GPT4 Correct Assistant: This study aims to determine the frequency and mapping of unstable coronary plaques in patients at intermediate and high risk of coronary artery disease, using 18F-Na PET scans. Participants are categorized into four groups based on calcium score. The primary outcome measures the evolution of unstable coronary plaques through calcium score variation, coro-scanner plaque size and density variations, coro-scanner morphological aspect variations, coro-scanner variations in terms of stenosis diameter, and 18F-Na PET scan binding and binding intensity variations. Secondary outcome measures include the effectiveness of primary cardiovascular prevention strategy initiation by the care team, comparison of study cohort symptoms evolution to a historical local cohort, and comparison of the rate of occurrence of cardiovascular events between study cohort and historical cohort."
411,"GPT4 Correct Assistant: The White Matter Hyperintensity Shape and Glymphatics study aims to investigate the association of complex White Matter Hyperintensity (WMH) shape with abnormalities in small vessel morphology and its relationship with cognition and other cerebral small vessel disease markers. This cross-sectional study will be conducted at the Leiden University Medical Center and Alrijne Hospital Leiden, including patients over 65 years of age from memory or geriatric clinics. The study will utilize 3T and 7T MRI scans, neuropsychological assessments, and general baseline data. The primary outcome measure is WMH shape, with secondary outcomes including brain clearance, perivascular space volume, and WMH subtypes. The study aims to provide important information about the pathophysiology of cerebrovascular pathology contributing to dementia."
412,"GPT4 Correct Assistant: This is a single-center, case-control, diagnostic study investigating the role of Artificial Intelligence (AI) in endoscopic diagnosis of Esophagogastric Junctional Adenocarcinoma. The study includes endoscopic images of patients aged 18-75 who underwent endoscopic examination or treatment. The intervention is an Intelligent Endoscopic Diagnosis System developed and verified based on deep learning. The primary outcomes measured are sensitivity, specificity, negative predictive value, positive predictive value, and accuracy of the AI model in comparison with endoscopists of different levels."
413,"GPT4 Correct Assistant: The study aims to evaluate the efficacy and safety of FRSW107, a recombinant human coagulation factor VIIIFc fusion protein, in pediatric patients with severe hemophilia A. The trial includes two participant groups: Group 1 (≥6 years old and <12 years old) and Group 2 (<6 years old pediatric patients). The primary outcome measure is the annual bleeding rate (ABR) during the treatment period. Secondary outcome measures include the annual joint bleeding rate (AJBR), frequency and severity of adverse events (AE/ADR), and the incidence of positive FVIII inhibitor."
414,"GPT4 Correct Assistant: This clinical trial aims to assess the differences in feasibility and acceptability of music therapy sessions played live compared to a recording at the palliative care ward of the University Hospital Zurich. The study includes patients with terminal illnesses, such as metastatic cancer or severe illness with limited life expectancy. The intervention involves a monocentric study with a prospective repeated measures design, where participants experience both live music therapy and a recording of the same music. The primary outcome measure is the intervention-specific acceptability questionnaire based on the Theoretical Framework of Acceptability. Secondary outcome measures include subjective quality of life, symptom severity, anxiety and depression levels, and objective measures of autonomic response, such as heart rate, heart rate variability, electrodermal activity, and temperature."
415,"GPT4 Correct Assistant: This clinical trial aims to investigate the effect of reusing operative supplies on cataract surgery and its impact on climate change. The study compares two groups: one where the surgeon changes the gown and glove between each case, and another where only the glove is changed. The primary outcome measure is the rate of postoperative complications, specifically endophthalmitis, within six months. The trial also examines the use of sterilization methods and the reuse of gowns to reduce financial costs and environmental waste."
416,"GPT4 Correct Assistant: This study aims to investigate the efficacy and safety of deep transcranial magnetic stimulation (dTMS) targeting the anterior cingulate cortex (ACC) in the treatment of adult patients with anorexia nervosa (AN). It is a multicenter randomized controlled study, with participants randomly assigned to either the dTMS treatment group or the pseudo-stimulation group. The primary outcome measure is body mass index (BMI), with secondary outcome measures including eating disorder-related questionnaires and psychological assessments. The study aims to establish a new intervention program for AN and provide a theoretical and practical basis for ACC-targeted dTMS treatment in China."
417,"GPT4 Correct Assistant: This clinical trial aims to assess the acceptability of expanded newborn screening to parents in France with or without genetics in the first line. The study will involve four participant groups: Population 1Q (parents or co-parents of a newborn child), Population 2 (parents or co-parents of a child 1 week to 3 years old), Population 3 (parents or co-parents of a child with a suspicious newborn screening result confirmed at the diagnosis phase), and Population 4 (parents or co-parents of a child diagnosed later based on clinical signs for diseases not included in the French newborn screening list but included in the lists of other countries). The study will use a mixed method design, combining quantitative and qualitative data, to measure parental acceptability of expanded newborn screening. The primary outcome measure is a mixed matrix of parental acceptability dimensions of expanded newborn screening. The study is expected to conclude in November 2023."
418,"GPT4 Correct Assistant: This clinical trial, titled ""Remote Tai Ji for Low Back Pain: a Randomized Trial,"" aims to study the effectiveness of T'ai Chi and Qigong Rehabilitation in treating low back pain. The trial includes participants aged 18 and older who have experienced low back pain for at least six weeks. The intervention involves a 12-week, twice-per-week t'ai chi and qigong gentle movement and meditation program, while the control group receives usual care. The study will measure primary outcomes using the Oswestry Disability Index and secondary outcomes using the visual analogue scale for low back pain, VAS leg pain, SF-36 Short Form Health Survey questionnaire, and 9-Item Pittsburgh Sleep Quality Index."
419,"GPT4 Correct Assistant: This observational study aims to assess the safety and efficacy of CD19-directed CAR T cell therapy in people living with HIV (PLWH) who have been diagnosed with B-cell lymphoid malignancies. The study includes participants aged 18 years and older with a documented history of HIV infection who have received CD19-directed CAR T cell therapy for acute lymphoblastic leukemia, diffuse large B-cell lymphoma, high-grade B-cell lymphoma, transformed follicular lymphoma, or primary mediastinal B-cell lymphoma. The primary outcome measure is the rate of toxicities related to CAR19 therapy, while secondary outcome measures include changes in CD4 count, absolute lymphocyte count, and HIV viral load. The study aims to provide valuable data on the safety and efficacy of CAR19 therapy in PLWH, which is currently limited due to the exclusion of HIV-positive patients in previous clinical trials."
420,"GPT4 Correct Assistant: The PEAR-MET study is a UK-based observational trial aiming to discover novel predictive biomarkers for treatment decision-making and improved outcomes in patients with advanced triple-negative breast cancer (TNBC). The study will run on Pear Bio's test while patients receive therapy as per their physician's choice. The trial involves a mandatory biopsy and blood collection from participants. The primary outcome measure is to establish a functional dose of each commonly used FDA-approved therapeutic/combination. Secondary outcome measures include complete response rate correlation accuracy, progression-free survival prediction accuracy, and overall survival prediction accuracy."
421,"GPT4 Correct Assistant: The clinical trial titled ""Delayed Elective Surgery in Inflammatory Bowel Disease - a Health Economic Analysis Including Quality of Life"" aims to investigate the effects of delayed surgery on health economy and quality of life in patients with Inflammatory Bowel Disease (IBD). The study involves two groups: those waiting for elective surgery and those who have already undergone surgery. The primary outcome measure is the impact of delayed surgery on health economy, including quality of life, and secondary outcomes include socioeconomic differences in delayed surgery and the effects of waiting for surgery on complications and failures. The study is conducted at Sahlgrenska University Hospital and includes participants aged 18 and above."
422,GPT4 Correct Assistant: This clinical trial aims to study the role of myeloid-derived suppressor cells (MDSCs) and cancer stem cells in non-small cell lung cancer (NSCLC) and their cross talks. The study will assess the non-immunological pro-tumor functions of MDSC isolated from lung cancer patients. The primary outcome measure is the comparative analysis of the modifications of phenotype and functions of lung cancer cell lines when exposed to MDSC extracted from patient tumor tissue.
423,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of substituting unsweetened sparkling water for sugar-sweetened beverages (SSB) on sweetness perception and physiological measures of glycemia among adolescents at risk of diabetes. The study will use an intervention model of a prospective, before and after, cohort study and will measure changes in 2-hour glucose concentration, dietary consumption of SSB and sparkling water, insulin sensitivity, glycemic variability, and flavor perception of beverage sweetness."
424,"GPT4 Correct Assistant: This study is a randomized, double-blind, monocentric, and prospective trial that aims to evaluate the early wound healing after the utilization of NOVOSYN® Quick and MONOSYN® Quick suture materials in resective periodontal surgery. The primary outcome measure is the early wound healing score (EHS) evaluated in patients undergoing resective periodontal surgery. Secondary outcome measures include postoperative wound dehiscence, dentinal hypersensitivity, oral candidiasis, angular cheilitis, swelling, bleeding, infection, systemic complications, pain assessment, patient satisfaction, bacterial contamination of the thread, and assessment of the handling of the suture material."
425,"GPT4 Correct Assistant: This clinical trial is a small, unicentric, randomized, controlled study investigating the use of coenzyme I for injection in the treatment of sudden sensorineural hearing loss. The study includes participants aged 18 years and older diagnosed with sudden deafness. Participants are randomly assigned to either an experimental group receiving conventional treatment plus coenzyme I for injection or a control group receiving conventional treatment alone. The primary outcome measures include pure tone average (PTA) and speech recognition rate, while secondary outcome measures include tinnitus handicap inventory (THI) and visual analogue scale of tinnitus (VAS). The study aims to evaluate the efficacy of coenzyme I for injection in treating sudden sensorineural hearing loss."
426,GPT4 Correct Assistant: The study aims to investigate the transferability of genetic newborn screening for cystinosis and hyperoxaluria to other laboratories and lay the scientific basis for screening for these diseases. The study will observe infants diagnosed through the pilot project and compare them to patients diagnosed outside of the project to determine whether early diagnosis and therapy lead to a more favorable prognosis. The study will test newborns for two mutations in the CTNS gene and one mutation in the PH1 gene and PH3.
427,GPT4 Correct Assistant: The study is a randomized controlled trial investigating the effect of negative pressure drainage on reducing surgical site infection in patients undergoing abdominal surgery. The trial is double-blinded and participants are randomized into two groups: those with negative pressure drainage in their surgical wound and those without. The primary outcome measures are the rates of surgical site infection at various time points after surgery. Secondary outcome measures include length of hospital stay and quality of life scores.
428,"GPT4 Correct Assistant: This clinical trial aims to compare the immune modulation effects of palbociclib, ribociclib, and abemaciclib with letrozole in neoadjuvant treatment for ER+/HER2- early breast cancer. The study will collect tumor tissue, blood, and stool samples before treatment, at 2 weeks after treatment, and after 12 weeks of treatment at the time of surgery. Immune modulation effects will be compared between treatment groups using breast tumor RNAseq analysis. The primary outcome measure is the expression of immune-related signature change after different CDK4/6 inhibitor treatments by RNAseq."
429,"GPT4 Correct Assistant: The study, ""Caring for Caregivers and People Living With Dementia Under Home-Based Primary Care,"" aims to develop and test the feasibility of implementing the Dementia Care Quality at Home intervention in two Home-Based Primary Care (HBPC) practices. The intervention focuses on improving outcomes for people living with dementia (PLWD) and their caregivers. The study will assess the feasibility, acceptability, and fidelity of the intervention through an open pilot and survey caregivers at the end of the pilot. Participants must be adults living with and caring for an individual with Alzheimer's Disease or Alzheimer's Disease Related Dementias, anticipate providing care for the next 6 months, and have been identified by the practice as experiencing caregiver stress. The intervention includes a standardized assessment tool, seven modules to optimize the well-being of PLWD and their caregivers, and a team-based case conference approach to address care challenges. Primary outcome measures include feasibility for the caregiver to engage with and complete baseline assessments, access educational materials and community resources, and the practice's ability to identify potential patients/caregivers and assess eligible patient/caregiver dyads."
430,"GPT4 Correct Assistant: This clinical trial aims to compare the effects of resistance training and flexibility training on postpartum depression in women. The study will include 36 postpartum females aged 20-40, divided into two groups: one receiving resistance training and the other receiving flexibility training. The primary outcome measures are exercise self-efficacy, depression symptoms, and maternal quality of life. The study will last for 8 weeks, with assessments conducted before and after the interventions."
431,GPT4 Correct Assistant: This clinical trial aims to investigate the surface hardness and wear characteristics of prefabricated and CAD/CAM milled artificial teeth in completely edentulous patients with angle class I maxillomandibular relations. Participants aged between 55 and 65 years will be randomly assigned to receive either prefabricated or CAD/CAM milled artificial teeth. The primary outcomes measured are the wear resistance and surface hardness of the artificial teeth over a 6-month period.
432,"GPT4 Correct Assistant: The ARIADA trial is a randomized, open-label, phase 3 trial evaluating the efficacy of trastuzumab deruxtecan (T-DXd) compared to standard therapy in HER2-positive breast cancer patients undergoing neoadjuvant treatment. The primary outcome measure is the pathologic complete response (pCR) rate of HER2-enriched patients. T-DXd is administered in cycles 1-3, and further treatment is decided by the intrinsic molecular (PAM50) subtype of the tumor. The study also evaluates the pathologic complete response (pCR) rate of other molecular groups, event-free survival, and overall survival."
433,"GPT4 Correct Assistant: This clinical trial aims to compare the effects of using intravenous anesthetic propofol and inhaled anesthetic sevoflurane on the prognosis of patients with primary brain, liver, lung, and ovarian cancer undergoing surgery. The study will measure overall survival, disease progression, postoperative complications, and Karnofsky performance status score. The trial is designed as a randomized, parallel assignment study with triple masking. The intervention groups are sevoflurane and propofol, and the primary outcomes are 6-month, 1-year, and 3-year overall survival, as well as the presence of disease progression. Secondary outcomes include postoperative complications within 30 days, Karnofsky performance status score at 6, 12, and 36 months, and length of hospital stays."
434,"GPT4 Correct Assistant: This study aims to assess the effectiveness of promoting physical activity-related health competence (PAHCO) among nursing students in Bavaria, Germany. The study is a cluster-randomized controlled trial (cRCT) with 16 schools and four intervention arms, including expert-based interventions delivered by physical activity specialists and teachers, as well as a control group with regular education and health promotion. The study measures short-term and medium-term outcomes related to PAHCO, psychological movement quality, quality physical activity, general health status, work ability, musculoskeletal complaints, and physical job stress in nursing."
435,"GPT4 Correct Assistant: This clinical trial aims to evaluate the effects of a Diosmin/Hespiridin combination on clinical outcomes in patients with Polycystic Ovary Syndrome (PCOS). The study includes premenopausal women aged 18-40 with PCOS, and participants are randomly assigned to one of three groups: a combination of Metformin and combined oral contraceptive (standard therapy), Diosmin/Hespiridin and combined oral contraceptive, or Diosmin/Hespiridin, Metformin, and combined oral contraceptive. The primary outcome measures are the improvement of inflammation and glycemic index, while secondary outcome measures include the improvement of PCOS status levels and patient's quality of life. The study lasts for four months."
436,"GPT4 Correct Assistant: The study aims to develop a fluorescent visualization system for non-visible lung cancer nodules. The primary objective is to test the use of Cetuximab-IRDye800 as a tracker during minimally invasive surgical procedures for lung cancer, to improve nodule detection and reduce the limitations of traditional localization strategies. Participants are clinical stage I non-small cell lung cancer patients considered candidates for minimally invasive surgical resection. The study will measure nodule detection, lymph node detection, unexpected cancer localization detection, negative surgical margins, detection speed, and toxicity incidence."
437,"GPT4 Correct Assistant: The Standard Versus Prolonged Antibiotic Prophylaxis After Pancreatoduodenectomy (SPARROW) trial is a multicenter, randomized controlled study designed to evaluate the additional value of pre-emptive antibiotic treatment on clinically relevant organ/space surgical site infections (OSIs) in patients undergoing pancreatoduodenectomy with a high risk for contaminated bile. The study compares perioperative versus pre-emptive antibiotic treatment for five postoperative days after pancreatoduodenectomy. The primary endpoint is the rate of clinically relevant organ/space surgical site infections within 90 days after surgery requiring a therapeutic intervention. The study aims to achieve a sample size of 322 included patients to demonstrate superiority for the intervention."
438,GPT4 Correct Assistant: This is a Phase 2 basket trial investigating the efficacy of a combination of oral sotorasib and intravenous panitumumab in patients with advanced solid tumors carrying the KRAS G12C mutation. The primary outcome measure is the objective response rate based on RECIST v1.1.
439,"GPT4 Correct Assistant: This study investigates the use of a novel volume-stable collagen matrix (VCMX) in the treatment of single gingival recession associated with non-carious cervical lesion partially restored. The study is a randomized clinical trial with two arms: one with a restorative procedure and coronally advanced flap (CAF), and the other with the same procedure plus the use of VCMX. The primary outcome measure is recession reduction, assessed at 180 days. Secondary outcome measures include dentine hypersensitivity, patient-centered esthetic evaluation, oral health impact profile, patient discomfort, number of analgesics, percentage of complete combined defect coverage, modification of the root coverage esthetic score, and clinical parameters."
440,"GPT4 Correct Assistant: This study investigates the effects of different nutritional support modes based on nutritional risk screening on the postoperative nutritional status of patients with gastrointestinal cancer. The study includes 302 patients admitted to the First Hospital of Shanxi Medical University from July 2021 to June 2023. Patients are divided into intervention and control groups based on their nutritional risk screening results. The intervention group receives a five-step malnutrition treatment model, while the control group receives conventional nutritional intervention. The study measures changes in various nutritional indexes before and after the intervention. The primary outcomes are nutritional risk screening 2002 and patient-generated subjective nutrition assessment. Secondary outcomes include dietary energy and protein intake, total energy, total protein, body mass index, fat-free weight, walking time, grip strength, and other nutritional indicators such as hemoglobin, albumin, and prealbumin. The study aims to analyze the effects of different nutritional interventions on patients' nutritional status and provide insights for clinical practice."
441,"GPT4 Correct Assistant: The clinical trial aims to investigate the effect of the abutment-prosthesis connection on marginal bone loss and gingival sealing around dental implants. It is a randomized parallel assignment study comparing two interventions: the experimental group using Connect® abutment and the active comparator group using a conventional multi-unit abutment. The primary outcome measure is marginal bone level measured by standardized periapical radiography at one year, while secondary outcome measures include peri-implant microbiome and peri-implant inflammation evaluated at one year. The study includes participants aged between 18 and 75 years with specific eligibility criteria."
442,"GPT4 Correct Assistant: This clinical trial, titled ""Non-invasive Monitoring of Blood Flow in the Brain by Using a Wearable Ultrasound Patch,"" aims to assess the clinical feasibility of a wearable ultrasound patch in comparison to a conventional transcranial Doppler probe for measuring blood flow in the brain. The study will recruit 60 participants with a diverse range of physiological parameters. The primary outcome measure is the agreement between the two devices on peak systolic velocity, mean flow velocity, and end diastolic velocity of the measurements. The study will run for 1.5 years."
443,"GPT4 Correct Assistant: This clinical trial, titled ""Hemodiafiltration With Endogenous Reinfusion on Uremic Toxins Clearance of Maintenance Hemodialysis Patients,"" aims to evaluate the clearance rate of uremic toxins by using hemodiafiltration with endogenous reinfusion (HFR) in maintenance hemodialysis patients. The study includes participants aged 18-75, who have been on hemodialysis for at least 3 months and have a blood flow rate of ≥200mL/min. The primary outcome measures are the concentrations of β2-microglobulin (β2-MG), indoxyl sulfate, and λ-free light chain (λFLC) before and after HFR. Secondary outcome measures include single-compartment urea clearance index (spKt/V), urea reduction ratio, and other uremic toxins. The study is designed as a single-group assignment, open-label trial."
444,"GPT4 Correct Assistant: This clinical trial investigates the effect of multi-kinase inhibitors (including sorafenib, lenvatinib, and donafenib) combined with bevacizumab as adjuvant therapy on recurrence, survival, and safety in patients with hepatocellular carcinoma (HCC) at high risk of recurrence after liver transplantation. The study includes participants aged between 18 and 75 years, with a confirmed pathological diagnosis of HCC and meeting at least one of several high-risk criteria. The primary outcome measure is the one-year recurrence-free survival rate (1-year RFS rate). The study is randomized, controlled, open-label, and multi-center."
445,"GPT4 Correct Assistant: The study is a pragmatic trial aiming to evaluate the effectiveness of a weekly supportive-expressive group therapy (SEGT) intervention for inpatients with limb loss compared to treatment as usual (TAU). The trial will be conducted at a free-standing rehabilitation hospital in Toronto, Canada. The primary objective is to determine whether SEGT leads to better mental health outcomes (depression and anxiety) for inpatients with limb loss compared to those receiving TAU. The study will recruit 130 inpatients, 65 in each arm, and will measure changes in Patient Health Questionnaire-9 (PHQ-9) scores, Generalized Anxiety Disorder 7-Item (GAD-7) scores, and Generalized Self-Efficacy Scale (GSE) scores at baseline, discharge, and 3 months post-discharge. The SEGT approach fosters mutual support, promotes openness and emotional expression, and has been shown to improve mental health outcomes in breast cancer survivors. The study will explore the potential of SEGT to improve mental health outcomes for inpatients with limb loss and enhance their ability to cope with their condition."
446,"GPT4 Correct Assistant: The Coagulation Parameters With Albumin in Decompensated Cirrhosis (CoPA-D) is an open-label, randomized controlled trial that aims to study the effects of 20% human albumin infusions on coagulation parameters in patients with decompensated cirrhosis of the liver. The study will include patients aged 18 to 70 years with decompensated cirrhosis and serum albumin levels ≤ 2.5 g/dl, who provide written consent to participate. The primary outcome measures are changes in clotting time, clot formation time, and maximum clot formation in both groups, while the secondary outcome measures include changes in inflammatory parameters, endothelial dysfunction, pulmonary function, renal function, adverse effects of human albumin solution, and albuminome. The study will last for one year, with a follow-up period of 28 days."
447,"GPT4 Correct Assistant: This study aims to evaluate the MRD biomarker in patients with potentially resectable stage III non-small cell lung cancer (NSCLC). The study includes 65 patients without EGFR/ALK mutation, who undergo neoadjuvant therapy, surgery, and adjuvant treatment. Peripheral blood samples are collected and analyzed through high-throughput sequencing. The primary outcome measure is disease-free survival (RECIST), while secondary outcomes include overall survival, prediction of recurrence by positive MRD, pCR rate of MRD-negative patients, negative MRD rate in pCR patients, and 2-year DFS of ctDNA-negative patients in the operation group and inoperable group. The study lasts for 3 years, with patients followed up for 2 years."
448,"GPT4 Correct Assistant: The study, ""Comparing Ciprofol and Propofol for Sedation in Hypotensive ICU Patients: a Single Center Prospective Cohort Study,"" aims to compare the effectiveness of ciprofol and propofol as sedatives in hypotensive ICU patients. The study includes participants aged 18 or older who require sedation for comfort and safety. The primary outcome measure is the proportion of patients meeting the RASS sedation score within 24 hours. Secondary outcome measures include dosages of propofol or ciprofol, dosages of norepinephrine, duration of mechanical ventilation, incidence of adverse events, ICU stay duration, and mortality rate."
449,"GPT4 Correct Assistant: The study aims to evaluate the intermediate effectiveness of laparoscopy with CO2 insufflation on the short-term evolution of premature infants with ulcerative necrotizing enterocolitis (NEC) who require surgical treatment. This is a pilot trial comparing laparoscopy plus laparotomy versus laparotomy alone in a 1:1 ratio. The main objective is to assess the inflammatory response on Day 2 postoperative in preterm infants with NEC who have undergone surgery. Secondary objectives include evaluating the postoperative biological inflammatory response, post-operative mortality, morbidity, re-intervention rate, length of hospital stay, and neurological morbidity in premature babies with NEC who have had a surgical intervention."
450,"GPT4 Correct Assistant: This is a randomized controlled trial comparing the efficacy of intense pulsed light (IPL) and diode laser for hair removal in the axilla region for women. The study involves 4 treatment sessions with a month apart, followed by a 30-day and 6-month follow-up. The primary outcome measures are hair count and global aesthetic improvement scale (GAIS). Secondary outcome measures include hair thickness, pain score, quality of life, satisfaction level score, and self-esteem scale. The study aims to determine the more effective and tolerable method for hair removal in the axilla region."
451,"GPT4 Correct Assistant: The PRecisiOn Medicine In StrokE (PROMISE) study aims to assess the evolution of plasma brain-derived tau (BD-tau) levels in 100 patients with acute ischemic stroke. The primary outcome is to characterize the time point when plasma BD-tau levels start to rise after onset, the type of rise, and until when plasma BD-tau levels continue to rise. Secondary outcomes include functional outcomes at 7 and 90 days, infarct progression, and the occurrence of early recurrent ischemic stroke, secondary intracerebral hemorrhage, and hemorrhagic transformation."
452,"GPT4 Correct Assistant: This clinical trial, titled ""Artificial Intelligent Accelerates the Learning Curve for Mastering Contrast-enhanced Ultrasound of Thyroid Nodules,"" aims to investigate the effectiveness of artificial intelligence in accelerating the learning curve for mastering thyroid imaging reporting and data system of contrast-enhanced ultrasound. The study includes participants with thyroid nodules, aged 18 years or older, who underwent conventional ultrasound, contrast-enhanced ultrasound, and fine-needle aspiration biopsy. Artificial intelligence is used to assist radiologists in extracting ultrasound features of thyroid nodules. The primary outcome measures are the area under the curve, the number of cases, and the case time, assessed at the end of the first, third, and sixth months of the trainees' rotation."
453,"GPT4 Correct Assistant: This clinical trial aims to investigate the effectiveness of AI-powered artificial vision for visual prostheses in patients with acquired blindness. The study will involve basic experimental studies with human participants, who will be implanted with visual prostheses such as Argus II, Orion, or Cortivis. The participants will undergo various tests to measure their perception and performance in simple tasks, such as object recognition and navigation. The study will compare the performance of prosthesis patients to that of normally sighted control subjects. The primary outcome measures include phosphene shape, pattern discrimination accuracy, and scene understanding performance."
454,"GPT4 Correct Assistant: The clinical trial titled ""Surveillance of Regional Nodal Basins in Patients With Primary High Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck"" aims to study the surveillance of lymph node basins in patients with primary high-risk cutaneous squamous cell carcinoma of the head and neck. The study participants are divided into three groups based on the stage of their cancer. The primary outcome measure is the number of participants with nodal metastasis, while the secondary outcome measures are the number of participants with local recurrence of squamous cell carcinoma, disease-specific death, and overall survival rate. The study uses ultrasound as a diagnostic test for surveillance."
455,"GPT4 Correct Assistant: The study aims to investigate salivary biomarkers as a diagnostic tool for gastroesophageal reflux (GER) in infants. It is a non-randomized, parallel assignment study with an open-label design. The study will include infants aged 1 month to 12 months with reflux symptoms and undergoing 24-hour esophageal MII-pH. Saliva samples will be collected from cases and controls, and the study will measure the prevalence of GERD in infants with symptoms of gastroesophageal reflux. The primary outcome measure is GERD symptoms, while the secondary outcome measures are the biochemical profile of saliva samples and possible circadian variations in the biochemical profile."
456,"GPT4 Correct Assistant: The study, titled ""Effect of Dulaglutide vs Empagliflozin on Non-alcoholic Fatty Liver Disease of Patients With Type 2 Diabetes Mellitus"" aims to compare the effects of Dulaglutide and Empagliflozin on liver fat fraction in patients with type 2 diabetes mellitus and Non-Alcoholic Fatty Liver Disease (NAFLD). The study is a prospective open-label observational trial conducted in Greece, where participants are divided into three groups: Empagliflozin group, Dulaglutide group, and Control group. The primary outcome measure is the change in liver fat fraction after 52 weeks of treatment, while secondary outcome measures include changes in HbA1c, Body Mass Index, Fatty Liver Index, Fibrosis-4 Index, Aspartate Aminotransferase to Platelet ratio Index, and NAFLD Fibrosis Score."
457,"GPT4 Correct Assistant: This clinical trial aims to assess the feasibility of using a surgical template for the surgical exposure of palatally impacted upper canines with an open-eruption technique compared to the conventional free-hand method. The study includes 20 patients in each group, and the primary outcome measures are the success of the intervention and the success of the open eruption technique. Secondary outcome measures include surplus costs, duration of the surgical intervention, postoperative pain, and intra- and postoperative complications."
458,"GPT4 Correct Assistant: The CAVEAT trial is a feasibility study examining the Clinician Assisted Videofeedback Exposure Approach Therapy (CAVEAT) for violence-exposed mothers and their young children (ages 1-5 years). The therapy is based on a combination of four evidence-based psychotherapy models and aims to improve maternal sensitivity, child's emotional communication, and parent-child interaction. The study does not have a control group and is designed as an open-trial feasibility study. The primary outcome measure is treatment satisfaction, while the secondary outcome measures are parenting stress and maternal attributions towards the child."
459,"GPT4 Correct Assistant: This clinical trial aims to reduce the risk of Type 2 diabetes (T2D) and pre-diabetes in Asian women and their children with a history of gestational diabetes (GDM) in Singapore. The study will assess the efficacy of a holistic lifestyle digital intervention, focusing on diet, physical activity, sleep, and mental well-being. The intervention will be compared to a control group using the HAPPY App and Oura ring and Oura App. The study will follow participants for one year, with a three-year follow-up period, and measure glucose tolerance changes, anthropometric measurements, blood pressure, biosample collection, bioelectrical impedance analysis, depression, anxiety, health status, sleep, lifestyle, and social-emotional development in children."
460,"GPT4 Correct Assistant: This study aims to investigate the effect of dry heat and dry cold application on pain, anxiety, and fear levels in school-age children before blood sample collection. The study is a randomized controlled trial, with participants aged 7-12 years divided into three groups: control (no intervention), dry heat application, and dry cold application. The primary outcome measure is the Wong Baker Faces Pain Rating Scale, measured one minute after blood sampling. Secondary outcome measures include the Child Fear Scale, Child Anxiety Scale, and Medical Procedures Fear Inventory."
461,"GPT4 Correct Assistant: The clinical trial aims to evaluate the safety profile of chemoreduction with intra-arterial melphalan, followed by ruthenium brachytherapy, in patients with choroidal melanoma who would otherwise need enucleation due to tumor size. The study includes participants aged 18 or older with a diagnosis of choroidal melanoma with a thickness of 8 mm or greater on ultrasound evaluation. The intervention consists of intra-arterial injection of melphalan followed by ruthenium brachytherapy. The primary outcome measure is the determination of treatment safety through electroretinography (ERG) exams at baseline, 1, 3, and 6 months after the first intervention. Secondary outcome measures include reduction of tumor size, best corrected visual acuity (BCVA), signs of intraocular inflammation, treatment-related adverse events, and globe salvage."
462,"GPT4 Correct Assistant: The study aims to analyze the incidence of trauma in a general hospital in Villavicencio, Colombia. It is an observational retrospective trial that includes patients admitted to the emergency ward due to trauma, with no age or gender restrictions. The study focuses on blunt and penetrating injuries and measures outcomes such as mortality, hospitalization length, ICU need, and mechanical ventilation need within 28 days or at discharge. The objective is to provide essential information to prioritize policies, resources, and improve clinical practice guidelines for trauma management."
463,GPT4 Correct Assistant: The Lumbosacral Spinal Stenosis - Non-Invasive Postural Therapy for Older Adult Veterans (LSS-NIPT) trial aims to evaluate the effectiveness of non-invasive postural therapy (NIPT) for older adult veterans with Lumbar Spinal Stenosis. Participants must be between 60 and 80 years old and have symptoms for over 3 months. The intervention includes the use of durable medical equipment (DME) and training to maintain a flexion posture during a 6-week trial. The primary outcome measure is the change in mobility as determined by actigraphy at Week 6 compared to baseline.
464,"GPT4 Correct Assistant: This is a pilot study aiming to assess the effects of self-administered nitrous oxide (SANO) on urodynamic study (UDS) parameters. The study participants will be randomly assigned to receive SANO during one UDS run and oxygen during the other. The primary outcome measure is bladder capacity, and secondary outcome measures include pain, anxiety, post-void residual, max flow rate, detrusor overactivity, and detrusor pressure at maximum flow. The study is designed to support participants experiencing lower urinary tract symptoms and aims to explore the effects of SANO on UDS parameters."
465,"GPT4 Correct Assistant: The study ""Adverse Childhood Experiences, AdaPtatiOn and Breast Cancer"" aims to investigate the impact of adverse childhood experiences on the quality of life of women in remission from breast cancer. The intervention includes genetic measures such as biological and epigenetic assessments. The primary outcome measure is the quality of life assessed using the Short Form Survey 12 (SF-12 scale). Secondary outcome measures include fear of recurrence, fatigue, anxiety and depression, attachment, adverse childhood experiences, resilience, and RMSSD values. The study is designed as a single-arm study with a sample size of 200 participants aged 18 or older, who have had breast cancer and are in remission."
466,"GPT4 Correct Assistant: This clinical trial aims to assess the effectiveness of the DiscoveryTM AI-assisted polyp detector system during screening colonoscopy in clinical practice. The study is a single-center, crossover trial, comparing the adenoma detection rate (ADR) and polyp detection rate (PDR) between expert and non-expert endoscopists using both conventional colonoscopy and colonoscopy assisted by AI. The primary outcomes are ADR and PDR, while the secondary outcome is the adenoma miss rate (AMR). The study will also evaluate the diagnostic performance of the AI-assisted system."
467,"GPT4 Correct Assistant: This clinical trial aims to investigate the effectiveness and tolerability of a low glycemic index (LGI) diet in pregnant people with epilepsy. The study will enroll 21 participants, with 14 in the LGI diet group and 7 in the control group. The primary outcome measures are the tolerability of the LGI diet, seizure frequency, gut bacteria composition, and metabolite alterations. The study will provide insights into the potential benefits of the LGI diet for pregnant people with epilepsy, while also examining its effects on gut bacteria and metabolic pathways."
468,"GPT4 Correct Assistant: This study aims to investigate the feasibility of using mesothelin-targeted CAR-T cells as a neo-adjuvant treatment for patients with resectable pancreatic cancers. The primary outcome measure is the proportion of major pathologic response on resected pancreatic tumor specimens. Secondary outcome measures include radiological response, rate of R0 surgical resection, serious adverse events, and disease-free and overall survival."
469,"GPT4 Correct Assistant: This clinical trial aims to assess the efficacy of a Decision Support System (DSS) and a machine learning web application called TREAT (TREatment Adherence SupporT) in fostering adherence to oral anticancer treatments among 100 metastatic breast cancer (MBC) patients over a three-month period. The DSS is designed to help patients manage their oral treatment and enhance adherence through evidence-based education. The study also seeks to identify clinical, psychological, and quality of life factors that predict adherence to oral anticancer treatments among MBC patients."
470,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of weight bearing exercises with and without Jaffrey's core stability exercise training on dynamic balance and trunk muscles strength in children with Down Syndrome. The study includes children aged 4 to 10 years, both genders, who can stand and walk. The trial is designed as a randomized, parallel assignment, single-masked study. The primary outcome measures are Pediatric Balance Scale and Trunk Control Measurement Scale, both assessed at 4 weeks."
471,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of melatonin as a dietary supplement on glycemic parameters, cardiovascular disease risk factors, bone metabolism markers, and quality of life in peritoneal dialysis patients. The study is a randomized, quadruple-masked, parallel assignment trial with an active comparator group receiving melatonin and a placebo group. The primary outcome measures include serum concentrations of lipoprotein-a, malondialdehyde, high sensitivity c-reactive protein, soluble intercellular adhesion molecule-1, fasting glucose, pentosidine, carboxy-methyl lysine, procollagen 1 intact N-terminal propeptide, osteoprotegerin, tartrate-resistant acid phosphatase 5b, receptor activator of nuclear factor kappa-Β ligand, systolic blood pressure, diastolic blood pressure, triglyceride, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, kidney disease quality of life index, Beck depression test, and Pittsburgh Sleep Quality Index. The secondary outcome measures include serum concentrations of albumin, calcium, phosphorous, and intact parathyroid hormone."
472,"GPT4 Correct Assistant: This clinical trial aims to optimize the strategy for oxygen delivery during cardiac surgery under cardiopulmonary bypass (CPB). The study includes patients aged over 18 years who are scheduled for elective cardiac surgery at the university hospital of Lille, France. The intervention involves the use of CPB as usual care, with specific management strategies left to the discretion of the anesthesiologist. The primary outcome measure is the values of DO2 calculated with the CONNECT software, measured every 20-30 seconds during CPB and up to 28 days post-surgery. Secondary outcomes include the incidence of postoperative acute kidney injury, postoperative delirium, and vital status up to 28 days postoperative."
473,"GPT4 Correct Assistant: This clinical trial aims to investigate the changes in lumbar region temperature during auricular acupressure at the Kidney point in healthy volunteers. Participants will be randomly divided into two groups: AA-SA (auricular acupressure on the left ear, auricular acupressure on the right ear, sham auricular acupressure on the left ear) and SA-AA (sham auricular acupressure on the left ear, auricular acupressure on the right ear, auricular acupressure on the left ear). The primary outcome measures are the change in temperature of the left and right lumbar regions during the procedure. Secondary outcome measures include the proportion of auricular acupressure side effects."
474,"GPT4 Correct Assistant: This clinical trial aims to compare three different strategies of mean arterial pressure (MAP) management during cardiopulmonary bypass (CPB) in patients undergoing cardiac surgery. The three groups of treatment are: Standard MAP (MAP values between 50-60 mmHg), High MAP (MAP values between 70-80 mmHg), and Patient-tailored MAP (MAP comparable to the patient's pre-operative MAP). The primary outcome measure is the peak serum lactate level (Lmax) during CPB. Secondary outcome measures include the area under the curve (AUC) of the serum lactate values, number of cases with serum lactate peak > 3 mmol/l during CPB, and evaluation of intraoperative cerebral perfusion, among others. The study will enroll 993 patients and the primary endpoint will be compared using the Mann-Whitney test."
475,"GPT4 Correct Assistant: The clinical trial aims to study the acute effects of furosemide on hemodynamics and pulmonary congestion in patients with acute decompensated heart failure. The study involves administering 80 mg of furosemide intravenously and measuring blood pressure, peripheral oxygen saturation, pulmonary fluid content, and other parameters at various time points up to 6 hours. The primary outcome measure is the change in pulmonary fluid content after furosemide administration, measured using remote dielectric sensing (ReDS)."
476,GPT4 Correct Assistant: This clinical trial aims to study the effectiveness of a smartphone application in reducing binge drinking among university students aged 18-25 years. The study participants will be randomly assigned to either the experimental group (using the smartphone application) or the active comparator group (using a standard binge drinking control). The primary outcome measure is the change in the number of standard drinks per week over a 30-month period. Secondary outcome measures include changes in phosphatidylethanol (PEth) concentration at various time points during the study.
477,"GPT4 Correct Assistant: This clinical study aims to evaluate the potential benefit of nitazoxanide in patients with type 2 diabetes mellitus. The study includes 70 patients with glycated hemoglobin (HbA1c) between 7% and 9%, and a body mass index (BMI) of ≥ 25 kg/m2. Participants will be randomly assigned to either a control group receiving metformin and dipeptidyl peptidase-4 (DPP-4) inhibitors or an experimental group receiving nitazoxanide 500 mg orally twice daily in addition to metformin and DPP-4 inhibitors. The primary outcome measure is glycemic control, assessed by fasting blood glucose and glycated hemoglobin levels at 12 weeks. Secondary outcome measures include insulin resistance, lipid profile, and serum levels of A-kinase anchoring protein 1 and asprosin at 12 weeks."
478,"GPT4 Correct Assistant: This clinical trial aims to investigate clinical risk factors of autism and elucidate changes in gut microbiome in Egyptian autistic children. The study will analyze the intestinal microbiome and metabolome in autistic children aged 3-9 years and assess their correlation with clinical outcomes and disease severity. The trial will not involve any intervention and will focus on prenatal, natal, and postnatal history, as well as stool sample collection and fecal metabolome analysis."
479,"GPT4 Correct Assistant: The study aims to develop and test an internet-based self-help money management program for adults with severe mental illness. The program will consist of four weekly modules and will be compared to a waitlist control group. The primary outcome measures are changes in financial self-efficacy, financial behaviour, and financial well-being. Secondary outcome measures include psychological well-being, anxiety symptoms, depressive symptoms, and quality of life. The study will also assess treatment adherence, treatment satisfaction, and acceptability of the internet for delivering online programs."
480,"GPT4 Correct Assistant: This clinical trial aims to investigate the effectiveness of Startle Adjuvant Rehabilitation Therapy (START) in enhancing arm function post-stroke. START is a low-cost, accessible solution that uses a startling acoustic stimulus alongside traditional therapy to activate the brainstem and enhance training outcomes. The trial will randomize participants into experimental and sham control groups, measuring changes in electromyography (EMG) onset and amplitude, movement onset and linearity, functional reaching task scores, and skill transfer to untrained tasks. The study aims to determine if START can improve functional outcomes for stroke patients, particularly those with low socioeconomic status."
481,"GPT4 Correct Assistant: This clinical trial investigates the effects of endoscopic lung volume reduction on diaphragm function and conformation in patients with COPD. The intervention involves endobronchial valve insertion, and the study measures changes in diaphragmatic strength and conformation before and 3 months after the procedure. The primary outcomes are transdiaphragmatic pressure and diaphragmatic conformation, assessed using transdiaphragmatic pressure measurements and high-resolution computed tomography."
482,"GPT4 Correct Assistant: The study aims to evaluate the clinical performance of dual- and light-cure bulk-fill resin composites in Class II restorations over a two-year period. Participants must be between 21 and 50 years old with at least three permanent molars and premolars requiring Class II restorations due to primary carious lesions. They must also have full and normal occlusion and maintain adequate oral hygiene. The study is a randomized clinical trial with three arms: Fill-Up, QuiXfil, and Tetric N-Ceram Bulk Fill. The primary outcome measures are esthetic, functional, and biological properties, assessed using FDI criteria."
483,"GPT4 Correct Assistant: The NET RETREAT trial is a phase II study comparing the effects of 177Lu-DOTATATE PRRT versus everolimus in patients with metastatic/unresectable midgut neuroendocrine tumors who have progressed after previous PRRT. The primary objective is to evaluate the effect of these treatments on progression-free survival (PFS). Secondary objectives include evaluating toxicity and safety, overall response rate (ORR), overall survival (OS), post-progression survival (PPS), time to second objective disease progression (PFS2), and patient quality of life. Patients are randomized into two arms, receiving either 177Lu-DOTATATE or everolimus."
484,"GPT4 Correct Assistant: This clinical trial aims to compare the effects of Mulligan techniques versus McKenzie extension exercises for patients with chronic unilateral radicular low back pain. The study will include 32 participants aged between 28 and 50 years with lumbar radiculopathy. The primary outcome measures are pain reduction, Oswestry Disability Scale, and lumbar Range of Motion. Both groups will undergo treatment for four weeks, with two sessions per week and single session per day. Data will be analyzed using SPSS 29."
485,"GPT4 Correct Assistant: This is a Phase 2, multicenter, long-term, open-label extension trial investigating the safety, tolerability, and efficacy of weekly subcutaneous doses of TransCon CNP in children and adolescents with Achondroplasia. The study includes participants aged 3-15 years who have completed a previous clinical trial with TransCon CNP. The primary outcome measures are safety and tolerability, measured by the incidence of treatment-emergent adverse events. Secondary outcome measures include height Z-scores and annualized growth velocity."
486,"GPT4 Correct Assistant: This study aims to explore the impact of illness perceptions and coping strategies on the quality of life of patients with paroxysmal atrial fibrillation (PAF). The study is an observational design, and the participants' quality of life is measured using the 12-item Short Form Health Survey (SF-12). The study is inclusive of patients aged 18-75 years with a diagnosis of PAF, who can read and write in Chinese. Exclusion criteria include severe complications and certain psychiatric conditions. The study aims to assess the mediating effects of self-efficacy, coping, depression, and anxiety on the quality of life of PAF patients."
487,"GPT4 Correct Assistant: The LORENA Trial is a clinical trial investigating the effectiveness of transanal local excision for organ preservation in early rectal cancer without adjuvant treatment. The study aims to determine the success rate of patients with no need for Total Mesorectal Excision after follow-up and secondary outcomes such as morbidity rate, radicality of resection, histological poor outcome predictor rate, and radical rescue surgery specimen quality. The trial includes patients with clinical staging cT1N0M0 rectal cancer and excludes patients younger than 18 years old, those scheduled to receive adjuvant chemotherapy, and those with a clinical TNM staging different to T1N0M0."
488,"GPT4 Correct Assistant: This study aims to evaluate the impact of the center volume-outcome relationship on mortality in patients undergoing surgery for Type A Aortic Dissection (TAAD). The study aims to investigate outcome predictors in patients undergoing surgery for TAAD, including clinical and perioperative variables. The study will evaluate four different surgical strategies and aims to determine whether precise risk stratification can provide better patient counseling and be used for unit-surgeon benchmarking. The study will follow up patients beyond 15 years."
489,"GPT4 Correct Assistant: This clinical trial aims to assess the effects of virtual reality and traditional guided visualization on academic stress and performance among physiotherapy and nursing students at the University of the Balearic Islands. The study will randomize participants into three groups: an experimental group that undergoes virtual reality guided visualization of exams, an active comparator group that undergoes traditional guided visualization, and a control group that receives no intervention. The primary outcomes are between-group and intra-group changes in academic stress and perceived stress from the last month. Secondary outcomes include between-group differences in stress levels, blood pressure, maximal heart rate, and salivary cortisol levels just before exams, as well as differences in exam qualifications."
490,"GPT4 Correct Assistant: This clinical trial aims to compare the use of remimazolam and propofol as anesthetic induction agents for morbid obesity patients undergoing laparoscopic sleeve gastrectomy. The study involves 44 subjects in each group, with an expected dropout rate of 10%. The primary outcome measure is the rate of hypotension event during anesthesia induction. Secondary outcome measures include induction time, and vasopressor (total amount) during anesthesia induction."
491,"GPT4 Correct Assistant: This study aims to test the drug darolutamide in combination with leuprolide acetate and exemestane in patients with recurrent ovarian granulosa cell tumors. The primary objective is to determine the objective response rate of the drug combination, while secondary objectives include determining the duration of response, progression-free survival, and overall survival. The study also seeks to elucidate the toxicities of the drug combination and identify biomarkers predictive of response. Patients receive exemestane and darolutamide starting before the first cycle and continue throughout each cycle, with leuprolide acetate administered on day 1 of each cycle. The study measures the patients' response to the drug combination and monitors any adverse events."
492,"GPT4 Correct Assistant: This clinical trial aims to evaluate the safety and effectiveness of using the drug nivolumab in combination with chemotherapy (cisplatin and gemcitabine) for the treatment of nasopharyngeal carcinoma (NPC) in children, adolescents, and young adults. The primary objective is to determine the rate of grade 3 or higher immune-related adverse events during induction chemoimmunotherapy. Secondary objectives include estimating the 2-year event-free survival, evaluating the objective response rate, and assessing the feasibility of combining chemotherapy with an anti-PD1 immune checkpoint inhibitor. The study will also explore various exploratory objectives, such as estimating 5-year event-free survival and overall survival, comparing response assessment methods, and evaluating treatment outcomes."
493,"GPT4 Correct Assistant: This is an observational cohort study using MRI to measure gastrointestinal (GI) function, lung structure and function, and liver endpoints in children with cystic fibrosis aged 6 to 11 years. The study aims to identify changes in these measures before and after starting ETI (Elexacaftor/ Ivacaftor/ Tezacaftor). Participants will undergo MRI scans at baseline and at several timepoints after consuming a high-fat meal. The primary outcome measure is Delta Small Bowel Water (DeltaSBW), which is a measure of the change in small bowel water between study timepoints. Secondary outcome measures include small bowel water content, liver volume, liver elastography, and lung ventilation."
494,"GPT4 Correct Assistant: This clinical trial aims to compare the analgesic efficacy and safety of methylprednisolone versus dexamethasone in caudal block for children undergoing hypospadias surgical repair. The study is a randomized, double-blind, controlled bi-center study with the primary outcome being the duration of analgesia. Participants are male children aged 1 to 6 years, and the trial measures the duration of analgesia, severity of postoperative pain, and side effects."
495,"GPT4 Correct Assistant: This is a prospective randomized pilot study evaluating the addition of hemodiafiltration (HDF) to ex-vivo lung perfusion (EVLP) for the regeneration of marginal donor lungs. The study includes participants with marginal donor lungs according to ISHLT criteria, donor age ≥ 55 years, smoking history ≥ 20 pack-years, infiltrates in chest radiograph, significant secretions in bronchoscopy, and organisms on sputum gram stain. The primary outcome measure is the suitability for transplantation of the lungs after 6 hours of EVLP with HDF, and the secondary outcome measures include survival, length of mechanical ventilation, length of ICU stay, length of hospital stay, and lung function parameters at various time points."
496,"GPT4 Correct Assistant: This study aimed to compare the effectiveness of white noise and multisensory stimulation in retinopathy examination on premature infants. The study employed a randomized controlled experimental design, with premature infants as the study participants. The infants were randomly assigned to three groups: the control group, the white noise group, and the multisensory stimulation group. The white noise group received auditory stimulation through the presentation of white noise, while the multisensory stimulation group received additional visual and tactile stimuli during the retinopathy examination. Several outcome measures were used to evaluate the effectiveness of the interventions, including physiological responses, behavioral indicators, and overall examination success rate. The findings of this study have the potential to contribute to the development of effective and well-tolerated retinopathy examination protocols for premature infants."
497,"GPT4 Correct Assistant: This clinical trial, titled ""A Modified Calculation Formula for Meibomian Gland Grading,"" aims to investigate the effectiveness of a modified calculation formula for grading Meibomian Gland Dysfunction. The study includes participants aged 18 to 80, excluding contact lens wearers, those with a history of eye surgeries, systemic health conditions affecting ocular health, and those unable to cooperate with examinations. The primary outcome measures are the area of the Meibomian Glands (MGs) and the whole eyelids, as well as the WTW distance of the cornea. The study compares the previous calculation formula with the modified calculation formula for Meibomian Gland Grading."
498,"GPT4 Correct Assistant: This is a single-blind randomized clinical trial aimed at preventing oral mucositis in head and neck cancer patients undergoing radiotherapy. The study compares the effectiveness of a zinc gluconate spray and a sodium bicarbonate rinse in reducing the incidence and severity of oral mucositis. The primary outcome measure is the presence of oral mucositis one week after the end of radiotherapy, while secondary outcomes include the time of onset and severity of oral mucositis. The study is open to patients aged 18 and older, regardless of sex, who have a diagnosis of head and neck cancer and are undergoing local radiotherapy."
499,"GPT4 Correct Assistant: This clinical trial aims to determine the predictive ability of a panel of biomarkers in saliva for healthy and periodontally affected subjects. The study includes participants aged 18 or older with various periodontal health statuses, excluding those with uncontrolled diabetes, compromised general health, drug or alcohol abuse, and those who have undergone certain surgeries or antibiotic intake within specified timeframes. The primary outcome measure is the combination of salivary biomarkers, including C-reactive protein (CRP), triggering receptor expressed on myeloid cells-1 (TREM-1), interleukin (IL)-1beta, metalloproteinase (MMP)-8, IL-10, IL-6, monocyte chemoattractant protein-1 (MCP-1), Macrophage Inflammatory Protein-1 Alpha (MIP-1), interferon-gamma (IFN-gamma), osteoprotegerine (OPG), Receptor activator of nuclear factor kappa B ligand (RANKL), and Tumor Necrosis Factor-Alpha (TNF-alpha)."
500,"GPT4 Correct Assistant: This study aims to compare the effectiveness of a dual-hormone artificial pancreas system with a single-hormone system in managing blood glucose levels in adults with type 1 diabetes. The dual-hormone system uses both insulin and glucagon for glucose control, while the single-hormone system uses insulin alone with rescue carbohydrate recommendations. The study involves a 12-hour inpatient trial with unannounced exercise sessions and meal challenges, comparing the two systems in terms of time spent below the target glucose range and the occurrence of hypoglycemic events."
501,"GPT4 Correct Assistant: This clinical trial investigates the effect of white noise, heart sound, and music on reducing neonatal pain during heel lance in infants with a gestational age of 28-42 weeks. The study uses a randomized controlled experimental design and measures the pain of infants using the Neonatal Infant Acute Pain Assessment Scale (NIAPAS). The trial also evaluates the duration of the procedure and the crying time. The intervention groups include exposure to white noise, heart sounds, and music that the mother listened to most frequently during pregnancy."
502,"GPT4 Correct Assistant: This clinical trial aims to compare the effectiveness of two training methods for clinicians in Caregiver Skills Training (CST). The first group will receive remote training and supervision, while the second group will receive face-to-face training and supervision. Both groups will undergo 15 hours of training, followed by 12 weeks of supervision. The study will measure changes in caregiver skills and knowledge, parenting stress, and child adaptive behavior using various assessment tools. The results will help determine if the type of training provided to facilitators (face-to-face versus remote) impacts parent progress."
503,"GPT4 Correct Assistant: This clinical trial aims to investigate the effectiveness of transcranial electrical stimulation (TES) in addition to therapeutic exercises for the functional recovery of subjects with subacromial pain syndrome. The study is a randomized clinical trial with a total of 64 participants, aged between 18 and 65 years, with a duration of pain greater than or equal to 3 months. Participants will be randomly assigned to either the experimental group (strengthening exercises + a-TES) or the control group (strengthening exercises + a-TES placebo). The primary outcome measures include changes in the Pain and disability Index (SPADI), Western Ontario Rotator cuff (WORC) scale, Visual Analogic scale for shoulder pain intensity, and shoulder pain pressure threshold. Secondary outcome measures include changes in shoulder muscle strength, active range of movement, joint position sense, head forward posture, scapulohumeral rhythm, subacromial space width, scapulothoracic muscle activation, and primary motor cortex (M1) amplitude."
504,"GPT4 Correct Assistant: This study aims to retrospectively determine any association between hyperbaric oxygen therapy (HBOT) and change in verbal scores in children with autism spectrum disorder (ASD). Children aged 2 to 17 years, diagnosed with ASD and receiving applied behavioral analysis at Oxford Recovery Center, were screened for inclusion. Some of these children had elected to receive HBOT (at least 40 sessions for 60 minutes at 2.0 ATA). The primary outcome measures are the verbal scores measured using the Verbal Behavior Milestones Assessment and Placement Program (VBMAPP) and the Assessment of Basic Language and Learning Skills (ABLLS). The study compares the verbal scores of children who underwent HBOT to those who did not."
505,"GPT4 Correct Assistant: This study is a comparative randomized double-blinded trial investigating the analgesic efficacy of ultrasound-guided adductor canal block versus 4-in-1 block in patients undergoing knee surgeries. The primary outcome measures include postoperative pain scores at various time points (6, 12, 18, and 24 hours postoperative). Secondary outcome measures include changes in blood pressure and heart rate, as well as postoperative opioid requirements. The study aims to compare the effectiveness of these two techniques in managing postoperative pain following knee surgeries."
506,"GPT4 Correct Assistant: This clinical trial aims to determine if immediate lymphatic reconstruction (ILR) with lymphatico-venous anastomosis can reduce the occurrence of arm lymphedema in breast cancer patients after axillary lymph node dissection. The study is a prospective randomized controlled trial, with participants randomly assigned to either the ILR group or the non-ILR group. The primary outcome measure is the occurrence of arm lymphedema at two years, while secondary outcome measures include drainage amount, seroma or lymphocele occurrence, patient-reported outcome measures, and subclinical lymphedema occurrence."
507,"GPT4 Correct Assistant: This study is a descriptive study of the cosmetic and functional sequelae of patients who received releasing incisions in the management of acute upper limb burns. The study includes adult patients with hand burns, chemical, thermal, or electrical burns of the hand, and burns that required a skin graft. The primary outcome measures are functional score, healing time, scar quality, and burn VAS (Visual Analog Scale) at 3 and 6 months. The study aims to assess the functional and aesthetic recovery of patients after burns and their healing process."
508,"GPT4 Correct Assistant: The Stanford Plant-based Educational Study: Providers Learning About Nutrition Together (PLANT) is a randomized, delayed intervention trial testing a 6-week multimodal WFPBD (Whole-food Plant-based Diet) educational program for providers at Stanford in any department. The study aims to assess the change in diet quality, mindset about WFPBD, and motivation/confidence to adopt a WFPBD among participants. The intervention includes interactive didactic sessions, cooking classes, and weekly emails with suggested resources and activities. The primary outcome measures are the change in Diet ID score, mindset about WFPBD, and stage of change in motivation/confidence from baseline to week 6."
509,"GPT4 Correct Assistant: This clinical trial aims to validate a questionnaire called Patient Reported Outcome (PRO) Survivorship Concerns, which evaluates the rehabilitation needs in patients with early-stage breast cancer. The study includes 80 participants in the transcultural adaptability phase, and more than 280 participants in the validation phase. The primary outcome measure is the translation and validation of the PRO questionnaire. The questionnaire consists of 17 items, and the Interclass Correlation Coefficient (ICC) model 3.1 will be applied to assess the level of agreement between the two assessments. The study will run for 6 months."
510,"GPT4 Correct Assistant: The study titled ""A Postpartum Adaptation Study of the Connecting and Reflecting Experience (CARE) Program"" aims to evaluate the effectiveness of a 12-session CARE group therapy for parents experiencing postpartum depression, anxiety, and stress. The study targets parents of infants aged 3-12 months who are receiving postpartum OB/GYN or mental health services at Montefiore Medical Center. The primary outcomes measured are changes in postpartum anxiety, depression, parenting stress, and parent-infant bonding. Secondary outcomes include changes in parental reflective functioning and infant temperament. The study is designed as a single-group assignment with an open-label intervention."
511,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of electroencephalography-based neurofeedback (EEG-NFB) on cognitive function in healthy young men. The study involves 50 male students randomly assigned to either the training group (TR) or control group (CO). The TR group undergoes 3 weeks of EEG-NFB training, while the CO group does not. The primary outcome measures include the Trail Making Test (TMT) and Stroop Test (ST), which assess cognitive processing speed, executive function, selective attention, and inhibition. The study will use the Shapiro-Wilk test, Wilcoxon signed-rank test, and Student's t-test to analyze the data."
512,"GPT4 Correct Assistant: This clinical trial, titled ""Radial Versus Femoral Access For Thrombectomy in Patients With Acute Basilar Artery Occlusion,"" aims to compare the effectiveness of two methods of endovascular recanalization in patients with acute ischemic stroke: the radial approach and the femoral approach. The study plans to randomly assign eligible patients to either the radial group or the femoral group, with the primary outcome measure being favorable neurological function (defined as mRS score ≤ 3) at 90 days post-operation. The secondary outcome measure is the procedure time of the endovascular thrombectomy."
513,"GPT4 Correct Assistant: The BUNDLE study is a prospective mixed-methods study aimed at integrating community doulas into prenatal care in Southeastern Wisconsin. The study will develop an integrated prenatal care model, compare its effectiveness to standard prenatal care, and disseminate findings to promote policy changes. The study includes 412 Black/African American pregnant participants, randomly assigned to BUNDLE intervention or usual care. The primary outcome measure is healthcare engagement, while secondary outcomes include trust in provider, perceived discrimination, and severe maternal morbidity."
514,GPT4 Correct Assistant: This is a Phase 1 open-label study to evaluate the safety and determine the maximum tolerated dose of IBRX-042 in subjects with HPV-associated tumors. The study involves up to 60 subjects who will receive IBRX-042 by injection once every 3 weeks for a total of 3 injections. The primary outcome measure is to determine the maximum tolerated dose of IBRX-042. Secondary outcome measures include determining the safety profile and reactogenicity of IBRX-042 and examining HPV-specific humoral and cellular immune responses.
515,"GPT4 Correct Assistant: This study is a 3-arm randomized controlled trial investigating the effects of connective tissue massage, classical massage, and a control group consisting of transcutaneous electrical nerve stimulation (TENS), therapatic ultrasound, and heat treatment on pain, functional status, and quality of life in patients with chronic non-specific low back pain. The study included 30 participants equally divided into three groups, with interventions administered over 4 weeks. Outcome measurements were taken at the beginning and 4 weeks after the completion of the program."
516,"GPT4 Correct Assistant: This clinical trial, titled ""Comparison of Clinical Outcomes in Patients Undergoing Cataract Surgery With OMNI Canaloplasty vs Cataract Surgery With OMNI Canaloplasty and Hydrus Stent,"" aims to determine the differing pressure-lowering effects between OMNI canaloplasty alone and when combined with HYDRUS microstent in patients with glaucoma undergoing cataract surgery. The study will randomize one eye of each participant to receive OMNI canaloplasty alone and the other eye to receive OMNI canaloplasty with HYDRUS stent. The primary outcome measure is the change in unmedicated intraocular pressure from baseline to 12 months after washout of all pressure-controlling drops. Secondary outcome measures include the reduction in the number of medications needed to control intraocular pressure and the percentage of patients with a greater than 20% reduction in intraocular pressure from baseline at 12 months."
517,"GPT4 Correct Assistant: This study is a comparative, open-label, randomized trial evaluating the efficacy and safety of Dorzotimol eye drops (20 mg/mL + 5 mg/mL) versus Cosopt eye drops (20 mg/mL + 5 mg/mL) in patients with primary open-angle glaucoma (POAG). The primary outcome measure is the mean intraocular pressure (IOP) change from baseline at week 12. Secondary outcome measures include IOP reduction rate to the target level of ≤ 18 mm Hg, IOP reduction rate greater than 20%, and IOP reduction rate greater than 30%. The study included 110 participants, with 55 in each group, and the treatment duration was 12 weeks. The results showed non-inferiority of Dorzotimol eye drops compared to Cosopt eye drops in terms of efficacy and safety parameters."
518,"GPT4 Correct Assistant: This is a pilot study examining the use of text messaging to improve adherence to repeat colonoscopy in a Veterans Affairs (VA) hospital. The study aims to assess the effectiveness of text message instructions and motivational messages in increasing patient satisfaction and attendance for scheduled colonoscopy appointments. Participants are randomly assigned to either receive text messages or no intervention. The primary outcome measure is the National Annie Colonoscopy Survey Score, assessed 21 days after the procedure. Secondary outcome measures include percentage of participants who attend scheduled colonoscopy appointments and percentage of participants with adequate bowel preparation at the appointment, both assessed up to 14 days after the procedure."
519,"GPT4 Correct Assistant: This clinical trial aims to compare the efficacy of management by endouterine aspiration versus hysteroscopy of trophoblastic retention after early miscarriage at 6 weeks after surgery, using endovaginal ultrasound. The study includes 220 patients, with 110 in each arm, and follows them for up to 26 months. The primary outcome measure is uterine vacuity determined by endovaginal pelvic ultrasound. Secondary outcomes include the rates of complications, use of second-line surgical management, synechiae, and fertility at 2 years after surgery."
520,"GPT4 Correct Assistant: The study, titled ""On-line Crowdsourcing of Multi-Timescale Inference Strategies,"" aims to investigate human inference using online testing. The primary purpose of the study is basic science, and it employs a single group assignment model with an open-label design. Participants must be adult Prolific participants with a 95% approval rating and a minimum score of 80% on the pre-test. They must also be fluent in English and be in the US. The study involves three blocks of trials: short-term inference, long-term inference, and multi-timescale inference. The primary outcome measure is binary behavioral decision responses, measured through subject-provided choices on a computer."
521,"GPT4 Correct Assistant: This N-of-1 trial aims to evaluate lemborexant, a new class of insomnia medication, for efficacy and safety in adults with early-onset dementia and insomnia. The trial will use an ABiBABAAB sequence of lemborexant and placebo treatments over an 8-week period, with daily tracking of sleep outcomes and weekly follow-up phone calls. The primary outcomes measured include total sleep time, sleep onset latency, wake time after sleep onset, sleep efficiency, and number of awakenings. Secondary outcomes include the presence and severity of adverse drug reactions and patient willingness to drop-out due to ADRs."
522,"GPT4 Correct Assistant: This clinical trial is a prospective, double-blind, randomized, multicenter study comparing the efficacy of Sinomenine and Glucocorticoid in treating early knee osteoarthritis. Participants aged 40-70 with bilateral knee pain lasting more than 6 months and having Kellgren and Lawrence grade 2 or 3 knee osteoarthritis are eligible. The primary outcome measures are the total WOMAC score and tibial cartilage volume at 24 months after the first injection, with secondary outcome measures being the change in The Timed Up and Go and 20m walking time from baseline."
523,"GPT4 Correct Assistant: The study aims to determine the effect of breathing exercises applied with virtual reality glasses on dyspnea, anxiety, and quality of life in COPD patients. It is a single-blind pre-test post-test parallel group randomized controlled experimental design with 48 patients, 24 in each group. The experimental group receives breathing exercises with virtual reality glasses, while the control group receives routine treatment and care. The study measures oxygen saturation, respiratory rate, forced vital capacity, volume of air exhaled in 1 second of forced expiration, peak expiratory flow rate, FEV1/FVC, COPD Evaluation Test (CAT), Modified Medical Research Council (mMRC) Dyspnea Scale, Hospital Anxiety and Depression Scale (HADS), St George Respiratory Questionnaire, and Virtual Reality Experience Evaluation Form."
524,"GPT4 Correct Assistant: This clinical trial, titled ""A Biobehavioral Approach to Understand the Multilevel Determinants of Cardiovascular Health in Black Women,"" aims to investigate the cardiovascular health of Black women between the ages of 18 and 49. The study involves an observational group, where participants undergo lab-based assessments to evaluate their vascular health and a 10-day free-living monitoring period using mobile and wearable devices. The primary outcome measures include macrovascular function, arterial stiffness, and blood flow measurements, while the secondary outcome measure is physical activity."
525,"GPT4 Correct Assistant: The study aims to evaluate the efficacy and safety of RCN3028 in treating drug-induced moderate to severe vasomotor symptoms in breast cancer subjects. The trial is a randomized, placebo-controlled, double-blind, parallel, phase 2 study. The primary outcome measures include mean change in frequency and severity of vasomotor symptoms from baseline to weeks 4 and 12. The study includes female breast cancer patients who have completed chemotherapy and radiotherapy and are on a stable dose of tamoxifen or aromatase inhibitors. The intervention consists of 0.8 mg RCN3028 or placebo, given orally."
526,"GPT4 Correct Assistant: This retrospective cohort study aims to investigate the association between higher doses of tranexamic acid (TXA) and the incidence of post-operative delirium after cardiac surgery. The study will analyze data from patients undergoing elective or in-house urgent cardiac surgery at RPH between 05/2018 and 08/2022, excluding patients with specific conditions. The primary outcome measure is the Richmond Agitation Sedation Score up to 48 hours after surgery, while the secondary outcome measure is 30-day mortality."
527,"GPT4 Correct Assistant: The study aims to compare the effects of Myofascial Decompression Therapy and Positional Release Therapy on pain, range of motion, and functional disability in patients with chronic non-specific neck pain. The trial includes participants aged 25 to 50 with mild to moderate neck pain for at least three months. The primary outcome measures are Numerical Rating Scale (NPRS) for pain intensity and Neck Disability Index (NDI) for functional disability, both measured at the sixth week. Secondary outcome measures include range of motion measurements in cervical spine flexion, extension, side flexion, and rotation."
528,"GPT4 Correct Assistant: This clinical trial is a randomized parallel-controlled study comparing the Dumpling suture method and the traditional suture method for ileostomy in rectal anterior resection surgery with specimen extraction via stoma. The study aims to investigate the complication rate of stoma, stoma DET score, stoma pain score, and quality of life scale score for patients with stoma at 30 days post-surgery. Participants must be aged between 18 and 100 years, have no serious systemic infection or immunosuppression, and be expected to survive for more than 6 months. The study has two arms, with one group receiving the Dumpling suture method and the other receiving the traditional suture method."
529,"GPT4 Correct Assistant: The clinical trial aims to assess the progression of cognitive and associated activities of daily living (ADL) impairment in Parkinson's Disease (PD). The study includes patients diagnosed with PD who participated in the Amyloid-Beta in cerebrospinal fluid as a risk factor for cognitive dysfunction in Parkinson's Disease (ABC-PD) study. The primary outcome measure is the diagnosis of Parkinson's disease dementia (PDD) or Level II diagnosis of mild cognitive impairment in PD (PD-MCI). Secondary outcome measures include the comparison of instrumental activities of daily living (IADL) function based on patients' self-impression and informant-rating, and follow-up scores in global cognition and cognitive domain performance. The study employs a detailed neuropsychological test battery, the Pfeffer Activities of daily living scale, and the Movement Disorder Society Unified Parkinson's disease rating scale to assess cognitive and ADL functions."
530,"GPT4 Correct Assistant: The clinical trial aims to determine the median effective dose of rocuronium for the prevention of myofibrillation caused by the injection of succinylcholine. The study includes participants aged 18 to 80, with an ASA grade I-II, and excludes those with airway difficulties, allergies or contraindications to rocuronium and succinylcholine, cardiac insufficiency, hepatic or renal dysfunction, neuromuscular disease, and other specified conditions. The study is designed as a randomized, parallel assignment, open-label trial with three experimental groups: ages 18 to 44, 45 to 59, and 60 to 80. The primary outcome measure is the appearance of myofibrillation, measured by a positive or negative reaction within an average of 45 seconds."
531,"GPT4 Correct Assistant: This clinical trial investigates the effects of dietary phospholipids on measures of human brain health and psychological wellbeing. Participants, aged 25-49, are randomly allocated to receive either a bioactive whey protein concentrate containing dairy phospholipids or a placebo powder for 12 weeks. The study aims to measure the effects of the supplementation on cognitive function, mood, stress, sleep quality, levels of fatigue, physical symptoms, and general health and wellbeing. Participants will undergo a series of cognitive assessments, questionnaires, and blood tests at various time points throughout the study. The primary outcome measure is the cognitive domain factor score, which will assess the effects of supplementation on memory tasks. Secondary outcome measures include measures of mood, stress, sleep quality, and physical symptoms."
532,"GPT4 Correct Assistant: This clinical trial aims to investigate the presence of environmental pollutants in human carotid atherosclerotic plaques and their relationship with plaque phenotype and clinical outcomes. The study will enroll 300 patients with asymptomatic carotid stenosis undergoing carotid endarterectomy. The presence of microplastics and volatile organic compounds in the plaques will be assessed using various techniques, such as pyrolysis-gas chromatography-mass spectrometry, transmission electron microscopy, immunohistochemistry, ELISAs, and Western Blot. The study will compare patients with polluted plaques and non-polluted plaques for the incidence of a composite outcome of myocardial infarction, stroke, and all-cause mortality over 24 months."
533,"GPT4 Correct Assistant: This clinical trial is titled ""Transarterial Radioembolization (TARE) in COlorectal MEtastasis of Liver."" The study aims to investigate the effectiveness and safety of Therasphere device in treating liver metastases in patients with colorectal cancer who have undergone radioembolization. Participants must be over 18 years old and have a histopathologically proven colorectal cancer diagnosis. The primary outcome measure is the comparison of mean effective tumor doses between patients with and without response to radioembolization at the 3rd month after treatment. Secondary outcome measures include investigating dose-response and dose-toxicity relationships at the 6th month after treatment."
534,"GPT4 Correct Assistant: The clinical trial aims to evaluate the clinical performance of chemically cured conventional glass ionomer restorative (Ketac Universal Aplicap) with and without light-emitting diode radiant heat enhancement. Eighteen healthy patients with 36-second molar teeth will be randomly assigned to two groups: M1 group will be restored with chemically cured conventional GICs without any enhancement, while the M2 group will be restored with chemically cured conventional GICs enhanced with radiant heat. The clinical performance of the restorations will be evaluated immediately after restoration (T0), six months later (T1), and after 12 months (T2) using Federation Dentaire International (FDI) criteria for assessment of dental restorations."
535,"GPT4 Correct Assistant: The FAPO-X study is an interventional trial conducted at the Heart Institute of the Clinics Hospital of the Medical School of the University of São Paulo. It aims to develop and validate an assisted digital telemonitoring platform for patients with postoperative atrial fibrillation (POAF) using wearable smartwatches. The study is divided into six phases, with patients receiving telemonitoring through a Samsung Galaxy smartwatch and FAPO SI³ platform in the experimental group, while the control group follows standard care. The primary outcome measures are rehospitalization rate, scheduled consultations, and extra occurrences within a 30-day period. Secondary outcome measures include technological and treatment adherence, and use of the mobile application by patients."
536,"GPT4 Correct Assistant: The study aims to test the effectiveness of two digital solutions, HSmartBPM and HyperHealth, in managing patients with high blood pressure compared to standard care. It is a randomized controlled trial where patients will be assigned to either one of the two digital solutions or standard care. The primary outcome measures are changes in systolic and diastolic blood pressure at 2 and 6 months. Secondary outcome measures include user satisfaction measured with a visual analogue scale (VAS) at 2 and 6 months."
537,"GPT4 Correct Assistant: The Liver Care Trial is a randomized controlled study that aims to screen for liver disease in individuals attending treatment for alcohol use disorder. The study includes participants aged 18 to 110 years, irrespective of sex, with a diagnosis of alcohol dependence or harmful alcohol use. The intervention group receives a liver stiffness measurement (Transient Elastography) and blood sampling, while the control group only receives a blood screening test. The primary outcome measure is alcohol abstinence or light consumption (≤ 10 units/week) in the last 30 days, assessed six months after randomization. Secondary outcome measures include heavy drinking days and change in AUDIT-C score since randomization."
538,"GPT4 Correct Assistant: This study aims to assess the value of trio exome sequencing in the etiological assessment of specific non-syndromic language and learning disorders. It includes index cases aged 3 to 40 years with severe learning disorders, not yet having undergone genetic testing. The study involves blood sampling for array CGH, consultation for results delivery, and a study of humanities and social sciences. The primary outcome measure is the identification of a genetic cause defined by the presence of at least one ACMG class 4 or 5 variant."
539,"GPT4 Correct Assistant: The Five Days for Health (FDH) study is a small group-based lifestyle modification program aimed at weight loss for adults with a BMI between 25-45. The program consists of five days of education, nutrition, physical activity, and psychological support. Participants receive practical recommendations for lifestyle changes and follow-up assessments at one month, three months, six months, and one year. The primary outcome measure is weight loss, while secondary outcome measures include changes in body composition and metabolic parameters."
540,"GPT4 Correct Assistant: A Phase 1 study of Bio-008 in patients with advanced or metastatic solid tumors aims to evaluate the safety, tolerability, pharmacokinetics, immunogenicity, and antitumor activity of Bio-008. The study includes dose escalation and dose expansion stages, with different dose groups receiving Bio-008 intravenously. The primary outcome measures include adverse events, dose limiting toxicity, and maximum tolerated dose. Secondary outcome measures include objective response rate, disease control rate, duration of response, and progression-free survival."
541,"GPT4 Correct Assistant: The study aims to determine the effect of different music played during retinopathy examination on the pain and comfort levels of premature infants. The study is a stratified randomized controlled experimental type study, with two experimental groups: one group listens to a rainstick, and the other group listens to ""The Happiest Baby"" music. The control group receives routine care without any music during the examination. The primary outcome measure is the Premature Infant Pain Profile (PIPP) score, while the secondary outcome measure is the Baby Information Form. The study will measure the impact of music on pain and comfort levels in premature infants during retinopathy examination."
542,"GPT4 Correct Assistant: The study aims to assess the safety and efficacy of sovateltide in patients with acute cerebral ischemic stroke. It is a multicentric, randomized, double-blind, parallel, placebo-controlled phase III clinical study. The primary outcome measure is the proportion of patients with a good outcome (modified Rankin Scale score of 0-2) on day 90 post-randomization. Secondary outcome measures include excellent functional outcome, NIHSS score, mRS score, Barthel Index score, quality of life, incidence of recurrent stroke, and mortality."
543,"GPT4 Correct Assistant: This is an ambispective cohort study investigating the outcome and influencing factors in patients with Borderline Personality Disorder (BPD). The study includes participants aged 12 and above, diagnosed with BPD based on ICD-10 (F60.3), excluding those with severe physical or neurological diseases, or mental retardation. The primary outcome measure is the remission rate, while secondary measures include social disability and quality of life. Patients are followed up every 6 months for a total of 2 years, with the data collected from electronic medical records, telephone interviews, web-based questionnaires, or in-person assessments."
544,"GPT4 Correct Assistant: This clinical trial aims to assess the management of evaporative dry eye (EDE) with intense pulsed light (IPL) in combination with diquafosol eye drops. The study will investigate the effects of IPL and diquafosol on dry eye signs and symptoms, non-invasive tear break-up time (NIBUT), ocular surface disease index (OSDI), fluorescein and lissamine conjunctival and cornea staining (CFS), meibomian gland function and secretion quality, tear film lipid layer score (TFLL), tear meniscus height (TMH), and conjunctival hyperemia (RS score). Participants will be randomly assigned to one of four groups: IPL+DQS, IPL, DQS, or control. The study will measure the outcomes at baseline, day 14, and day 28."
545,"GPT4 Correct Assistant: This study aims to evaluate the effectiveness of Cognitive-Behavioral Therapy (CBT) and Mindfulness-Based Cognitive Therapy (MBCT) in improving patient-centered mental health outcomes, quality of life, well-being, and functional impairment among autistic adults with co-occurring anxiety and/or depressive disorders. The study will also explore patient characteristics that may moderate the relationship between CBT or MBCT and patient outcomes, and compare the implementation outcomes of CBT and MBCT in terms of acceptability and feasibility. The study will use the Patient Health Questionnaire Anxiety-Depression Scale (PHQ-ADS) as the primary outcome measure to assess change in anxiety and depression symptoms. Secondary outcome measures include changes in mental health, psychiatric diagnosis, quality of life, well-being, self-acceptance, functional impairment, disability, potential negative effects of intervention, intervention services satisfaction, and intervention therapist and therapy satisfaction."
546,"GPT4 Correct Assistant: The Methotrexate for Immune Related Arthritis or Arthralgias (IMPACT 2.1) clinical trial aims to evaluate the efficacy and safety of Methotrexate in patients with immune related arthritis or arthralgias. The study includes participants who are 18 years of age or older, capable of providing consent, and have a performance status of ECOG 0-2. The primary outcome measure is the discontinuation of prednisone without recurrence of grade 2 or higher irAA by 12 weeks. Secondary outcome measures include total steroid usage, development of immune related adverse events (irAEs) other than irAA, adverse events, re-initiation of immune checkpoint inhibitor therapy, and progression free survival."
547,"GPT4 Correct Assistant: This clinical trial aims to compare the effects of general and regional anesthesia on sleep quality in patients undergoing total hip arthroplasty. The study includes 60 patients, and sleep quality is assessed using PID-20 (Pittsburg Insomnia Rating Scale) before and after surgery. The primary outcome measure is subjective sleep quality, while secondary outcome measures include subjective anxiety and pain levels. The results of this study may help identify patients with pre-existing sleep disorders and determine the best anesthesia method for better sleep quality in patients undergoing total hip arthroplasty."
548,"GPT4 Correct Assistant: The study aims to assess the change in disease activity in adult Japanese participants with episodic migraine using oral atogepant tablets. It is a phase 2/3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. The primary outcome measure is the change from baseline in mean monthly migraine days. Participants receive atogepant dose A, dose B, dose C, or placebo for 12 weeks, followed by re-randomization at week 12 for those receiving placebo. The study includes participants with a history of migraine, aged between 18 and 80 years."
549,"GPT4 Correct Assistant: This clinical trial is a Phase 2, randomized, double-blind, controlled study to evaluate the safety and efficacy of Efgartigimod Alfa-Fcab in patients with Guillain-Barre Syndrome (GBS). The study aims to compare the outcomes of patients receiving Efgartigimod Alfa-Fcab with those receiving Intravenous Immunoglobulin (IVIg) using the Guillain-Barre Syndrome Disability Scale (GBS-DS). The primary outcome measure is the GBS-DS score at 12 weeks, with secondary measures at 4, 24, and 48 weeks. Other assessments include Neuropathy Impairment Scale (NIS), Inflammatory Rasch-Built Overall Disability Scale (I-RODS), Forced Vital Capacity (FVC), Maximal Inspiratory Pressure (MIP), and Maximal Expiratory Pressure (MEP)."
550,"GPT4 Correct Assistant: The trial is a Phase 2B, double-blind, randomized, placebo-controlled study evaluating the safety and efficacy of oral PF-07817883 in non-hospitalized adult participants with COVID-19. Participants will be randomly assigned to receive either the drug or a placebo. The primary outcome measure is the change from baseline in SARS-CoV-2 RNA level from baseline to day 5. Secondary outcome measures include change from baseline in SARS-CoV-2 RNA level at days 3, 10, and 14, incidence of treatment-related adverse events, incidence of serious adverse events, incidence of clinically significant abnormal laboratory values, incidence of AEs leading to discontinuations, incidence of clinically significant abnormal vital signs, and incidence of clinically significant abnormal ECGs."
551,"GPT4 Correct Assistant: This study is a prospective cohort study investigating the use of letrozole add-on in the treatment of cesarean scar pregnancy (CSP). Women with increasing B-human chorionic gonadotropin (B-hCG) concentrations are included. The study compares two treatment arms: MTX monotherapy and MTX + letrozole add-on, both followed by hysteroscopic evacuation of products of conception (POC). The primary outcome measures are blood loss during the procedure, blood loss volume during the procedure, and conversion rate from hysteroscopy to laparoscopy or laparotomy due to hemorrhage. Secondary outcome measures include the effect of treatment on bone marrow function, liver function, and kidney function."
552,"GPT4 Correct Assistant: The BLEED study is a feasibility pilot study investigating the use of blood salvage from liver donors for liver transplant recipients. The study aims to assess the primary outcome of the number and percentage of liver transplant recipients who receive donor red blood cell concentrates for intraoperative transfusion support during liver transplant. Secondary outcomes include blood product need in enrolled patients and graft failure rate in the prospective sample compared to controls. The study is designed as an open-label, single-group assignment study, with participants aged 18 years or older receiving a liver transplant from deceased donors at Fondazione Policlinico A. Gemelli IRCCS."
553,"GPT4 Correct Assistant: This clinical trial studies the efficacy of sublingual versus subcutaneous allergen immunotherapy in patients with bronchial asthma. Fifty asthmatic patients were included before treatment with subcutaneous immunotherapy (SCIT) vaccines and another fifty asthmatic patients were included before treatment with sublingual immunotherapy (SLIT) vaccines. The primary outcomes measured were total IgE and sputum eosinophil levels after 6, 12, and 18 months of treatment with immunotherapy vaccines."
554,"GPT4 Correct Assistant: This clinical trial aims to determine the minimum number of contrast-enhanced stereotactic biopsy (CESB)-guided tissue samples needed to establish a final histopathological diagnosis for recombined-only lesions (ROLs) observed during a regular contrast-enhanced mammography (CEM) examination. The study is a prospective, single-center, observational cohort study, and participants will undergo CESB, which involves an intravenous injection of iodinated contrast agent before image acquisition. The primary outcome measure is the cumulative diagnostic yield per specimen, which will help define the minimum number of biopsies required for a reliable diagnosis using CESB. Secondary outcomes include general parameters of the biopsy procedure, such as patient characteristics, histopathological results, pain experienced during the procedure, and complication rates (hematoma, infection)."
555,"GPT4 Correct Assistant: This clinical trial aims to compare the effects of concentric quadriceps strengthening and facilitatory kinesiotaping on gait parameters in individuals with knee osteoarthritis. The study includes adults aged 50-60 with knee OA for at least 6 months. Participants are randomly assigned to either group A (concentric muscle training) or group B (facilitatory kinesiotaping). The primary outcome measures are temporo-spatial gait parameters, while secondary outcome measures include numerical pain rating score, functional status (WOMAC questionnaire), and strength. The study duration is 6 weeks."
556,"GPT4 Correct Assistant: The Family Therapy Training and Implementation Platform (FTTIP) Supplement Study aims to collect qualitative data to complement the parent study's quantitative data, focusing on the experiences of trainees and agency leaders with the platform. The study includes 20 therapists and 16 agency leaders who will participate in qualitative interviews at two time points. The primary outcome measures are the Therapist Interview Timepoint 1 and 2, and the Agency leader Interview Timepoint 1 and 2. The study aims to gather insights on the process of learning and practicing specific CIFFTA competencies, the experiences related to implementation of the Evidenced Based Treatment, the application of EBT in a real-world context, and the experiences of agency leaders in facilitating EBTs at their agencies."
557,"GPT4 Correct Assistant: This clinical study aims to investigate the analgesic effect of a freshly manufactured 35kDa Hyaluronan fragment (HA35) in the treatment of herpes zoster pain and shoulder, neck, back, and temporal pain. The study will be conducted on 26 patients with shoulder, neck, back, and temporal pain and 10 patients with herpes zoster pain. The intervention involves a single-group, open-label clinical study where the HA35 injection is prepared by mixing hyaluronidase PH20 injectable solution and high-molecular-weight HA injectable solution. The primary outcome measure is the pain scores of all patients before and after treatment, which will be assessed using a pain scale."
558,"GPT4 Correct Assistant: This is a prospective randomized clinical trial conducted at Mansoura University Hospital for at least 24 months. The study aims to compare hysteroscopic septoplasty with scissors and hysteroscopic septoplasty with resectoscope in patients with a diagnosis of a septate or subseptate uterus, who have a history of recurrent pregnancy loss or subfertility. The primary outcome measures are operative time, fluid deficit, operative and post-operative complications, and need for second intervention. Secondary outcome measures include pregnancy rate and live birth rate. A total of 40 patients (20 in each group) are enrolled in the study."
559,"GPT4 Correct Assistant: This clinical trial, conducted at Reunion University Hospital, aims to evaluate the effectiveness of a breathing control technique, Cardiac coherence, on Long COVID symptoms. Patients aged 18 and over with a diagnosis of Long COVID are eligible for participation. The study is randomized, with one group receiving complementary respiratory training to Cardiac coherence for six months, in addition to usual care. The control group receives only usual care. The primary outcome measure is the reduction in symptomatology at six months, as assessed by the Long COVID Symptom Tool (ST) scale. Secondary outcome measures include the decrease of overall and specific symptoms such as fatigue, dyspnea, anxiety, depression, cognitive disorders, and post-traumatic stress disorder. The impact of the disease on daily life will also be assessed."
560,GPT4 Correct Assistant: This is a single-center cohort study investigating the cardiovascular complications of Ibrutinib therapy. The study includes patients aged 18 and over who have an indication for Ibrutinib treatment for hematologic reasons and have given informed consent. The study arms include patients receiving Ibrutinib treatment. The primary outcome measure is the rate of patients developing atrial fibrillation (AF) and comparing the values of selected biomarkers between patients who have developed AF and patients without AF 12 months after the introduction of Ibrutinib. Interventions include ophthalmological examination and blood tests.
561,GPT4 Correct Assistant: The study aims to investigate the effect of bicarbonate profiling in dialysis fluid on phosphate removal during hemodialysis and blood pH. The study includes two groups of patients with phosphorus metabolism disorders and acid-base balance disorder. The intervention involves different bicarbonate levels during hemodialysis treatments. The primary outcome measure is the blood phosphorus concentration change in hemodialysis patients using dialysate bicarbonate profiling. Secondary outcome measures include maintaining the acid-base balance in accordance with applicable recommendations.
562,"GPT4 Correct Assistant: This clinical trial aims to evaluate the potential effectiveness of a multimodal intervention for the treatment of unipolar depression, combining Transcranial Direct Current Stimulation (tDCS) with metacognitive therapy (MCT). The study involves a randomized, double-blind design with three treatment arms: active tDCS, sham tDCS and MCT, and active tDCS followed by MCT. The primary outcome measure is the change in the Hamilton Depression Rating Scale at different time points. Additionally, a pilot study will explore the TMS-EEG correlates of the change in depressive symptomatology."
563,"GPT4 Correct Assistant: This clinical trial aims to compare the efficacy and safety of using proton pump inhibitor (Lansoprazole) in patients with moderate gastrointestinal bleeding risk and coronary artery disease who underwent percutaneous coronary angioplasty and were on dual antiplatelet drugs. The study enrolls participants who are 19 years or older and have coronary artery disease. The intervention group receives Lansoprazole 15 mg, while the control group receives no intervention. The primary outcome measure is the occurrence of upper gastrointestinal clinical events within six months after randomization. Secondary outcome measures include the occurrence of cardiovascular clinical events within the same period."
564,"GPT4 Correct Assistant: This clinical trial aims to investigate the influence of hot and cold cognition on prospective memory in HIV+ patients. The study includes both HIV+ patients and healthy control subjects, who will undergo neuropsychological testing, including the Memory for Intentions Screening Test (MIST), Montreal Cognitive Assessment (MOCA), Interpersonal Reactivity Index (IRI), and Modified Five Point Test. The primary outcome measure is prospective memory in HIV+ patients and healthy subjects, while the secondary outcome measures are the influence of global cognitive performance, hot cognition, and cold cognition on prospective memory. The study will run for one year."
565,"GPT4 Correct Assistant: The study aims to determine the effects of vertical sitting versus supine lying traction on pain, range of motion, and function in patients with chronic radicular low back pain. The intervention involves applying continuous mechanical traction in the vertical sitting position for Group A and supine lying position for Group B. The primary outcome measures include the Oswestry Disability Index and Numeric Pain Rating Scale, assessed at the 12th week follow-up."
566,"GPT4 Correct Assistant: This is a randomized, double-blind clinical trial comparing the effectiveness of Dry Needling and Lasertherapy in treating Greater Trochanteric Pain Syndrome (GTPS) in patients with lateral hip pain. The study includes participants aged 35 to 60 years, with a minimum pain intensity of 3 on the Visual Analog Scale (VAS) for at least 3 months. The intervention consists of 6 weeks of treatment, 2 times a week, with primary outcome measures being changes in pain intensity and hip function. Secondary outcome measures include changes in lower limb function."
567,GPT4 Correct Assistant: This clinical trial aims to evaluate the diagnostic accuracy of a rapid technique for detecting intestinal anti-transglutaminase antibodies in patients with suspected celiac disease. The study includes patients undergoing elective esophagogastroduodenoscopy for various gastrointestinal conditions. The primary outcome measures are the sensitivity and specificity of the EMA assay and rapid anti-TG2 test detected on mechanically lysed intestinal biopsies compared to the reference standard (serology + histopathology). The secondary outcome measure is the concordance of EMA assay and rapid anti-TG2 test with Culture-EMA results.
568,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of cognitive-behavioral therapy (CBT) on insomnia in nurses with post-COVID-19 condition. The study is designed as a randomized, parallel assignment, open-label trial with two arms: experimental (CBT for 6 weeks) and control (treat as usual). Participants must be between 20 and 65 years old, and all genders are eligible. The primary outcome measures include insomnia severity, sleep quality, and sleep efficiency, while secondary outcome measures include anxiety, depression, and health-related quality of life. The study will last for 20 weeks."
569,"GPT4 Correct Assistant: The RAPID AFib Pilot Trial is a prospective, randomized pilot study evaluating the acceptability of a web-based decision aid for stroke prevention in patients with atrial fibrillation (AF). The decision aid estimates stroke and bleeding risk, allows patients to compare oral anticoagulation therapies, and generates a Summary Report for discussion with their physician. The study aims to determine if the decision aid leads to more effective shared decision-making than standard care among patients with AF who are considering oral anticoagulation. The primary outcome measure is the 9-Item Shared Decision Making Questionnaire (SDM-Q-9: patient version) measured immediately after the clinic visit."
570,"GPT4 Correct Assistant: A Phase I clinical trial is being conducted to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of a new medicine, NNC0491-6075, in healthy participants and those with high levels of fat in the blood (dyslipidaemia). The study includes three parts: single ascending dose (SAD) cohorts in healthy participants, multiple ascending dose (MAD) cohorts in dyslipidaemia participants, and single ascending dose (SAD) cohorts in healthy Japanese participants. The primary outcome measures are the number of treatment-emergent adverse events (TEAEs) in each part. Secondary outcome measures include the area under the NNC0491-6075 serum concentration-time curve from 0 to infinity after a single dose, the maximum serum concentration of NNC0491-6075 after a single dose, the terminal half-life of NNC0491-6075 after a single dose, the time to maximum concentration of NNC0491-6075 after a single-dose, the area under the NNC0491-6075 serum concentration-time curve from time 0 to 168 hours after last dose, the maximum serum concentration of NNC0491-6075 after last dose, the terminal half-life of NNC0491-6075 after last dose, and the time to maximum concentration of NNC0491-6075 after last dose."
571,"GPT4 Correct Assistant: This study aims to evaluate the efficiency of high-flow nasal cannula (HFNC) versus noninvasive ventilation (NIV) in patients with acute type 2 respiratory failure. The study includes 100 patients, divided into two groups: Group A (50 patients) treated with HFNC and Group B (50 patients) treated with NIV. The primary outcome measure is the failure of the treatment modality, measured within one hour. Secondary outcome measures include mortality during ICU stay and ICU stay duration within 28 days."
572,"GPT4 Correct Assistant: The trial aims to implement a digital-first care delivery model for heart failure patients in Uganda. The intervention includes enhanced heart failure clinical care and a digital health intervention (Medly Uganda) plus enhanced heart failure clinical care. The study measures the change in self-care of heart failure index (SCHFI) and clinical effectiveness, as well as secondary outcomes like participant fidelity to self-care, facility fidelity to implementation strategy, and various health markers. The trial will run for 36 months."
573,"GPT4 Correct Assistant: This clinical trial is a comparative pharmacokinetic study of ibuprofen and diphenhydramine hydrochloride modified-release tablets in healthy adults under fasting conditions. The study aims to compare the bioequivalence of the compound ibuprofen polyrelease tablet and the reference products, Motrin® IB (ibuprofen tablets) and BENADRYL® (diphenhydramine hydrochloride tablets). The primary outcome measures include the area under the curve from time zero to the time of the last quantifiable plasma concentration of the period (AUC0-last), the area under the curve from time zero to infinity (AUC0-inf), and the peak concentration at each treatment period (Cmax,tp). The secondary outcome measures include the peak concentration of the first dosing (Cmax), time to reach peak concentration of the first dosing (Tmax), terminal half-life (T1/2), and mean residence time (MRT)."
574,"GPT4 Correct Assistant: This clinical trial aims to study the impact of apalutamide in metastatic hormone-sensitive prostate cancer (mHSPC) patients. The study includes male participants aged 18 years or older with a confirmed diagnosis of adenocarcinoma of the prostate. The primary outcome measure is the undetectable PSA rate in mHSPC patients receiving apalutamide. Secondary outcome measures include the impact of apalutamide on fatigue, cognitive function, and health-related quality of life, as assessed using patient-reported questionnaires. The study is a multicentre, prospective observational study with a planned duration of August 2023 to April 2027."
575,GPT4 Correct Assistant: This clinical trial aims to demonstrate the hair and scalp benefits of Duobrii (0.045% Tazarotene/0.01% Halobetasol Lotion) in treating scalp psoriasis. The study includes male and female subjects aged 18 and above with moderate to severe scalp psoriasis. The intervention is an FDA-approved drug applied once daily to the scalp for 12 weeks. The primary outcomes measured are hair growth improvement and reduction in scalp itch.
576,"GPT4 Correct Assistant: This clinical trial is investigating the efficacy and safety of the combination treatment of idasanutlin and selinexor in children with progressive/relapsed AT/RT or MRT. The trial aims to determine the maximum tolerated dose (MTD) and recommended phase 2 dose (RP2D) of the combination treatment. The primary outcome measures include objective response rate in subjects with progressive/relapsed AT/RT or MRT, and progression-free survival and overall survival in these subjects."
577,"GPT4 Correct Assistant: This study is a comparative analysis between radius and capitate shortening in patients with Ulna Minus Kienbock's Disease. The participants are aged between 18 and 65, with stages II & III of the disease. The study is designed as a randomized parallel assignment with an open-label design. The primary outcome measure is the Modified Mayo Wrist Score, assessed at one year. The study compares two interventions: radial shortening using the Henry approach and volar approach, and capitate shortening using the dorsal approach."
578,"GPT4 Correct Assistant: This clinical trial aims to investigate the impact of a 4-week multimodal prehabilitation program on functional capacity, nutritional status, and patient-reported health-related quality of life in patients with pancreatic or periampullary cancer undergoing surgery. The study includes two groups: the intervention group, which receives prehabilitation, and the control group, which receives usual care. The primary outcome is the Comprehensive Complication Index (CCI) at 90 days after surgery. Secondary outcomes include functional recovery time, length of hospital stay, and health-related quality of life. The study will also analyze the effect of prehabilitation on the concentration and activity of a panel of circulating molecules involved in cancer cachexia and chronic inflammation."
579,"GPT4 Correct Assistant: This clinical trial aims to evaluate the effectiveness of dual task exercise training in children with cerebral palsy (CP) on balance, mobility, physical performance, and quality of life. The study includes children aged 5-12 years with CP, GMFCS level 1 or 2, who are randomly assigned to either an experimental group (dual task exercise training) or a control group (conventional rehabilitation). The primary outcomes measured are changes in Pediatric Balance Scale (PBS), Timed Up and Go Test (TUG), One Leg Standing Test (OLST), 3-Meter Backward Walk Test (3MBWT), 6 Meter Walk Test (6MWT), and the Generic Children's Health-Related Quality of Life Questionnaire (KINDL) at 12 weeks."
580,"GPT4 Correct Assistant: This is a pilot study in Belgium to actively surveillance influenza virus zoonotic transmission events among workers and volunteers with regular contact with animals within their job/activity framework. The study includes participants from avian influenza outbreak farms, poultry farm sentinel network, wild bird/life rehabilitation centre sentinel network, and pig industry veterinarian sentinel network. The primary outcome measure is the number of sentinel participants and outbreak participants positive for a non-seasonal influenza virus. The secondary outcome measure is the number of outbreak participants with seroconversion against a non-seasonal influenza virus."
581,"GPT4 Correct Assistant: This clinical trial, titled ""Evaluating the Impact of a Canine-assisted Therapy Program in Youth Residing in a Residential Treatment Center,"" aims to assess the effectiveness of a 6-week canine therapy intervention for youth with behavioral disorders, emotional regulation issues, and low self-esteem in a residential treatment facility. The study uses a longitudinal, within-person design with two parallel conditions: a canine therapy intervention and a waitlist control (treatment as usual). The primary outcome measures include changes in emotional regulation, attention and inhibitory control, self-esteem, and negative affect. Secondary outcome measures include attendance and attrition, change in positive affect, significant event report, and change in attitudes towards pets."
582,"GPT4 Correct Assistant: This study aims to investigate the effect of myofascial release in addition to foot core exercises on young adults with asymptomatic flexible pes planus. The study will be conducted using a randomized controlled prospective study design, with participants aged 18-25 years, who have a navicular fall test measurement of 10mm or more and flexible pes planus according to Jack's finger lift test. The participants will be divided into two groups: one group will perform foot core exercises only, while the other group will perform foot core exercises in addition to myofascial release using foam rollers. Both groups will follow a 6-week exercise program, with weekly follow-ups. The primary outcome measure is the change in balance, measured by the Y balance test, while secondary outcome measures include changes in flexibility, power, and gait, assessed using the sit and reach test, vertical jump test, and 10-meter walk test, respectively."
583,"GPT4 Correct Assistant: This clinical trial aims to investigate the effectiveness of an 8-week daily arm training program in reducing pain during insertion of a peripheral venous catheter in patients undergoing neoadjuvant or adjuvant chemotherapy. The study is designed as a randomized controlled trial with parallel assignment, where participants are either assigned to the training group or the normal care group. The primary outcome measures include the level of pain measured using the Numeric Rating Scale (NRS) at different time points. The secondary outcome measures include the number of usable veins assessed via ultrasound at different time points."
584,"GPT4 Correct Assistant: This clinical trial aims to study the product of conception derived from ultrasound-guided manual vacuum aspiration (USG-MVA) in women with miscarriage or termination of pregnancy (TOP) in the first trimester. The study seeks to determine whether decidual leukocyte subpopulations and their associated activation markers are different between women having miscarriage of either a trisomy 16 conceptus (47XY+16 or 47XX+16) compared with a chromosomally normal male conceptus (46XY). The study will also investigate the primary outcome measures, including histopathologic diagnosis of chorionic villi and immunohistochemistry staining of maternal decidua."
585,"GPT4 Correct Assistant: This is a clinical trial investigating the safety, tolerability, pharmacokinetics, and pharmacodynamic properties of Lu AF28996 in Japanese adults with Parkinson's disease. Participants must be diagnosed with idiopathic PD, have motor fluctuations, and be currently taking levodopa. The study involves receiving ascending oral doses of Lu AF28996 for 14 days, followed by a down-titration period. The primary outcome measures are the number of participants with treatment-emergent adverse events and the pharmacokinetic properties of Lu AF28996."
586,"GPT4 Correct Assistant: The study aims to assess the acceptability, cost-effectiveness, and required capacity of a facility-based seasonal influenza vaccination program in selected hospitals in Bangladesh. The study focuses on four high-risk groups: children aged six months to eight years, pregnant women, elderly aged 60 years and older, and adults with chronic diseases. The study will measure the proportion of high-risk group people who report an intention to receive the influenza vaccine and the incremental cost-effectiveness ratios (ICERs). The study will also assess perceived susceptibility and severity to the influenza virus, perceived barriers and benefits to the vaccine, and required capacity related to vaccine doses, self-injection equipment, and storage capacity."
587,"GPT4 Correct Assistant: The SUSPECT Italian Prospective Study is a clinical trial investigating the performance characteristics and technical outcomes of Single-Use Duodenoscopes in patients with gastrointestinal tract diseases. The study includes participants aged 18 years or older, both male and female, who are undergoing clinically indicated ERCP or other duodenoscope-based procedures. The primary outcome measures are technical performance and procedural performance, which will be assessed over a 24-month period."
588,"GPT4 Correct Assistant: This study aims to assess the feasibility of a technology-enabled hybrid service delivery model for pulmonary rehabilitation in patients with chronic respiratory disease. The intervention involves an 8-week pulmonary rehabilitation programme using the Active+me REMOTE App, which includes remote monitoring of adherence, symptoms, and physiological parameters, live video exercise classes, pre-recorded classes, a paced walking programme, an educational programme, and personalized care plans. The study will compare outcomes for patients recruited to the hybrid pulmonary rehabilitation programme with a propensity-matched control group that has previously received standard pulmonary rehabilitation. The primary objectives are to assess patient recruitment rates, participant retention rates, and the availability of data for primary and secondary outcomes of a larger definitive trial. The study will also explore the success of integrating the hybrid pulmonary rehabilitation into routine practice and the patient/staff acceptability of the programme."
589,"GPT4 Correct Assistant: This observational study aims to describe the baseline demographics and clinical characteristics of patients who received EVUSHELD™ (Tixagevimab/Cilgavimab) as pre-exposure prophylaxis (PrEP) against SARS-CoV-2 infection/COVID-19 in Japan. The study will include patients aged ≥ 12 years who were administered EVUSHELD as PrEP and have a record of administration in the database. The primary outcome measures are the demographics and clinical characteristics of patients received Evusheld as PrEP. Secondary outcome measures include medically attended COVID-19, COVID-19 hospitalization, in-hospital mortality due to COVID-19, and all-cause mortality."
590,"GPT4 Correct Assistant: This is a Phase 4 multicenter, randomized, double-blind study assessing the safety and efficacy of subcutaneously injected risankizumab in adult participants with moderate to severe genital or scalp psoriasis. The study includes two groups: Study G for participants with moderate to severe genital psoriasis and Study S for participants with moderate to severe scalp psoriasis. The primary outcome measures are the percentage of participants with achievement of static Physician Global Assessment of Genitalia (sPGA-G) of 0 or 1 for Study G and Scalp Investigator Global Assessment (IGA) of 0 or 1 for Study S at week 16. Secondary outcome measures include other assessments of psoriasis severity and impact on quality of life."
591,"GPT4 Correct Assistant: This study aims to investigate the prevalence of the Linburg-Comstock Variation (LCV) in patients with symptomatic thumb CMC arthritis. Five hundred male and female patients aged 35-89 will be recruited through convenience sampling. The study involves a single group assignment, with no control group, and an open-label design. Patients will undergo a clinical examination to determine the presence of LCV. The study will take place at the Bone and Joint Center and satellite offices, with data collection lasting up to two years. There are no risks to patients, and the test involves simply bending the tip of the thumb. The primary outcome measure is a positive or negative clinical exam for LCV, which takes 10 seconds."
592,"GPT4 Correct Assistant: This is a Phase 3, multicenter, 12-week, double-blind, placebo-controlled study evaluating the safety and efficacy of Atogepant for the preventive treatment of episodic migraine in pediatric subjects aged 6-17 years. The study aims to assess the change in disease activity and adverse events of oral Atogepant tablets in pediatric participants with episodic migraine. The primary outcome measure is the change from baseline in mean monthly migraine days, while secondary outcome measures include change in mean monthly headache days, acute medication use days, percentage of participants achieving at least a 50% reduction in average monthly migraine days, Pediatric Quality of Life Inventory (PedsQL) total score, and Pediatric Migraine Disability Assessment (PedMIDAS) total score."
593,"GPT4 Correct Assistant: The study aims to examine the effects of a 2-week home-based targeted touchscreen training program on touchscreen skills in patients with Parkinson's Disease (PD). The intervention consists of practicing the Swipe Slide Pattern (SSP) task in both single and dual-task conditions for approximately 10 minutes per session, five days a week. The primary outcome measures are the average slide duration and performance accuracy after two weeks of training. Secondary outcomes include retention effects after four weeks without training, consolidation of learning, and the transfer of learning to an untrained task (mobile phone task). The study will include 36 PD patients, randomly assigned to either the experimental group (receiving training) or the control group (no intervention)."
594,"GPT4 Correct Assistant: The study aims to investigate the effect of intensified tactile contact with a newborn on the emotional transformation of women after physiological delivery through a non-randomized quasi-experimental design. The experimental group received Shantali massage, a form of intensified tactile contact, while the control group received no intervention. The study measures the change in Edinburgh Postnatal Depression Scale, Hospital Anxiety and Depression Scale, Positive and Negative Affect Schedule questionnaire, and Parenting Sense of Competence questionnaire before and after the 12-week observation period."
595,"GPT4 Correct Assistant: This is a non-randomized, open-label, parallel assignment study evaluating the safety and efficacy of Paclitaxel, Bevacizumab, and Atezolizumab in patients with advanced non-squamous NSCLC who have progressed after treatment with immunotherapy and a doublet of platinum-based chemotherapy. The study aims to assess the primary outcome of Progression Free Survival at 6 months, as well as secondary outcomes such as Progression Free Survival, Overall Survival, and adverse events."
596,"GPT4 Correct Assistant: The study, titled ""Role of OMT in the Management of the Persistent Post-COVID-19 Syndrome - A Pilot Prospective Cohort Study,"" aims to investigate the effectiveness of osteopathic manipulative treatment (OMT) in managing persistent post-COVID-19 symptoms. The study will include participants aged 18 years and above, with at least one persistent symptom of post-COVID-19 that has lasted for at least four weeks after diagnosis. The primary outcome measures are patient recruitment rate and data completion rate, while secondary outcome measures include neurocognitive and psychological symptoms, physical symptoms, global health, and return to work. The study will use the Rivermead Post Concussion Symptoms Questionnaire, Long COVID-Household Pulse Survey, PROMIS SF v1.2 Global Health scale, and a 4-point scale for assessing return to work."
597,"GPT4 Correct Assistant: The study aims to prospectively compare the use of ICG microangiography and conventional angiography in severe frostbite cases. The primary outcome measure is the assessment of angiography and ICG microangiography imaging demonstrating ischemic tissue present in severe frostbite scored by Hennepin Frostbite Score. The study hypothesizes that these two imaging modalities will be concordant at demonstrating the ischemic tissue present in severe frostbite. Secondary outcome measures include the safety of indocyanine green when delivered in close association with contrast dye, measured by the number of adverse events."
598,"GPT4 Correct Assistant: This clinical trial aims to investigate the impact of a multidisciplinary approach in the Perioperative Geriatrics Unit on the functional status of patients aged 70 and over who undergo surgery for colorectal cancer. The study compares two groups: those receiving classical management in the digestive surgery department and those treated in the Peri-Operative Geriatrics Unit. The primary outcome measure is the change in functional status after surgery, measured by the Instrumental Activities of Daily Living (IADL) score at baseline and month 3. Secondary outcome measures include changes in basic functional status, patient motor ability, patient satisfaction with care, length of hospital stay, medical complications, surgical complications, destination of patients on discharge, weight change, quality of life, and overall survival."
599,"GPT4 Correct Assistant: This clinical trial aims to investigate the safety and efficacy of 64Cu-DOTA Pembrolizumab for imaging metastatic solid tumors in patients receiving stereotactic body radiation therapy. The primary objectives are to describe toxicities of 64Cu-DOTA-pembrolizumab and identify changes in 64Cu-DOTA-pembrolizumab uptake in radiated metastatic lesions pre- and post-SBRT. The study involves administering standard of care pembrolizumab and 64Cu-DOTA-pembrolizumab intravenously, followed by positron emission tomography scans and stereotactic body radiation therapy. The trial includes patients with metastatic disease from a solid-tumor malignancy currently being treated with single-agent pembrolizumab, who have been referred for stereotactic body radiation therapy. The study measures dose limiting toxicities, changes in 64CDP uptake, and change in standard-uptake-value (SUV-max)."
600,"GPT4 Correct Assistant: This is a Phase 3b, non-randomized, open label, multi-country, cohort study to describe the safety of study participants who received RSVPreF3 maternal vaccination (any dose) or controls from previous RSV MAT studies during any pregnancy conceived post vaccination/control. The study focuses on participants with respiratory syncytial virus infections, with interventions including the RSVPreF3 vaccine and controls such as placebo, Tdap, or influenza vaccine. The study measures pregnancy outcomes, pregnancy-related adverse events of special interest, and infant adverse events from Day 1 up to Day 42 post-delivery of the first pregnancy conceived within 2 years post-vaccination."
601,"GPT4 Correct Assistant: This clinical trial is a cross-sectional pilot study investigating the use of 19F MRI in healthy children and children with mild cystic fibrosis lung disease. The study aims to assess the participation rate, completion rate, and parental and child acceptability scores of the intervention. The primary outcome measures are MRI-defined ventilation defect parameters (VDP) and MRI-defined fraction of lung volume with slow gas washout time (FLVlongtau2) in both healthy participants and participants with cystic fibrosis. The trial utilizes a combination product of inhaled perfluoropropane during MRI procedures, with image acquisition at breath-hold and during tidal breathing."
602,"GPT4 Correct Assistant: This study is a randomized clinical trial investigating the effects of open chain exercises and closed chain exercises among athletes with Patellofemoral Pain Syndrome. The study will be conducted in Pakistan sports board Lahore, Model town Sports Club Lahore, and Sheikh Zaid Hospital, Lahore. The participants will be randomly assigned to two groups: Group A will receive open kinetic chain exercises, and Group B will receive closed kinetic chain exercises, both along with general training. The study will measure the participants' pain, function, and balance using Numerical Pain Rating Scale (NPRS), Lower Extremity Functional Scale (LEFS), and Y balance test. The study will run for 6 weeks."
603,"GPT4 Correct Assistant: The study aims to investigate the effects of the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet on oxidative stress, inflammation, and neurodegenerative risk biomarkers in American football players. The MIND diet, rich in antioxidants and anti-inflammatory properties, is hypothesized to improve these biomarkers and potentially reduce the risk of neurodegenerative diseases later in life. The study includes 30 American football players, randomly assigned to either the MIND diet group or the control group. The MIND diet group will receive guidance on incorporating the diet's food groups into their meals, while the control group will maintain their usual eating habits. Biomarkers associated with oxidative stress, inflammation, and neurodegenerative risk will be analyzed in blood samples taken before and after a nine-week follow-up period."
604,"GPT4 Correct Assistant: This clinical trial investigates the effectiveness of left bundle branch area pacing (LBBAP) in heart failure patients with ejection fraction below normal. The study includes two participant groups: a prospective LBBAP-HF cohort and a retrospective LBBAP-HF cohort. The primary outcome measures are the acute success rate of LBBAP and acute complications related to the procedures. Secondary outcome measures include the incidence of acute procedure-related complications, repeat procedures, pacemaker upgrades, heart failure hospitalizations, cardiovascular deaths, and all-cause deaths within one year."
605,"GPT4 Correct Assistant: This is a Phase 1a, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and pharmacokinetics of CSX-1004 injection in healthy adults. The study focuses on participants aged 18 to 50 years with a history of opioid overdose or opioid use disorder. The intervention involves single ascending doses of CSX-1004 (a recombinant human immunoglobulin G (IgG) 1λ monoclonal antibody specific for fentanyl and structurally related fentanyl analogs) or placebo. The study measures treatment-emergent adverse events, clinical laboratory assessments, vital signs, electrocardiogram, physical examination, and infusion site examination. Secondary outcomes include maximum serum concentration, area under the curve from time zero extrapolated to infinity, area under the curve from time zero to the last measurable concentration, time to maximum serum concentration, beta terminal elimination half-life, and other pharmacokinetic parameters."
606,"GPT4 Correct Assistant: This clinical trial aims to investigate joint aspiration in dysfunctional hip, knee, or shoulder prostheses due to chronic infection or implant failure. The study is a prospective cohort study with an open-label design. Participants undergo joint fluid aspiration (JFA) to analyze bacteriological concordance between JFA and perioperative samples. The study includes patients aged over 18 years with a hip, knee, or shoulder joint prosthesis, who have indications for FJA due to mechanical or septic reasons and have over one-month symptoms' evolution. The study measures the concordance between JFA and perioperative samples to evaluate the diagnostic value of joint fluid aspiration in prosthetic joint infection."
607,"GPT4 Correct Assistant: This clinical trial aims to study the quantitation and spatial registration of airways dysfunction with dynamic 19F MRI in cystic fibrosis patients. The intervention used is a combination product of 19F MRI with inhalation of a biologically inert contrast gas, perfluoropropane, combined with 19F-tuned MRI with image acquisition at breath-hold and during tidal breathing. The primary outcome measures are changes in ventilation defect parameter (VDP) and forced expiratory volume in one second (FEV1) over 14 days and 365 days. Secondary outcome measures include changes in MRI severity score and correlation of MRI severity score with VDP and forced expiratory volume in one second (FEV1) at baseline."
608,"GPT4 Correct Assistant: This study is a randomized, open, single-dose, two-sequence, two-cycle, double-cross design bioequivalence trial evaluating the fasting single oral STI-1558 capsule in healthy Chinese subjects. It aims to compare the maximum observed concentration (Cmax) profiles, Area Under the Curve (AUC) from time 0 to last time point (AUC0-t), AUC from time 0 extrapolated to infinity (AUC0-inf), Tmax, t1/2, λz, and %AUCex profiles of two different kinds of oral STI-1558 to determine the relative bioavailability. The study involves 32 eligible subjects randomly assigned to either TR or RT group, with each group taking the test preparation and reference preparation under fasting conditions."
609,"GPT4 Correct Assistant: This clinical trial aims to determine the effectiveness of detaching the breathing circuit on the rate of double-lumen endotracheal tube malposition after a change in patient position in patients undergoing thoracic surgery. The study includes patients aged 18 to 65 years who require a left-sided double-lumen endobronchial tube. The intervention group has the breathing circuit disengaged when the patient's position changes, while the control group maintains the normal connection of the breathing line. The primary outcome measure is the malposition rate of the double-lumen endobronchial tube immediately after a change in body position. Secondary outcome measures include effects of lung collapse, blood oxygen saturation, and PACU length of stay."
610,"GPT4 Correct Assistant: This clinical trial aims to investigate the effectiveness of personalized comprehensive diabetes support for families of children newly diagnosed with Type 1 Diabetes. The study includes children aged 16 years or younger and their families, with a stable living situation. The intervention is a personalized comprehensive diabetes support provided for 6 months following the diagnosis. The primary outcomes measured are Diabetes Distress Scale and Problem Areas in Diabetes (PAID) at 24 months."
611,"GPT4 Correct Assistant: This clinical trial aims to evaluate the efficacy of telemedicine management in the treatment of patients with major depressive disorder (MDD) in non-psychiatric care pathways. The trial is a randomized multicenter clinical trial with two parallel arms, comparing usual care to usual care plus telemedicine monitoring. The primary outcome measure is the treatment response rate at 6 months after inclusion, defined as a 50% reduction in Hospital Anxiety and Depression Scale (HADS-Depression) score compared to baseline. Secondary outcomes include incremental cost-utility ratio over 3 years, quality of life scores, number of relapse episodes, medication compliance, integration into a psychiatric care pathway, and feasibility and satisfaction with telemedicine tools. The trial includes patients aged 18 years and older, with a MDD diagnosis, hospitalized in medicine or surgery, and receiving liaison psychiatry opinion. The trial will follow patients for 3 years, with assessments at 3, 6, 12, 18, 24, 30, and 36 months."
612,GPT4 Correct Assistant: This clinical trial aims to develop an AI algorithm to differentiate between benign and malignant soft tissue masses using artificial intelligence (AI) and additional quantitative MR images. Patients with a soft tissue mass will be asked to consent to extra MR images being acquired during their standard MRI scan. These images will be used to provide extra information to the AI algorithm. The study will measure diagnostic accuracy and classification accuracy of the AI algorithms.
613,"GPT4 Correct Assistant: This study is a randomized controlled clinical trial that aims to comparatively evaluate microneedling alone and along with hyaluronic acid on thin gingival phenotype. The trial will be conducted in the department of periodontics and oral implantology, Post Graduate Institute of Dental Sciences, Rohtak, and will last for 24 months. A total of 20 patients with thin periodontal phenotypes will be recruited and randomly allocated to either microneedling alone or microneedling with hyaluronic acid. The primary outcome measure is the measurement of gingival thickness at baseline, 1 month, 6 months, and 9 months."
614,"GPT4 Correct Assistant: This clinical trial is a randomized, double-masked study investigating the effects of preoperative immunonutrition on patients undergoing elective colorectal surgery for neoplasm. The study aims to determine the impact of Oral Impact Nestle, a dietary supplement, on surgical site infections, anastomotic leakage, length of stay, and adipose tissue inflammation. Participants are randomized into two groups: one receiving the supplement and colorectal surgery, and the other receiving a placebo and colorectal surgery. The primary outcome measure is the number of participants developing surgical site infections within 30 days after the surgical procedure. Secondary outcome measures include anastomotic leakage, length of stay, and inflammatory infiltration in subcutaneous and visceral adipose tissues."
615,"GPT4 Correct Assistant: This clinical trial aims to investigate the impact and potential benefits of adding an oculomotor therapy treatment to a manual therapy protocol for patients with migraine. The study involves patients aged 18-65 with a specific set of migraine characteristics. Participants are randomly assigned to either a control group receiving cervical treatment alone or an experimental group receiving both cervical and oculomotor treatments. The primary outcome measure is the impact of migraine, assessed using the Headache Impact Test (HIT-6) questionnaire. Secondary outcome measures include pain intensity, migraine disability, depression, anxiety, sleep quality, kinesiophobia, catastrophizing, central sensitization, neck disability, head repositioning, deep cervical flexor strength, ocular movement, ocular movement with head variation, range of movement, and quality of life."
616,"GPT4 Correct Assistant: The CRATOS clinical trial aims to evaluate the Cratos™ Branch Stent Graft System in the treatment of descending aorta lesions, specifically aortic dissection Type B, intramural hematoma, and penetrating aortic ulcer. The study is open to all eligible participants aged 18 and above, with aortic pathology requiring surgical repair. The intervention is the use of the Cratos™ Stent Graft for thoracic endovascular repair (TEVAR). The primary outcome measure is all-cause mortality within 30 days of the procedure."
617,"GPT4 Correct Assistant: This comparative study aims to describe the level obtained with the Shamrock technique and compare depth of lumbar plexus, image quality, and presence of vessels between the Trident and Shamrock techniques for ultrasound-guided lumbar plexus block (BPLE). The study includes adult volunteers with an indication for lumbar echography and excludes those with a history of spine surgery or spinal malformation. The primary outcome measure is the projection of line C on the costiform processes. Secondary outcome measures include depth of lumbar plexus, image quality, and presence of vessels."
618,"GPT4 Correct Assistant: The study aims to investigate the efficacy of standardized pre-operative pelvic floor physical therapy (PFPT) in reducing stress urinary incontinence (SUI) and improving patient quality of life (QoL) following Holmium Laser Enucleation of the Prostate (HoLEP). The study is a prospective randomized trial with two groups: Group A (preoperative PFPT) and Group B (postoperative PFPT). The primary outcome measure is the time to continence, with secondary measures including uroflow, post void residual, international prostate symptom score, operative time, length of stay, catheter duration, infectious complications, emergency room visits, and adverse events."
619,"GPT4 Correct Assistant: The DETECT-IP trial is a randomized, controlled study aiming to reduce acute renal failure and/or hyperkalemia adverse drug events in older inpatients by incorporating specific rules into a computerized support system and dedicated procedures. The study involves two groups: an intervention group that receives clinical decision support and a control group that does not. The primary outcome measure is the number of adverse drug events such as acute renal failure and/or hyperkalemia in older hospitalized patients. Secondary outcome measures include the presence of an adverse event related to the intervention provided, therapeutic adaptations implemented in case of acute renal failure or hyperkalemia upon hospital admission, relevance of CDSS alerts, number of pharmaceutical interventions accepted, changes in ADEs prevention/management work process induced by the introduction of alerts, and the cost-effectiveness of the pharmaceutical intervention."
620,"GPT4 Correct Assistant: This clinical trial, titled ""Mesenteric Bacterial Translocation in Evolved Crohn's Disease,"" aims to study the differences in bacterial taxa and function profiles between Crohn's Disease (CD) patients with and without early post-surgical disease recurrence. The trial includes two participant groups: CD patients requiring surgical treatment and a control group of patients requiring an ileocecal resection for a cause other than CD. The primary outcome measures are the differences in bacterial taxa and function profiles between the mesentery, ileal tissue, and blood of the two groups. Secondary outcome measures include an association analysis of genetic variants related to innate immunity and the bacterial microbiome profile of CD patients."
621,"GPT4 Correct Assistant: This clinical trial, titled ""Effect of Injection Site on the Relative Bioavailability of a Single Dose of LY3437943 in Healthy Participants With a High Body Mass Index,"" aims to study the effect of injection site on the relative bioavailability of a single dose of LY3437943 in healthy participants with a high body mass index (BMI between 27.0 and 45.0 kg/m²). The study is designed as a randomized, open-label, parallel assignment trial, and participants will be divided into two groups: one receiving LY3437943 administered subcutaneously (SC) in either thigh, upper arm, or abdomen, and the other receiving LY3437943 administered intravenously (IV). The primary outcome measures are the pharmacokinetics (PK) parameters, area under the plasma concentration versus time curve from zero to infinity (AUC[0-∞]) and maximum concentration (Cmax) of LY3437943. The study is open to healthy volunteers aged 18 to 70 years."
622,"GPT4 Correct Assistant: The research registry titled ""A Research Registry on Aggressive PitNETs"" aims to study endocrine tumors in patients with pituitary tumors. The study includes patients aged 18 years or older, of all sexes, and excludes those who object to participating in the research. The study design involves one participant group/arm with no specific intervention or treatment. The primary outcome measure is the characterization of the aggressiveness of pituitary tumors by transcriptome analysis, which will be predictive of prognosis. The study duration is three years."
623,"GPT4 Correct Assistant: The OPTI-DOSE study aims to investigate the feasibility of a lower starting dose with step-up approach for older adults (≥65 years) receiving anticancer tablet treatments. The trial includes 30 patients starting treatment with one of the following drugs: pazopanib, olaparib, lenvatinib, sunitinib, or palbociclib. The control group will receive standard-of-care doses, while the interventional group will start with the lowest dose, increasing every two weeks if tolerated. The primary outcome measures include the percentage of patients willing to participate, the percentage of patients successfully completing the first 12 weeks, and the percentage of data points collected during the first 12 weeks. Secondary outcomes include overall treatment utility, progression-free survival, overall survival, quality of life, safety, hospital care use, and pharmacokinetic parameters."
624,"GPT4 Correct Assistant: The study, titled ""Preoperative Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Rectal Adenocarcinoma: a Prospective, Multicenter, Randomized Controlled Study (PRECAM-R), aims to evaluate the pathologic complete response (pCR) rate following short-course radiation then Envafolimab Plus CAPEOX in patients with MSS (microsatellite stable) locally advanced rectal adenocarcinoma. The study will also assess tumor regression grade, overall survival (OS) at 3 years, progression-free survival (PFS) at 3 years, treatment-related adverse events (TRAEs), surgical complications, and quality of life (QoL) in participants. The study will enroll 108 patients, with 54 patients receiving the experimental intervention (neoadjuvant chemoradiotherapy combined with immunotherapy and total mesorectal excision) and 54 patients receiving the control intervention (neoadjuvant chemoradiotherapy and total mesorectal excision)."
625,"GPT4 Correct Assistant: This is a two-stage clinical trial investigating the efficacy, safety, pharmacokinetics, pharmacodynamics, and immunogenicity of various doses of Levilimab administered intravenously or subcutaneously to healthy subjects and those with active rheumatoid arthritis. In the first stage, healthy subjects receive single doses of Levilimab, while in the second stage, subjects with active rheumatoid arthritis receive repeated doses of Levilimab in combination with methotrexate. The primary outcome measure is the safety profile of Levilimab, and the secondary outcome measures include low disease activity, RA remission, pharmacokinetics, and immunogenicity."
626,"GPT4 Correct Assistant: This clinical trial aims to evaluate the efficacy of White Kidney Bean on Oral Glucose Tolerance Test in healthy adults aged 25-45 years. The study is designed as a randomized, double-blind, crossover trial, with participants being allocated to four groups: Phase 1 Wonderlab Product, Phase 1 Placebo, Phase 2 Placebo, and Phase 2 Wonderlab Product. The primary outcome measure is the change of blood glucose level in mmol/L based on OGTT after intervention, while the secondary outcome measure is the change of fasting blood glucose level in mmol/L based on OGTT after intervention."
627,"GPT4 Correct Assistant: The IMPlementation of Evidence Based Facility and Community Interventions to Reduce the Treatment Gap for depRESSion is a clinical trial aiming to test the effectiveness of community intervention and Healthy Activity Program (HAP) in treating depression. The study includes two arms: a community model that combines facility model with community intervention strategies, and a facility model that delivers HAP through existing healthcare workers. The primary outcome measure is the Patient Health Questionnaire 9 items (PHQ-9) score at three months post recruitment. Secondary outcome measures include sustained effectiveness, remission, response to treatment, client service receipt inventory, WHO Disability Assessment Schedule (WHODAS 2.0), and cost-related measures. The study aims to recruit adults aged 18 years and above, residing in the clusters included in the trial and speak English or one of the local languages."
628,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of low-intensity blood flow restriction training in normoxia and hypoxia conditions on muscle strength, thickness, catecholamine, and inflammatory responses in physically active adults. Participants are randomly assigned to one of five intervention groups, including low-intensity resistance training, high-intensity resistance training, low-intensity resistance training combined with blood flow restriction, low-intensity resistance training in hypoxia condition, and low-intensity resistance training combined with blood flow restriction in hypoxia condition. The study measures primary outcomes such as force output, one-repetition maximum, maximum number of repetitions, countermovement jump height, countermovement jump power output, catecholamine response, muscle stiffness, and muscle thickness. Secondary outcomes include perception of pain, perception of effort, and blood pressure."
629,"GPT4 Correct Assistant: This is a Phase II multicenter clinical trial investigating the efficacy of subcutaneous mosunetuzumab monotherapy in follicular lymphoma patients with early relapse (POD24). The primary objective is to evaluate the progression-free survival 2 years after the initiation of second-line treatment in POD24 patients. The study will also investigate the safety of mosunetuzumab, the prognostic significance of 18F-FDG-PET-CT response, the rate of transformation to higher-grade lymphoma following mosunetuzumab, and patients' self-reported quality of life during and after mosunetuzumab treatment."
630,"GPT4 Correct Assistant: This clinical trial aims to test the safety and effectiveness of combining two drugs, PLX2853 and trametinib, in treating advanced uveal melanoma. The study has two primary objectives: to determine the maximum tolerated dose and recommended phase II dose, and to evaluate whether the combination of these drugs demonstrates clinical activity in advanced uveal melanoma. Secondary objectives include evaluating the overall response rate, progression-free survival, overall survival, and adverse event profile associated with the combination of PLX2853 and trametinib. The study is designed as a phase I dose-escalation study followed by a phase II study. Participants receive both drugs orally throughout the study and undergo computed tomography, magnetic resonance imaging, and blood collection at various time points."
631,"GPT4 Correct Assistant: The ASCERTAIN study is a Phase IV, randomized, open-label trial investigating the implementation and utility of a primary care model in patients with Atherosclerotic Cardiovascular Disease (ASCVD) or ASCVD-risk equivalents and elevated LDL-C. The study aims to assess the effectiveness of a new model of care compared to usual care in patients who have not reached their LDL-target. Participants will receive maximally tolerated statin and/or ezetimibe therapy with or without other LDL-C lowering therapies as per the treating physician's discretion. The primary outcome measure is the effect on LDL-C concentration at baseline and at day 180."
632,"GPT4 Correct Assistant: This is a randomized, controlled, single-blinded study conducted at Al-Azhar university hospital's urology operating theatre. It involved 48 patients aged between 21-65 years, scheduled for elective open renal surgeries under general anesthesia. The patients were classified into one of three groups: ESPB (Erector spinea block), TPVB (Thoracic Para-vertebral block), and QLB (Quadratus lamborum block). The primary outcome measure is the total morphine requirements 24 hours postoperatively."
633,"GPT4 Correct Assistant: This study aims to evaluate and describe musculoskeletal health in adult haematological cancer survivors. It is a mixed methods study, which includes both questionnaire and interview components, and involves participants with various ages, genders, and time since cancer treatment. The study focuses on the prevalence of musculoskeletal conditions, the probability of fractures, sarcopenia and frailty, and quality of life related to musculoskeletal function."
634,"GPT4 Correct Assistant: This clinical trial is a Phase 2 basket study investigating the efficacy of disitamab vedotin in adult subjects with previously treated, locally-advanced unresectable or metastatic solid tumors that express HER2. The study includes four cohorts: HNSCC (head and neck squamous cell carcinoma), NSCLC (non-small-cell lung cancer), ovarian cancer, and endometrial cancer. The primary outcome measure is the confirmed objective response rate (ORR) per RECIST v1.1 by investigator assessment. The study aims to assess the safety and efficacy of disitamab vedotin monotherapy in these patient populations."
635,"GPT4 Correct Assistant: This clinical trial aims to investigate the driving rehabilitation and innovation for evaluating risk in post-intensive care unit (ICU) survivors. The study focuses on older adults who have experienced cognitive, psychological, and physical impairments known as Post-Intensive Care Syndrome (PICS) and are at high risk of automobile crashes. The trial seeks to determine the feasibility and acceptability of neurocognitive assessments and in-vehicle sensor deployment for assessing and addressing ICU survivor driving safety. Participants will undergo neurocognitive measures and participate in driving data collection via in-vehicle sensors over a 6-month post-hospital discharge period. The study will also evaluate the relationship between neurocognitive assessments and driving behavior and safety in older ICU survivors and conduct stakeholder advisory panels on driving assessments for older ICU survivors."
636,"GPT4 Correct Assistant: This clinical trial aims to evaluate the effectiveness of a brief Acceptance and Commitment Therapy (ACT) workshop for women with obesity. The study will recruit 70 women with a BMI of >30.0 kg/m2, who will be randomly assigned to either the ACT workshop intervention or a waitlist control group. The primary outcomes measured are change in psychological flexibility, distress tolerance, and valued living at weeks 1 and 1 month post-intervention. Secondary outcomes include change in weight self-stigma, body image, emotional eating, physical activity, diet quality, and body weight at weeks 1 and 1 month post-intervention."
637,"GPT4 Correct Assistant: This clinical trial aims to investigate the effectiveness of a drug holiday treatment mode based on minimal residual disease (MRD) detection in gastrointestinal stromal tumor (GIST) patients at high risk of recurrence. The study includes GIST patients who have been treated with imatinib for three years after surgery and have achieved disease control. The primary outcome measures are progression-free survival, drug re-use rate, and drug retreatment response rate. The secondary outcome measures include overall survival, genetic mutation profiling of ctDNA-MRD, and comparison of MRD conversion and disease progression assessed by imaging examination."
638,"GPT4 Correct Assistant: This study is a randomized control trial comparing the effects of Dohsa hou exercises on functional mobility in children with Down syndrome. The study will involve 6 to 12-year-old children of both genders with a normal BMI and no psychiatric or physical illnesses. The participants will be divided into two groups using simple random sampling techniques. One group will receive standard treatment protocol, while the other group will receive Dohsa hou exercises. The primary outcome measures are the Trunk Impairment Scale and Time Up and Go Test, both of which will be assessed at the end of the 6-week study."
639,"GPT4 Correct Assistant: The Supporting Physical Literacy at School and Home (SPLASH) study aims to increase children's physical activity through a multilevel, comprehensive physical literacy-focused program that reaches children both at school and at home. The study uses a 2-arm, group randomized controlled trial with 400 3rd-5th grade students from low-income schools, who are either given the multilevel Rising New York Road Runners (RNYRR) program or a delayed-intervention control. The primary outcome measures are baseline and end-point physical activity levels, while secondary outcome measures include baseline and end-point fundamental movement skills."
640,"GPT4 Correct Assistant: A Phase III clinical trial is being conducted to test the efficacy and safety of BI 456906, a drug for the treatment of obesity in Japanese patients. The study will involve 76 weeks of treatment and will compare the drug's effectiveness to a placebo. The primary outcomes measure the percentage change in body weight from baseline to week 76, and the achievement of body weight reduction of ≥5% from baseline to week 76. Secondary outcomes include additional measures of body weight, blood pressure, and eating behavior."
641,"GPT4 Correct Assistant: This study aims to evaluate the pre- and postoperative gastric volume in pediatric patients undergoing adenotonsillectomy surgery using ultrasound. The primary outcome measure is gastric volume (ml/kg), while secondary outcome measures include cross-sectional area (ACSA) of the stomach, postoperative presence and severity of PONV, blood volume in the suction system, and duration of surgery. The study includes ASA 1,2,3 patients aged 1-18 years who will undergo adenotonsillectomy surgery at Istanbul University. Gastric volume will be assessed using ultrasound in the right lateral decubitus position before, immediately after intubation, and 10 minutes before extubation."
642,"GPT4 Correct Assistant: This clinical trial aims to investigate the effect of pituitrin on the prognosis of patients with pulmonary hypertension undergoing cardiac surgery. The study is a randomized controlled trial, with participants divided into two groups: pituitrin group and normal saline group. The primary outcome measure is a composite endpoint of mortality or severe postoperative complications within 30 days after cardiac surgery. Secondary outcome measures include postoperative infection, septic shock, duration of mechanical ventilation, postoperative pulmonary complications, time to achieve hemodynamic stability, use of dobutamine or other vasoactive drugs, incidence of digital ischemia, acute mesenteric ischemia, gastrointestinal complications, incidence of acute myocardial infarction, new onset tachyarrhythmia, water poisoning, vasodilative shock, incidence of pulmonary embolism, low cardiac output syndrome, acute respiratory distress syndrome, delirium, need for renal replacement therapy, need for hemodialysis, incidence of readmission to ICU, length of ICU stay, length of hospital stay, levels of serum antidiuretic hormone in patients, levels of copeptin in patients, and secondary endotracheal intubation."
643,"GPT4 Correct Assistant: The study aims to evaluate the feasibility and safety of home initiation of noninvasive positive pressure ventilation (NiPPV) in children with medical complexity (CMC) using remote telemonitoring compared to the standard of care, which is in-hospital polysomnography (PSG) laboratory-based initiation. The study will recruit children aged 5-17 years who are newly prescribed NiPPV and tolerate awake NiPPV trials. The primary outcome measures are recruitment and retention rates, while the secondary outcome measures include adherence, psychological scales, and caregiver reported sense of mastery. The study aims to explore the potential benefits of home NiPPV initiation, including increased patient and family empowerment, improved patient-centered care, and optimized NiPPV use."
644,"GPT4 Correct Assistant: This study is a single-blind randomized clinical trial investigating the effects of dry needling on vertical jump performance in female volleyball athletes with latent myofascial trigger points in their gastrocnemius. Participants will be randomly assigned to either the intervention group (receiving dry needling) or the control group (waiting on the intervention couch). The primary outcome measure is counter-movement jump performance, assessed at various time points."
645,"GPT4 Correct Assistant: This clinical trial aims to investigate the clinical features of refractory gastrointestinal Henoch-Schönlein purpura and the clinical outcome of mycophenolate mofetil (MMF) in these patients. The study includes participants aged 3 to 18 years who meet the diagnostic criteria for HSP and have refractory gastrointestinal type HSP. Participants are treated with MMF, and the primary outcome measures are the incidence of abdominal pain, hematemesis, and bloody stools. The secondary outcome measure is the count of red blood cells in stool. The study is designed as a single-group assignment, open-label trial."
646,"GPT4 Correct Assistant: This clinical trial is a staged, open-label, Phase II/III safety, feasibility, and efficacy investigational device trial for Electroencephalogram (EEG) Enhanced Transcranial Magnetic Stimulation (eTMS) for Chronic Trauma and Stressor-Related Disorders (TSRD). The study aims to assess the safety, feasibility, and preliminary efficacy of eTMS as an adjunct to standard of care TSRD treatment. The primary outcome measures are the number of participants with device-related serious adverse events and the rate of participants completing 80% of scheduled visits. The secondary outcome measure is the mean change in Veterans RAND 36-item health survey (VR-36) mental component scores (MCS) from baseline to week 6 in participants who completed 80% of eTMS sessions."
647,"GPT4 Correct Assistant: This retrospective study aims to evaluate the effectiveness of radiotherapy combined with EGFR-TKI for patients with stage III EGFR mutant lung cancer. The primary study metric is progression-free survival (PFS). Participants must be diagnosed with lung cancer, have EGFR mutation testing, and meet specific TNM stage criteria. The treatment includes radiotherapy (3DCRT or IMRT) and EGFR-TKI (gefitinib, erlotinib, oseltinib, or ametinib). The study measures PFS for two years."
648,"GPT4 Correct Assistant: The study aims to identify the microorganisms responsible for acute head and neck infections in patients over the age of 18 with Streptococci infections, using samples from Northampton General Hospital. The primary outcome measure is the identification of Streptococci species using DNA analysis and biochemical testing. Secondary outcome measures include patient characteristics such as age, sex, site of infection, length of hospital stay, antibiotic treatment, and diabetic status. The study will analyze data over a 4-year period."
649,"GPT4 Correct Assistant: The study aimed to assess the effectiveness of functional magnetic stimulation and pelvic floor muscle training in treating stress urinary incontinence in women. Participants were randomly divided into two groups: one receiving functional magnetic stimulation, and the other undergoing a pelvic floor muscle training program. The study used the International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) and Incontinence Impact Questionnaire-Short Form (IIQ-7) to evaluate urinary incontinence symptoms and their impact on quality of life. Pelvic floor muscle strength and endurance were assessed using a Pelvexiser perineometer. The study found that both treatments significantly improved symptoms and quality of life in women with stress urinary incontinence."
650,"GPT4 Correct Assistant: This clinical trial aims to optimize the selection and treatment outcomes of biologic therapies for psoriatic arthritis (PsA) and seronegative rheumatoid arthritis (RA) patients. The study focuses on phenotyping of synovial immune and stromal cells to generate a comprehensive cellular and molecular atlas of PsA and RA. Participants include PsO patients at risk of PsA development, naive to treatment PsA, TNF-inhibitor and IL-17-inhibitor resistant PsA, TNF-inhibitor and IL-17-inhibitor induced remission PsA, c-DMARDs resistant PsA, and c-DMARDs resistant RA. The primary outcome measures are minimal disease activity status achievement, PsA development, and remission maintenance. The study will run for 12 months with a follow-up period of 6 months."
651,"GPT4 Correct Assistant: This clinical trial aims to investigate the use of artificial tears (methylcellulose) in preventing nasolacrimal duct obstruction in patients with thyroid cancer treated with radioactive iodine therapy. The study is a randomized, parallel assignment, open-label trial, with two groups: one receiving artificial tears and the other receiving no intervention. The primary outcome measure is the incidence of post-radiotherapy nasolacrimal duct obstruction, assessed by tear duct irrigation by an ophthalmologist at 2 years."
652,"GPT4 Correct Assistant: This clinical trial is a phase II randomized controlled trial investigating the use of atorvastatin in patients with resected high-risk stage IIA melanoma. The primary objective is to compare recurrence-free survival (RFS) of patients treated with atorvastatin to placebo. Secondary objectives include comparing distant metastasis-free survival (DMFS) and overall survival (OS) between treatment arms, and assessing the clinical utility of gene expression profiling in melanoma. Patients are randomly assigned to receive either atorvastatin or placebo, both administered orally, for up to 5 years. Patients undergo computed tomography (CT) and/or magnetic resonance imaging (MRI) throughout the study. The trial aims to determine if atorvastatin can improve RFS, DMFS, and OS in high-risk melanoma patients."
653,"GPT4 Correct Assistant: The ACHIEVE (Advancing Community and Clinical Care for Childbirth-related Hypertension Through Implementation, Engagement, and Valuing Equity) initiative aims to improve maternal health outcomes for individuals at risk of complications from high blood pressure during pregnancy and postpartum. The study focuses on the implementation of the Severe Hypertension During Pregnancy and Postpartum Period Safety Bundle (HTN bundle) in outpatient clinics. The HTN bundle includes five areas of focus to improve care for patients with high blood pressure. The clinical trial involves 20 outpatient clinics in central North Carolina, which will receive either usual care or the ACHIEVE multi-component implementation strategy. The primary outcomes measured are fidelity to blood pressure measurement technique, fidelity to the patient education protocol, and fidelity to recognition and response to simulated and actual episodes of severe hypertension."
654,"GPT4 Correct Assistant: The trial aims to evaluate the effectiveness of gain and loss framed text messaging programs in reducing alcohol consumption among older adults aged 50-85 with hazardous drinking habits. The study will randomize participants into three groups: loss-framed messaging, gain-framed messaging, and a combination of both. The primary outcome measures are the weekly sum of standard drinks and the weekly sum of heavy drinking days, assessed at baseline, week 4, week 8, and week 16. Secondary outcome measures include adherence to daily and weekly drinking assessments via text messages and willingness to continue the program."
655,GPT4 Correct Assistant: The Fluselenamyl - Beta Amyloid PET Imaging for Alzheimer Disease clinical trial aims to investigate the safety and effectiveness of the drug 18F-Fluselenamyl in detecting Alzheimer's disease using PET imaging. The study includes healthy volunteers and those with mild cognitive impairment. The primary outcome measures are the safety of the tracer [18F]-Fluselenamyl for PET imaging and the sensitivity of [18F]-Fluselenamyl in imaging Amyloid beta in the setting of mild cognitive impairment. The study will last for 2 years.
656,"GPT4 Correct Assistant: This clinical trial examines the long-term effects of Transcranial Magnetic Stimulation (TMS) in individuals with Primary Progressive Aphasia (PPA), Frontotemporal Dementia, and Alzheimer Disease. The study uses a parallel assignment with a triple mask design, comparing active TMS and language therapy to a sham TMS and language therapy. The primary outcome measure is changes in brain metabolism as measured by FDG-PET imaging at 0 and 6 months. Secondary outcome measures include changes in spontaneous language, language assessment, daily-living activities, and neuropsychiatric symptoms at 0, 3, and 6 months."
657,"GPT4 Correct Assistant: This clinical trial aims to investigate the impact of methylprednisolone, a generally well-tolerated and affordable drug, on cognitive deficits in patients with post-COVID-19 syndrome (PCS) with suspected autoimmune involvement. The study is a two-arm, double-blind, randomized, placebo-controlled trial evaluating the effects of methylprednisolone versus placebo in patients with PCS and cognitive deficits. The trial spans 52 weeks, and participants will be stratified based on age, sex, and cognitive screening using the Montreal Cognitive Assessment Scale (MoCA). The intervention group will receive approximately 1mg/kg body weight oral methylprednisolone once daily for 6 weeks, followed by an additional 6 weeks of open treatment phase with methylprednisolone after a 6-weeks treatment pause. The primary outcome measure is improvement in memory satisfaction as measured by the Multifactorial Memory Questionnaire (MMQ) at week 8. Secondary outcome measures include long-term improvement in memory satisfaction, improvement in memory ability and memory strategy, improvement in neurocognitive functions as measured by the Montreal Cognitive Assessment (MoCA) and the symbol digit modalities test (SDMT), improvement in quality of life (QoL) as measured by the PROMIS questionnaire, improvement in physical and mental fatigue as measured by the Chalder Fatigue Scale, improvement in fatigue as measured by the Fatigue Severity Score (FSS), and improvement in mood as measured by the Becks Depression Inventory (BDI-II). The study also aims to assess the difference of occurring adverse events (AE) and serious adverse events (SAE) comparing methylprednisolone with placebo (IMP safety)."
658,"GPT4 Correct Assistant: This clinical trial aims to analyze the aetiological factors of malnutrition, specifically disease-related malnutrition and inflammation, in patients with an inflammatory response. The study involves a dietary supplement rich in omega-3 and olive oil polyphenols as the intervention. The primary outcome measures include blood biochemistry data such as albumin, prealbumin, C-reactive protein, ferritin, neutrophils, lymphocytes, and platelets. Secondary outcome measures include bioelectrical impedance data, functional parameters, oral intake, and malnutrition diagnosis using GLIM criteria. The study follows patients for three consecutive months."
659,"GPT4 Correct Assistant: The Kaiser Permanente Evaluating Nutritional Interventions in Food-Insecure High-Risk Adults (KP ENRICH) Study aims to assess the impact of financial support for healthy foods and free home delivery on glycosylated hemoglobin levels, medical resource utilization, and patient-reported outcomes in food-insecure high-risk adults with Type 2 diabetes. Participants are randomized into intervention or control groups, and assessments are conducted at baseline, 6 months, and 12 months after enrollment."
660,"GPT4 Correct Assistant: This is a four-arm, double-blind, randomized controlled clinical trial investigating the effect of solvent evaporation time on the quality of cervical lesion restorations using two different universal adhesives. The study includes 140 participants with non-carious cervical lesions who will receive composite resin restorations in the selective enamel etching strategy. Experimental groups 1 and 2 will use an alcohol- and water-based solvent universal adhesive (Scotchbond Universal Plus; 3M) and an acetone-based universal solvent adhesive (Gluma Universal Bond; Kulzer), respectively, with solvent evaporation times of 25 seconds. Control groups 1 and 2 will use the same adhesives but with solvent evaporation times of 5 seconds. The primary outcome measure is the retention of restorations, assessed using World Dental Federation (FDI) criteria, at 24 months post-randomization. Secondary outcome measures include marginal adaptation and marginal staining of restorations."
661,"GPT4 Correct Assistant: This is a Phase II/III clinical trial evaluating the immunogenicity and safety of the SWIM816 vaccine for SARS-CoV-2 compared to the Pfizer Bivalent vaccine in previously vaccinated subjects. The study aims to assess the immunogenicity and safety of the SWIM816 vaccine, as well as its efficacy in comparison to the Pfizer Bivalent vaccine. The trial includes participants aged 18 years and older who have been previously vaccinated with 2/3 doses of COVID-19 vaccine, with or without a previous COVID-19 diagnosis. The primary outcomes measured are the geometric mean titers (GMTs) of SARS-CoV-2 Omicron and related strain neutralizing antibody levels for SWIM816, and the non-inferiority of neutralizing antibody response in terms of geometric mean titers (GMT) of COVID-19 mRNA vaccine (SWIM816) compared with the mRNA COVID-19 vaccine (Pfizer Bivalent vaccine) 14 days post dose."
662,"GPT4 Correct Assistant: The Esbjerg Cohort is a cross-sectional study investigating the relationship between ergonomic exposure and physical capacity in relation to work ability and musculoskeletal pain in workers aged 55 to 70 years. The study includes physical tests, questionnaires, and a long-term evaluation of work ability. The primary outcome measure is work ability, assessed using the Work Ability Index (WAI) questionnaire. Secondary outcome measures include height, weight, BMI, waist-to-hip ratio, blood pressure, pressure pain threshold, warm and cold detection threshold, heat and cold pain threshold, temporal summation, conditioned pain modulation, physical activity, musculoskeletal pain, and additional questions about ergonomics and pain. The study aims to provide knowledge on the consequences of high physical workload on the musculoskeletal system in the oldest group of workers to improve treatment, counseling, and guidelines for optimizing the balance between physical work demands and worker capacity."
663,"GPT4 Correct Assistant: This is a phase I clinical trial investigating the safety and feasibility of a cellular immunotherapy using autologous T cells lentivirally transduced to express L1CAM-specific chimeric antigen receptors for the treatment of patients with locally advanced and unresectable or metastatic small cell neuroendocrine prostate cancer. The study involves dose-escalation of the treatment, and measures the incidence of adverse events, dose-limiting toxicity rates, objective response, radiographic progression-free survival, and overall survival as secondary outcomes."
664,"GPT4 Correct Assistant: This study assesses the safety and efficacy of a new technique, Whipple over the splenic artery (WOTSA), as a treatment for pancreatic ductal adenocarcinoma (PDAC) which traditionally requires total pancreatectomy (TP). The study group consists of 40 consecutive patients who underwent WOTSA for PDAC, and their clinicopathological characteristics and survival were compared with those of a historical control group of 30 consecutive patients who underwent TP. The primary outcome measures are the measurement of the remnant pancreatic volume before and one week after the operation. The secondary outcome measures are the postoperative chemotherapy and follow-up one month after the operation."
665,GPT4 Correct Assistant: This clinical trial aims to investigate the effect of breastfeeding education given to fathers via WhatsApp messaging application in the postpartum period on breastfeeding. The study is designed as an experimental design with four groups using a solomon four-group design. The primary outcome measures are the Breastfeeding Support Scale and The Partner Breastfeeding Influence Scale. The trial includes 18-year-old participants and focuses on the support of fathers in the breastfeeding process.
666,"GPT4 Correct Assistant: This clinical trial aims to study biomarker testing and treatment patterns among patients with PIK3CA mutation in advanced breast cancer. The study includes patients with PIK3CA positive and negative mutations, and measures various outcomes such as number of patients with PIK3CA mutations, time from first diagnosis to evaluation, and treatment patterns. The trial aims to provide insights into the progression and treatment of breast cancer patients with PIK3CA mutations."
667,"GPT4 Correct Assistant: This clinical trial aims to study the effects of melatonin on sleep spindles in children with Autism Spectrum Disorder (ASD). The study includes male and female subjects aged 12-18 years who are English-speaking and able to understand and respond to questionnaires in English. Participants with chronic medical conditions affecting sleep, unstable chronic medical conditions, head injuries resulting in prolonged loss of consciousness, other neurological disorders, diagnosed sleep disorders, or known genetic causes of ASD are excluded. The study uses a single-group assignment design and is open-label. Participants receive a 5mg melatonin gummy 30 minutes before bedtime for two consecutive nights. The primary outcome measure is the change in sleep spindle density during non-Rapid Eye Movement (NREM) sleep between baseline and melatonin nights, measured using a portable EEG device over five nights of sleep within two weeks. The secondary outcome measure is the change in sleep quality between baseline and melatonin nights."
668,"GPT4 Correct Assistant: The DETERMINE trial (Treatment Arm 04) investigates the combination of trastuzumab and pertuzumab in adult, teenage, and pediatric patients with cancerous tumors that have HER2 amplification or activating mutations. The trial aims to evaluate the safety and efficacy of the treatment in these patient populations. The primary outcome measures include objective response rate and durable clinical benefit. The study also evaluates the impact of the treatment on patients' quality of life and explores the correlation between molecular subtypes and clinical outcomes."
669,"GPT4 Correct Assistant: This clinical trial aims to study the etiology of persistent velopharyngeal insufficiency in children with operated velopalatine cleft by analyzing velopharyngeal motor skills in static and dynamic MRI. The study includes children aged 7 to 12 years with isolated cleft lip and operated velopalatine cleft without syndromic cleft or Pierre Robin sequence. The intervention is real-time MRI, and the primary outcome measures are the ratio between the diameter of the pharynx at rest and during phonation, and the closure distance between the velar knee and the posterior pharyngeal wall."
670,"GPT4 Correct Assistant: The study aims to evaluate the feasibility and efficacy of a remotely-delivered exercise training program for improving cognition and mobility among older adults with multiple sclerosis (MS). Participants aged 50 years or older, with mild-to-moderate cognitive impairment and walking impairment, will be randomized into either an Aerobic and Resistance Exercise Program (GEMS program) or a Flexibility and Stretching Program (FLEX-MS program), both delivered via telerehabilitation. The primary outcomes measured are cognitive function, physical function, lower-extremity function, functional mobility, walking endurance, and walking speed. Secondary outcomes include physical activity level, exercise behavior, vascular function, and biomarkers of arterial stiffness."
671,"GPT4 Correct Assistant: This pilot study aims to measure the clinical and biological effects of using the oXiris hemofiltration membrane in treating critically ill patients with vasoplegic shock. The study will analyze the clearance of vasoactive metabolites and the impact of the treatment on the patients' hemodynamic stabilization. The primary outcome measure is a 50% reduction in the vaso-inotropic score within 24 hours of initiating oXiris treatment. Secondary outcome measures include the evolution of the vaso-inotropic score within 72 hours, the quantitative determination of angiotensins and regulatory enzymes, the clearance of endothelial permeability markers, and markers of sepsis-induced immunosuppression. The study will also assess the correlation between the concentrations of angiotensin metabolites and 90-day mortality."
672,"GPT4 Correct Assistant: This study aims to compare the efficacy of central and lateral urinary bladder dissection during total laparoscopic hysterectomy in cases with previous cesarean section. The primary outcome measure is the rate of urinary bladder injury during dissection, while secondary outcome measures include operative time, amount of blood loss, and late urological complications. The study is a randomized controlled trial with participants allocated to either central or lateral urinary bladder dissection, both performed using the Wolf laparoscopy tower."
673,"GPT4 Correct Assistant: This is a 6-month observational study that aims to investigate the association between the asthma microbiome and disease characteristics, severity, and treatment response. The study includes patients with possible or established asthma diagnoses. The study will collect and analyze various biomedical samples, including blood, oral rinse, nasopharyngeal swab, exhaled breath condensate, stool, and induced sputum. It will also use validated symptom questionnaires and pulmonary function testing to assess asthma control and treatment response. The study seeks to determine if the microbiome signature can predict treatment response or resistance and establish any association between the asthma phenotype and microbiome signature."
674,"GPT4 Correct Assistant: This study aims to compare the effects of split-body and full-body resistance training on strength and functional performance in amateur cricket players. It is a randomized controlled trial with 28 participants, divided into two groups: split-body and full-body resistance training. Both groups undergo training for six weeks, and their performance is assessed using the bench press test, leg press test, and 30-second sit-to-stand test. The study aims to determine which training method is more effective in improving strength and functional performance in amateur cricket players."
675,"GPT4 Correct Assistant: This clinical trial aims to investigate the effect of training on breastfeeding given to fathers on breastfeeding, parent-baby bonding, and breastfeeding self-efficacy level. The study includes three groups: experimental group 1 (breastfeeding training for both mothers and fathers), experimental group 2 (breastfeeding training for mothers only), and control group (routine hospital care). The primary outcome measures are breastfeeding self-efficacy scale, mother to infant bonding scale, father breastfeeding self-efficacy scale short form, and paternal-infant attachment questionnaire. The study will be conducted for three months, and the results will be analyzed to determine the impact of father's involvement in breastfeeding training on breastfeeding, parent-baby bonding, and breastfeeding self-efficacy level."
676,"GPT4 Correct Assistant: The study aims to investigate the effects of Amway Bundle Combination of Products on Osteoarthritis and Sarcopenia. The study population consists of Chinese males and females aged between 50-70 with Osteoarthritis and Sarcopenia. Participants are randomly assigned to one of four groups: Bundle Group 1 with Nutrilite Lifestyle, Bundle Group 2 without Nutrilite Lifestyle, Control Group 1, and Control Group 2 with Nutrilite Lifestyle. The primary outcome measure is the change of Short Physical Performance Battery (SPPB) score from baseline to day 180. Secondary outcome measures include changes in WOMAC Questionnaire Scores, Visual Analogue Scale/Score (VAS), Chalder Fatigue Scale (CFS), fat and muscle portions measured by Inbody S10, hand and grip strength measured by Jamar Smart Hand Dynamometer, and bone density measured by DXA Bone Densitometer."
677,"GPT4 Correct Assistant: This clinical trial aims to evaluate the effectiveness of a randomized, Type 1 Hybrid Effectiveness-Implementation Trial of Screening, Brief Intervention, and Referral to Treatment (SBIRT) in family planning clinics in reducing alcohol and drug use, and improving health outcomes among reproductive-aged women. The study will enroll women aged 18-45 who are seeking family planning services at participating clinics in the Northeast region of the United States. Participants will be randomly assigned to either the SBIRT intervention or the usual care group. The primary outcomes include average drinks per drinking day, depression score, and number of days of alcohol and drug use. Secondary outcomes include anxiety score, quality of life score, general self-reported health, condom and contraceptive nonuse, incidence of regretted/nonconsensual sex and sexual violence, and unintended pregnancy. The study will also assess the implementation of SBIRT in family planning clinics, including fidelity to the intervention, provider training, and patient referral rates."
678,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of Herbal tea infusions, specifically TeinTrimHerbalTeas' Welsh Herbal Teas, on gut microbiome and blood lipid markers in participants. The study consists of three intervention groups: green tea control, senna herb mix, and rhubarb root herb mix, with a double-blind design. The primary outcomes are changes in total plasma cholesterol and low-density lipoprotein cholesterol after 21 days of intervention. Secondary outcomes include changes in high-density lipoprotein cholesterol, triglycerides, non-high-density lipoprotein cholesterol, diet choices, BMI, and short-chain fatty acids concentrations in plasma. The study includes participants aged 18 or older, with a focus on obesity and well-being."
679,"GPT4 Correct Assistant: This clinical trial aims to investigate the effect of adding strengthening exercises for hip rotators and ankle muscles to knee exercises on pain, function, muscle strength, and knee proprioception in patients with knee osteoarthritis. Participants will be randomly allocated to either the experimental group, which receives strengthening exercises for hip rotators and ankle muscles in addition to knee exercises, or the control group, which receives only knee exercises. The study will measure the primary outcomes of pain level, functional level, and knee proprioception, and the secondary outcomes of hip internal and external rotator strength, ankle dorsi flexors, planter flexor, invertor, and evertor strength, and quadriceps strength, all assessed at baseline and after 4 weeks of treatment."
680,"GPT4 Correct Assistant: This clinical study aims to evaluate the safety and effectiveness of the Novabel bioabsorbable steroid-releasing stent for the treatment of chronic sinusitis. Participants with chronic sinusitis and scheduled for primary or revision bilateral functional endoscopic sinus surgery are randomized to receive either the experimental Novabel stent or an active comparator stent. The primary outcome measure is the non-reintervention rate at 30 days. Secondary outcome measures include the Lund-Kennedy and Lund-Mackay scores, VAS score for pain, sinus patency rate, and implantation success rate at various time points."
681,"GPT4 Correct Assistant: This is a clinical trial examining the effects of providing cancer care closer to home for patients with multiple myeloma. The study is a non-randomized parallel assignment, comparing care transition to a satellite site and no care transition. The primary outcome measure is the proportion of eligible participants who successfully transfer to the provider at a satellite location. Secondary outcome measures include types of candidacy for care transfer, treatment burden, participant-provider interaction satisfaction, and financial toxicity. The study aims to explore differences in experience and satisfaction between patients who elect to transfer to a satellite site and those who decline to transfer."
682,"GPT4 Correct Assistant: This clinical trial aims to compare the effectiveness of virtual reality goggles as a method of distraction to nitrous oxide in pediatric dentistry. The study will include pediatric patients aged 4-12 years who require nitrous sedation for painful dental treatment. Participants will be randomized into control or treatment groups, with the control group receiving nitrous oxide and the treatment group receiving virtual reality goggles. The study will measure the rate of effectiveness of virtual reality goggles in reducing pain and compare it to nitrous oxide. The primary outcome measures include the use of the FLACC scale, Wong-Baker scale, and Houpt scales to assess pain or discomfort levels in patients."
683,"GPT4 Correct Assistant: The clinical trial aims to identify patients with a high risk of recurrent colorectal lesions and design optimal intervals for surveillance colonoscopies using mutation and clinical-pathologic phenotype. The study involves 200 patients, with a focus on determining the mutation profile and mutation burden, clinical and histopathological evaluation, and correlating patient mutational phenotype with the occurrence of metachronous lesions. The primary outcome measure is the development and clinical utility of a new method to identify patients with risk of recurrent colorectal lesions and personalization of their surveillance based on mutation burden and clinical-pathological phenotype."
684,"GPT4 Correct Assistant: The SAM Project is a study focused on malnutrition. It aims to characterize malnutrition through the identification of specific biomarkers, analyze untargeted microRNA expression profiles in blood and saliva samples, study plasmatic extracellular vesicles, and perform metagenomic and metabolomic analyses of fecal and salivary samples. The study includes participants of Caucasian ethnicity, both sexes, and aged between 0 and 85 years. The study plans to collect clinical, anamnestic, and lifestyle data, as well as faecal, blood, and saliva samples. The study is scheduled to last for 36 months."
685,"GPT4 Correct Assistant: The study aims to understand how people with Parkinson's disease manage their physical activity and exercise participation with different levels of support. Participants are enrolled in one of three groups: standard care, written exercise guidance by neurologists, or consultative physical therapy. The study measures minutes per day of moderate to vigorous physical activity and steps per day using activity trackers and accelerometers."
686,"GPT4 Correct Assistant: This clinical trial aims to investigate the use of multi-channel time-resolved functional near infrared spectroscopy (tr-fNIRS) for the early detection and prevention of perioperative brain injury in adult patients undergoing elective shoulder surgery in the beach-chair position. The study will employ a state-of-the-art full head coverage tr-fNIRS device to monitor the entire brain, as opposed to select regions, in order to detect specific brain regions at-risk of ischemic injury with a high degree of certainty. The primary outcome measure is the impact of intraoperative hemodynamic parameters on regional differences in cerebral oxygenation (ScO2) between brain regions during surgery, while secondary outcomes include regional differences in cerebral autoregulation and the association between cerebral desaturation events and clinical outcomes such as stroke and delirium."
687,"GPT4 Correct Assistant: The study aims to evaluate the feasibility and safety of using mechanical insufflation-exsufflation (MI-E) in critically ill adults who are invasively ventilated. The intervention involves applying MI-E sessions twice a day for up to 7 days, with a positive and negative pressure of 40 cmH2O. The primary outcome measure is the proportion of complete MI-E sessions delivered. Secondary outcomes include safety measures such as pneumothorax, endotracheal tube obstruction, and hypoxemia, as well as measures of acceptability, appropriateness, and feasibility of the intervention. The study is a randomized clinical feasibility trial with a parallel assignment model."
688,"GPT4 Correct Assistant: The Enavogliflozin Outcome Trial in Functional Tricuspid Regurgitation (EVENT) is a multicenter, randomized, double-blind, placebo-controlled study designed to test the hypothesis that therapy with the SGLT2 inhibitor enavogliflozin for 18 months would improve clinical and echocardiographic outcomes in heart failure patients with functional tricuspid regurgitation and preserved left ventricular ejection fraction. The primary outcome measure is a composite of cardiovascular death, hospitalization for heart failure, or worsening of tricuspid regurgitation during follow-up. Secondary outcome measures include all-cause death, cardiovascular clinical event, renal event, change of tricuspid regurgitation, and change of right ventricular strain."
689,"GPT4 Correct Assistant: This clinical trial aims to investigate the relationship between daily physical activity (measured by the number of daily steps using the SenseWear armband device) and the pharmacokinetic variability of infused rec-FVIII concentrate in patients with severe hemophilia A. The study will enroll patients aged 12-60 years with severe hemophilia A under FVIII concentrates prophylaxis and exclude patients with malignant tumors, patients treated with anticoagulant/antiplatelet agents, and patients with other congenital coagulation disorders. The primary outcome measures are the association between physical activity and the Area Under the Curve (AUC) PK parameter in patients with severe hemophilia A under prophylaxis and the association between the PK parameter and the number of daily steps. The study duration is 12 months."
690,"GPT4 Correct Assistant: The study, titled ""Critical Time Window for Rehabilitation After Incomplete Spinal Cord Injury: Early vs Late Locomotor Training,"" aims to investigate the effects of body weight supported treadmill training on persons with spinal cord injuries. Participants will be randomly assigned to one of four groups: early intervention (training begins no more than 60 days following injury), sub-acute intervention (training occurs 3 months after injury), chronic intervention (training occurs 6-12 months after injury), or standard of care (no intervention). The primary outcome measure is the 10-meter walk test, and secondary outcome measures include the 6-minute walk test, walking index for spinal cord injury, and daily step counts. The study will enroll participants aged 16-74 with acute and traumatic spinal cord injuries between the neurological levels of C5 and T12."
691,"GPT4 Correct Assistant: The study aims to investigate the effect of education given according to the Health Promotion Model on premenstrual symptoms, emotional eating behavior, and perceived stress in women. The study will be conducted as a pretest-posttest randomized controlled study, with 60 participants divided into experimental and control groups. The experimental group will receive training based on the Health Promotion Model and Philips 66 technique, while the control group will not receive any intervention. The primary outcome measure is the Premenstrual Syndrome Scale (PMSS), and secondary outcome measures include the Emotional Eating Scale, Perceived Stress Scale, and other related scales."
692,"GPT4 Correct Assistant: The AMP SCZ® Observational Study: PREDICT-DPACC is a non-interventional study examining clinical trajectories and predictors of outcomes in the Clinical High Risk (CHR) population for psychosis. The study aims to develop a deep biomarker-informed functional characterization and longitudinal clinical profiling of CHR individuals to support the development of algorithms that predict the trajectories and outcomes of CHR individuals. The study collects data on clinical, cognitive, neurophysiology, neuroimaging, genetics and fluid biomarkers, speech and facial expression, and outcome assessments. The study's primary outcome measure is conversion to psychosis, while secondary outcome measures include remission and non-conversion/non-remission."
693,"GPT4 Correct Assistant: The PROSPER study is a pilot randomized controlled trial (RCT) evaluating the feasibility and acceptability of implementing the Problem Management Plus (PM+) intervention in Dutch prisons. PM+ is a brief, scalable intervention designed to address common mental health problems and is delivered by trained non-specialists. The study includes 60 Dutch-speaking adults aged 18 or older who are imprisoned in Dutch prisons and have an elevated level of psychological distress. Participants are randomly assigned to either the treatment group, receiving PM+ and care-as-usual, or the control group, receiving care-as-usual only. The primary outcome measures include PM+ fidelity, perceptions about PM+ from stakeholders, indicators of intervention delivery, retention rate of PM+ sessions, and recruitment and consent rates. Secondary outcome measures include preliminary indications of pre to post-effects on symptoms of depression and anxiety, self-identified problems, daily functioning, and symptoms of trauma and suicidality vulnerability."
694,"GPT4 Correct Assistant: This study aims to determine the best safe dose of xevinapant when given in combination with radiation and chemotherapy for patients with head and neck cancer. The primary outcome is to determine the maximum tolerated dose (MTD) of xevinapant. Secondary outcomes include progression-free survival, overall survival, locoregional failure, distant failure, and response rate. The study will also monitor side effects seen when xevinapant is given in combination with radiation and chemotherapy."
695,"GPT4 Correct Assistant: This study is a phase 1, open-label trial evaluating the pharmacokinetics, safety, and tolerability of ARV-471 as a single agent in Chinese participants with ER+/HER2- advanced breast cancer. The primary outcome measures are single dose and multiple dose Cmax and AUCtau, while secondary outcome measures include objective response rate, percentage of participants with clinical benefit, duration of objective response, presence or absence of blood biomarkers, notable electrocardiogram values, laboratory abnormalities, clinically significant change from baseline in vital signs, and adverse events."
696,"GPT4 Correct Assistant: This clinical trial aims to study the efficacy of the combination of olaparib and alpelisib in patients with metastatic breast cancer who have a PIK3CA mutation or who have previously been treated with a PARP inhibitor. The trial consists of three cohorts, with Cohort 1 evaluating the combination therapy in PARP-inhibitor naive patients, Cohort 2 comparing the combination therapy with olaparib monotherapy in patients with PIK3CA mutations, and Cohort 3 evaluating the combination therapy in patients with PARP inhibitor-resistant metastatic breast cancer. The primary objective of Cohort 2 is to determine if the combination of olaparib and alpelisib improves PFS compared to olaparib alone. The secondary objectives include assessing the ORR, PFS, OS, and CBR in Cohorts 2 and 3, as well as evaluating the incidence of adverse events and the concordance of diagnostic tumor mutation profiles."
697,"GPT4 Correct Assistant: This study is a multi-center, two-arm, parallel group, assessor-blinded, randomized controlled superiority study comparing Schema Therapy (ST) with Treatment as Usual (TAU) for patients diagnosed with Treatment-Resistant Chronic Depression (TRCD). The primary outcome measure is the change from baseline in depression symptoms on the Hamilton-6 Rating Scale for Depression at 12 months after baseline measurements. The study aims to determine the efficacy of ST in reducing depression symptoms in patients with TRCD compared to TAU. The study also includes secondary outcomes, such as changes in subjective functional impairment, psychological well-being, personal recovery, and reactions to anger, as well as exploratory outcomes, such as changes in schema modes and early maladaptive schemas."
698,"GPT4 Correct Assistant: This clinical trial is a prospective, multicenter, randomized, controlled, open-label, phase III, stepped wedge cluster randomized design study. The trial aims to evaluate the effectiveness of ventilatory adjustments by nurses according to a pre-established care protocol in patients with Acute Respiratory Distress Syndrome (ARDS). The primary endpoint is the combination of mortality and the number of days without mechanical ventilation at 28 days. Secondary outcomes include measures of tidal volume ventilation, plateau pressure, positive end-expiratory pressure (PEEP), FiO2, oxygenation, number of days without mechanical ventilation, number of days without catecholamine, number of days without continuous sedation, duration of mechanical ventilation, occurrence of mechanically ventilated pneumothorax, duration of ARDS, duration of weaning from mechanical ventilation, number of participants with rescue therapy, rate of re-intubation, rate of use of non-invasive ventilation and curative high-flow oxygen therapy, tracheostomy rate, length of stay in intensive care and in hospital, number of deaths in ICU and hospital, and number of nurses trained in paramedical protocol per center."
699,"GPT4 Correct Assistant: The study aims to test a culturally tailored engagement and retention intervention for Haitian immigrants living with HIV (HILWH) to improve HIV outcomes. The study will be conducted as a prospective, quasi-experimental single arm with a sample of newly diagnosed or nonvirally suppressed HILWH adults drawn from 2 Federally Qualified Health Centers (FQHC) sites in Miami. The intervention is an adaptation of the iENGAGE intervention, culturally adapted for Haitian immigrants with HIV. The study will measure care engagement index score and viral suppression as primary outcomes."
700,"GPT4 Correct Assistant: This clinical trial is a randomized, non-blinded study comparing the effectiveness and safety of three root canal cleaning methods: passive ultrasonic irrigation (PUI), the Endoclean device using hydraulic cavitation, and conventional root canal preparation. The trial includes 109 participants with apical periodontitis, who will be followed for up to 24 months. The primary outcome measure is the success of healing the periapical lesion up to 12 months post-procedure, while the secondary outcome measures include safety and long-term effectiveness of the methods."
701,"GPT4 Correct Assistant: The FRACT-AI trial aims to evaluate the impact of artificial intelligence-enhanced image analysis on the diagnostic accuracy of frontline clinicians in detecting fractures on plain X-rays. The study includes emergency medicine doctors, trauma and orthopaedic surgeons, emergency nurse practitioners, physiotherapists, general radiologists, and radiographers. The trial measures the performance of the Gleamer Boneview algorithm and compares it to the reference standard. It also assesses the performance of readers with and without AI assistance in terms of sensitivity, specificity, and area under the ROC curve (AU ROC). Additionally, it evaluates reader speed with and without AI assistance."
702,"GPT4 Correct Assistant: This clinical trial aims to investigate the fine motor skills, hand grip strength, and anthropometric characteristics of children with Specific Learning Disorder (SLD) compared to healthy children. The study also seeks to examine the effect of fine motor skills on the quality of life and participation in activities at home, school, and community environments for children with SLD. The primary outcome measures include the Bruininks-Oseretsky Test of Motor Proficiency-2 (BOT-2), Purdue Pegboard Test, Hand Dynamometer, and Pinch Gauge. Secondary outcome measures include the Participation and Environment Measurement Child & Youth (PEM-CY) and the Pediatric Quality of Life Inventory (PEDS-QL)."
703,"GPT4 Correct Assistant: The IM-ZBULLE Study is a multicenter, prospective, randomized, double-blind, controlled trial investigating the efficacy of the combination of Z-track and Airlock techniques during intramuscular injection of Haloperidol decanoate in adult patients with schizophrenia or related disorders. The study aims to evaluate pain reduction and other secondary outcomes, such as drug leakage reduction, impact of the injection, participant satisfaction, and therapeutic alliance. The trial will compare the experimental group receiving intramuscular injection using Z-track and Airlock techniques with the control group receiving usual intramuscular injection techniques."
704,"GPT4 Correct Assistant: This study is a feasibility trial investigating the use of preoperative 5-day hypofractionated radiotherapy for primary soft tissue sarcoma. The primary outcome measure is the feasibility of the 5-day HFRT, and secondary outcome measures include rate of favorable pathologic response, rate of major wound complication, local control, acute toxicity, and 1-year late HFRT toxicity. The study aims to determine if the preoperative 5-day HFRT regimen is a viable alternative to conventional fractionated radiotherapy for primary soft tissue sarcoma, potentially increasing clinical trial participation and addressing socioeconomic disparities in access to radiation therapy."
705,"GPT4 Correct Assistant: This clinical trial study, titled ""Postoperative Analgesia Outcomes of Pericapsular Nerve Group Block (PENG Block) Combined with Lateral Femoral Cutaneous Nerve Block After Hip Replacement Surgery: A Randomized Controlled Study,"" aims to compare the effectiveness of two postoperative pain management methods after hip replacement surgery. Patients are randomly assigned to either receive pain relief through Patient-Controlled Analgesia (PCA) with morphine or pain relief through PENG Block and Lateral Femoral Cutaneous Nerve Block (LFCN Block) using ropivacaine. The primary outcome measure is the Visual Analogue Scale (VAS) score at rest and on movement, which measures pain intensity. The study also records side effects such as vomiting, nausea, itching, urinary retention, and respiratory failure."
706,"GPT4 Correct Assistant: This clinical trial, titled ""Study of Pelvic Organ Mobility by Dynamic MRI in Pelvic Endometriosis,"" aims to investigate the mobility of pelvic organs in patients with endometriosis using dynamic MRI. The study includes two participant groups: those with pelvic endometriosis and those without. The primary outcome measure is the mean vertical displacement (in millimeters) measured on the anterior wall of the vagina between rest and maximum pushing force during dynamic MRI. Secondary outcome measures include the mean vertical displacement on the cervix and posterior wall of the vagina, as well as the variation in mean vertical displacement on the wall of each pelvic organ at the push effort during dynamic MRI. The study also explores the statistical association between the symptoms of patients with endometriosis and the mean vertical displacement on the wall of each pelvic organ at the push effort during dynamic MRI."
707,"GPT4 Correct Assistant: This retrospective, observational study aims to provide epidemiological evidence on the uptake of Childhood Live Attenuated Influenza Vaccine (LAIV) and influenza-related healthcare resource use in children in England during the 2012 to 2022 flu seasons. The study will analyze data from the Clinical Practice Research Datalink (CPRD) and Hospital Episode Statistics (HES) databases. The primary outcome is the uptake of influenza vaccination, while secondary outcomes include GP consultations, laboratory confirmed influenza, admitted patient care episodes, accident and emergency attendances, outpatient attendances, length of stay in hospital, and antibiotic and antiviral prescriptions associated with influenza and influenza-like-illness."
708,"GPT4 Correct Assistant: This clinical trial is a pilot pre-post interventional study investigating the effects of fun activities for reciting Tang poems on happiness and well-being in South Asian children in primary schools (Grades 1-2, age 6-9) in Hong Kong. The intervention consists of three 1.5-hour sessions of Tang poem reciting and one session for participant performances, led by experienced instructors. The primary outcomes measured are the number of successful recited poems, change in the number of successful recited poems reported by students, and change in happiness reported by students. Secondary outcomes include changes in acculturation, ability in speaking Chinese, and attitude in Chinese learning."
709,"GPT4 Correct Assistant: The trial aims to assess the effectiveness of a digital platform called Vira in improving clinical outcomes for adolescents at high risk of suicide. The study involves 200 adolescents aged 13-18 years, randomly assigned to either the Vira group or the treatment as usual control group. The Vira platform uses mobile sensing data and communication tools to monitor and manage the patients' mental health. The primary outcome measure is the Columbia Suicide Severity Rating Scale (C-SSRS) assessed at six months. Secondary outcome measures include the Scale for Suicidal Ideation (SSI), Screen for Anxiety Related Emotional Disorders (SCARED), Risky Behavior Questionnaire for Adolescents (RBQ-A), Pittsburgh Sleep Quality Index (PSQI), Mood and Feelings Questionnaire (MFQ), and Anticipatory & Consummatory Interpersonal Pleasure Scale (ACIPS)."
710,GPT4 Correct Assistant: This clinical trial aims to study the impact of sex and age on non-visual light input affecting sleep and circadian rhythms in participants aged 18-85 years with normal physiology. The study involves pupillometry and light box exposure to assess pupil size and melatonin levels. Participants will be randomized into one of eight different light stimuli within the pupillometer testing. The primary outcomes measured are pupil size during pupillometry testing and melatonin levels for circadian timing assessment and hormone response.
711,"GPT4 Correct Assistant: The ""Evaluation of Improving Parenting Skills Adult ADHD (IPSA): A New Parent Training Program for Parents With ADHD"" is a randomized controlled trial (RCT) designed to evaluate the efficacy and feasibility of a new parent training program for parents with ADHD. The study aims to assess whether participation in the IPSA program is associated with positive treatment outcomes in terms of parental self-efficacy and secondary outcomes, such as parental stress, levels of household disorganization, and frequency and perception of disruptive behavior problems in the participant's target child. The study will also explore the potentially moderating or mediating effects of baseline variables and levels of active participation on efficacy outcomes. The intervention consists of a parent training program that combines structured group-based skills training with individualized support, including occupational therapist support. The primary outcome measure is parental self-efficacy, while secondary outcome measures include parental stress, household disorganization, and child behavior problems."
712,"GPT4 Correct Assistant: The Substance Use and Health Risk Intervention (SUHRI) for Justice-involved Youth is a 1-arm study examining the preliminary efficacy of an adapted intervention. The study targets youth aged 14 to 18 on community supervision and includes four individualized technology-based intervention sessions. The intervention addresses substance use, risky sex practices, and related health-risk. The study measures primary outcomes such as problem recognition, decision making, intention to reduce personal risk, service initiation, substance use, and sexual/STI health risk."
713,"GPT4 Correct Assistant: This is a phase II open-label, single-center, single-arm futility trial investigating the use of remote ischemic conditioning (RIC) as a treatment for reducing disability progression in patients with Primary Progressive Multiple Sclerosis (PPMS). The study aims to demonstrate non-futility of RIC for reducing progression of disability, as measured by the timed 25-foot walk (T25FW). Participants will undergo RIC treatment for 12 months, with primary and secondary outcomes measured at 12 months follow-up."
714,"GPT4 Correct Assistant: This clinical trial investigates the predictive value of prothrombin time in determining steroid response in severe alcoholic hepatitis patients. Participants must be between 18 and 70 years old and have a clinical diagnosis of first episode severe alcoholic hepatitis with a Maddrey's function score of 32 or higher. The primary outcome measure is the response to standard medical treatment assessed with the Lille score at day 7. Secondary outcome measures include death, early liver transplantation, and infections within 28 days."
715,"GPT4 Correct Assistant: This is a randomized control trial comparing the effects of functional task training versus functional therapy program on gross motor function, range of motion, and balance in children with cerebral palsy. The trial will include children aged 6-12 years with a GMFCS score of 1-2. The intervention will last for 8 weeks, with each group receiving 50 minutes of treatment per day, three times per week. The primary outcome measures are goniometer for range of motion, Pediatric balance scale, and Gross Motor Function Measure scale. The data will be analyzed using SPSS version 29."
716,"GPT4 Correct Assistant: This retrospective observational study aims to determine the prognostic value of neutrophil-lymphocyte ratio (NLR), absolute lymphocyte count (ALC), and thrombocyte-lymphocyte ratio (TLR) in predicting outcomes of tetralogy of Fallot (ToF) primary repair. The study included patients with ToF who underwent primary repair between January 2020 and December 2022. The primary outcome measures were the number of patients requiring redosurgery, mortality, and complications. The secondary outcome measures were hospital length of stay and postoperative length of stay."
717,"GPT4 Correct Assistant: This pilot randomized double-blind clinical trial study aims to assess the effectiveness of patient-applied aqueous lidocaine via tampon as a pre-treatment prior to intra-uterine device (IUD) placement. Subjects apply the lidocaine or a saline placebo to a tampon with a plastic applicator and place it 1 hour before the procedure. The primary outcome measures include procedure time and patient-reported pain level. Secondary outcome measures include patient-reported satisfaction with the procedure, patient-reported interest in subsequent procedures, and provider-reported procedural difficulty. The study includes participants aged 18 to 54, and both arms of the study use tampons, with one group receiving a 4% aqueous solution of lidocaine and the other receiving a saline solution."
718,"GPT4 Correct Assistant: This is a low-risk, single-center, interventional pilot study assessing the feasibility and acceptability of capillary screening for early staging of chronic metabolic, cardiovascular, and autoimmune diseases in a population from Cantalupo, Italy. Participants will undergo capillary blood sampling to test for various disease markers, and blood pressure will be measured. The study aims to measure the feasibility and acceptability of the screening program, as well as blood glucose and lipid levels, autoantibodies, and blood pressure."
719,"GPT4 Correct Assistant: The SMaRT Mom trial is a study designed to evaluate the effectiveness of a behavioral intervention called SMaRT Mom in reducing smartphone addiction and improving breastfeeding experience for mothers. The trial includes participants aged 20-40 years with smartphone addiction and infants aged 3-6 months old. The intervention involves instructing mothers not to use their smartphones during breastfeeding for one week. Primary outcomes measured are infant temperament and maternal self-efficacy, while secondary outcomes include breastfeeding as a rewarding experience, maternal attention towards the infant, and changes in breastfeeding mothers' neural activity, physiology, and behavior. The study aims to assess the impact of the intervention on the primary and secondary outcomes."
720,"GPT4 Correct Assistant: This study aims to investigate the effectiveness of Low-Level Laser Therapy (LLLT) in treating Plantar Fasciitis (PF), a common cause of heel pain. The study is a randomized, controlled trial, with participants randomly assigned to either the active treatment group (PBMT) or the sham treatment group (Sham-PBMT). All participants will receive the usual care protocol, which includes cryotherapy and stretching, in addition to the assigned treatment. The primary outcome measure is the change in plantar fascia thickness, measured using ultrasound imaging. Secondary outcome measures include pain levels, as assessed using the Defense and Veterans Pain Rating Scale (DVPRS), and functional ability, as assessed using the Foot and Ankle Ability Measure (FAAM). The study will follow participants for 6 months post-treatment."
721,"GPT4 Correct Assistant: This study is a randomized, open-label, crossover bioequivalence trial evaluating the effects of Entacapone, Levodopa, and Carbidopa tablets in healthy Chinese subjects in the postprandial state. The primary outcomes measured are peak plasma concentration (Cmax) and area under the plasma concentration versus time curve (AUC0-t and AUC0-∞). The study aims to determine the bioequivalence of the test and reference preparations of the tablets."
722,"GPT4 Correct Assistant: This clinical trial aims to investigate the use of simultaneous electroencephalography-functional magnetic resonance imaging (EEG-fMRI) and 7 Tesla structural MRI in healthy participants and patients with tremor, psychosis, and epilepsy. The study will use non-invasive techniques with no ionizing radiation or injected contrasts. The primary outcome measures include contrast-to-noise ratio between thalamic nuclei in 7T structural MRI, Pearson correlation between thalamocortical brain regions in 7T functional MRI, and microstate duration in EEG acquired concurrently with 7T functional MRI. Secondary outcome measures include neuroimaging datasets published in fully anonymized form in suitable public data repositories."
723,"GPT4 Correct Assistant: This clinical trial aims to investigate the effect of weight loss on hepcidin levels and iron status in subjects with obesity. The study consists of two phases: Phase 1, a cross-sectional study comparing hepcidin levels, iron status, and inflammatory markers in individuals with and without obesity, and Phase 2, a randomized controlled clinical trial assessing the impact of weight loss on hepcidin levels, iron status, and inflammatory markers in individuals with obesity and iron deficiency. Participants will be assigned to one of two dietary intervention groups and will receive ferrous sulfate supplementation for three months. The study will measure changes in serum hepcidin concentration, serum iron concentration, and other related biomarkers."
724,"GPT4 Correct Assistant: This clinical trial, titled ""Non-invasive Electrophysiological Monitoring in High Risk Pregnancies at the Obstetric High Care: the NIEM-O Study,"" aims to investigate the effectiveness of continuous antepartum electrophysiological monitoring using the Nemo Fetal Monitoring System (NFMS) in high-risk pregnancies. The study includes 1911 pregnant women aged 18 years or older with a singleton pregnancy between 23+0 and 32+0 weeks of gestation requiring hospitalization at the Máxima Medical Center. The primary outcome measure is the incidence of perinatal mortality and major neonatal morbidity. The study compares continuous eCTG monitoring using the NFMS with conventional intermittent CTG monitoring. The researchers aim to develop and verify mathematical models for predicting the time until preterm birth and detecting fetal movements using the collected data."
725,"GPT4 Correct Assistant: This clinical trial aims to explore genetic susceptibility to severe infections, including various types of viral, bacterial, and fungal infections. The study will recruit a small cohort of patients with rare and severe infections and will involve blood sample drawing and skin biopsy for predisposition individuals. The primary outcome measures include identifying chromosomal regions associated with the disease, identifying candidate genes for genetic susceptibility, and validating candidate genes as factors of susceptibility to infectious diseases. The study will be conducted over an average of 10 years."
726,"GPT4 Correct Assistant: This clinical trial aims to investigate the prevalence, type, and risk factors of urinary incontinence (UI) in married women and its effect on their quality of life. The study includes married women over 18 years of age and utilizes a diagnostic test to assess UI. The primary outcome measure is the Incontinence Quality of Life score, which ranges from 22 to 110, with higher scores indicating a higher quality of life."
727,"GPT4 Correct Assistant: This clinical trial aims to compare the effectiveness of bone marrow aspirate concentrate (BMAC) and minimally manipulated adipose tissue (MM-AT) in the treatment of knee osteoarthritis. The study includes 204 patients aged 40-75 with symptomatic unilateral knee OA who will undergo intra-articular infiltration of either BMAC or MM-AT. The primary outcome measure is the Western Ontario and McMaster University Osteoarthritis Index (WOMAC) - Pain subscale at 6 months follow-up. Secondary outcome measures include other WOMAC subscales, Knee Injury and Osteoarthritis Outcome Score (KOOS), Visual Analogue Scale (VAS), EuroQol Visual Analogue Scale (EQ-VAS), Tegner Activity Level Scale, Range of Motion, Circumferences, Patient Acceptable Symptom State (PASS), Minimally Clinical Important Difference (MCID), and expectations about the effectiveness of the treatment. The study will also analyze the presence of osteophytes, cartilage thickness, and synovial membrane status at 12 months follow-up."
728,"GPT4 Correct Assistant: This Phase III clinical study aims to evaluate the efficacy and safety of CBD TPM capsules in adults with insomnia. The study includes three groups: placebo, 75mg CBD, and 150mg CBD. The primary outcome measures are the mean change from baseline in Insomnia Severity Index (ISI) score and subject sleep efficiency (sSE) at 8 weeks."
729,"GPT4 Correct Assistant: This clinical trial aims to investigate the pattern of intestinal parasitic infection among cirrhotic patients at Sohag University Hospital. The study includes 200 participants, with 100 cirrhotic patients and 100 non-cirrhotic patients with GIT complaints. The primary intervention is a diagnostic test: stool analysis. The study's primary outcome measure is the detection of prevalence and pattern of intestinal parasitic infection in cirrhotic patients and the difference between cirrhotic and non-cirrhotic patients with no comorbidity. The study will determine the most common risk factors of intestinal parasitic infection in cirrhotic patients over a 12-month period."
730,"GPT4 Correct Assistant: The REtinal Detachment Outcomes Study (REDOS) is a factorial, randomized controlled trial that investigates the outcomes of treating rhegmatogenous retinal detachment. Participants are randomly assigned to undergo one of four procedures: pars plana vitrectomy (PPV) with sulfur hexafluoride gas tamponade, PPV with scleral buckle and sulfur hexafluoride gas tamponade, PPV with perfluoropropane gas tamponade, or PPV with scleral buckle and perfluoropropane gas tamponade. The primary outcome measure is single surgery anatomic success, defined as freedom from reoperation for recurrent retinal detachment. Secondary outcome measures include pinhole visual acuity, best-corrected visual acuity, time to onset of retinal detachment recurrence, severity and number of complications, and quality of life."
731,"GPT4 Correct Assistant: This clinical trial investigates the effects of 0.25%, 0.5%, and 1% ropivacaine on the onset and duration of ultrasound-guided ankle blocks in patients undergoing forefoot surgery. The study aims to determine if 1% ropivacaine results in a faster onset time and longer sensory block duration compared to 0.25% and 0.5% ropivacaine. The primary outcome is the difference in sensory block duration, while secondary outcomes include onset time, postoperative pain scores, and opioid consumption."
732,"GPT4 Correct Assistant: This clinical trial, titled ""The Effect of Compression Stockings on the Complaints, Well-Being and Sleep Quality of Pregnant Women With Restless Legs Syndrome,"" aims to investigate the impact of compression stockings on pregnant women with Restless Legs Syndrome (RLS). The study includes participants aged 18-40, in their 27th gestational week or later, with a severity of 11 or above according to the RLS Severity Rating Scale. The primary outcome measure is the change in RLS Severity Rating Scale score from baseline to the end of the study. The secondary outcome measure is the change in Pittsburgh Sleep Quality Index score from baseline to the end of the study. The trial is a randomized, parallel assignment study with an open-label design and includes two groups: a compression stockings group and a placebo sock group."
733,"GPT4 Correct Assistant: This study aims to evaluate the efficacy of home-based strength and Tai-chi exercise snacking for improving physical function in older adults. Participants aged 65 and older who are able to perform daily physical activities independently and not regularly engaging in recreational sports or structured exercise will be recruited. The study will take place over approximately 3 months, with 5 assessments remotely and a subset of 60 participants assessed in person. Participants will be randomized into either the intervention group, who will perform home-based exercise snacking and Tai-chi snacking, or the control group, who will receive usual care. The primary outcome measure is the change in Short Physical Performance Battery (SPPB) scores between weeks 0, 4, 8, and 12. Secondary outcome measures include changes in leg press strength, balance and strength functions, agility and flexibility, quality of life and wellbeing, physical activity levels, mental health, self-confidence for exercise, attitudes to exercise, acceptability of the intervention, general health, mental health and wellbeing, and quality of life."
734,"GPT4 Correct Assistant: The study aims to evaluate the role of pre-emptive caudal epidural analgesia for postoperative pain relief in lumbosacral surgeries and to compare the effect of adding dexamethasone to ropivacaine with respect to quality of analgesia, duration of analgesia, hemodynamic effects, and associated side effects. Patients are randomly allocated to two groups: one receiving caudal epidural injection with 0.25% ropivacaine 20 ml containing dexamethasone 8 mg, and the other receiving caudal epidural injection with 0.25% ropivacaine 20 ml only. The primary outcome measure is the postoperative Visual Analogue Scale (VAS) score at various time points post-surgery."
735,"GPT4 Correct Assistant: The study aims to determine the effect of nursing care based on Kolcaba's comfort theory on the comfort, care satisfaction, and sleep quality of intensive care patients. It is a randomized controlled experimental study with a total of 80 participants, divided into an experimental group receiving care based on Kolcaba's comfort theory and a control group receiving standard care. The study measures the General Comfort Scale, Newcastle Satisfaction Scale, Richard Campbell Sleep Scale, and Comfort Behaviours Checklist."
736,"GPT4 Correct Assistant: The P-KIDs CARE study aims to address health systems delays in care for injured children in Tanzania. It consists of three aims: Aim 1 involves formative research, including enrollment of 100 children into a pediatric injury registry, capacity assessments, in-depth interviews, and focus group discussions with family members and healthcare providers. Aim 2 uses the formative data to develop the P-KIDs CARE intervention during a 2-day workshop, followed by pre-implementation assessment and refinement through focus group discussions and a community-engaged panel. Aim 3 pilots the intervention in two study facilities, enrolling 10 healthcare providers and 200 pediatric injury patients, and assessing implementation outcomes and patient-level outcomes. The study's primary outcome is mortality."
737,"GPT4 Correct Assistant: This study aims to investigate the effectiveness of combining pelvic floor rehabilitation with postural re-education in women with stress urinary incontinence and chronic low back pain. The study is a preliminary trial with a parallel assignment design, randomized allocation, and triple masking. Participants will undergo either pelvic floor rehabilitation and postural re-education or pelvic floor rehabilitation and spinal mobilization, both accompanied by perineal exercises. The primary outcome measure is the change in International Consultation on Incontinence Questionnaire-Urinary Short Form (ICIQ-UI SF) scores, while secondary outcome measures include changes in Pain Visual Analogue Scale (VAS) and Modified Oxford Scale (MOS) scores."
738,"GPT4 Correct Assistant: The study aims to develop a pharmacodynamic model for propofol in older adults. It involves patients over 65 years of age undergoing non-cardiac elective surgery requiring general anesthesia. The intervention is an intravenous infusion of propofol with prespecified plasma targets. The primary outcome measure is performance error, while secondary outcome measures include median absolute performance error, median prediction error, time of loss of response, time of burst-suppression, and time of return of response. The study aims to create a PKPD model that uses pharmacokinetic parameters from the Eleveld model and new pharmacodynamic parameters derived from frontal EEG in a population older than 65 years."
739,"GPT4 Correct Assistant: The study aims to compare the efficacy of short-course antibiotics (one day) versus standard course antibiotics (4 to 7 days) in patients with acute cholangitis after adequate biliary drainage. The primary outcome measure is the clinical cure rate by day 14 after endoscopic retrograde cholangiopancreatography (ERCP) without relapse by day 30. Secondary outcomes include all-cause 90-day mortality, relapse of cholangitis within 90 days, rate of any other subsequent infection requiring antibiotic therapy within 90 days, rate of subsequent infections with multidrug-resistant bacteria or Clostridioides difficile within 90 days, rate of other adverse drug events within 14 days, length of intensive care and hospital stay for the initial episode of cholangitis, quality of life and health utility, and societal costs and cost-effectiveness/-utility."
740,"GPT4 Correct Assistant: This is a prospective randomized clinical double-blinded study assessing the efficacy of conventional lung recruitment maneuver versus ultrasound-guided lung recruitment maneuver in morbidly obese patients undergoing laparoscopic bariatric surgery. The study will be conducted at the Anesthesiology Department in Tanta University Hospitals for one year. The primary outcome is the change in lung ultrasound score, and the secondary outcomes are the incidence of atelectasis and intra-operative desaturation."
741,"GPT4 Correct Assistant: The trial is a prospective randomized open-label study aiming to optimize fractionation schedules of heel spur radiotherapy. The study compares the efficacy of different radiation dosages (standard fractioned dose vs. experimental single dose) in providing pain relief for heel spur patients. The primary outcome measure is the comparison of 2 arms in 3 months after radiotherapy, with follow-up examinations consisting of personal examination, questionnaire survey, and evaluation of pain symptoms, use of appliances, professional activities, daily/leisure activities, and gait/limp. Secondary outcome measures include comparison of different single fraction radiotherapy prescriptions, reirradiation needs, and quality of life assessment. The study is conducted at the Department of Radiation Oncology at Masaryk Memorial Cancer Institute Brno, with a total of six groups receiving different total doses of orthovoltage radiotherapy, delivered in various single fractions."
742,"GPT4 Correct Assistant: This study aims to examine if a behavioral weight reduction program combined with Pain Neuroscience Education (PNE) and Cognition-Targeted Exercise Therapy (CTET) is superior to reduce pain at 12 months follow-up compared to PNE and CTET alone, in overweight or obese people with chronic low back pain (CLBP). The study is designed as a randomized controlled trial with follow-up assessments at 12 months post-treatment. Participants are randomly assigned to either the experimental intervention (combining behavioral weight reduction, PNE, and CTET) or the control intervention (PNE and CTET alone). The primary outcome measure is the average pain intensity on an 11-point numeric rating scale. Secondary outcomes include other pain-related measures, anthropometrics, energy balance-related behavior, and health economics."
743,"GPT4 Correct Assistant: This clinical trial aims to compare the outcomes and efficacy of single versus double pyloromyotomy techniques in gastric per-oral endoscopic myotomy (G-POEM) for the treatment of refractory and severe gastroparesis. The study will follow participants for 12 months after the procedure, measuring clinical success, Gastroparesis Cardinal Symptom Index (GCSI) scores, technical success rate, total procedure time, adverse events, and recurrence of symptoms."
744,"GPT4 Correct Assistant: This is a single-arm, open-label clinical trial examining the efficacy of Minayo Iron-rich Yeast Drink with SOD on female nutritional anemia, skin condition, and Qi-blood deficiency syndrome. The study includes female participants aged 18 to 35 with hemoglobin concentration levels below 110g/L. The intervention is a dietary supplement, the Minayo Yeast Drink Product, which contains 13mg of iron per piece. The primary outcome measure is the change of serum ferritin level in blood, while secondary outcome measures include changes in hemoglobin concentration level, Superoxide Dismutase (SOD) concentration level, Glutathione (GSH) concentration level, and skincare measurement - lines/wrinkles. The study lasts for 4 weeks, with participants consuming one piece of the product daily."
745,"GPT4 Correct Assistant: This study aims to investigate the effects of combined acute intermittent hypercapnic-hypoxia (AIHH) and transcutaneous spinal cord stimulation (tSCS) on cervical neural drive in individuals with chronic spinal cord injury (SCI). The study will be conducted in a randomized, crossover design, with participants receiving either AIHH and tSCS-paired respiratory and upper extremity strength training, or sham AIHH and sham tSCS-paired respiratory and upper extremity strength training. The primary outcome measures include change in respiratory cortical and spinal drive, and change in upper extremity cortical and spinal drive. Secondary outcome measures include change in maximum respiratory voluntary force production, change in airway occlusion pressure (P0.1), change in forced vital capacity, and change in upper extremity functional assessment. The study will also explore the potential role of subclinical inflammation and/or dysfunctional single nucleotide polymorphism in genes regulating neuroplasticity in modulating the response to the intervention."
746,"GPT4 Correct Assistant: The study aims to investigate the effects of anesthetic maintenance agents and vasopressors on cerebral hemodynamics and metabolism during adult surgery. Four groups of participants will be randomized to receive either propofol or sevoflurane as anesthetic maintenance agents, combined with either phenylephrine or ephedrine as vasopressors. The primary outcome measure is the cerebral metabolic rate of oxygen consumption (CMRO2) during surgery, with secondary outcomes including cerebral hemodynamics and metabolism during induction. The study aims to determine the effects of different anesthetic agents and vasopressors on cerebral hemodynamics and metabolism in adult surgery, which may help improve patient outcomes."
747,"GPT4 Correct Assistant: The RaDiCo-IDMet study is a national cohort study focused on imprinting disorders and their metabolic consequences. It includes patients with Silver Russell Syndrome, Beckwith-Wiedemann Syndrome, Transient Neonatal Diabetes Mellitus, Angelman Syndrome, Prader-Willi Syndrome, Temple Syndrome, Kagami-Ogata Syndrome, Pseudohypoparathyroidism, and Familial Precocious Puberty. The study aims to measure the clinical, genetic, biological, and morphometric characteristics of patients with these disorders. Secondary outcomes include searching for associations between metabolic phenotypes and biological profiles, determining the prevalence of metabolic abnormalities, estimating the risk for metabolic complications, describing therapeutic approaches, and analyzing (epi)genetic mutations transmission. The study follows patients for an average of 10 years."
748,"GPT4 Correct Assistant: This clinical trial aims to compare the effectiveness of unipolar and bipolar interlocking in the treatment of humeral shaft fractures in adults. The study includes patients aged 18 and above with humeral shaft fractures requiring surgical treatment with intramedullary nailing. The primary outcome measure is the proportion of patients with radiologically assessed bone healing at 12 months. The study is designed as a randomized parallel assignment with open-label allocation. The intervention groups are the unipolar interlocking group and the bipolar interlocking group, both receiving questionnaires and CT scans at specific time points."
749,"GPT4 Correct Assistant: This clinical trial aims to investigate the efficacy of a combined cognitive and social cognitive training program, along with the Personalized Real-Time Intervention for Motivational Enhancement (PRIME) app, in improving cognitive function and motivation in individuals with early psychosis. The study will enroll participants aged 18-40 with early psychosis who are not currently participating in significant cognitive training programs. Participants will be randomly assigned to either the experimental group (cognitive and social cognitive training plus PRIME app) or the active comparator group (treatment as usual). Primary outcome measures include changes in Test My Brain scores, Dysfunctional Attitudes Scale-Defeatist Beliefs Subscale (DAS-DB) scores, and quality of life scores. Secondary outcome measures include changes in Behavioral Inhibition and Activation Scale (BIS/BAS) scores and Motivation and Pleasure Scale-Self Report (MAPS-SR) scores. The study will follow participants for 18 months to assess the long-term effects of the intervention on cognitive function and motivation."
750,"GPT4 Correct Assistant: This clinical trial aims to assess the effectiveness of using wearable fitness trackers in prehabilitation programs for patients with cancer. The study will randomize participants into two groups: one group will exercise to a heart rate zone using wearable fitness trackers, while the other group will exercise based on their rating of perceived exertion. The primary outcome measure is the total number of minutes of moderate intensity exercise achieved by participants. Secondary outcome measures include volume of physical activity, weekly adherence, duration of exercise, and intensity of exercise. The study will also assess the acceptability and usability of wearable fitness trackers in a prehabilitation setting through participant feedback."
751,"GPT4 Correct Assistant: The LA POPA trial is a randomized, single-blinded, controlled, superiority trial comparing minimally invasive treatments for pilonidal disease. The trial includes two arms: 1) pit-picking surgery and 2) pit-picking surgery with sinus laser-assisted closure. The primary outcome measure is the success rate of treatment, defined as wound healing outcomes at 1 year. Secondary outcomes include success rate at long-term follow-up, pain scores, patient-reported outcomes, wound healing and complications, work rehabilitation, return to daily activities, recurrence rate, need for secondary or revision surgery, patient satisfaction, and quality of life."
752,"GPT4 Correct Assistant: This study aims to identify sociodemographic, personal characteristics, and patterns of illicit drug abuse in patients admitted for addiction treatment at Assiut University Hospital. The study includes patients with substance use disorders who are 18 years old or older. The intervention is supportive psychotherapy, which aims to help patients detox and rehabilitate. The study measures the sociodemographic characteristics, personality traits, and patterns of substance abuse among the patients."
753,"GPT4 Correct Assistant: This is a phase 2 study investigating the efficacy and safety of a combination of immune checkpoint inhibitors (Durvalumab and Tremelimumab) and radioembolisation for previously untreated metastatic hepatocellular carcinoma. The study aims to measure the best objective response rate, rate of abscopal effect, progression-free survival, overall survival, incidence of treatment-related side effects, local control rate, and distant control rate."
754,"GPT4 Correct Assistant: This clinical trial is a phase II study examining the efficacy of neoadjuvant durvalumab and tremelimumab in combination with gemcitabine and cisplatin in patients with intrahepatic cholangiocarcinoma that is borderline resectable or resectable but with a high risk for recurrence. The primary outcome measure is the rate of conversion from unresectable to resectable after 4 or 8 cycles of treatment. Secondary outcome measures include overall survival, progression-free survival, and patient-reported outcomes, among others."
755,"GPT4 Correct Assistant: This multi-center clinical study aims to establish normal reference values for high-frequency ultrasound of extremity arterial structure and hemodynamics in Chinese Han adults. The study will explore the influencing factors to provide a quantitative reference for the early diagnosis, degree evaluation, and curative effect observation of the structure and blood flow of the extremities. Healthy volunteers between the ages of 18 and 79 will undergo high-frequency ultrasound examination of the extremity arteries, and the primary outcome measure is intima thickness of dorsalis pedis artery and proper palmar digital artery."
756,"GPT4 Correct Assistant: This clinical trial aims to evaluate the efficacy and safety of STERIFY GEL in the treatment of periodontitis following scaling and root planing (SRP). The study involves participants with grade III and IV chronic periodontal disease and compares the use of STERIFY GEL in combination with SRP to SRP alone. The primary outcome measure is pocket depth, while secondary outcome measures include gingival recession, clinical attachment level, plaque index, bleeding index, furcations, grade of mobility, and quantification of bacterial contamination."
757,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of hyperbaric oxygen therapy (HBOT) and hippocampal training on memory recovery and PTSD symptoms in veterans with PTSD. Participants will be randomly assigned to either HBOT alone or HBOT combined with hippocampal training. The study will assess memory gaps, time to inaccessible memory surfacing, brain activity changes, cognitive performance, and memory test scores. The findings may contribute to the development of biological memory manipulations for PTSD and other memory-related conditions."
758,"GPT4 Correct Assistant: The study aims to evaluate the use of 64Cu-DOTATATE PET/CT scans for diagnosing cardiac sarcoidosis. The trial includes four participant groups: Group A (22 patients with clinically suspected cardiac sarcoidosis), Group B (22 patients with known cardiac sarcoidosis), Group C (up to 10 patients with clinically suspected or confirmed acute lymphocytic myocarditis), and Group D (22 patients with neuroendocrine tumors without known inflammatory heart disease). The primary outcome measure is the proportion of patients with tracer uptake in the heart on 64Cu-DOTATATE PET/CT in patients with verified cardiac sarcoidosis and the proportion of patients without tracer uptake in the heart on 64Cu-DOTATATE PET/CT for patients with a neuroendocrine tumor without a history of inflammatory heart disease (the control group). The secondary outcome measures include 24-month rates of adverse outcomes and tracer uptake in patients with myocarditis."
759,"GPT4 Correct Assistant: This clinical trial aims to investigate the effect of probiotics on immunosuppressive-drug-associated diarrhea among renal transplant recipients. The study is a double-blinded, placebo-controlled, parallel assignment trial, with participants randomly assigned to either the probiotics group or the placebo group. The primary outcome measures are the reduction in immunosuppressive drug-associated diarrhea, analysis of inflammatory biomarkers, and association between inflammatory markers and fecal microbiome. The study will enroll participants aged between 18 and 80 years who have experienced diarrhea after receiving a living or deceased donor kidney transplant and are on a specific dose of immunosuppressive drugs."
760,"GPT4 Correct Assistant: The trial aims to assess the efficacy of inhaled sevoflurane compared to current intravenous sedation practice for improving PaO2/FiO2 in ICU patients at high risk for ARDS. The hypothesis is that inhaled sedation with sevoflurane could be more effective at improving pulmonary function during the early days of ICU admission in patients at risk of ARDS. The trial is a randomized clinical trial with two arms: inhaled sedation with sevoflurane and intravenous sedation (current practice). The primary outcome measure is the longitudinal evolution of the PaO2/FiO2 ratio within 5 days from randomization. Secondary outcome measures include progression to ARDS, rate of pneumonia, ventilator-free days to day 28, organ failure to day 5, mortality at day 28, length of ICU-stay up to 28 days, and various physiological and hemodynamic measures."
761,"GPT4 Correct Assistant: This clinical trial aims to study the outcomes of different treatment modalities for massive rotator cuff tendon tears. The study includes patients aged between 50 to 80 years with a grade III tear according to the Davidson and Burkhart classification. The study is conducted at Tartu University Hospital Sports Traumatology Centre and involves three orthopaedic surgeons with long experience in arthroscopic shoulder surgery. The primary objective is to assess the functional status of the included subjects in different treatment groups, and the secondary objective is to confirm whether the tendons are intact on follow-up MRI scans. The post-operative therapy regimen is the same for each study group, and subjects come for scheduled visits at 6-month, 12-month, and 24-month timepoints. The assessment tools include range of motion, strength measurements, functional scores, and MRI scans."
762,"GPT4 Correct Assistant: The IRIS Program is a study aimed at optimizing the treatment of injection-related infections for people who inject drugs in Hamilton, Ontario. The study focuses on a holistic injection-related injection treatment, which includes diagnosis and treatment of infections, substance use treatment, peer support, and care coordination/systems navigation. The primary outcome measures are the number of emergency department visits and hospital readmissions within 30 days of initial hospital admission or program enrolment. Secondary outcome measures include treatment completion, hospital readmissions for the primary infection, emergency department visits, new initiations or continuation of substance use treatment, mortality rates, and program drop-out rates. The study is open to participants aged 16-105, of all sexes, and who have a confirmed or suspected injection-related infection and a history of injection drug use within three months of recruitment."
763,"GPT4 Correct Assistant: This randomized controlled trial aims to compare the use of a mobile app (CanImmunize) for surveillance of adverse events following influenza immunization with a web-based platform. Participants, aged 18 and above, who have been immunized with the seasonal influenza vaccine are eligible for the study. The primary outcome measure is the usability of the platform, measured through a user experience survey. The study is designed with parallel assignment and single masking."
764,"GPT4 Correct Assistant: The study aims to investigate the relationship between peri-implantitis and COX-2 gene polymorphisms, active MMP-8 levels, and characterization of associated microbiota. Patients with screw-retained implant restorations loaded for at least 12 months and treated for periodontal disease are included. Patients with diabetes, immunosuppressant diseases, or those who received antibiotics within three months before the study are excluded. The study plans to analyze gene polymorphisms of MMP-8 in saliva samples from both peri-implantitis and healthy groups. The primary outcome measure is the gene polymorphisms of MMP-8, with a follow-up period of three years."
765,"GPT4 Correct Assistant: This clinical trial aims to explore the effect of virtual reality on pain, anxiety, and patient comfort during trigger point injections. Patients are randomly assigned to either an experimental group, who watch videos through virtual reality glasses for 10 minutes during the procedure, or a control group, who continue with routine practice. Patient anxiety, comfort, and pain levels are evaluated before and after the trigger point injection. The study measures the State Anxiety Scale, General Comfort Scale, and Visual Analog Scale at specific time points after the procedure. The trial is designed as a supportive care study with a parallel assignment and single masking."
766,"GPT4 Correct Assistant: This study aims to investigate the effect of autonomic dysfunction on hemodynamic instability during per-oral endoscopic myotomy in patients with Achalasia. The trial will include two participant groups: those with and without autonomic dysfunction, as determined by a heart rate variability test. The primary outcome measure is the wobble of systolic arterial pressure during surgery. The study will be conducted at Gangnam Severance Hospital, and participants will be monitored with advanced hemodynamic monitoring during the procedure."
767,"GPT4 Correct Assistant: This clinical trial aims to evaluate the use of Virtual Reality (VR) glasses during inhaler treatment in children aged 2-5 years. The study will compare the effectiveness of VR audio-visual users (Roller Coasters, group 1) and VR audio-visual users (Wild Dolphins, group 2) with a control group that did not use any additional equipment (group 3). The primary outcome measure is the change in the pain scoring system. The study will observe the children during their 15-minute inhaler treatment and compare crying times, changes in RR, SpO2, HR values, and family questionnaires between the groups."
768,"GPT4 Correct Assistant: This clinical trial aims to evaluate the feasibility, acceptability, and effectiveness of a transdiagnostic psychological treatment, the Unified Protocol (UP-C/A), for children and adolescents aged 7-17 years with anxiety disorders, obsessive-compulsive disorders, and/or depression in a primary care setting. Participants will complete self-report scales to assess satisfaction, feasibility, and acceptability of the intervention, and treatment effects will be analyzed using paired sample t-tests. The study will also investigate the therapists' ratings of acceptability, feasibility, and treatment effects at a 6-month follow-up."
769,"GPT4 Correct Assistant: The PALISA Study is a clinical trial investigating pain assessment during less-invasive surfactant administration in premature infants. The study aims to measure skin conductance and video recordings during the procedure to evaluate pain and stress levels. The primary outcome measures are median peaks per second at prespecified time-points, and the secondary outcome measures include neonatal pain and sedation scale, apneas, desaturations, bradycardia, arterial hypotension, blunt surfactant reflux, and differences in heart-rate and oxygen saturation. The study seeks to understand the effectiveness of less-invasive surfactant administration in reducing pain and stress in premature infants."
770,"GPT4 Correct Assistant: This study is a feasibility cluster randomized controlled trial examining the effectiveness of a home-based depression care intervention for older people in Nigeria, delivered by lay providers. The intervention, called emhGAP-Age, is designed to help older individuals with depression. The study includes participants aged 60 years and older, with a PHQ-9 score of ≥11 during routine consultation. The primary outcome measure is depression remission, assessed using the Patient Health Questionnaire (PHQ-9) score at six months post trial entry. The study has two arms: an experimental group receiving emhGAP-Age, and an active comparator group receiving generic emhGAP-IG and psychoeducation."
771,"GPT4 Correct Assistant: The study aims to compare the efficacy of augmented ACL integration via platelet-rich plasma (PrP) enriched collected autologous bone (bone/PrP-composite) to standard ACL technique in reducing tunnel widening. The trial involves a single-center, single-blinded, 2-arm-parallel, randomized, controlled study with 24-month follow-up. Participants are recruited from the Knee Surgery department at Schulthess Klinik when scheduled for ACL reconstruction. The study sample consists of 107 patients allocated 1:1 on experimental and control arms. Outcome measures are taken at 0, 6, 12, and 24 months. The total study duration is 48 months. The study duration per patient is 24 months. The primary outcome measures are tibial tunnel diameter change and tibial tunnel volume change. Secondary outcome measures include femoral tunnel diameter change, femoral tunnel volume change, graft maturity, graft integration, and bone healing and integration."
772,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of high flow oxygen in preoxygenation during rapid sequence induction in infants and small children. The study will randomize participants into one of three groups: 1) face-mask preoxygenation, 2) high-flow nasal oxygen cannula (HFNOC) preoxygenation, and 3) HFNOC preoxygenation combined with face-mask preoxygenation. The primary outcomes are the impact of HFNOC preoxygenation on oxygen saturation and heart rate during anesthesia induction. Secondary outcomes include the safety of the rapid sequence induction protocol, Cormack-Lehane score, incidence of difficult airway management, number of intubation attempts, and episodes of regurgitation/aspiration."
773,"GPT4 Correct Assistant: This clinical trial aims to examine the long-term safety, tolerability, and effectiveness of the combination therapy of Pozelimab and Cemdisiran in adult patients with Paroxysmal Nocturnal Hemoglobinuria (PNH). The study will evaluate the incidence, severity, and types of treatment-emergent serious adverse events (SAEs) and adverse events of special interest (AESIs). The primary outcome measures include the incidence and severity of treatment-emergent SAEs, incidence and severity of treatment-emergent AESIs, and incidence of treatment-emergent adverse events leading to permanent treatment discontinuation. Secondary outcome measures include maintenance of adequate control of hemolysis, transfusion avoidance, breakthrough hemolysis, hemoglobin stabilization, percent change in lactate dehydrogenase (LDH), change in fatigue, change in physical function scores on the EORTC QLQ-C30, and change in global health status/quality of life scores on the EORTC QLQ-C30."
774,"GPT4 Correct Assistant: The study aims to examine the engagement predictors of health and fitness app uptake and subscription in the general population. It is a 24-week prospective study using WayBetter Inc.'s app, WayBetter, to analyze user engagement. The primary objectives are to identify predictors of initial six-month subscription and subscription renewal rates at six months for the WayBetter app. The secondary objective is to characterize WayBetter app engagement over the first 24 weeks of app use. The study will include approximately 400 adult users aged 18 or older who are new to the app and have completed a seven-day free trial. The primary outcomes are rates of initial six-month subscription and subscription renewal rates at six months. Secondary outcomes include app engagement metrics such as app opens per week, date of joining the first game, game adherence, and number of games started and won each week."
775,"GPT4 Correct Assistant: The study aims to compare the effects of Aerobics and Pilates exercises on depression and sleep quality in primigravida females. It is a randomized clinical trial conducted in children hospital sheikhupura and Mehmooda hospital sheikhupura. The study will include 42 participants, randomly assigned to either Aerobic exercises (Group A) or Pilates exercises (Group B). The study will last for 10 months, and data will be collected using CES-D and PSQI questionnaires. The primary outcome measures are the Center for Epidemiologic Studies Depression Scale (CES-D Scale) and the Pittsburgh Sleep Quality Index (PSQI)."
776,"GPT4 Correct Assistant: This clinical trial aims to determine the effect of swaddling and inhaling mother's breast milk odour on the pain and comfort during the placement of peripheral intravenous catheter in term infants. The study was conducted in the neonatal intensive care unit of Karadeniz Ereğli State Hospital between October 2020 and October 2021. The sample size of 120 term infants was equally assigned to four groups: swaddled, inhaling mother's breast milk odour, both swaddled and inhaling mother's breast milk odour, and a control group with no procedure. The Neonatal Infant Pain Scale and Neonatal Comfort Behaviour Scale were used to assess pain and comfort levels before, during, and after the procedure."
777,"GPT4 Correct Assistant: This study aims to investigate the biological mechanism of the efficacy of psychotherapy for depression using the Near-Infrared Functional Imaging System (fNIRS). The study will recruit patients with depressive disorder and randomize them into three groups: medication therapy, interpersonal psychotherapy (IPT), and a combination of medication therapy and IPT. The primary outcomes measured are changes in fNIRS after treatment and change in remission rate of Hamilton Depression Scale (HAM-D24) score after treatment. Secondary outcomes include changes in remission rate of Patient Health Questionnaire-9 (PHQ-9) score, Beck Depression Inventory (BDI) score, and Beck Scale for Suicidal Ideation (SSI) score after treatment."
778,"GPT4 Correct Assistant: This clinical trial aims to evaluate the safety and effectiveness of 111In panitumumab as a molecular imaging agent for nodal staging in head and neck cancer patients. The study will compare the sensitivity and specificity of identifying sentinel lymph nodes by systemic injection of 111In-panitumumab prior to surgery versus conventional local injection with an optical dye. The trial will also explore if systemic injection of 111In-panitumumab can identify tumor-positive lymph nodes on preoperative SPECT/CT and compare the sensitivity, specificity, and negative predictive value of 111In-panitumumab SPECT/CT findings to preoperative MRI and 18F-FDG PET/CT."
779,"GPT4 Correct Assistant: This clinical trial aims to investigate the efficacy and mechanism of transcutaneous vagus nerve stimulation (tVNS) in treating generalized anxiety disorder (GAD). The study will include two participant groups: one receiving medication-combined tVNS and another receiving medication-combined sham stimulation. The primary outcome measure will be changes in the Hamilton Anxiety Scale scores at baseline and week 2 of treatment. Secondary outcome measures include changes in the Hamilton Anxiety Scale, Hamilton Depression Scale, and Generalized Anxiety Scale scores at baseline and week 4 of treatment, brain function indicators, and incidence of adverse events."
780,GPT4 Correct Assistant: This clinical study aims to investigate the clinical characteristics and treatment outcomes of nasolacrimal duct obstruction using dacryoendoscopy. The intervention is dacryoendoscopic-assisted laser dacryoplasty with silicone intubation. The study includes participants aged 18-80 years with a confirmed diagnosis of nasolacrimal duct obstruction or stenosis. The primary outcome measure is the cumulative success rate of DLDI within a 2-year follow-up period.
781,"GPT4 Correct Assistant: The clinical trial aims to investigate the immediate effects of proprioceptive neuromuscular facilitation (PNF) with lower leg kinesio taping on ankle dorsiflexion, gait, and functional mobility in patients with chronic stroke. The study involves three groups: lower leg kinesiotaping, proprioceptive neuromuscular facilitation, and proprioceptive neuromuscular facilitation with lower leg kinesiotaping. The primary outcome measures include the time up and go test, Barthel Index, Motor Assessment scale, and Dynamic gait index. The trial seeks to determine the effectiveness of these interventions in improving mobility and functional independence in patients with chronic stroke."
782,"GPT4 Correct Assistant: The study aims to develop and evaluate an algorithm for vascular access management in peripheral venous catheter placement. It is a mixed, multicentre, non-randomised, quasi-experimental, before-and-after, open, cross-sectional study with control and experimental groups. The study consists of three phases: observational, interventional with the A-DIVA Scale, and interventional with the algorithm composed of the A-DIVA Scale and the new decision-making tree (A-DIVA Tool). The primary outcome measure is the number of venipunctures performed per patient after implementation of the algorithm. Secondary outcome measures include acceptability and feasibility of using the VAD score in isolation and the score in conjunction with the catheter placement algorithm, patient pain score, number of venipunctures performed per patient after implementation of the venous access difficulty score, insertion technique used for catheter placement, number of operators required for catheter insertion, frequency of second-line referral to another practitioner, puncture result, and care strategies implemented in the event of difficulties encountered when inserting peripheral venous lines."
783,"GPT4 Correct Assistant: This clinical trial aims to evaluate the effectiveness of STARgraft-3 for hemodialysis access in patients with End Stage Renal Disease. The intervention involves implanting a 6mm diameter STARgraft-3 shunt in the upper arm, which will be used for hemodialysis access. The primary outcome measure is the percentage of subjects without an occurrence of either an access thrombosis or an access procedure performed to maintain patency at 6 months post-implantation. Secondary outcome measures include primary unassisted patency, assisted primary patency, secondary patency, frequency of interventions, blood flow rates in grafts, and safety outcomes."
784,"GPT4 Correct Assistant: The Primary Care Online Emotion-regulation Treatment (POET) clinical trial aims to test the efficacy of a digital emotion regulation treatment in adolescents with mental health problems. The study will randomize participants to either a digital emotion regulation treatment or an active comparator, both with therapist support. The primary outcome measure is the Clinical Global Impressions-Severity scale, assessing symptom severity at various time points. Secondary outcomes include measures of mental health, emotion regulation, and cost-effectiveness. The study will also explore potential moderators of treatment outcomes and differences in distal outcomes between POET and the active comparator."
785,"GPT4 Correct Assistant: The study aims to evaluate the comparative efficacy of two modalities of radiotherapy over surgery alone on local tumor control in older patients with non-melanoma skin cancer (NMSC). It is a multicenter, randomized, open-labeled, comparative 3 arms phase III trial, including patients aged ≥ 70 years with high-risk NMSC who have undergone surgery. The patients are randomized into three arms: surgery alone (Arm A), surgery with moderate hypofractionation (Arm B), and surgery with extreme hypofractionation (Arm C). The primary outcome measure is local tumor control at 3-year follow-up, assessed using the cancer-specific European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) and QLQ-ELD14 module. Secondary outcome measures include rate of toxicity, efficacy of treatment modalities on regional recurrence, progression-free survival, and overall survival."
786,"GPT4 Correct Assistant: The Surveillance Colonoscopy in Older Adults: The SurvOlderAdults Study aims to investigate the cumulative colorectal cancer (CRC) risk among older adults with a history of normal colonoscopy or colonoscopy with polypectomy, and assess the comparative effectiveness of exposure vs. no exposure to surveillance colonoscopy after age 75 for reducing CRC risk. The study will analyze data from a cohort of older adults with a history of normal colonoscopy or colonoscopy with polypectomy, and among older adults with polypectomy, examine the risk of incident and fatal CRC in those exposed vs. unexposed to surveillance colonoscopy. Additionally, the study will engage stakeholders, including veterans, primary providers, geriatricians, gastroenterologists, VA leaders, and policy makers, to obtain multi-level perspectives on CRC risk and surveillance outcomes to inform future use and VA policy regarding surveillance colonoscopy in older veterans."
787,"GPT4 Correct Assistant: The study aims to assess the effect of early bedside cycling exercises on selected physical and psychological outcomes in patients after heart valve surgery. It will involve 50 patients diagnosed with valve heart disease undergoing valve replacement or intervention at the National Heart Institute-Cairo, Egypt. The patients will be randomly assigned to either the intervention group (bedside cycling) or the control group (routine physiotherapy). The primary outcomes measured include functional capacity, forced vital capacity, psychological status, activities of daily living and functional level, and the quality of life. The study will also assess the incidence of adverse events and prothrombin international normalized ratio (INR) at one-month follow-up."
788,"GPT4 Correct Assistant: The Molecular Analysis of Screen Detected Non-invasive Breast Cancer and Atypical Breast Hyperplasias Identified by the Sloane Project is a study focused on DCIS, LCIS, and atypical hyperplasias in females. The study aims to measure the progression of breast disease from diagnosis to the end of 2016."
789,"GPT4 Correct Assistant: This clinical trial is designed to study the effects of Tirzepatide treatment in combination with insulin therapy for the concurrent treatment of obesity and Type 1 Diabetes Mellitus. The study includes participants aged 18-70 years with a clinical diagnosis of Type 1 Diabetes Mellitus for less than 12 months and a Body Mass Index (BMI) of 30kg/m2 or higher. Participants will be randomly assigned to either continue their insulin therapy alone or receive Tirzepatide in addition to their insulin therapy for 32 weeks. The primary outcome measure is the percentage change in body weight over the 32-week period. Secondary outcome measures include changes in HbA1c levels, time in range, total daily insulin dose, insulin carbohydrate ratio, waist and neck circumference, blood pressure, mean glucose, time in hypoglycemia and hyperglycemia, and various lipid parameters."
790,"GPT4 Correct Assistant: The study titled ""Efficacy of Losartan in the Prevention of Paclitaxel-induced Peripheral Neuropathy in Breast Cancer Patients"" aims to investigate the efficacy of Losartan in preventing paclitaxel-induced peripheral neuropathy in breast cancer patients. The study is a randomized, parallel assignment, single-masked trial, with a primary outcome measure of the incidence of paclitaxel-induced peripheral neuropathy and a secondary outcome measure of patient quality of life assessed by Functional Assessment of Cancer Therapy/Gynecologic Oncology Group - Neurotoxicity (FACT/GOG-NTX). The trial will run for 12 weeks, with participants receiving either standard-of-care management for chemotherapy-induced nausea and vomiting or standard-of-care plus Losartan 100mg."
791,"GPT4 Correct Assistant: This clinical trial aims to study the effects of Ginkgo biloba ketone ester tablets on cognitive function in patients with type 2 diabetes and mild cognitive impairment. The study is divided into two groups: the experimental group receiving Ginkgo biloba ketone ester tablets combined with conventional hypoglycemic treatment, and the control group receiving placebo combined with conventional hypoglycemic treatment. The primary outcome measure is cognitive function testing using Alzheimer's Disease Assessment Scale-Cognitive section, with secondary measures including memory function assessment, daily living ability assessment, and functional evaluation. The study duration is six months."
792,"GPT4 Correct Assistant: This clinical trial aims to compare the efficacy and safety of two treatments for severe aplastic anemia (SAA) in elderly patients: CsA+ATG+AVA and CsA+AVA. The study includes patients aged 60 years or older with newly diagnosed SAA. The primary outcome measure is the overall response rate at 6 months. Secondary outcome measures include complete response rate, relapse rate, and adverse event rate at 6 and 12 months."
793,"GPT4 Correct Assistant: The study aims to determine the sensitivity and specificity of zirconium Zr 89 panitumumab for the detection of indeterminate metastatic lesions in head and neck squamous cell carcinoma. It also seeks to compare the sensitivity and specificity of standard of care imaging modalities to 89Zr-panitumumab-PET/CT for detecting indeterminate metastatic lesions. Participants receive panitumumab and 89Zr panitumumab intravenously, along with PET/CT scans. The study measures the sensitivity and specificity of 89Zr-panitumumab and compares it to standard of care imaging modalities."
794,"GPT4 Correct Assistant: This is a Phase III study evaluating the effectiveness of prophylactic central neck dissection in low-risk papillary thyroid cancer patients. The study includes patients aged 18-70 with cT1bT2 papillary thyroid carcinoma and cN0 status, and excludes those with metastatic neck lymph nodes, extrathyroidal extension, other malignancies, or pregnant/breastfeeding women. The primary outcome measure is excellent response at one year, while secondary measures include recurrence-free survival at one and two years. The study compares prophylactic central neck dissection with no central neck dissection."
795,"GPT4 Correct Assistant: The Net Transition Initiative study aims to evaluate the efficacy of two next-generation nets, Veeralin LLIN and Interceptor G2 LLIN, compared to the control arm MAGNet LLIN, for controlling malaria in Cote d'Ivoire. The study will be conducted in the department of Tiebissou, Southern Bouake city, and involves 33 villages with a total of 50 children per cluster for a 12-month follow-up period. The primary outcome measure is malaria case incidence, while secondary outcomes include malaria infection prevalence, vector density, and sporozoite rate in Anopheles mosquitoes."
796,"GPT4 Correct Assistant: The PRECISION Study is a single arm, 2 stage Phase II study that aims to test the safety of a 3 fraction radiotherapy schedule for prostate cancer using the RayPilot system and HypoCath image guidance. The study will recruit 100 patients and will measure the number of patients with acute and late radiation oncology/toxicity grading (RTOG) and common terminology for adverse events (CTCAE) urinary and bowel toxicity. Additionally, quality of life patient reported outcome measures will be assessed."
797,"GPT4 Correct Assistant: This clinical trial aims to investigate the effectiveness of low-level laser therapy in reducing root resorption of the upper incisors during intrusion movement using mini-implants in adult patients with deep overbite. The study is a randomized controlled clinical trial with two arms: a control group receiving traditional orthodontic treatment and an experimental group receiving low-level laser therapy. The primary outcome measures are change in root volume and change in root length, measured using cone-beam computed tomography (CBCT) images."
798,"GPT4 Correct Assistant: This is a clinical trial focused on the study of lymphadenectomy in right hemicolectomy, specifically in colon cancer patients. The study aims to analyze the correlation between the number of lymph nodes and their positivity, and the radicality of the surgical resection performed. The primary outcome measures include tumor free margin, length of terminal ileum, level at which colic vessels are closed, mesocolic sail integrity, number of lymph nodes harvested, and number of lymph nodes positive for metastatic involvement. The study also seeks to investigate the vascular anatomical variability of the patients and how this may affect the extent of lymphadenectomy. The study includes patients aged 18-95, of both sexes, who have undergone right hemicolectomy for colorectal adenocarcinoma."
799,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of Cawthorne Cooksey exercises on balance and quality of life in children with hearing deficits. The study includes children aged between 7 and 12 years with sensorineural hearing deficits and normal vision. Participants are randomized into two groups: one group performs Cawthorne Cooksey exercises, while the other group performs Swiss Ball exercises. The primary outcome measure is the Pediatric Berg Balance Scale, and the secondary outcome measure is the Four-step square test. The study duration is 12 weeks."
800,GPT4 Correct Assistant: The study aims to explore the psychological impact of Gestational Trophoblastic Neoplasia (GTN) on women who have completed chemotherapy treatment. The study will involve 20 participants who will undergo semi-structured telephone interviews. Thematic analysis will be used to identify common themes in patients' experiences and opinions on the support received after treatment. The findings will help improve the follow-up support for future patients with GTN.
801,"GPT4 Correct Assistant: This clinical trial aims to evaluate the utility of bone grafts in open wedge corrective osteotomy and plate fixation for patients with malunited distal radius fractures. The study will include participants over the age of 18 with symptomatic malunion of the distal radius, eligible for open wedge osteotomy and plate fixation with or without bone grafting from the iliac crest. Participants will be randomly assigned to either a group with bone grafting or a group without bone grafting. The primary outcome measures include complications, quality of life using the EQ-5D-5L questionnaire, and time to complete bone healing. Secondary outcome measures include subjective and objective functional outcomes and cost-effectiveness analysis."
802,"GPT4 Correct Assistant: The study aims to examine the short-term effects of a brief behavioral teacher training on behavioral difficulties in elementary school children. The intervention consists of three sessions of behavioral teacher training, with or without additional practice as usual. The primary outcome measure is the severity of teacher-rated daily target behaviors in specific classroom situations. Secondary outcome measures include the severity of daily target behaviors in other classroom situations, teacher-reported severity of behavioral difficulties, teacher-reported number of child behavioral difficulties in the classroom that the teacher considers troublesome, teacher-reported child impairment at school associated with behavioral difficulties, teacher-reported quality of the teacher-student relationship, teacher's sense of self-efficacy, and teacher-reported frequency of supportive and non-supportive management strategies. The study has a two-arm, randomized controlled design, with teachers and children being randomly assigned to either the intervention group (brief teacher training with practice as usual) or the control group (practice as usual only)."
803,"GPT4 Correct Assistant: This study aims to evaluate the feasibility, acceptability, and usability of a tele-rehabilitation program combining immersive virtual reality exercises and therapeutic education for individuals with chronic non-specific neck pain. Participants will undergo a 6-week intervention consisting of virtual reality sessions, teleconsultations, and reading therapeutic education brochures. The study will measure the retention rate, adherence to treatment, safety, implementation at home, online consultations, satisfaction, and usability of the virtual reality system and online consultations. Secondary outcomes include changes in range of motion, neck disability, pain intensity, kinesiophobia, illness perception, and global perceived effect. Semi-structured interviews will be conducted to explore participants' experiences with the intervention and virtual reality system."
804,"GPT4 Correct Assistant: This clinical trial aims to assess the effectiveness of a home-based implementation of the Hand-Arm Bimanual Intensive Therapy (HABIT-ILE) for children with bilateral cerebral palsy (CP) aged 6 to 18 years. The study aims to compare HABIT-ILE at home with the traditional HABIT-ILE therapy in a rehabilitation center to determine if it is non-inferior in terms of physical abilities, functional activities, and participation of the participants. The study also investigates whether a post-therapy follow-up at home improves the transfer of learned skills to daily life. Participants will be divided into four groups: HABIT-ILE at home without a follow-up, HABIT-ILE at home with a follow-up, traditional HABIT-ILE therapy without a follow-up, and traditional HABIT-ILE therapy with a follow-up. The primary outcome measure is the change in gross motor function (GMFM-66) at baseline, 2 weeks, and 12 weeks after baseline. Secondary outcomes include changes in the Both Hand Assessment (BOHA), Box and Block Test (BBT), Six Minutes' Walk Test (6MWT), ABILHAND-Kids questionnaires, PEDI questionnaire, ACTIVLIM-CP Questionnaire, ABILOCO-Kids Questionnaire, Jebsen Hand Function Test, ESTIMILL-CP questionnaire, PILS-CP questionnaire, lower limbs and upper limbs physical activity, functional goals assessed by the Canadian Occupational Performance Measure (COPM) questionnaire, 3D T1-weighted structural imaging, Fractional Anisotropy (Diffusion tensor imaging (DTI)), Resting-state functional magnetic resonance imaging (rs-fMRI), and Mean Diffusivity (Diffusion tensor imaging (DTI))."
805,"GPT4 Correct Assistant: This is a randomized controlled trial comparing digital and speculum exams in patients with preterm prelabor rupture of membranes (PPROM) between 22 weeks 0 days and 33 weeks 5 days gestation. The primary outcome measure is pregnancy latency, and secondary outcomes include maternal and neonatal complications. The study aims to determine the optimal method for cervical evaluation in patients with PPROM."
806,"GPT4 Correct Assistant: This clinical trial is titled ""Sequential Adult Left Lateral Lobe Liver Transplantation (SALT) in Patients With Liver Cirrhosis With Hepatocellular Carcinoma(HCC): a Single-center, Prospective, Single-arm Study."" The study aims to evaluate the overall survival rate of patients with liver cirrhosis with HCC who undergo sequential adult left lateral lobe liver transplantation (SALT). The primary outcome measure is overall survival, and the secondary outcome measure is disease-free survival. The study is designed as a single-group assignment, open-label study with a SALT operation plan for eligible patients who successfully match a donor liver."
807,"GPT4 Correct Assistant: This clinical trial aims to establish the validity and reliability of a Dexterity Assessment Tool in patients with degenerative cervical myelopathy (DCM) and healthy populations. Participants must be between 35 and 75 years old, able to fluently speak and read English, and for patients, have no other neurological disorders. The study measures dexterity using the Dexterity Assessment Tool, which employs pressure sensor pads. The primary outcome measures include assessing dexterity in patients with cervical myelopathy, correlating the Dexterity Assessment Tool with the GRASSP-M tool, and evaluating inter-rater and test-retest reliability in healthy participants."
808,"GPT4 Correct Assistant: This is a non-interventional, single-center, multi-surgeon, observational study evaluating the effect of intraocular lens (IOL) centration and tilt on visual performance in patients who have undergone Clareon® Vivity® IOL implantation. The study will include individuals implanted with Clareon® Vivity® and Vivity® Toric IOLs, with a target of 100 implanted patients (200 eyes). The primary outcome measure is monocular best-corrected distance visual acuity (BCDVA) at Visit 1. Secondary outcome measures include decentration of IOL, tilt of IOL, monocular uncorrected distance visual acuity (UCDVA), monocular distance-corrected intermediate visual acuity (DCIVA), monocular uncorrected intermediate visual acuity (UCIVA), and manifest refraction/manifest refraction spherical equivalent (MRSE) at Visit 1."
809,"GPT4 Correct Assistant: This clinical trial aims to investigate the efficacy of US-guided Serratus Posterior Superior Interfascial Plane Block (SPSIPB) for postoperative analgesia management after mastectomy and axillary lymph node dissection surgery. The trial will compare postoperative pain scores (NRS) and evaluate the need for rescue analgesics, block-related complications, dermatome level, and side effects associated with opioid use between the SPSIPB group and the control group. The primary outcome measure is pain scores (NRS) at postoperative 1 hour, and the secondary outcome measures include the need for rescue analgesia, adverse events, and dermatomal coverage of SPSIPB in the SPSIPB group."
810,"GPT4 Correct Assistant: The study aims to explore the optimization of ductography technique and assess the clinical value of delayed ductal imaging of contrast-enhanced spectral mammography (CESM) in patients with pathological nipple discharge. The study is designed as an exploratory study, where participants undergo CESM 4-6 hours after the routine iopromide 370 mgI/ml-enhanced ductography. The primary outcome measure is the percentage of changes from baseline in imaging diagnosis caused by the results of delayed ductal imaging. The study also measures the diagnostic accuracy of delayed ductal imaging results for the nature of the lesion, changes in imaging diagnosis in patients with dense breasts and non-palpable breast mass/no abnormal findings on palpation, and kappa values for the evaluation of diagnostic imaging results of delayed ductal imaging by different radiologists."
811,"GPT4 Correct Assistant: This clinical study aims to investigate the association between postoperative dyslipidemia and organ rejection in heart transplant patients. The study includes patients aged 18 years and older who have undergone heart transplantation and have a disease duration of symptomatic heart failure for at least 6 months prior to the screening date. The primary outcome measures are blood lipid measurements (TG, TC, HDL-C, LDL-C, ApoB) and graft/patient survival, both assessed over a 4-year period. The secondary outcome measure is the left ventricular ejection fraction (LVEF) at rest, determined by contrast echocardiography, also over a 4-year period. The study explores terms related to heart transplantation, macrophages, fatty acid, PCSK9, and lipid metabolism."
812,"GPT4 Correct Assistant: This study is a prospective cohort study comparing the effectiveness of a virtual pelvic floor physical therapy with a pelvic floor trainer, known as Pelex Upp, in treating stress urinary incontinence in women over 18 years of age. Participants will be randomized into one of three arms: Pelex Upp device only, Pelex Upp device with pelvic floor physical therapy, or pelvic floor physical therapy only. The primary outcome measure is the change in stress urinary incontinence symptoms as assessed by the International Consultation on Incontinence Questionnaire - Urinary Incontinence Short Form (ICIQ-UI SF). The study duration is four weeks."
813,"GPT4 Correct Assistant: The study aims to improve attendance in the Community Wise intervention, a multi-level manualized behavioral intervention designed to decrease alcohol and substance misuse (ASM) frequency in a population of self-identified men with histories of substance use disorder (SUD) and incarceration. The study will employ a 23 full factorial design to examine the impact of different intervention delivery strategies on attendance and ASM reduction. These strategies include recruiting individuals under supervision, incentivizing intervention attendance, and delivering the intervention in an open group format. The study will also expand eligibility criteria to include women and people with SUD living in marginalized communities who have not been previously incarcerated."
814,"GPT4 Correct Assistant: This study aims to compare the efficacy of interpectoral area block + serratus anterior area block and erector spinae block in managing postoperative pain and recovery in patients undergoing minimally invasive cardiac surgery. The primary outcome measure is the pain assessment scale (NRS) within 48 hours after surgery. Secondary outcome measures include opioid consumption, recovery criteria, intraoperative data, and CPOT score until extubation."
815,"GPT4 Correct Assistant: This clinical trial aims to evaluate the efficacy of Botox and internal sphincterotomy in pain relief after hemorrhoidectomy. The study includes participants aged between 18 and 70 years old with grade III and IV hemorrhoids who have failed conservative treatment. The trial is designed as a randomized controlled study with three arms: Botox injection post hemorridectomy, internal sphincterotomy, and hemorridectomy alone (control group). The primary outcome measure is post-operative pain assessed using the visual analogue scale (VAS) at two weeks. Secondary outcome measures include the time taken to return to daily activities without complaint at four to six weeks."
816,"GPT4 Correct Assistant: The study, ""Efficacy of Modified Fruquintinib in Colorectal Cancer Liver Metastases: A Phase II Study,"" aims to explore the clinical efficacy and safety of fruquintinib as maintenance therapy for colorectal cancer patients who achieve NED (No Evidence of Disease) after adjuvant chemotherapy. The study is a prospective, single-arm, phase II study with a 2-year recurrence and metastasis rate as the primary indicator. Patients will receive fruquintinib maintenance treatment for six months or until tumor recurrence, metastasis, or intolerable drug toxicities occur within six months."
817,"GPT4 Correct Assistant: The study aims to investigate the efficacy of Methylphenidate (MPH) for the treatment of Posttraumatic Stress Disorder (PTSD) with associated neurocognitive complaints in Veterans. It is a randomized, placebo-controlled, N-of-1 crossover trial, where participants receive MPH and placebo in randomized order, separated by a 1-week washout. The primary outcome measure is the PTSD Symptom Checklist for DSM-5 (PCL-5), and secondary outcome measures include the Neuro-QoL Cognitive Function short form (NeuroQoL) and Symbol Digit Coding (SDC). The study aims to assess MPH's efficacy in reducing PTSD and depression symptoms, its impact on neurocognitive functioning, and the baseline predictors of treatment response, including whether Veterans with a history of mild traumatic brain injury (mTBI) show greater average treatment response to MPH versus placebo."
818,"GPT4 Correct Assistant: The trial aims to validate the capacity of CFRflow as a predictor of angina in patients with INOCA (Invasive Normal Coronary Arteries) at 3 months. It also aims to identify hemodynamic factors related to the persistence of angina at 3 and 12 months, establish the prevalence of patients with coronary microvascular dysfunction within the INOCA cohort, identify predictors of major cardiovascular events at 12 months, and validate the pathological value of MMR and establish the pathological value of AF. The study will use continuous thermodilution flow reserve as a diagnostic test for microvascular coronary dysfunction."
819,"GPT4 Correct Assistant: This clinical trial aims to determine the safety and efficacy of adding ruxolitinib to tacrolimus and methotrexate as graft-versus-host disease (GVHD) prophylaxis in pediatric and young adult patients with hematologic malignancies undergoing allogeneic hematopoietic cell transplantation (HCT) from a matched donor. The primary objective is to assess the incidence of adverse events and GVHD-free and relapse-free rates at 1 year post-transplant. Secondary objectives include estimating the cumulative incidence of acute and chronic GVHD, overall and progression-free survival, and other outcomes such as infection rates and secondary malignancies."
820,"GPT4 Correct Assistant: This clinical trial aims to investigate the effectiveness of a temple stay in improving the intestinal microbiome profile in patients with irritable bowel syndrome (IBS). The study involves participants aged 20-69 with diarrhea-predominant IBS, who will undergo a temple stay experience for up to 8 days. Observations will be made before, during, and 4 weeks after the temple stay. The primary outcome measure is the IBS-SSS symptom score, while the secondary outcome measure is fecal microbiome composition. The study hypothesizes that the temple stay experience will alter the gut microbiome, leading to a reduction in IBS symptoms and improved quality of life."
821,"GPT4 Correct Assistant: This study aims to assess asthma patients' and prescribers' willingness to change inhalers for environmental reasons, focusing on the climate impact of inhalers. The study will provide low-risk educational interventions to patients and providers, and measure the primary outcome of rotation of Ventolin MDI to Bricanyl Turbuhaler within 30 days of the study visit. Secondary outcomes include rate of failure of the intervention, proportion of patients who filled Bricanyl Rx change, awareness of patients regarding the climate impact of inhalers, and providers' willingness to change inhalers for environmental reasons."
822,"GPT4 Correct Assistant: This study aims to evaluate the durability of endoscopic plications, weight loss outcomes, and improvements in obesity-related co-morbidities for the combined hybrid argon plasma coagulation plus endoscopic sleeve gastroplasty (HAPC-ESG) procedure when compared to traditional ESG. The study is a single-center, randomized, single-blinded clinical trial that includes adult patients with a BMI between 30 and 40 kg/m² who have failed to achieve and maintain weight loss with non-surgical management. The primary outcome measure is the durability of plications and endoscopic sutures on repeat endoscopy at 6 months. Secondary outcome measures include weight loss, blood pressure, HbA1c percentage, quality of life, depression, and eating behavior."
823,"GPT4 Correct Assistant: The study aims to determine the effectiveness of cancer education based on the Health Belief Model on the awareness of women with disabilities and their participation in screening. The study includes women with physical disabilities aged 18-65 who have never or have not had a mammography, pap smear test, or clinical breast examination within the last three years. The study uses a randomized controlled experimental design with two interventions: cancer awareness training based on the Health Belief Model and standard cancer education. The primary outcome measure is the Gynecological Cancers Awareness Scale, which measures awareness of gynecological cancer. The secondary outcome measure is the Champion's Health Belief Model Scale for Breast Cancer and Screening, which measures perceived barriers to performing breast self-examination and mammography."
824,"GPT4 Correct Assistant: This systematic review assessed the effectiveness of neoadjuvant chemotherapy and Trastuzumab in achieving pathological complete response (pCR) in patients with HER2-positive breast cancer. Nine clinical trials were identified, including patients with non-metastatic operable, locally advanced, or inflammatory breast cancer. The overall pCR rate among 1,209 patients was found to be 42%. The review provided information on trial design, patient characteristics, disease staging, HER2 status, treatment regimens, and primary/secondary endpoints."
825,"GPT4 Correct Assistant: The study aims to assess the feasibility of a coach-led digital platform using an intelligent coaching assistant for promoting healthy lifestyle and preventing lifestyle-related diseases in the Irish community. The platform will be tested in Athy for six months, with participants having access to educational content, health coaches, and data from wearable devices. The study will examine the feasibility of the platform, the implementation of the intelligent coaching assistant, and participants' experiences through qualitative interviews and focus groups. The primary outcomes include assessing the reach, adoption, engagement, and experience of the platform, while secondary outcomes include changes in mental health and lifestyle medicine vital signs among participants."
826,"GPT4 Correct Assistant: This clinical trial investigates the effects of Progressive Muscle Relaxation (PMR) and Deep Breathing Exercises (DBE) on dyspnea, fatigue, and quality of sleep in COPD patients. The study is a randomized controlled clinical trial with a parallel assignment and double-masked design. Participants are randomly assigned to one of three groups: PMR Group, DBE Group, or Control Group. The PMR Group undergoes PMR exercises twice a day for eight weeks, while the DBE Group undergoes DBE exercises. The Control Group receives no intervention. The study measures the impact of these interventions on fatigue, dyspnea, and sleep quality using the COPD and Asthma Fatigue Scale, Dyspnea-12 Scale, and Pittsburgh Sleep Quality Index, respectively."
827,"GPT4 Correct Assistant: The clinical trial titled ""Functional Diagnostic Accuracy of Ultrasonic Flow Ratio in Assessment of De Novo Coronary Artery Lesions"" aims to evaluate the sensitivity and specificity of ultrasonic flow ratio (UFR) in predicting functionally significant coronary stenosis at the patient and vessel level using fractional flow reserve (FFR) as the reference standard. The study includes participants with stable or unstable angina pectoris, or after the acute phase of myocardial infarction. The intervention involves diagnostic tests, including FFR, UFR, and intravascular ultrasound (IVUS). The primary outcome measures are sensitivity and specificity of UFR in predicting functionally significant coronary stenosis at the patient level, and secondary outcome measures include sensitivity and specificity of UFR in predicting functionally significant coronary stenosis at the vessel level, diagnostic accuracy of UFR in predicting functionally significant coronary stenosis at the patient level, and the area under the receiver-operating characteristic curve (AUC) for coronary stenosis with FFR as the gold standard."
828,"GPT4 Correct Assistant: This is a randomized controlled trial examining the effects of Balint group activities on burnout and self-efficacy of nurse leaders in China. The study includes nurse leaders in clinical departments who voluntarily participate and have not previously participated in Balint groups. The intervention consists of Balint training for three months, including two lectures and ten small group discussion sessions. The primary outcome measures are the Maslach Burnout Inventory-Human Services Survey (MBI-HSS) subscales for emotional exhaustion, depersonalization, and personal accomplishment, assessed at baseline and three months after the completion of Balint group activities. The secondary outcome measure is the General Self-Efficacy Scale (GSES), also assessed at baseline and three months after the completion of Balint group activities."
829,"GPT4 Correct Assistant: This study aims to test the effectiveness of non-pharmacological and TCM-based treatments for cognitive impairment in people with long COVID symptoms. The trial is a randomized controlled study with four arms: acupuncture, TCM-based lifestyle management, both interventions combined, and a wait-list control group. The primary outcome measure is global cognitive function, while secondary measures include cardiopulmonary function, fatigue, health-related quality-of-life, psychological distress, neurocognitive functions, and neurobiological outcomes. Participants must be at least 18 years old and have had a SARS-CoV-2 infection at least 3 months prior to recruitment."
830,"GPT4 Correct Assistant: The myCare-102 trial aims to survey physician and molecular tumor board perspectives on the clinical utility and usability of Cellworks Singula™ and Cellworks Ventura™ reports in facilitating treatment decisions for pan-cancer patients. The study includes patients with cancer, relapsed cancer, or refractory cancer who have already received first-line therapy. The primary outcome measure is the surveyed view of the Cellworks Singula™ and Ventura™ reports, and the study will last approximately 24 months."
831,"GPT4 Correct Assistant: This clinical trial aims to investigate the effect of Cognitive Stimulation Therapy (CST) on apathy, loneliness, anxiety, and daily living activities in elderly individuals diagnosed with Alzheimer's disease. The study will be conducted in a single center and experimental research design with pretest, posttest, and control group. CST will be applied by a trained researcher for 14 sessions of 45-50 minutes, and the participants will be assessed using various scales to measure the outcomes. The study seeks to determine the impact of CST on cognitive, psychological, and social aspects of Alzheimer's patients, as there is limited research on this topic."
832,"GPT4 Correct Assistant: This clinical trial is a prospective, parallel, two-arm, randomised controlled study examining the effect of counselling and follow-up after breast cancer awareness education on early diagnosis behaviours and healthy lifestyle behaviours among female administrative staff at Mersin University. The study consists of two groups: an experimental group receiving a reminder message via SMS every week for six months after training, and a control group receiving no additional intervention. The primary outcomes measured are early diagnosis behaviours, counselling, and healthy lifestyle behaviours."
833,"GPT4 Correct Assistant: The study aims to determine the effect of simulation-based postpartum hemorrhage management on the application skills, satisfaction, self-confidence, and self-efficacy-competences of 3rd-year midwifery students at the Health Sciences University Hamidiye Health Sciences Faculty Midwifery Department. The study population consists of 82 students, and the intervention group receives practical training on postpartum hemorrhage assessment and management using a high-reality simulator. The control group receives similar training using a standard adult patient model. The study measures student satisfaction and self-confidence using the Student Satisfaction and Self-Confidence Scale in Learning, and self-efficacy using the Self-Efficacy Scale. The study also measures the effect of the intervention using the Early Postpartum Hemorrhage Management Skill Assessment Form and the Evaluation Scale of Simulation-Based Learning."
834,"GPT4 Correct Assistant: The clinical trial, conducted by the School of Environmental Sciences at the University of Indonesia, aims to study the effect of mangrove sword bean food bars on the weight of older people aged 60-80 years. Participants are divided into two groups: the treatment group receives mangrove sword bean food bars, while the control group receives sword bean food bars. Both groups receive balanced nutrition education. The study's primary outcome measure is the weight change of participants over two weeks, and the secondary outcome measure is the change in balanced nutrition knowledge among participants."
835,"GPT4 Correct Assistant: The pAIn-sense study aims to develop a novel telemonitoring system using artificial intelligence and wearable sensing technology to monitor and treat pain patients. The system will characterize the pain nature of patients through physical and emotional data, enabling efficient personalized treatments. The study will monitor patients with nociceptive pain, neuropathic pain, or healthy controls for up to one month. The primary outcome measures include pain level, psychosocial components of pain experience, physiological components of pain, psychological and clinical factors affecting pain, and medication intake. Secondary outcome measures include rehabilitation, sleep, activity, predictors of chronification from the acute phase, quality of life, and responsiveness to medication."
836,"GPT4 Correct Assistant: This is a Phase 2a/b single-arm open-label study evaluating the safety and efficacy of intracystic administration of TARA-002 in participants aged 6 months to less than 18 years for the treatment of macrocystic and mixed cystic lymphatic malformations. The study includes participants with a diagnosis of macrocystic or mixed cystic lymphatic malformations in the head, neck, or mediastinum. The primary outcome measure is the proportion of participants with clinical success after one treatment cycle of TARA-002. The study measures safety and efficacy through various outcome measures such as the percentage of participants with solicited and unsolicited adverse events, serious adverse events, and investigator assessment of clinical improvement."
837,"GPT4 Correct Assistant: This clinical trial aims to investigate the efficacy and safety of Chiglitazar added to insulin glargine in patients with type 2 diabetes who have not achieved adequate blood sugar control with metformin and insulin glargine treatment. The study includes 128 patients who are randomly assigned to either a Chiglitazar sodium group or a placebo group. The primary outcome measure is changes in HbA1C from baseline after 18 weeks of treatment. Secondary outcome measures include changes in insulin dose, triglyceride levels, fasting blood glucose, and fasting C-Peptide."
838,"GPT4 Correct Assistant: The study aims to evaluate the robustness of the EarSwitch technology in detecting voluntary eardrum movements in people with assistive needs and gather information from assistive device users about their ability to perform voluntary eardrum movements. The methodology includes four main parts: co-design questionnaires, Earswitch insertion, ear rumbling test, and usability testing (optional). The study will include both participants with assistive technology needs and healthy volunteers. The primary outcome measure is the F-score, MCC, ROC curve, and AUC, while the secondary outcome measures include the accuracy of TT movements, differences in accuracy between assistive technology users and healthy participants, and comfort and ease-of-use of the EarSwitch."
839,"GPT4 Correct Assistant: The study aims to prospectively validate an EHR-based pancreatic cancer risk model, PRISM, in a real-time clinical setting. The trial involves a multi-center prospective cohort study with participants aged 40 years and above from 44 healthcare organizations in the USA. The primary outcomes are assessed using metrics such as Area under the receiver operating characteristic curve (AUROC), sensitivity, specificity, positive predictive value/negative predictive value for discriminative performance and calibration. Secondary outcomes include the timing of incident PDAC occurrence and tumor stage at PDAC diagnosis."
840,GPT4 Correct Assistant: This study aims to compare the effectiveness of autologous adipose tissue graft with hyaline cartilage graft mixed with fibrin glue versus microfracture for treating articular cartilage defects in patients with knee osteoarthritis. The study will include participants aged 18 to 60 with a single full-thickness symptomatic femoral condyles ulcer and a varus deformity of the affected knee between 50 and 100. The primary outcome measure is the clinical assessment of International Knee Documentation Committee (IKDC) scores at one year.
841,"GPT4 Correct Assistant: This clinical trial aims to investigate the relationship between exercise training and recovery to improve physical performance and health indices. The study involves three groups: a control group with a regular training volume, a lower exercise volume group, and an extended recovery group. Participants will be assessed for changes in immune system, cardiometabolic measurements, endocrine measurements, aerobic capacity, and body composition at baseline and after 8 weeks of intervention."
842,"GPT4 Correct Assistant: This clinical trial aims to investigate the accuracy of quantifying phosphodiesterase 4B (PDE4B) in the human brain and whether it is reduced in individuals with major depressive disorder (MDD). The primary objective is to determine if PDE4B is reduced in the brains of MDD patients experiencing a major depressive episode (MDE). Secondary objectives include determining the optimal scanning length and retest variability and reliability of [18F]PF-06445974 PET scans, and assessing the relationship between clinical rating scales and PDE4B binding. The study uses [18F]PF-06445974 drug and includes MDD patients aged 18-70 and healthy volunteers aged 18-70. The trial has a diagnostic purpose with a single group assignment and an open-label intervention. The primary outcome measure is the distribution volume of PDE4B, while the secondary outcome measures include the optimal scanning length, retest distribution volume, and the relationship between clinical rating scales and PDE4B binding."
843,"GPT4 Correct Assistant: This clinical trial aims to evaluate the importance of weight-bearing and flexion in knee osteoarthritis using 3D joint space evaluation. The study includes patients aged 18 years or older with symptomatic knee osteoarthritis, excluding those who have undergone knee surgery or cannot stand for 15 minutes without assistance. The intervention is a weight-bearing MRI scan, and the primary outcome measure is the medial joint space width, with secondary outcome measures including lateral joint space width."
844,"GPT4 Correct Assistant: The i-BiSSkApp clinical trial aims to test the effectiveness of a novel at-home surface electromyography (sEMG) biofeedback therapy tool called Biofeedback in Strength and Skill Training (BiSSKit) on swallowing safety and efficiency in patients with Parkinson's disease (PD). Dysphagia, or disordered swallowing, is prevalent in PD patients and can lead to aspiration pneumonia, a leading cause of death in this population. The study will compare the use of the i-BiSSkApp with traditional swallowing therapy in PD patients to evaluate the impact of the device on swallowing outcomes. The primary outcome measures include Penetration Aspiration Scale Score (PAS) and Total Pharyngeal Residue, both assessing swallowing safety. Secondary outcome measures include the Eating Assessment Tool-10 (EAT-10), a quality of life measure of swallowing function."
845,"GPT4 Correct Assistant: The Global Burden Estimation of Human Papillomavirus (GLOBE-HPV) study aims to estimate the point-prevalence of high-risk HPV in low socio-economic populations and the incidence of persistent HPV infection among specific sub-populations in 8 countries. The study will employ cross-sectional surveys (CSS) and longitudinal studies (LS) to gather data on HPV prevalence and incidence. The study will also explore potential risk factors for HPV infection and cervical cancer. The primary outcomes are the prevalence of HPV 16 and/or 18 infection among girls and women aged 9-50, and the incidence of ≥6-month persistent HPV 16 and/or 18 infection in selected populations over 2 years."
846,"GPT4 Correct Assistant: The study aims to investigate the efficacy of strategic memory training coupled with non-invasive brain stimulation techniques in healthy aging population and subjective cognitive decline patients. The primary goal is to assess whether the application of transcranial direct current stimulation (tDCS) during strategic memory training (online neurostimulation) enhances the effect of strategic memory training. The treatment protocol consists of 5 sessions of strategic memory training combined with online tDCS, applied to the dorsolateral prefrontal cortex, in healthy older participants. The study measures the impact of the intervention on various memory tests, including associative learning, list learning, name-face learning, place learning, text learning, and grocery learning. The follow-up visits allow for investigating whether eventual improvements are preserved over time and if this combined intervention affects the evolution of cognitive decline."
847,GPT4 Correct Assistant: The FIND-HF trial aims to develop and validate a predictive model for identifying risk factors of new onset heart failure using population-based nationwide electronic health records. The study includes participants aged 16 years and older with no history of heart failure and follows them for a minimum of one year. The primary outcome measures are to develop a predictive model and identify the magnitude of predictors of new onset heart failure. The study uses an observational cohort with no intervention given and analyzes data from primary care and secondary administrative data sources.
848,"GPT4 Correct Assistant: The study, ""Recommended Time to Resume Sexual Activity After Hysterectomy: Impact on Sexual Function (FSFI® Score) and Complication Rate ISHYS Study,"" aims to determine the impact of time between hysterectomy and resumption of sexual relations on sexual function using the FSFI® score. Participants must be 18 years or older, sexually active, and receiving a conservative or non-conservative total hysterectomy for benign pathology. The study will randomly assign participants to either resume sexual intercourse 4 weeks or 8 weeks after hysterectomy. The primary outcome measure is the FSFI® score, with secondary measures including postoperative complications and follow-up to the recommendation. The study will follow participants for one year."
849,"GPT4 Correct Assistant: This clinical trial aims to determine if human skeletal muscle possesses an epigenetic memory of testosterone. It includes sedentary males aged 55-70 with serum testosterone levels >8 nmol/L. Participants are randomly assigned to one of four groups: placebo, testosterone undecanoate, resistance exercise training with placebo, or resistance exercise training with testosterone undecanoate. The primary outcomes measured are changes in fat-free mass, skeletal muscle size and cross-sectional area (CSA), and skeletal muscle fibre CSA. Secondary outcomes include DNA methylation in skeletal muscle and blood, gene expression in skeletal muscle and blood, myonuclei, satellite cells, isometric muscle strength, dynamic muscle strength, and muscle force-velocity profiling."
850,"GPT4 Correct Assistant: This is a two-stage stratified design sero-prevalence study in the metropolitan area of Buenos Aires to determine the prevalence of dengue and other flavivirus infections. Participants aged 18 and older residing in the area are eligible. The diagnostic test used is Dengue Immunoglobulin G antibodies performed with ELISA. The primary outcome measure is the seroprevalence of dengue fever, and secondary outcomes include the prevalence of other flaviviruses and specific dengue serotypes. The study completion is expected to take an average of one year."
851,"GPT4 Correct Assistant: The ""Performance Assessment of COVID-19 Antigen Rapid Diagnostic Tests and Algorithms in Low-Prevalence Settings"" study aims to evaluate the performance characteristics of rapid SARS-COV-2 detection kits, including the Abbott Panbio™ COVID-19 Ag Rapid Test, for sensitivity, specificity, and overall agreement with standard nucleic acid testing using polymerase chain reaction (PCR) tests. The study focuses on participants aged 18-75 years who are crossing ports of entry in Greater Gaborone Health District. The primary outcome measure is the performance characteristics of two available Ag-RDTs for the detection of SARS-CoV-2 antigens in nasal swabs. The secondary outcome measure is the cost estimates of Ag testing compared to PCR testing for COVID-19 case detection."
852,"GPT4 Correct Assistant: The DESC-HBR trial aims to compare the impact of de-escalating P2Y12 inhibitor therapy to clopidogrel 75mg, prasugrel 5mg or ticagrelor 60mg bid, with full-dose potent P2Y12 inhibitors, on the proportion of patients with optimal platelet reactivity (OPR) in high bleeding risk patients with recent ACS. The secondary objective is to explore the effect of de-escalating P2Y12 inhibitor therapy on clinical events and patients' quality of life. The primary outcome is the proportion of patients in the OPR range measured through the VerifyNow system at peak level after drug maintenance dose (MD) at 14±2 days. The trial will also assess cost-effectiveness by inputting direct and indirect costs in relation to outcomes."
853,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of different dietary and exercise mitigators on blood sugar levels and metabolite responses after consuming a standard rice meal. Participants, aged 18 and older, will be provided with a Continuous Glucose Monitor (CGM) and a Fitbit fitness tracker. They will follow a 10-day intervention plan, consuming a provided portion of white rice and various mitigator foods, while also performing exercise at specific times. Blood samples will be collected at various time points to measure glucose, metabolite, and proteomic responses. The primary outcome measures are the comparison of blood glucose levels after consuming the different mitigators, while secondary outcome measures include changes in postprandial metabolites response, postprandial proteomic responses, and changes in personal metabolic states through the day."
854,"GPT4 Correct Assistant: The study aims to adapt and test a behavioral intervention to prevent Fetal Alcohol Spectrum Disorders (FASD) and adverse infant outcomes. The intervention includes contingent incentives and text-based support to encourage abstinence from alcohol, tobacco, and cannabis use during pregnancy and breastfeeding. The study will measure the effectiveness of the intervention through urinalysis and blood tests, as well as self-reported use of alcohol, tobacco, and cannabis. Secondary outcomes include gestational incidents, infant weight, height, head circumference, and gestational weeks at birth."
855,"GPT4 Correct Assistant: This clinical trial aims to recruit individuals with limb amputation and chronic phantom limb pain for a study investigating the use of operant conditioning of sensory brain responses to reduce phantom limb pain. The study will involve three 1-hour sessions per week for 8-9 weeks, followed by two follow-up sessions at 3 and 6 months after the last session. Participants will undergo non-painful peripheral stimulation with electrodes placed on the scalp to record electrical brain responses. Visual feedback based on the response will be provided in pseudo real-time. The study will measure changes in pain intensity and quality, neurophysiological sensorimotor response, and inter- and intra-hemispheric functional connectivity and sensorimotor responses associated with amputation and operant conditioning training through exploratory electroencephalography (EEG) assessments."
856,"GPT4 Correct Assistant: This is a retrospective, single-center study investigating the use of ultrasound-guided axillary vein catheterization in the Trauma Intensive Care Unit (TICU). The study aims to evaluate the accurate placement of the central venous catheter (CVC) tip for measuring central venous pressure (CVP) or invasive hemodynamic monitoring, as well as the puncture complications, thromboembolism events, TICU mortality, TICU length of stay, and ventilator support during the TICU stay. The study includes trauma patients admitted to the TICU who received axillary vein catheterization and excludes patients without a record of axillary vein catheterization or without imaging confirming the catheter tip location."
857,"GPT4 Correct Assistant: The study aims to evaluate the safety and efficacy of cevostamab in combination with BCMA CAR T cell therapy in patients with relapsed/refractory multiple myeloma. The primary outcome measure is the proportion of participants achieving MRD-negative complete remission (CR) at 12 months post-CAR T cell therapy. Secondary outcome measures include safety and tolerability of cevostamab administration, feasibility of cevostamab administration post-BCMA CAR T cell therapy, and the impact of cevostamab consolidation on other clinical outcomes."
858,"GPT4 Correct Assistant: This study aims to investigate the impact of rehabilitative ultrasonography imaging on core muscles function in patients with visceral adiposity. The study includes 45 participants aged between 25 and 45 years with a BMI between 25 and 29.9 kg/m2. The study design is randomized, parallel assignment, and double-masked. The experimental interventions include cavitation ultrasonic lipolysis on the abdomen, rehabilitative ultrasonography imaging-guided core muscle exercise, and a combination of both. The primary outcome measures are diaphragm excursion and transverse abdominis contraction ratio, measured by ultrasound imaging. Secondary outcome measures include visceral fat thickness and waist circumference."
859,"GPT4 Correct Assistant: This is a prospective Cardiac MRI pilot study investigating the impact of atrial fibrosis surface area on the occurrence of atrial fibrillation in patients with ischemic stroke of undetermined origin. The study includes patients with cryptogenic ischemic stroke within 7 days of inclusion, who are scheduled for implantable loop recorder implantation within 3 months of ischemic stroke, with no history of atrial fibrillation, no long-term anticoagulant therapy, and a life expectancy of more than 12 months. The primary outcome measure is the episode of atrial fibrillation lasting more than 30 seconds on the implantable loop recorder at 3-year follow-up."
860,"GPT4 Correct Assistant: This is an open-label, randomized, phase II study for premenopausal metastatic or locally advanced breast cancer patients. The study aims to compare the effectiveness of different treatment combinations, including goserelin/fulvestrant, goserelin/fulvestrant/capivasertib, goserelin/fulvestrant/capivasertib/durvalumab, and goserelin/fulvestrant/durvalumab. The primary endpoint is objective response rate (ORR), with progression-free survival (PFS) and overall response rate (ORR) as secondary endpoints. Exploratory endpoints include biomarkers, such as TILs and PD-L1 correlation with treatment response."
861,"GPT4 Correct Assistant: The University of Maryland Charles Regional Medical Center (UM CRMC) is conducting a pilot study to test the effectiveness of a novel AI-based risk score, the RecuR Score, in identifying patients at higher risk of 30-day unplanned hospital readmission and implementing more complex interventions to reduce this risk. The study aims to test two primary hypotheses: 1) that using the RecuR Score combined with enhanced pre-discharge and follow-up care interventions, including additional educational materials, emphasis on the patient's readmission risk during interdisciplinary team huddles, and home health services, can reduce 30-day unplanned hospital readmissions in the high-risk group by 30%, and 2) that using the enhanced interventions, there will be a 30% reduction of unplanned hospital readmission risk in patients determined to be at medium-high risk of readmission (RecuR Score level 2 or 3). The study utilizes a parallel-group, two-arm, prospective, randomized, non-blinded, fallback design, controlled superiority study design. The target patient population is admitted patients at UM CRMC with a high readmission risk (RecuR Score) and/or specific admission diagnoses that are amenable to peri- and post-discharge interventions."
862,"GPT4 Correct Assistant: The ANCAR trial is an open-label, randomized, monocenter trial aiming to evaluate the effects of an acupuncture treatment protocol for nasal congestion in allergic rhinitis compared to azelastine nasal spray (Carelastin®). The study includes participants diagnosed with allergic rhinitis, aged 18 or older, and suffering from nasal congestion. The primary outcome measure is the Visual Analog Scale (VAS) score for nasal congestion after 6 weeks of treatments. Secondary outcome measures include VAS scores at different visits, Peak Nasal Inspiratory Flow (PNIF) scores, Adapted Nasal Obstruction Symptom Evaluation (NOSE) scores, and assessment of the effects of acupuncture on general health, concentration, energy level, and equalization of middle ear pressure in AR."
863,"GPT4 Correct Assistant: The study aims to investigate the recruitment rate and feasibility of a pilot trial examining the use of trans-coronary cooling and dilution for cardioprotection during revascularisation for ST-elevation myocardial infarction (STEMI). The primary outcome measures include recruitment rate, feasibility, and safety. Secondary outcomes include invasive haemodynamic assessment of coronary flow and microvascular function, blood biomarkers, and myocardial salvage assessed by magnetic resonance imaging (MRI) at 6 months."
864,"GPT4 Correct Assistant: This clinical trial investigates the feasibility of improving mental health outcomes in pregnant women with a history of anxiety and/or depression through targeted intervention on maternal gut microbiome. The study includes four groups of participants: Gutopia, Gutboost, Gutless, and Gutnone. Gutopia participants receive dietary modification, fish oil, and probiotics. Gutboost participants receive fish oil and probiotics, while Gutless participants receive fish oil and placebo probiotics. Gutnone participants receive standard care and a one-time dietary consult. The primary outcome measure is feasibility, with a focus on recruiting participants and completing study visits. Secondary measures include adherence to supplement intake, dietary protocol, and study visit completion."
865,"GPT4 Correct Assistant: This study aims to evaluate remotely delivered, culturally tailored weight loss interventions among Latina breast cancer survivors. The study includes a baseline run-in and randomized stage I and stage II studies. Participants receive various interventions, including online health education sessions, dietary modifications, home-based exercise sessions, and supportive materials. The primary outcome measure is body weight percent change at month 12, assessed across four embedded adaptive intervention groups using the doubly robust estimator model. Secondary outcome measures include body weight percent change moderated by baseline characteristics."
866,"GPT4 Correct Assistant: This is a retrospective study investigating the use of high dose Follitropin Delta in combination with either human chorionic gonadotropin (hCG) or highly-purified human menopausal gonadotropin (HP-hMG) in women aged 18 to 42 undergoing IVF/ICSI cycles. The study aims to evaluate the number of good quality blastocysts obtained in each group. Exclusion criteria include endometriosis stage III/IV, history of recurrent miscarriages, certain medical conditions, and use of growth hormone during the stimulation cycle."
867,"GPT4 Correct Assistant: The study aims to evaluate the effectiveness of telemedicine in managing Inflammatory Bowel Diseases (IBD), specifically Crohn's disease and ulcerative colitis. The study includes 60 patients, randomly assigned to either a telemedical intervention group or an observation group. The telemedical intervention group completes questionnaires on a web platform monthly, has access to online consultations with a gastroenterologist, and educational materials. The study measures the impact of telemedicine on the quality of life, clinical and endoscopic remission, adverse drug reactions, patient satisfaction, psychological well-being, and the number of surgical interventions and hospitalizations in patients with IBD."
868,"GPT4 Correct Assistant: The SAUNA trial is a randomized, open-label study that aims to investigate the efficacy of continuing somatostatin analogs upon progression in patients with gastroenteropancreatic neuroendocrine tumors (GEP NETs). The study involves two substudies: one for targeted therapy with sunitinib or everolimus, and another for PRRT with lutetium (177Lu) oxodotreotide. The primary outcome measures are progression-free survival (PFS) and time to deterioration (TTD) at 18 months after the start of second-line treatment. Secondary outcomes include overall survival, response rates, and quality of life measurements."
869,"GPT4 Correct Assistant: This study investigates the effects of a peer-mediated intervention on children with language impairment in inclusive preschool classrooms. The intervention involves training peers to engage in positive social interactions with the target child using specific strategies. The study uses a randomized controlled trial design, with 12 classrooms receiving the intervention and 13 serving as the control group. The primary outcome measure is the Preschool Language Screener 5 (PLS-5), which assesses expressive language skills. Secondary outcome measures include the Developmental Pragmatic Profile (DPP), Teacher-Child Rating Scale (TCRS), and measures of peer incoming and outgoing talk and social interactions. The study aims to determine whether the intervention can improve socialization experiences and accelerate growth in linguistic, social, and behavioral outcomes for children with language impairment."
870,"GPT4 Correct Assistant: This clinical trial aims to test the hypothesis that combining dalfampridine with motor-relearning physical therapy will produce superior gains in mobility in people with multiple sclerosis (MS) compared to either intervention alone. The study will include 48 participants with MS-related mobility deficits and EDSS ≤6.5. They will undergo a 6-week dalfampridine treatment, followed by stratified randomization to either 6 weeks of physical therapy with resumed dalfampridine or 6 weeks of physical therapy without dalfampridine. The primary efficacy outcome is the percent change from baseline in Timed 25-Foot Walk. The study aims to explore the comparative effectiveness of the combined intervention, dalfampridine alone, physical therapy alone, and to investigate the mechanisms of treatment effects using brain imaging outcomes."
871,"GPT4 Correct Assistant: The clinical trial, titled ""Test-Retest Reliability, Responsiveness and Interpretability of CLEFT-Q,"" aims to examine the reliability, responsiveness, and interpretability of the CLEFT-Q questionnaire in patients with cleft lip and palate. The study includes 50 patients each for secondary nose surgery, secondary lip surgery, and jaw surgery, as well as 50 patients for secondary speech improving surgery. Additionally, 20 healthcare professionals will be interviewed about their experiences with CLEFT-Q. The primary outcome measure is the CLEFT-Q change scores, while the secondary outcome measures include photographs and speech recordings before and after surgery."
872,"GPT4 Correct Assistant: This clinical trial aims to compare the effectiveness of core stabilization and dynamic stretching exercises in reducing the intensity, frequency, duration, and severity of primary dysmenorrhea. The study includes unmarried young girls aged 18-25 with primary dysmenorrhea who have not participated in regular physical activity. Participants are randomly assigned to either stretching exercises or dynamic core stabilizing exercises for 8 weeks. The primary outcome measures include the WaLIDD score, side bridge test, McGill Quality of Life, and PFSD scale."
873,"GPT4 Correct Assistant: This clinical trial aims to measure non-invasively, easily, and reliably the variations of cerebral perfusion in patients with or without cardiovascular risk factors during controlled variations performed during routine care to adjust the blood pressure level within the recommended safety standards during general anesthesia. The main objective is to identify a significant linear relationship between the percentage change in mean velocity (Vm) and the percentage change in the 95% spectral frequency front (SEF95) during the MAP change. The study will include adult patients undergoing scheduled surgery at Lariboisière Hospital under general anesthesia. All measurements are obtained non-invasively."
874,"GPT4 Correct Assistant: The PediQUEST Response to Pain Of Children With Neurologic Disability (PQ-ResPOND) is a pilot randomized controlled trial designed to evaluate the feasibility of a full-scale study comparing the effect of the PQ-ResPOND intervention vs. usual care in children and adolescents with severe neurologic impairment (SNI) and recurrent pain. The study aims to assess recruitment and retention rates, adherence to intervention delivery, and acceptability of the intervention by participants and clinicians. The primary outcome measure is child recurrent pain, while secondary outcome measures include child symptom burden, parent distress, and other related variables. The study seeks to address the lack of rigorous studies on interventions to alleviate recurrent pain in children with SNI."
875,"GPT4 Correct Assistant: This is a prospective observational study investigating the dynamic monitoring of minimal residual disease (MRD) in first-line treatment of extensive small cell lung cancer using Serplulimab plus chemotherapy. Participants receive 6 cycles of Serplulimab plus chemotherapy (etoposide + carboplatin/cisplatin) and MRD testing is performed at various time points. The primary outcome measure is progression-free survival (PFS) at one year after the end of chemotherapy. Secondary outcome measures include overall survival (OS), objective response rate (ORR), and disease-control rate (DCR) also at one year after the end of chemotherapy."
876,"GPT4 Correct Assistant: This clinical trial is designed to assess the effectiveness of the Aktivplan Digital Intervention (ACTIVE-CaRe Pilot) for supporting regular heart-healthy levels of physical activity following completion of a Phase II Rehabilitation Programme. The study involves two participant groups: one group receives the Aktivplan digital intervention, while the other group receives usual care. The primary outcome measures include recruitment rate, drop-out rate, data completeness, adherence to the Aktivplan digital intervention, usability, user experience, user acceptance, technical stability, use of alternative and additional strategies for supporting physical activity, experiences and perspectives of patients, and experiences and perspectives of rehabilitation professionals. Secondary outcome measures include exercise capacity, physical activity behavior, weight, blood pressure, blood cholesterol, HbA1c, smoking, health-related quality of life, exercise self-efficacy, and patient safety."
877,"GPT4 Correct Assistant: This clinical trial is a randomized, placebo-controlled, double-blind study investigating the effects of intranasal oxytocin on social and repetitive behaviors in youth with autism spectrum disorder (ASD). Participants between the ages of 12 and 20 with a confirmed ASD diagnosis are given either 24IU of oxytocin nasal spray or a placebo twice daily for four weeks. The primary outcomes measured are social behavior (using the Social Responsiveness Scale-Second Edition) and repetitive behavior (using the Repetitive Behavior Scale-Revised), both assessed by caregivers. Secondary outcomes include behavioral inflexibility, social cognition, repetitive cognition, and vagally-mediated heart rate variability."
878,"GPT4 Correct Assistant: The study aims to create and validate a Clinical Evaluation Scale for Abdominal Condition of the Premature (ECAP) in the neonatal intensive care units of Clermont-Ferrand hospital center. The study will include newborns born prematurely (before 37 weeks of amenorrhea) at least 3 days of life, excluding those with congenital pathology or under legal protection. The primary outcome measure is the ECAP scale score, which ranges from 0 to 20. The study will evaluate the validity of the ECAP scale and its impact on abdominal massage."
879,"GPT4 Correct Assistant: The study aims to investigate the effects of Empowered Relief (ER) on adults aged 18 and above with persistent pain. It is a randomized controlled trial that compares ER to a Wait-List Control (WLC) group. Participants will be recruited through ASPMN-related mechanisms and will be randomized 1:1 to either ER or WLC. Those in the ER group will complete a 2-hour Zoom ER class delivered by an ER-trained ASPMN nurse. Participants will be assessed for change in pain catastrophizing and pain intensity at baseline and at 2, 4, and 8 week timepoints."
880,"GPT4 Correct Assistant: This clinical trial aims to improve pain communication for patients' health by studying patients' and healthcare nurses' mental effort when choosing or understanding pain intensity ratings, and their confidence in the accuracy of pain intensity rating patterns. The study will explore various aspects of pain rating scales, mental effort, and confidence in pain intensity ratings, and their importance in pain communication between patients and nurses. The participants will be patients with chronic musculoskeletal pain and healthcare nurses who assess musculoskeletal pain in adult outpatients. The primary outcome measures are mental effort and importance of decreasing mental effort, while the secondary outcome measure is confidence in the accuracy of fictional pain intensity ratings."
881,"GPT4 Correct Assistant: This clinical trial is studying the use of mesenchymal stromal cells (MSCs) for the treatment of poor graft function after allogeneic hematopoietic stem cell transplantation. The trial is designed as an open-label study with a single group assignment. The intervention involves injecting 1×10^6/kg mesenchymal stem cells of cord blood weekly for four consecutive weeks. The primary outcome measures include hemogram recovery, white blood cells, red blood cells, and platelets. Secondary outcome measures include infection rate, graft-versus-host disease, and survival rate. The study is open to participants between 18 and 60 years old, with no serious functional damage to important organs and no other contraindications to hematopoietic stem cell transplantation."
882,"GPT4 Correct Assistant: The MOVIN' CARE for PD study is a randomized controlled trial investigating the effectiveness of mind-body interventions, specifically yoga and arts-based therapies, in improving the psycho-social-spiritual well-being of Parkinson's disease (PD) patients. The trial includes participants aged 18 or above with mild-to-advanced PD, who are able to comprehend Chinese and can access the internet and a smartphone/tablet/laptop. The study measures changes in perceived stress level, overall quality of life, PD-related symptoms, self-compassion, self-efficacy, perceived social support, constipation severity, bowel habits, and gut microbiota composition. The primary outcome measures are perceived stress level and overall quality of life, assessed using the Perceived Stress Scale (PSS) and the WHOQOL-BREF, respectively. The secondary outcome measures include PD-related symptoms, self-compassion, self-efficacy, perceived social support, constipation severity, bowel habits, and gut microbiota composition. User satisfaction with the interventions will also be assessed."
883,"GPT4 Correct Assistant: This study is a randomized controlled trial evaluating the effectiveness of an integrated digital intervention for alcohol use disorder (AUD) called Quit Genius Alcohol (QG-A) compared to usual care medical management (MM). QG-A combines a mobile app with cognitive-behavioral therapy (CBT) and pharmacotherapy, specifically naltrexone. The study aims to determine if QG-A is more effective in reducing alcohol use and associated psychological and functional outcomes in adults with AUD compared to usual care medical management. The primary outcome measure is the change in past 30-day alcohol use from baseline to 6-months post-treatment entry."
884,"GPT4 Correct Assistant: The Seven Trial is an Investigator Initiated Trial (IIT) that aims to explore the use of the unfolded protein response (UPR) as a potential therapeutic target in pancreatic cancer. The study seeks to determine if increasing ER stress (UPR) in cancer cells using a combination of chemotherapy and immunotherapy can induce apoptosis (cell death) and improve survival in patients with advanced pancreatic cancer. The trial consists of two parts: a dose escalation safety study and an expansion cohort study. The primary outcome measures include determining the maximum tolerated dose (MTD) of botensilimab, a novel anti-CTLA-4 antibody, in combination with balstilimab, a PD-1 checkpoint inhibitor, and triplet chemotherapy (nab-paclitaxel, gemcitabine, and cisplatin) plus chloroquine and celecoxib. Secondary outcome measures include assessing the safety, tolerability, and efficacy of the treatment regimen in terms of overall response rate, progression-free survival, and overall survival."
885,"GPT4 Correct Assistant: This clinical trial aims to compare the clinical pregnancy rate of frozen embryo transfer (FET) in natural vs substituted cycles among women under 40 years old. The study includes participants who have undergone FET cycles at Clinique OVO. The primary outcome measure is the clinical pregnancy rate, assessed at 6 to 8 weeks after FET."
886,"GPT4 Correct Assistant: This clinical trial aims to determine the effects of intravenous vs. inhalational anesthesia on incidence of postoperative delirium and cognitive dysfunction, functional decline, and patient-reported outcomes in older adults undergoing non-cardiac surgery. The trial will compare sevoflurane (inhalational anesthesia) and propofol (intravenous anesthesia) in a 1:1 randomized, double-blind study. Primary outcomes include incidence of postoperative delirium and cognitive dysfunction, while secondary outcomes involve delirium severity, delirium duration, postoperative functional decline, and patient-reported outcomes. Additionally, the study will examine blood biomarkers related to neuroinflammation and Alzheimer's pathology."
887,"GPT4 Correct Assistant: The study, titled ""Nutritional Assessment in Children With Congenital Heart Disease,"" aims to assess the nutritional status of children with congenital heart disease and adopt a protocol to avoid nutritional deficiency and achieve normal growth. The study includes children aged 5 weeks to 18 years with cyanotic and acyanotic congenital heart disease and excludes those with comorbidities other than congenital heart disease. The study uses anthropometric measures, including weight, height, length, head circumference, mid-arm circumference, and BMI, to assess nutritional status."
888,"GPT4 Correct Assistant: The study aims to investigate the effectiveness of pH sensitive MRI based resections of glioblastoma. It is a prospective, randomized controlled trial that will enroll patients with imaging consistent with WHO grade IV glioblastoma. The primary outcome measure is progression free survival, and secondary outcome measures include overall survival and quality of life metrics via karnofsky performance scale. The experimental arm involves resection of glioblastoma using pH weighted chemical exchange saturation transfer MRI, while the standard of care arm involves standard glioblastoma resection. The study aims to determine if maximal safe resection of CEST+ NE regions will minimize post-surgical tumor cell burden and allow for increased survival."
889,"GPT4 Correct Assistant: This clinical trial, conducted in Darfur, Sudan from 2020 to 2022, aims to investigate the patterns of urinary bladder cancer (BC) in the region. The study is cross-sectional and hospital-based, taking place at Nyala Specialized Hospital. It focuses on understanding the clinical outcomes, etiology, histology, and demographic distribution of the disease in Sudanese patients above 18 years of age living in Darfur. Exclusion criteria include patients not living in Darfur or those who refuse to participate."
890,"GPT4 Correct Assistant: This study aims to explore the correlation between mental stress and bowel preparation quality in patients undergoing colonoscopy at the Endoscopy Centre of the Department of Gastroenterology, Renji Hospital, between May 2023 and August 2023. A total of 1000 patients aged 18 to 75 years with an indication for colonoscopy were enrolled. The quality of bowel preparation was assessed using the Boston Rating Scale (BPS), with a score of less than 6 indicating poor preparation. The study's primary outcome measure is the quality of bowel preparation during colonoscopy, assessed within 20 minutes."
891,"GPT4 Correct Assistant: The study aims to examine the beneficial effects of a short playful interaction on the cognitive, social, and mood of older people. Participants will be randomly assigned to four arms: playful interactions in a face-to-face format, playful interactions in an online format, an active control condition in a face-to-face format, and an active control condition in an online format. The study will assess various measures such as cognitive tests, mood, flow, mindfulness, and subjective arousal. The investigators hypothesize that playful interactions will induce greater effects on emotional and social indices, as well as on executive functioning, compared to more familiar social interactions, and that these effects will be found in older populations."
892,"GPT4 Correct Assistant: The study aims to evaluate the efficacy of SkillFlix for Parents, an online video library, in improving sexual health communication skills of parents of youth with Autism Spectrum Disorder (ASD). A randomized controlled trial will assess the impact of the resource on parent skill demonstration and confidence, conversation frequency, and teen knowledge, attitudes, and behaviors. The study will include parent and youth dyads aged 13-17, with the intervention group receiving access to the SkillFlix for Parents web site and app, while the control group receives written materials with similar content. The study will measure primary and secondary outcomes at 3 months, and a follow-up assessment will be conducted 6 months after the start of the study."
893,"GPT4 Correct Assistant: The clinical trial, titled ""DDX17 Orchestrate Septic Vascular Endothelial Pyroptosis by Controlling Gasdermin D Pore Formation,"" aims to investigate the relationship between DDX17 and Gasdermin D (GSDMD) in sepsis and septic shock patients. The study will collect data on patient demographics, disease status, and treatment measures. Blood samples will be collected on Days 1, 3, and 7, and plasma will be analyzed using ELISA for DDX17 and GSDMD levels. The primary outcome measure is 28-day mortality, while the secondary outcome measures are the correlations between plasma levels of DDX17 and GSDMD with vascular endothelial injury, severity, and prognosis in sepsis patients."
894,"GPT4 Correct Assistant: This is a single-center, prospective study designed to evaluate non-invasive methods for diagnosing postoperative complications in liver transplant recipients. The study focuses on patients with rejection, liver failure, or liver dysfunction following liver transplantation. The primary outcome measure is early allograft dysfunction (EAD) diagnosed using Olthoff criteria. The study includes patients aged 18-75 years of both sexes and excludes re-transplant patients and those with liver transplant in fulminant hepatitis. The study measures EAD for 2 weeks following liver transplantation."
895,"GPT4 Correct Assistant: This is a multi-center, phase II, randomized, controlled clinical trial to test the safety and efficacy of Elemene plus Stupp Protocol compared with Stupp Protocol alone for newly-diagnosed Glioblastoma patients. The primary outcome measure is the overall survival (OS) rate in the 12th month (12m-OS). Secondary outcome measures include overall survival (OS), progression-free survival (PFS), progression-free survival (PFS) rate in the 6th month (6m-OS), and adverse events."
896,"GPT4 Correct Assistant: This clinical trial aims to study the effects of prone positioning on lung recruitability in infants and children with Acute Respiratory Distress Syndrome (ARDS). The study includes two groups: controls and patients. The controls will undergo a supine positioning protocol, while the patients will undergo a similar protocol followed by one hour of prone positioning. The primary outcome measure is the PaO2/FiO2 ratio at the end of the supine and prone positioning. Secondary outcome measures include differences in gas exchanges, ventilatory ratios, global and regional impedance-derived End-expiratory lung volumes, tidal volume distribution, and global and regional impedance-derived lung dynamic strain. The study also measures safety endpoints such as the number of displacements of the endotracheal tube during prone positioning and the number of oxygen desaturations during prone positioning."
897,"GPT4 Correct Assistant: This study aims to investigate and compare the effects of Progressive Relaxation Training (PRT) on pain characteristics, attack frequency, activity self-efficacy perception, and social participation in women with tension-type headache and migraine. The study will include 44 women aged 20-45 and will use various assessment tools to measure the outcomes. The study aims to provide insights into the benefits of PRT for women with these headache types and inform clinicians on more comprehensive intervention approaches to address challenges encountered in daily life."
898,"GPT4 Correct Assistant: The clinical trial aims to investigate the potential use of microRNA biomarkers for Neonatal Opioid Withdrawal Syndrome (NOWS) and Neonatal Abstinence Syndrome (NAS). The study involves infants exposed to in utero opiates, aged 1-5 days, who meet specific inclusion and exclusion criteria. The intervention is genetic testing using buccal swab saliva for further genetic testing. The study measures primary outcome measures such as neurodevelopmental outcome scores, maximum concentration of morphine required for withdrawal symptom control, and salivary microRNA levels (let-7a, microRNA-146a, and microRNA-192)."
899,"GPT4 Correct Assistant: This clinical trial aims to investigate the effect of patient education on pain level and fear of pain in orthopedics and traumatology patients. The study is a randomized controlled experimental research design with 52 patients who underwent elective surgery. The intervention group received patient education on preoperative preparation, operating room environment, breathing exercises, cough exercises, non-pharmacological and pharmacological pain management methods, while the control group received training on preoperative preparation and operating theatre environment. The primary outcome measures are pain level and fear of pain, assessed using the Visual/Visual Analogue Scale and the Fear of Pain Scale-III, respectively."
900,"GPT4 Correct Assistant: The Patch BRIDGE Trial is a randomized controlled trial assessing the use of a buprenorphine transdermal matrix patch for the induction of buprenorphine during pregnancy. The study aims to compare the efficacy of the buprenorphine patch with a sham patch in reducing withdrawal severity and improving treatment adherence and recovery success in pregnant women with opioid use disorder. The primary outcome measure is the subjective opioid withdrawal scale (SOWS) scores collected during buprenorphine induction, while secondary outcome measures include induction success, treatment adherence, and recovery success."
901,"GPT4 Correct Assistant: This clinical trial, titled ""Vascular Compression Assessment Using Transcutaneous Oxymetry in Patients Suspected of Having Thoracic Outlet Syndrome,"" aims to evaluate the effectiveness of transcutaneous oximetry as a diagnostic test for Thoracic Outlet Syndrome (TOS). The study includes patients who have undergone additional examinations, such as venous and arterial Doppler or dynamic arteriography and venography, and have a dynamic TcpO2 recording. The primary outcome measure is the DROPmin, which estimates the variation in upper limb ischemia based on TcpO2 measurement. Secondary outcome measures include the correlation between the severity of upper limb ischemia and the degree of arterial stenosis observed in diagnostic arteriography."
902,"GPT4 Correct Assistant: The study aims to determine the feasibility of the SmartCP mobile health app in managing patients with chronic pancreatitis. The app includes a symptom tracker, diet/physical activity log, alert system for escalating symptoms, quality of life assessment, red-flag alerts for diabetes/pancreatic cancer, educational content, push notifications, and messaging function. The study is a single-arm, unblinded, feasibility study with an embedded quantitative and qualitative process evaluation. Participants will receive the intervention for 16 weeks, supplementing usual clinical practice. The primary outcomes measured are recruitment, acceptability, retention, incidents, user statistics, occurrence of crisis events, and symptom occurrence. The study will also assess quality of life, hospitalization, use of communications and educational features."
903,"GPT4 Correct Assistant: This retrospective cross-sectional study conducted at Mansoura university isolation hospital over three months from September to November 2020, aimed to investigate the incidence of anal fissure among COVID-19 survivors. The study included patients aged between 20-70 years, who were diagnosed with COVID-19 and presented with anal fissure during follow-up. The primary outcome was the incidence of anal fissure among COVID-19 survivors, while the secondary outcome was the risk factors associated with the development of anal fissure."
904,"GPT4 Correct Assistant: This study is a randomized prospective controlled trial that investigates the effects of platelet-rich fibrin (PRF) on wound healing following palatal connective tissue harvesting. Patients with Miller class 1 or 2 gingival recession who require root coverage surgery are included in the study. The subepithelial connective tissue graft is obtained using a single incision technique, and patients are divided into two groups: a test group with PRF application and a control group without it. Ultrasonography is used to measure palatal tissue thickness and pulsatility index at various time points. The primary outcome measure is tissue thickness, and the secondary outcome measure is the pulsatility index. The study aims to determine the impact of PRF application on wound healing and tissue vascularization."
905,"GPT4 Correct Assistant: The ARRC III Trial is a pilot registry study conducted at the Royal Adelaide Hospital (RAH) to evaluate the Advanced Recovery Room Care (ARRC) model. The study aims to collect high-quality data on ARRC's impact on patient outcomes, hospital utilization, and costs of care. The ARRC model has shown to improve Days at Home after Surgery, decrease in-hospital complications, and mortality at 1, 3, and 12 months compared to usual ward care. The study includes patients aged 18 and above, scheduled for elective or unplanned surgery at RAH, with a 30-day mortality risk score between 0.5% and 8% by the US National Safety and Quality Improvement Program (NSQIP) risk score. The primary outcome measure is Days at Home after surgery, while secondary outcome measures include in-hospital complications, mortality, and cost-effectiveness."
906,"GPT4 Correct Assistant: This clinical trial aims to evaluate the effectiveness and implementation of oral (event-driven and daily) and long-acting pre-exposure prophylaxis (PrEP) in mobile men in sub-Saharan Africa. The study is conducted in South Africa and Uganda, targeting men who mainly have sex with women and may be at high risk of HIV acquisition. The trial compares the persistence in care, coital coverage, and participant choice of oral TDF-FTC (both daily and event-driven) and long-acting injectable cabotegravir (CAB-LA) among these men. The primary objective is to compare short-term (9 months) and long-term (18 months) PrEP persistence patterns across different PrEP modalities (oral and injectable) among mobile men in South Africa and Uganda. The study aims to provide evidence and cost-effectiveness analysis to inform African governments and donors on how to prioritize prevention resources and inform guidelines."
907,"GPT4 Correct Assistant: The study titled ""Preliminary Assessment of the Psycho-emotional State of Patients With TMD"" aims to assess the psycho-emotional state of patients with Temporomandibular Disorders (TMD) and compare it with a control group without TMD. The study involves 130 patients diagnosed with TMD (group I) and 130 control patients without TMD (group II). Both groups undergo clinical diagnostic tests and complete a questionnaire assessing their emotional state over the past 4 weeks. The primary outcome measure is the questionnaire, which covers aspects such as mood, irritability, sadness, concentration, self-isolation, and nervousness. The results will be analyzed over a 2-year period (2021-2023)."
908,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of affective touch, therapeutic touch (osteopathic manipulative treatment), and static/nonspecific touch on brain connectivity and metabolic biomarkers in preterm infants. The study includes preterm infants between 32.0 and 33.6 weeks gestational age, excluding those with comorbidities or additional complications. The study uses a randomized, parallel assignment design with double masking, and measures brain changes, electroencephalogram (EEG) changes, and urinary metabolites using Proton Nuclear Magnetic Resonance Spectroscopy (1H NMR) and Mass Spectrometry combined with Liquid Chromatography (CL-MS) and Gas Chromatography (CG-MS)."
909,"GPT4 Correct Assistant: This study is a Phase I/II trial investigating the safety and effectiveness of a non-myeloablative haploidentical hematopoietic cell transplantation as a potential curative option for patients with sickle cell disease. The primary objective is to evaluate the regimen success rate, defined as successful engraftment and absence of acute grade 3 or higher graft-versus-host disease or moderate to severe chronic GVHD at 1 year post-transplant. Secondary objectives include event-free survival, overall survival, and the incidence of viral reactivation and disease, autoimmune and hyperinflammatory complications. This study is open to participants aged 18 years and older with sickle cell disease at high risk for disease-related morbidity or mortality."
910,"GPT4 Correct Assistant: This clinical trial aims to investigate the effectiveness of two sperm preparation methods, microfluidic chip and density gradient centrifugation, on the euploidy rate of pre-implantation genetic testing in couples undergoing in vitro fertilization (IVF). The study will randomly assign eligible couples to one of the two groups and compare the primary outcome measure, the euploid rate of blastocysts, and secondary outcome measures, including live birth rate, positive pregnancy test rate, clinical pregnancy rate, ongoing pregnancy rate, miscarriage rate, multiple pregnancy rate, and DNA fragmentation."
911,"GPT4 Correct Assistant: This clinical trial aims to investigate the relationship between Brain-derived Neurotrophic Factor (BDNF) single nucleotide gene polymorphism and Nerve Growth Factor as risk factors that increase the severity of allergic rhinitis. The study involves participants aged 20-70 years, both sexes, with chronic allergic rhinitis. The intervention is a diagnostic test, genotyping, which involves withdrawing 5 ml of blood for DNA extraction and quantitative Real-time polymerase chain reaction. The primary outcome measures include BDNF gene single nucleotide polymorphism with allergic rhinitis risk, nerve growth factor serum level, IL-1 serum level, and C-reactive protein serum level, all measured in blood over a 2-month period."
912,"GPT4 Correct Assistant: This clinical trial aims to investigate the effect of mindfulness on EEG brain activity for cognitive and psychological well-being in elderly individuals. The study will enroll 60 participants aged between 60 and 75 years with normal cognition. They will undergo cognitive and psychological evaluation, EEG, and current pharmacological therapies will be recorded. Participants will then undergo an 8-week mindfulness-based intervention consisting of 2-hour sessions delivered in a group setting. The primary outcome measures include change from baseline in dispositional mindfulness on the Five Facet Mindfulness (FFM) Scale, change from baseline in verbal memory on the California Verbal Learning Test (CVLT), and change from baseline in interoceptive mindfulness on the Multidimensional Assessment of Interoceptive Awareness (MAIA) scale at week 8. Secondary outcome measures include change from baseline EEG alpha power at week 8."
913,"GPT4 Correct Assistant: This clinical trial aims to study the prevalence of Mycoplasma Genitalium (MG) infection and associated antimicrobial resistance among HIV-infected males in Hong Kong. The study will recruit 750 HIV-infected males attending an HIV specialist clinic in Hong Kong. Participants will self-administer an online questionnaire and self-collect urine samples, rectal, and pharyngeal swabs for MG, Chlamydia trachomatis, and Neisseria Gonorrhoeae screening. The study will measure the prevalence of MG infection, MG resistance mutations, CT infection, NG infection, syphilis, HCV infection, and overall STI prevalence among the participants."
914,"GPT4 Correct Assistant: The DAWNA-FES trial aims to investigate the efficacy of combining Dalpiciclib with physician-selected endocrine therapy for patients with advanced breast cancer who have experienced treatment failure with CDK4/6 inhibitors. The study will employ 18F-FES PET/CT as a non-invasive alternative to biopsy techniques for evaluating estrogen receptor (ER) expression in systemic lesions of patients. The primary outcome measure is investigator-assessed progression-free survival (PFS), while secondary outcome measures include objective response rate (ORR), disease control rate (DCR), and overall survival (OS)."
915,"GPT4 Correct Assistant: The FISSION Study is a prospective, single-arm, multicenter trial evaluating the efficacy and safety of XELOX combined with Fruquintinib and Sintilimab regimen conversion therapy for patients with gastric cancer/gastroesophageal junction adenocarcinoma with liver and/or retroperitoneal lymph node metastasis. The primary outcome measure is progression-free survival (PFS), while the secondary outcome measures include overall survival (OS), objective response rate (ORR), disease control rate (DCR), duration of response (DOR), translational rate, and adverse events (AEs)."
916,"GPT4 Correct Assistant: This clinical trial aims to evaluate the impact of alternative incentives, such as meal donations and monetary incentives, on the physical activity of older adults. The study will recruit 200 older adults aged 55 and above and randomize them into two groups: a treatment group receiving additional incentives and a control group not receiving incentives. The primary outcome measure is the change in step count, while the secondary outcome measure is the change in CES-D (Center for Epidemiologic Studies Depression Scale) Score. The study will track the step count of the two groups for 8 weeks using Fitbit devices."
917,"GPT4 Correct Assistant: This study is an interrupted time series conducted at the Moi Teaching and Referral Hospital neonatal ward in Kenya between April 2022 and June 2023. It aims to evaluate the clinical impact and cost-effectiveness of the neoGuard vital signs monitor for hospitalized newborns. The study participants include newborn patients admitted during the study period, with 4 subunits receiving the intervention (neoGuard device) and 4 subunits receiving standard-of-care monitoring. The primary outcome measures are nurse's response time to patients in distress and the percentage of actionable alarms. Secondary outcome measures include the incidence of patient complications, in-hospital mortality, and frequency of key interventions."
918,"GPT4 Correct Assistant: This study aims to evaluate pre- or post-operative hypofractionated radiation therapy in aged (≥ 70 years old) or fragile (≥ 65 years old) patients with limb or trunk soft tissue sarcoma. The intervention includes hypofractionated radiation therapy prior to surgery for the neo-adjuvant cohort and after surgery for the adjuvant cohort. The primary outcome measure is the rate of patients free of major surgical complications within 6 months of surgery. Secondary outcome measures include disease-free survival, surgical complications, wound disorders, healing time, quality of life, patient autonomy, geriatric parameters, and toxicities of the radiation therapy."
919,"GPT4 Correct Assistant: This retrospective study aims to determine the prevalence of head and neck cancer at the ENT-Head and Neck Surgery department of Shree Birendra Hospital in Nepal. The study includes patients aged 17-84 years with histologically proven head and neck cancer. Data collection took place between May 2022 and April 2023, and it considered demographic details, subsite specific head and neck cancers, treatment modalities, and histopathology. The data was analyzed using SPSS version 22, and the primary outcome measures include age-wise distribution of head and neck cancers, distribution of head and neck cancers according to subsite, histopathology of head and neck cancers, TNM staging of head and neck cancer, and treatment modalities of head and neck cancer."
920,"GPT4 Correct Assistant: The study aims to investigate the impact of a health communication message on the detection of pediatric obstructive sleep apnea (OSA). Children aged 2-13 years who are primary care patients and have screened positive for OSA are eligible for the study. Participants are randomized into two groups: those who view the health communication message (intervention) and those who receive usual care (no additional information about OSA). The primary outcome measure is the rate of completed OSA referral, and secondary outcome measures include the rate of OSA referral, rate of evidence-based evaluation, rate of OSA diagnosis, rate of OSA treatment, and rate of parent activation."
921,GPT4 Correct Assistant: This clinical trial aims to assess the speed of onset and durability of effectiveness of upadacitinib in adult participants with moderate to severe Crohn's disease in real-world clinical practice. The study includes participants diagnosed with moderate-to-severe Crohn's disease who initiate upadacitinib at the clinician's discretion. The primary outcome measures are time to achieve first clinical response per Patient-Reported Outcome 2 (PRO2) and the percentage of participants achieving clinical remission per Harvey Bradshaw Index (HBI) among those with clinical response-HBI at the end of induction therapy. The study will follow participants for up to 3 years.
922,"GPT4 Correct Assistant: This clinical trial is titled ""Testing of Online Version of QAPS"" and focuses on child development, specifically assessing prewriting skills in children aged 3 to 7 years old. The study involves various activities such as drawing games on a tablet, copying shapes, writing letters, and cutting paper. The primary outcome measures include the Online QAPS, Beery VMI, functional hand tasks, demographics survey, emotionality assessment, strengths and difficulties questionnaire inattention/hyperactivity subscale, and ego resiliency scale."
923,"GPT4 Correct Assistant: The study aims to evaluate the effectiveness of the Critical Time Intervention-Peer Support (CTI-PS) model for individuals with serious mental illnesses, such as psychotic disorders, schizophrenia, and bipolar disorder, who have been discharged from inpatient psychiatric treatment facilities in Portugal. The intervention is a time-limited, 9-month long program that focuses on developing durable connections to support systems and providing practical and emotional support during a critical period of transition. The study uses a randomized controlled design with two arms: a control group receiving no intervention and an experimental group receiving CTI-PS. The primary outcome measures are health-related quality of life and unmet needs, assessed at 18 months. Secondary outcome measures include psychopathology, level of disability, orientation toward recovery, self-stigma, and substance use."
924,"GPT4 Correct Assistant: The Registry for Vascular Trauma and Follow-up Examinations is a study aiming to examine vascular injury in patients over 18 years of age. The study involves regular follow-up examinations after the injury, with assessments at 3, 6, and 12 months post-trauma. The primary outcome measure is the patency of vessels/grafts, assessed using ultrasound, ABI-measurement, and clinical evaluation. Secondary outcome measures include reintervention rate and the development of treatment patterns. The study aims to provide insights into long-term follow-up after vascular injury and the effectiveness of various treatment methods."
925,"GPT4 Correct Assistant: This is a prospective randomized control trial studying the effects of blood flow restriction (BFR) rehabilitation after ORIF of distal radius fractures. The study includes adult subjects with acute fracture of distal radius requiring ORIF surgery, excluding those with certain health conditions. The study is divided into two groups: a control group receiving standard of care rehab and a BFR group incorporating BFR into their rehab. The primary outcome measures are body composition/bone density, forearm girth, grip strength, and pinch grip strength. Secondary outcome measures include patient-reported surveys on pain/symptoms and functional ability post-op."
926,"GPT4 Correct Assistant: This is a 2-arm randomized controlled trial studying the effect of the Stand up for Your Health® computer app on sitting time, musculoskeletal symptoms, cardiometabolic markers, and physical activity in office workers. The intervention group receives the computer app along with educational information, while the control group only receives educational information. Measurements include sedentary behavior, anthropometric measurements, musculoskeletal symptoms, and cardiometabolic biomarkers. The study aims to determine the adherence to the intervention program by identifying barriers and facilitators."
927,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of blood flow restriction and creatine supplementation on women's leg strength, body composition, neuromuscular function, and endothelial function. Participants will be randomly assigned to one of four groups: control (no intervention), creatine and blood flow restriction exercise, creatine and no-BFR with training, or placebo and blood flow restriction exercise. The study will last for approximately 10 weeks with 27 visits, including questionnaires, blood draws, and exercise tests. The primary outcome measures are strength, body composition, neuromuscular function, and endothelial function, while the secondary outcome measure is mood states."
928,"GPT4 Correct Assistant: This clinical trial aims to study the novel targetable biomarkers in Anorexia Nervosa (AN) patients, specifically focusing on Growth Differentiation Factor-15 (GDF-15) and cytokines. The study includes 8 adult patients with restrictive type AN, both exercising and non-exercising subtypes, and 16 control participants matched for age and sex. The primary outcome measures are GDF-15 levels in the plasma and cerebrospinal fluids of AN patients and normal-weight controls. The study aims to evaluate GDF-15 and cytokines as potential novel targets for AN treatment and to pave the way for a follow-up study using neutralizing antibodies or inhibitors against GDF-15 and respective cytokines for treating AN patients."
929,"GPT4 Correct Assistant: The PROSPECT study is a prospective, observational study collecting data on patients undergoing pleural procedures. The study aims to collect demographic, smoking history, pre-procedure observations, radiological findings, and medical history data. Complications and patient-reported outcomes, such as chest pain and breathlessness, will be recorded. The study will include participants aged 18 and above undergoing pleural interventions and aims to provide a best practice standard for pleural procedures."
930,"GPT4 Correct Assistant: The Artificial Intelligence for Preventing Heart Disease (AiPHD) trial is an observational, single-center, prospective and retrospective study focused on coronary artery disease (CAD). The study aims to develop an AI-based model for CAD risk stratification and create a novel imaging marker of CAD with an unfavorable outcome. The trial consists of a retrospective cohort of 2,500 patients and a prospective cohort of 500 patients. The primary outcome measure is a composite of death by cardiovascular events or non-fatal myocardial infarction within 36 months from CCTA examination."
931,"GPT4 Correct Assistant: The SIM0355-201 trial is a multicenter, randomized, double-blind, placebo-controlled exploratory clinical trial evaluating the safety and tolerability of different doses of Edaravone Dexborneol concentrate for injection combined with conventional medical therapy in patients with cerebral hemorrhage. The study includes two periods, Period A and Period B, with two dose levels in each period. The primary outcome measure is the incidence of serious adverse events up to 90 days after the first dose of treatment. Secondary outcome measures include the incidence of deaths, proportion of subjects with adverse events, modified Rankin Score at 90 days, and other clinical and imaging endpoints."
932,"GPT4 Correct Assistant: This study aims to evaluate the effectiveness and safety of Manzhi Guben granules in improving exercise tolerance and promoting body rehabilitation in patients with COVID-19. It is a multicenter, randomized, double-blind, placebo-controlled clinical study. The primary outcome measure is the results of the 6-minute walking test on day 14, and secondary outcome measures include the results of the 6-minute walking test on day 28 and pulmonary ventilation function on day 14 and 28."
933,"GPT4 Correct Assistant: This is a single-center non-interventional fMRI study aiming to investigate the relationship between executive and decision-making skills in 150 healthy individuals, and their possible changes with ageing. The study will assess participants' decision-making skills, executive functioning, brain activity, brain structure, and connectivity using a combination of behavioral assessments and fMRI sessions. The results will provide a baseline for understanding alterations in decision-making and executive functioning in pathological conditions."
934,"GPT4 Correct Assistant: The Neutrocheck Summative Usability Study aims to investigate the usability of Neutrocheck among healthy volunteers and healthcare professionals. The study includes participants aged 18 years or older, with both males and females eligible to participate. The study involves two arms: one group using paper instructions and the other using app instructions. The primary outcome measures include the identification of use errors, close calls, and use difficulties associated with selected hazard-related use scenarios, as well as participants' perceived root causes. The secondary outcome measures include the administration of a questionnaire to assess user satisfaction with the use of Neutrocheck and a comparison of task completion rates and user satisfaction between the two study groups. The study will run for two months."
935,"GPT4 Correct Assistant: This clinical trial, titled ""Promoting BEST (BEtter, Faster, Longer, STronger) Walking for People With Parkinson's,"" aims to identify obstacles and solutions for people with Parkinson's to adopt technology to improve their gait and quantify changes in gait biomechanics. The main intervention is the use of the Heel2Toe sensor, a wearable device that provides real-time auditory feedback when a person takes a good step. The study will measure changes in ankle angular velocity, coefficient of variation of angular velocity, motivation, walking behavior, health-related quality of life, cognitive performance, and self-reported cognitive ability over a period of 1 year. Participants will be randomly assigned to either immediate or delayed assignment of the sensor."
936,"GPT4 Correct Assistant: This study aims to investigate the effects of a laughter yoga program on the mood, anxiety, and loneliness of adolescents with intellectual and physical disabilities in a special school. The study is a pilot randomized controlled trial, with participants randomly assigned to either an intervention group that receives a 4-week laughter yoga program or a control group that receives routine care. The primary outcome measures include mood, anxiety, and loneliness, which will be assessed using questionnaires before and immediately after the intervention."
937,"GPT4 Correct Assistant: The study titled ""Effects of Decision Aids on the Participation of South Asian Women in Cervical Cancer Screening: A Randomised Controlled Trial"" aims to investigate the effects of decision aids on the participation of South Asian women in cervical cancer screening. The study includes women aged 25 to 64 from India, Pakistan, and Nepal, who have a history of sexual activity and have not had a Pap/HPV test in the past 3 years. Participants are randomly assigned to one of three groups: a placebo comparator group receiving a leaflet about healthy living, an experimental group receiving a printed decision aid, and an experimental group receiving a mobile decision aid. The primary outcome measure is decisional conflict, assessed using the 16-item Decisional Conflict Scale. Secondary outcome measures include cervical cancer screening uptake, risk perception, choice predisposition, and choice question."
938,"GPT4 Correct Assistant: This clinical trial aims to investigate the additional effect of forward head posture (FHP) correction on temporomandibular dysfunction (TMD). The study will be a randomized controlled trial, with participants experiencing TMD symptoms and having a forward head posture with a craniocervical angle (CVA) of less than 50. Participants will be allocated to either conservative treatment, conservative treatment with Denneroll cervical traction orthodontic, or an active comparator. The primary outcome measures are the anamnestic questionnaire by Fonseca and the craniocervical angle - CVA. Secondary outcome measures include the Boley Gauge, Visual Analog Scale (VAS), and mandibular opening."
939,"GPT4 Correct Assistant: This clinical trial compares the efficacy of Clindamycin Phosphate 1% Gel and Dapsone 5% Gel in treating moderate acne vulgaris. The study involves participants aged 20-50 years with moderate acne vulgaris, and they will be treated with either Clindamycin and Dapsone gel for three months. The primary outcome measure is the Global Acne Grading Score (GAGS), which will be assessed at the end of the treatment period."
940,"GPT4 Correct Assistant: This clinical trial aims to investigate the relationship between rotator cuff tear severity and scapular and rotator cuff muscle activation patterns. Participants with rotator cuff tears of various sizes (small, medium, large, or massive) will undergo surface electromyography (sEMG) assessment to measure muscle activation amplitude for scapular and rotator cuff muscles during functional tasks. The study will explore differences in muscle activation patterns between varying tear sizes and provide insight into the potential impact of tear severity on muscle activation."
941,"GPT4 Correct Assistant: The SENIOR RCT is a multicenter study in Italy aimed at evaluating the efficacy of a 6-month sustainable nutrition protocol on malnourished older adults (≥ 65 years old) compared to the hospital standard of care. The primary objective is to assess the improvement in nutritional status between pre- and post-intervention in experimental and control groups, measured by changes in body weight and strength. Secondary objectives include evaluating changes in blood biomarkers, dietary habits, quality of life, and sarcopenia. The study includes older adults diagnosed with malnutrition using the GLIM criteria and enrolled in the SENIOR cross-sectional study or new patients from the two hospitals. The intervention group receives a nutritional assessment followed by a personalized nutrition protocol, while the control group receives standard care. The study's primary and secondary outcome measures are assessed at various time points throughout the 24-month duration."
942,"GPT4 Correct Assistant: This is a double-blind, multicenter, prospective observational cohort study investigating the dynamic changes of Torquetenovirus (TTV) load in Chinese renal transplant recipients during immunosuppressive therapy. The study focuses on participants aged 18 to 65 years who have received ABO compatible renal allotransplantation and are receiving specific immunosuppressive medications. The primary outcome measures include renal allograft biopsy and serum creatinine, while secondary outcome measures include infection events, donor-specific antibodies, and donor derived cell-free DNA. The study aims to understand the impact of TTV on renal transplant recipients and the potential role of TTV in transplant rejection and infection."
943,"GPT4 Correct Assistant: This clinical trial investigates the effects of Vitamin B12 vs B3 therapy on nerve regeneration and functional recovery after pediatric traumatic brain injury (TBI). The study involves 300 children aged 6-15 years with severe TBI, with one group receiving Vitamin B3 (16 mg/day) and the other group receiving Vitamin B12 (125-250 mcg/day). The primary outcome measure is the change in Stair Climb Test (SCT) score at 18 months post-treatment."
944,GPT4 Correct Assistant: This clinical trial aims to evaluate the efficacy and safety of Pyrotinib after adjuvant anti-HER2 therapy in women with high-risk early or locally advanced stage breast cancer. The study includes female patients aged 18 to 75 years with HER2-positive breast cancer. The primary outcome measure is invasive disease-free survival (iDFS) at year 2. Pyrotinib is administered orally daily for one year.
945,"GPT4 Correct Assistant: The study aims to assess the impact of consuming pasta at lunch or dinner on sleep quality, anthropometric parameters, cardiovascular risk factors, gut microbiota composition, and functionality in a sample of normal-weight subjects. Participants are randomly assigned to either consume pasta at lunch or dinner for 3 months, followed by a crossover intervention. The primary outcome measure is sleep quality, assessed using actigraphy. Secondary outcomes include weight change, body mass index, fat mass change, basal metabolic rate, blood glucose levels, glycated hemoglobin, total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides, homocysteine, aspartate transaminase, alanine transaminase, gamma-glutamyl transferase, urea, creatinine, uric acid, gut microbiota profile, individual circadian rhythms, TBARS, ROS, leptin, ghrelin, insulin, IL-6, and C-Peptide YY."
946,"GPT4 Correct Assistant: This is a phase 2, open-label, single-center study evaluating 18F-fluciclovine PET/CT imaging in up to 55 participants with multiple myeloma. The primary objective is to determine the concordance between 18F-fluciclovine PET/CT and 18F-FDG PET/CT in participants with multiple myeloma. Participants will be enrolled into one of two cohorts based on disease status: newly diagnosed multiple myeloma (NDMM) or relapsed and/or refractory multiple myeloma (RRMM). All subjects will undergo an 18F-fluciclovine injection followed by a static whole-body PET/CT at three time points: Timepoint #1, Timepoint #2 (after induction for NDMM or at 6 months for RRMM), and Timepoint #3 (at progression or at 5 years). Results will be compared to 18F-FDG PET/CT imaging at those same timepoints."
947,"GPT4 Correct Assistant: This clinical trial aims to evaluate arm swing during walking in patients with early multiple sclerosis. The study includes two participant groups: early multiple sclerosis patients and healthy controls. The primary outcome measures are arm swing amplitude in shoulder and elbow degrees in flexion-extension direction, step-speed, Two Minute Walk Test (2MWT), Timed Up and Go (TUG), and Timed 25Foot Walk Test (T25FW). The study will assess functional mobility and gait disorders in patients with early multiple sclerosis."
948,"GPT4 Correct Assistant: This clinical trial is titled ""Adjuvant Pyrotinib and Capecitabine For HER2 Positive Micro Invasive Breast Cancer."" It is a study for women aged 18-70 with Stage I Breast Cancer. The intervention/treatment involves the use of Capecitabine and Pyrotinib. The study has two arms: one experimental arm receiving Pyrotinib and Capecitabine for half a year, and another control arm with no adjuvant chemotherapy or targeted therapy. The primary outcome measure is invasive disease-free survival (iDFS) for 5 years, with secondary outcome measures including distant disease-free survival (DDFS) and overall survival (OS) also for 5 years."
949,GPT4 Correct Assistant: This is a pilot randomized controlled trial (RCT) comparing the effectiveness of video biofeedback and behavioral therapy in the treatment of Paradoxical Vocal Fold Motion (PVFM). The primary endpoint is the change in Dyspnea Index score before treatment and one month after treatment. The study aims to provide critical data for designing a fully powered trial comparing these two interventions and to advance the investigators' goal of providing clinicians with important evidence for guiding treatment.
950,"GPT4 Correct Assistant: The study aims to evaluate the implementation of a multifaceted and multidisciplinary protocol to improve sleep quality in critically ill patients. The protocol includes adjusting sound intensity, reducing noise, thermal comfort adjustments, dimming of lights, and optimization of analgesics and medications. The primary outcome measure is the change in the Richards-Campbell Sleep Quality Score before and one month after the implementation of the sleep protocol. Secondary outcome measures include changes in the Sleep in ICU Questionnaire, Confusion Assessment Method for the ICU, Questionnaire on the patient's perception of sleep from the family member's point of view, and the Questionnaire for the evaluation of the multidisciplinary team regarding prior knowledge of sleep protocol."
951,"GPT4 Correct Assistant: The study is a pilot trial that aims to test the PACHA program, a community pharmacy-based program designed to enhance adherence to adjuvant endocrine therapy among breast cancer survivors. The trial uses mixed methods, including quantitative and qualitative approaches. It involves 66 pharmacies in Quebec, Canada, with 132 women participating. The study measures the impact of the PACHA program on various outcomes, such as intention to adhere to adjuvant endocrine therapy, knowledge, attitude, social support, perceived behavioral control, anticipated regret, coping planning, fear of recurrence, side effects, and cognitive representations of medication. The study also assesses the program's acceptability and feasibility."
952,"GPT4 Correct Assistant: The study aims to investigate the effects of Melissa extract in phytosome form on sleep quality and duration. Participants will be randomly assigned to either a Melissa phytosome or placebo group, with each group receiving both interventions in a crossover design. The primary outcome measure is total sleep duration, while secondary measures include perceived sleep quality, perceived anxiety levels, quality of life, and adverse symptoms using the DOTES scale. The study will utilize the Garmin VenuSQ wrist device to monitor sleep duration and phases."
953,"GPT4 Correct Assistant: This clinical trial aims to investigate the efficacy of lenvatinib and tislelizumab plus CapeOX chemotherapy as a first-line treatment for advanced gastric cancer or gastroesophageal junction adenocarcinoma with PD-L1 positive and low tumor microenvironment score (TMEscore). The study is a multi-center, prospective, phase II study that will measure primary outcomes such as progression-free survival (PFS) and overall survival (OS). Secondary outcomes include objective response rate (ORR), disease control rate (DCR), and duration of response (DoR)."
954,"GPT4 Correct Assistant: This is a single-arm R61 phase trial studying the Social Engage Coaching (S-ENG) intervention in 30 adults aged 60 and older with clinically significant loneliness and suicide ideation residing in senior living communities. The study uses smartphone-based assessments to evaluate the impact of S-ENG on social connection and related outcomes over 16 weeks. Participants will undergo 10 individual coaching sessions focused on increasing social connection, and the study will measure loneliness, satisfaction with social activities, time in conversations, and time outside the home."
955,"GPT4 Correct Assistant: This clinical trial aims to assess the efficacy, safety, and tolerability of higher doses of estrogen therapy in women with primary ovarian insufficiency. Participants will receive either transdermal estradiol gel 0.1% 1.5mg/day or 2.0mg/day in addition to micronized progesterone 200mg for 14 days per cycle. The primary outcome measures will evaluate the severity of estrogen deficiency symptoms, quality of life, and menopause-related quality of life using the Green scale questionnaire, Short Form Health Survey-36 (SF-36), and Menopause-Specific Quality of Life (MENQOL) questionnaire, respectively. Secondary outcome measures will assess changes in sex hormone levels and bone mineral density."
956,"GPT4 Correct Assistant: The Symbiont-Restore Study aims to investigate the immunological effects of synbiotic supplementation with Limosilactobacillus reuteri PB-W1™ and a prebiotic blend in adults with a BMI of 30-40 kg/m², compared to the effects of the probiotic and prebiotic alone. The study includes four arms: two active control groups (probiotic and prebiotic), one experimental group (synbiotic), and one placebo group. The primary outcome measure is the change in immune profile at 8 weeks. Secondary outcome measures include changes in gut microbiome composition, metabolic profile, satiety rating, and gastrointestinal tolerance to dietary fibre."
957,"GPT4 Correct Assistant: This clinical trial aims to evaluate the safety, tolerability, and pharmacokinetics of AD16 tablets in adult healthy subjects after a single administration. The study includes participants aged 18-45 years, both male and female, and involves seven dosing cohorts receiving single oral doses of AD16 or placebo. The primary outcome measures include adverse events, serious adverse events, abnormal laboratory test results, abnormal vital signs, abnormal electrocardiogram readings, abnormal physical examination findings, concomitant medication, and pharmacokinetic parameters such as Tmax, Cmax, t1/2z, AUC 0-∞, AUC 0-t, CL/F, Vd/F, λz, and MRT. Secondary outcome measures include drug excretion in urine and feces, and renal clearance."
958,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of urolithin A supplementation on endothelial function, cerebral blood flow regulation, and serum biomarkers of NO bioavailability and mitochondrial function in middle-aged adults with obesity. The study is a double-blind placebo-controlled parallel study involving 54 participants aged 40-64 years with a BMI equal to or greater than 30 kg/m2. Participants will consume either 1,000 mg of urolithin A daily or a placebo for four weeks. The study measures changes in arterial function and local stiffness, blood flow on the surface of the hand, homeostatic cerebral blood flow, plasma biomarkers of NO homeostasis, and plasma biomarkers of mitochondrial function."
959,"GPT4 Correct Assistant: This study aims to investigate the effects of vibration therapy applied with a percussion massage gun on pain, functionality, and proprioception in individuals with cervical disc herniation. The study participants will be randomly assigned to either a control group receiving conventional treatment or a vibration group receiving both conventional treatment and vibration therapy. The primary outcome measure is the evaluation of joint position sense using the Laser Cursor Assisted Angle Repetition Test (LI-YATT). Secondary outcome measures include the Neck Disability Index (NDI) scale, Visual Analogue Scale (VAS) for pain intensity, and the Tampa Kinesiophobia Scale (TKÖ) for kinesiophobia. The study will last for 10 minutes per patient."
960,"GPT4 Correct Assistant: The study aims to create a register of patients with heart failure with preserved ejection fraction (HFpEF) for comprehensive assessment of the influence of gender characteristics, clinical and anamnestic factors, body composition, topical characteristics of congestion, instrumental data and markers of cellular inflammation and stress on immediate and long-term outcomes in patients with acute decompensated heart failure with preserved ejection fraction. The study will involve 120 patients hospitalized with a clinical picture of acute decompensation of heart failure and 40 control participants. The primary outcome measure is the amount of secondary hospitalizations within 6 months. Secondary outcome measures include the amount of hospitalizations with acute coronary syndrome, stroke, pulmonary embolism, and other cardiovascular events within 6 months."
961,"GPT4 Correct Assistant: This study aims to adapt and pilot Brothers Building Brothers by Breaking Barriers (B6), a group-level intervention designed to affirm intersectional identities and augment social capital among young Black gay, bisexual and other men who have sex with men (YB-GBMSM) living with HIV, for telehealth delivery. The study will involve two arms: the experimental group receiving Tele-B6 and a waitlist control group. The intervention consists of six group sessions delivered over six weeks. Primary outcome measures include acceptability, change in the acceptability surveys, change in recruitment rates, change in retention, change in intervention fidelity, and safety (adverse events). Secondary outcome measures include change in perception of structural racism and discrimination, change in perception of discrimination, change in perception of HIV stigma, change in perception of internalized homonegativity inventory, qualitative description of intersectional stigma, change in logistical barriers, qualitative description of logistical barriers, changes in perception of individual resilience process: Identity Affirmation, qualitative description of individual resilience process: Identity Affirmation, changes in the community resilience process: social capital, qualitative description of the community resilience process: social capital, changes in the perception of minority stress: depression, changes in the perception of minority stress: general well-being, and qualitative description of the minority stress."
962,"GPT4 Correct Assistant: This clinical trial investigates the effects of caregiver training on Dynamic Temporal and Tactile Cueing (DTTC) treatment outcomes in children with Childhood Apraxia of Speech (CAS). 40 children aged 2;5 to 7;11 years will receive DTTC treatment 2x/week over an 8-week period with home practice. Participants will be randomized into either Direct Training Group (DTTC + Home Practice + Direct Caregiver Training) or Indirect Training Group (DTTC + Home Practice + Indirect Caregiver Training). The study aims to quantify the effects of direct vs. indirect caregiver training on whole word accuracy, phoneme accuracy, speech intelligibility, and functional communication at post-treatment and maintenance."
963,"GPT4 Correct Assistant: The study aims to test and validate the creation of self-help and support groups for laryngectomized patients. The study will include patients who have had a total laryngectomy and are able to travel to Bichat Hospital for four sessions. The primary outcome measure is the difference in quality of life scores before and after the program, between the program and non-program control groups. Secondary outcome measures include comparisons of overall quality of life and ENT-specific quality of life scores before and after the program. The study will evaluate the participation rate during each session."
964,"GPT4 Correct Assistant: The MS-DETECT study aims to investigate the early detection of Multiple Sclerosis (MS) progression using the MSCopilot® Detect mobile application. The study involves adult patients with Relapsing-Remitting Multiple Sclerosis (RRMS) or Secondary Progressive Multiple Sclerosis (SPMS), aged 30-65, with a disease duration of more than 5 years. The primary outcome measure is the sensitivity of the MSCopilot® Detect application in detecting disability worsening based on the revised-Multiple Sclerosis Functional Composite (revised-MSFC) scores. Secondary outcome measures include assessing the application's ability to detect disability worsening based on Expanded Disability Status Scale (EDSS) scores, detecting disease progression in the absence of relapsing activity, and evaluating the association between digital and clinical scores. The study also aims to assess the application's reproducibility and reliability, evaluate patient quality of life, and examine the application's safety and adherence."
965,"GPT4 Correct Assistant: The PCOS Challenge Study aims to collect information to advance research and improve care for patients with Polycystic Ovary Syndrome (PCOS). The study includes individuals diagnosed with PCOS by a healthcare provider, self-diagnosed with PCOS, or exhibiting PCOS symptoms. The target population is females aged 12-80 years, and the control population includes biologically female individuals without PCOS or PCOS symptoms. The study's primary outcome measure is the collection of information, such as responses to survey questions, over a one-year period."
966,"GPT4 Correct Assistant: The study is a cluster-randomized trial aimed at evaluating the safety and efficacy of two low molecular weight heparins, dalteparin and tinzaparin, in patients with indications for low molecular weight heparin treatment. The primary outcome measure is 30-day all-cause mortality and bleeding requiring blood transfusion. Secondary outcome measures include 30-day and 365-day all-cause mortality, blood transfusion during admission, 90-day risk of pulmonary embolism and deep venous thrombosis, heparin-induced thrombocytopenia, liver failure, length of hospital admission, and days alive out of hospital. The study is an open-label, parallel assignment, randomized trial with a 1-hour timeframe for cluster allocation."
967,"GPT4 Correct Assistant: This clinical trial, titled ""Comparison Between Two Respiratory Muscle Training Protocols: Inspiratory Muscle Training vs Expiratory Muscle Training in Acquired Brain Injury Patients,"" aims to assess the efficacy of two respiratory muscle training protocols in patients with acquired brain injury. The trial compares Inspiratory Muscle Training (IMT) and Expiratory Muscle Training (EMT) groups, with both interventions conducted for 8 weeks using pressure threshold devices. The primary outcome measures are inspiratory and expiratory muscle strength, while secondary outcome measures include pulmonary volume (forced expiratory volume in 1 second, or FEV1) and pulmonary flow (peak expiratory flow, or PEF)."
968,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of technological balance and gait rehabilitation on functional, motor, and cognitive outcomes in patients with multiple sclerosis. Patients are randomly assigned to either the experimental group (HO) or the observational group (OH). The experimental group undergoes specific rehabilitation for balance disorders using the robotic platform Hunova® Movendo Technology srl for 4 weeks, followed by 4 weeks of observation. The observational group first undergoes 4 weeks of observation and then 4 weeks of rehabilitation using the same robotic platform. The primary outcome measure is the change from baseline in the Berg Balance Scale at 4 and 8 weeks. Secondary outcome measures include the Modified Fatigue Impact Scale, Fatigue Scale for Motor and Cognitive Function, Timed Up and Go test, Ambulation Index, Walking Handicap Scale, Functional Ambulation Classification, 10 Meter Walk Test, Six-minute walk test, Multiple Sclerosis Walking Scale, Modified Barthel Index, Multiple Sclerosis Impact Scale, Beck Depression Inventory-II, State-Trait Anxiety Inventory, Stroop Colour Word Test, and Symbol Digit Modalities Test at 4 and 8 weeks."
969,"GPT4 Correct Assistant: The ASARD-TMA Study aims to evaluate an automated algorithm for the surveillance, alert, and rapid diagnosis of Thrombotic Microangiopathies (TMA) in patients admitted to hospitals. The study includes patients aged 18 to 100 years, with a predictive probability of TMA ≥ 90% according to the diagnostic algorithm. The primary outcome measure is the time of diagnosis and treatment of TMA. The study is designed to assess the effectiveness of the algorithm in smaller hospitals without a 24-hour hematological guard service and low awareness for TMA. The study duration is 24 months."
970,"GPT4 Correct Assistant: The Access-H20 study aims to develop a smart faucet for individuals with spinal cord injuries (SCI) to access water more independently for daily activities. The faucet incorporates electromechanical controls, software programs, a proximity sensor, and voice recognition function. The study recruited subjects with SCI and controls to test the functionality of the faucet, focusing on eye gaze, voice, and motion sensors for drinking, rinsing, and grooming. The primary outcome measures include water access for activities of daily living and a System Usability Scale. The study aims to assess the feasibility of the prototype Access-H2O faucet for individuals with SCI."
971,"GPT4 Correct Assistant: This is a cluster-randomized controlled trial aimed at studying the effect of an activity wristband-based intermittent teaching unit in Physical Education on students' physical activity and its psychological mediators. The study includes participants aged 12-16 years, enrolled in the seventh to tenth grade at the secondary education level. The experimental group performs an intermittent teaching unit twice a week for eight weeks, while the control group carries out two Physical Education lessons a week without using the wristband or receiving any specific behavior modification strategy. The study measures changes in perceived autonomy support, basic psychological needs, motivation toward Physical Education, self-determined motivation towards physical activity, intention to be physically active, and habitual physical activity."
972,"GPT4 Correct Assistant: This clinical trial, titled ""Continuous and Non-invasive Measurements by Task Force® CORE/CARDIO in Autonomic Function Testing (AFT),"" aims to assess the agreement of blood pressure, heart rate, and cardiac output measurements between the investigational and reference devices in adult patients with autonomic dysfunction and orthostatic intolerance. The study involves Autonomic Function Testing, including the Valsalva maneuver, deep breathing test, and head-up tilt table testing. The primary outcome measures include the agreement of blood pressure and heart rate between the devices at various time points during the testing."
973,"GPT4 Correct Assistant: This study aims to develop and implement an online mental health care plan for post-secondary students using AI-assisted interventions. The proposed regional mental healthcare hub will deliver AI-driven online psychoeducation and diagnosis-specific online cognitive behavioural therapy (e-CBT) programs for students in the Kingston, Frontenac, Lennox & Addington (KFL&A) region. The study will follow a stepped-care approach and will be assessed through surveys and focus groups. The primary outcomes measured include changes in anxiety severity, depression severity, stress severity, quality of life, resilience, social anxiety severity, and ADHD severity."
974,"GPT4 Correct Assistant: This clinical trial aims to assess the efficacy of Omnivirol-Salicylic Acid (AV2-SA) combination therapy for cutaneous warts, with a focus on persistent warts. Participants must be 12 years or older, have one or more cutaneous warts, and be able to read Dutch. The study is randomized, with participants receiving either AV2-SA or standard SA treatment. The primary outcomes measured are cure rate and recurrence rate of the index warts at 12 weeks and 6 months after enrollment, respectively. Secondary outcomes include safety, time to clearance, change in size of index wart, number of remaining verrucae, genotype-specific distribution of wart-associated HPV types, and prevalence of mucosal HPV types in cutaneous warts."
975,"GPT4 Correct Assistant: This clinical trial aims to assess the efficacy of letrozole in comparison to methotrexate in the treatment of ectopic pregnancy. The study includes 75 women diagnosed with ectopic pregnancy who are randomly allocated to three groups: methotrexate, letrozole BD, and letrozole TDS. The primary outcome measures are βhCG on day 14 and anti-mullerian hormone 3 months after treatment."
976,GPT4 Correct Assistant: This study aims to evaluate the effect of fenestrated closure compared to non-fenestrated closure on left ventricular size at systole and diastole in patients with atrial septal defect (ASD) and pulmonary hypertension. Patients with ASD secundum and pulmonary hypertension with complete preoperative and postoperative echocardiography data are included. The primary outcome measure is the improvement in left ventricular diameter during systole and diastole. The study compares the effect of fenestrated closure with non-fenestrated closure on left ventricular diameter.
977,"GPT4 Correct Assistant: This clinical trial aims to study the role of oxidative stress and mitochondrial TERT in the progression and therapeutic resistance of papillary thyroid cancer. The study will measure H202 generation, TERT mitochondrial localization, and the effects of exogenous oxidative stress and therapeutic agents on TERT nuclear to mitochondrial translocation in thyroid cancer cell lines. Secondary outcomes include genetic characterization of tumor tissues and expression profile of tumor tissues."
978,"GPT4 Correct Assistant: The COMET trial is a phase III prospective multi-centre open-label randomized controlled trial comparing whole-body hypothermia and targeted normothermia in neonates with mild encephalopathy. The primary outcome measure is the mean cognitive composite scale score from the Bayley IV examination at 22-26 months. Secondary outcomes include neonatal seizures, duration of intensive care, duration of hospital stay, and other clinical and developmental outcomes."
979,"GPT4 Correct Assistant: This is a first-in-human, Phase I/IIa trial of the novel T cell immunotherapy pTTL in patients with advanced colorectal cancer. The trial aims to evaluate the safety and tolerability of pTTL, as well as its efficacy in treating advanced colorectal cancer. Patients will receive a single dose of pTTL after pre-conditioning chemotherapy and will be followed for 26 weeks for safety. The trial will also assess objective response, time to treatment response, duration of treatment response, time to tumour progression, kinetics of tumour progression/growth, overall survival, progression-free survival, and disease-specific survival."
980,"GPT4 Correct Assistant: This clinical trial aims to investigate the diagnostic and prognostic role of Serum Amyloid A (SAA) in intrathoracic sarcoidosis patients. The study includes participants aged 18 and above, with intrathoracic sarcoidosis, and healthy controls. The primary outcome measures include the correlation of mean serum concentration of SAA in patients with intrathoracic sarcoidosis to mean value in healthy controls, correlation of serum concentrations of SAA at the time of diagnosis with serum concentrations of other biomarkers, and correlation of serum concentrations of SAA at the time of diagnosis to pulmonary function test results and radiologic extent of disease. The study will follow up with participants for 3 years to assess changes in lung function tests, HRCT disease extent, and the need for recent/ongoing therapy."
981,"GPT4 Correct Assistant: This clinical trial aims to investigate the benefit of early intrauterine transfer of blank culture medium prior to transfer of a thawed embryo from the first IVF attempt. The study is a randomized, single-blind, multicenter controlled trial. The primary outcome measure is the clinically progressive pregnancy rate between groups, measured on first-trimester ultrasound at 12 weeks of amenorrhea. Secondary outcome measures include occurrence of pregnancy, biochemical pregnancy, clinical pregnancy, early miscarriage, live birth, differential cost-result ratio, and total estimated expenditure for the two care strategies compared. The study includes female participants aged 39 years or younger who have had at least two embryos eligible for transfer or freezing during their first IVF attempt."
982,"GPT4 Correct Assistant: This study aims to construct a database of prognostic risk factors and quality of life of patients with primary solid malignant cancers receiving immunotherapy for the first time. The study is a multicenter, observable, and controlled cohort study, collecting baseline information and follow-up information after treatment. The primary outcome measure is progression-free survival (PFS) for two years. The study aims to provide evidence for the selection of immunotherapy schemes, prevention of adverse reactions, and improvement of survival prognosis for patients."
983,"GPT4 Correct Assistant: The study aims to examine the effect of acupressure on back pain in the late postpartum period after cesarean section. It is a randomized controlled experimental study with 70 participants divided into an acupressure group and a control group. The primary outcome measure is the Visual Analog Scale (VAS) for assessing back pain, which is filled in by participants before and after the application. The study seeks to determine if acupressure application reduces the level of back pain in puerperant women who have had a cesarean delivery in the late postpartum period."
984,"GPT4 Correct Assistant: The clinical trial titled ""Confidential Social Network Referrals for HIV Testing"" aims to study the effectiveness of two interventions, CONSORT referrals and Card referrals, in increasing the uptake of HIV testing among participants in Moshi, Tanzania. The study is designed as a parallel assignment, randomized trial with no masking. Participants must be at least 18 years old, literate, and live, work, or regularly receive care in Moshi, Tanzania. The primary outcome measure is the number of referred clients presenting for HIV testing within 30 days of the testing offer, per 100 index clients."
985,"GPT4 Correct Assistant: This is a randomized, placebo-controlled trial examining the effects of paroxetine on cardiovascular function in septic patients. The trial includes patients aged 18 and above, diagnosed with septic shock for less than 48 hours. Patients are randomized to receive either paroxetine or placebo, with the primary outcome measure being time to vasopressor discontinuation. Secondary outcome measures include cumulative vasopressor dose, variation in cardiovascular sequential organ failure assessment score, cumulative vasopressor dose for 120 hours, total sequential organ failure assessment score variation, length of ICU stay, and mortality during ICU stay."
986,"GPT4 Correct Assistant: This clinical trial aims to evaluate the effectiveness of a paramedical tele-education program on moderate depressive episodes in primary care. The study will randomize patients into either an experimental group receiving the tele-education program or a control group receiving usual care. The tele-education program consists of 5 individual sessions, with each session lasting an average of 60 minutes. The primary outcome measure is medication adherence at 6 months after inclusion. Secondary outcome measures include changes in self-efficacy and barriers to treatment at 3 months post-inclusion."
987,"GPT4 Correct Assistant: This is a pilot observational study aimed at assessing the ability of continuous 'home' EEG (electroencephalogram) to accurately diagnose Narcolepsy Type 1 and demonstrate response to treatment. The study will focus on participants aged 12 to 25 years with hypersomnolence, who are under investigation for the condition. The primary outcome measures include sensitivity, specificity, positive predictive value, and negative predictive value of the Dreem headband derived EEG compared to the standard ICSD-3 protocol. The study will follow participants for two years to evaluate these parameters."
988,"GPT4 Correct Assistant: This study is a phase I/II, triple-blind, active-controlled, parallel-group, randomized study to evaluate the safety, tolerability, and efficacy of a 12.5 mg lignocaine-embedded microneedle (MN) patch compared to the standard 5% EMLA patch for topical analgesia before venepuncture procedure in adult patients requiring venous cannulation for blood investigations before eye surgery. The study will be conducted in two phases: Phase I (Non-randomized, single-group, open-label, single-center safety study) and Phase II (Randomized, active-controlled, parallel-group, multi-center efficacy study). In Phase I, 20 patients will receive the lignocaine-embedded MN patch, and in Phase II, 120 patients will be randomized to receive either the lignocaine-embedded MN patch or the standard EMLA patch. The primary outcome measures are the Visual Analogue Score (VAS) and skin algesimeter index measured 1 minute after IV cannulation."
989,"GPT4 Correct Assistant: The study aims to investigate the effectiveness of psychopharmacological intervention, cognitive behavioral couple therapy (CBCT), and their combinations in reducing symptoms of perinatal depression and anxiety in couples. The trial is a randomized clinical study with experimental groups receiving psychopharmacological intervention, CBCT, combined intervention, and control groups receiving placebo or no intervention. The primary outcome measures include changes in scores of Parental Perinatal Distress Scale (PPDS), Multidimensional Scale for Perceived Social Support (MSPSS), Dyadic Coping Inventory (DCI), Flourishing Scale (FS), and World Health Organization's Quality of Life Brief (WOLQOL-BREF). The study will also assess blood concentration levels of escitalopram, sertraline, and alprazolam and the frequency of treatment-related adverse events."
990,"GPT4 Correct Assistant: This is a Phase 1/Phase 2 open-label study to evaluate the safety, tolerability, and efficacy of a single intravenous administration of SAR444836 in adult participants with phenylketonuria (PKU). The study includes participants aged 18-65 years with a diagnosis of PKU due to PAH deficiency. The primary outcome measure is the incidence of treatment-emergent adverse events (TEAEs) from baseline to Week 96. Secondary outcome measures include the proportion of participants with sustained plasma phenylalanine (Phe) levels below certain thresholds, changes in plasma Phe levels, and changes in dietary protein intake."
991,"GPT4 Correct Assistant: This clinical trial investigates the use of pCASL (pseudo-continuous arterial spin labeling) as a substitute for FDG-PET (fluorodeoxyglucose position emission tomography) in patients with mild cognitive impairment (MCI) and subjective cognitive decline (SCD). The study aims to correlate brain hypoperfusion and brain hypometabolism at baseline, analyze differences in brain perfusion indices among patients with various amyloid and tau status, and evaluate the predictive properties of brain hypoperfusion and brain hypometabolism for conversion to dementia. The trial includes participants aged 18-80, both genders, and does not accept healthy volunteers. The study uses a diagnostic test of pCASL and brain 3 Tesla MRI with a pCASL sequence."
992,"GPT4 Correct Assistant: This is a prospective, single-arm, multicenter, observational safety surveillance study evaluating the use of Tafamidis in patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in India. The study aims to assess the safety of Tafamidis within 6 months from first dosing. Adult patients aged 18 years or older with a diagnosis of cardiomyopathy of wild type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) are eligible for participation."
993,"GPT4 Correct Assistant: This clinical trial aims to evaluate the STERN FIX device as a sternal stabilization system in patients after sternotomy. The study includes patients undergoing surgery that requires median sternotomy and those with specific risk factors. The primary outcome measure is sternal stability assessed through the sternal instability scale (SIS) at one month after surgery. Secondary outcomes include safety, prevalence of device deficiencies, reinterventions, sternal wound infections, dehiscence, sternal closure time, ease of use, surgeon satisfaction, chest pain, blood loss, upper limb functional index, quality of life, sternal halves union/malunion, sternal halves alignment, sternum integrity, and closure system integrity."
994,"GPT4 Correct Assistant: This clinical trial aims to evaluate the effect of an active break intervention on reducing low back pain (LBP) and perceived musculoskeletal discomfort during prolonged sitting among young people. The study is a randomized controlled study with pre and post-intervention assessment, involving 50 participants aged 18 to 25 years with LBP. The experimental group will receive recommendations to take an active break with lumbar and hip extension exercises every 30 minutes of sitting, while the control group will receive self-care recommendations. The primary outcomes measured are average pain intensity, disability, and perceived musculoskeletal discomfort during prolonged sitting. The study's goal is to develop an exercise protocol and intervention to reduce LBP and musculoskeletal discomfort during prolonged sitting, maintaining health and quality of life for young people."
995,"GPT4 Correct Assistant: The study aims to evaluate the safety and performance of vaginal administration of tocopherol acetate (vitamin E) in pre-peri and postmenopausal women. The intervention involves the use of Filme Gyno-V® Vaginal Ovules for 14 days. The primary outcome measure is the acidity of vaginal secretions, while secondary outcome measures include vaginal mucosa dryness, mucosal integrity, mucosa pallor, vaginal discharge assessment, Whiff test, lactobacillus grade, microbiological evaluation by culture examination, and molecular sequencing-based microbiological analysis. The study will assess the number of participants with treatment-related adverse events."
996,"GPT4 Correct Assistant: This clinical trial aims to study the Hematocrit to Hemoglobin Ratio and Red Blood Cell Distribution Width in patients with Polycythemia Vera and Secondary Erythrocytosis. Participants must be aged 18 years or older and newly diagnosed with Polycythemia Vera between September 2014 and November 2022. Patients with Secondary Erythrocytosis will be included as controls. The study will collect data on clinical manifestations, history of thrombosis, and investigations, including Hematocrit and haemoglobin levels, serum uric acid, JAK2V617F mutation status, bone marrow aspiration, and biopsy with reticulin stain. The study will be conducted from December 2022 to September 2023."
997,"GPT4 Correct Assistant: This clinical trial aims to investigate the effect of Perfusion Index (PI) measurement on emergency triage classification in patients with dyspnea using the Masimo Radical-7 device. Adult patients aged 18-96 years presenting with dyspnea and having PI values measured at the time of admission, first hour, and second hour of admission are included. Patients with known vascular diseases, trauma, or COVID-19 PCR positivity that prevents PI measurement are excluded. The study is designed as a single group assignment, open-label trial, and measures the relationship between PI and emergency triage classification in patients admitted to the emergency department with dyspnea. Primary outcome measures include the determination of triage status using PI at the time of first admission, first hour, and second hour after admission."
998,"GPT4 Correct Assistant: The LPC-Study is a randomized, double-blind, active-placebo controlled Phase II study investigating the use of Lysergic Acid Diethylamide Tartrate (LSD) in palliative care. The study aims to assess the effects of LSD on state anxiety, pain levels, quality of life, demoralization, spiritual well-being, and other psychological aspects in patients with end-stage fatal diseases. Participants will be randomly assigned to receive either 100 or 200 μg LSD per os in the treatment arm or 25 μg LSD per os in the control arm. The primary outcome measure is the change in state anxiety assessed by the State Anxiety Inventory (STAI-S) compared with active placebo. Secondary outcome measures include changes in pain levels, opioid use, spiritual well-being, demoralization, quality of life, and other psychological aspects. The study will also assess the associations between acute LSD effects and long-lasting therapeutic effects, as well as the expectancy as a mediator for treatment effects. Safety measures include the assessment of adverse events, physical and general discomfort during drug sessions, and changes in vital signs during drug sessions."
999,"GPT4 Correct Assistant: This clinical trial, titled ""Teaching by Texting to Promote Health Behaviours in Pregnancy,"" aims to evaluate the effectiveness of a mobile health program called SmartMom in promoting healthy behaviors during pregnancy. The study is a randomized controlled trial with parallel assignment and open-label design. Pregnant individuals at 15 weeks gestation or earlier, who can read and understand English, and live in Canada (excluding British Columbia) are eligible for participation. The intervention group receives three text messages per week with evidence-based information to promote healthy behaviors during pregnancy, while the control group receives one text message per week with general information about pregnancy. The primary outcomes measured are change in weight during pregnancy and attendance at prenatal care visits. Secondary outcomes include changes in health knowledge, health literacy, fear of childbirth, depression, anxiety, use of tobacco, vaping, alcohol, or cannabis, rates of planned vaginal birth after cesarean, exclusive breastfeeding, and rates of adverse pregnancy outcomes."
